MIME-Version: 1.0 Content-Disposition: inline; filename="document.html" Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable Content-Location: document.html </title= ><style type=3D"text/css">@page Section_1 { size:595.3pt 841.9pt; margin:12= 7.6pt 85.05pt 72pt }div.Section_1 { page:Section_1 }body { line-height:107%= ; font-family:Calibri; font-size:11pt }h1, h2, h3, h4, h5, h6, p { margin:0= pt 0pt 8pt }li, table { margin-top:0pt; margin-bottom:8pt }h1 { margin-top:= 24pt; margin-bottom:6pt; page-break-inside:avoid; page-break-after:avoid; l= ine-height:107%; font-family:Calibri; font-size:24pt; font-weight:bold; col= or:#000000 }h2 { margin-top:2pt; margin-bottom:0pt; page-break-inside:avoid= ; page-break-after:avoid; line-height:107%; font-family:Calibri; font-size:= 13pt; font-weight:normal; color:#2e75b5 }h3 { margin-top:14pt; margin-botto= m:4pt; page-break-inside:avoid; page-break-after:avoid; line-height:107%; f= ont-family:Calibri; font-size:14pt; font-weight:bold; color:#000000 }h4 { m= argin-top:12pt; margin-bottom:2pt; page-break-inside:avoid; page-break-afte= r:avoid; line-height:107%; font-family:Calibri; font-size:12pt; font-weight= :bold; font-style:normal; color:#000000 }h5 { margin-top:11pt; margin-botto= m:2pt; page-break-inside:avoid; page-break-after:avoid; line-height:107%; f= ont-family:Calibri; font-size:11pt; font-weight:bold; color:#000000 }h6 { m= argin-top:10pt; margin-bottom:2pt; page-break-inside:avoid; page-break-afte= r:avoid; line-height:107%; font-family:Calibri; font-size:10pt; font-weight= :bold; color:#000000 }.BalloonText { margin-bottom:0pt; line-height:normal;= font-family:'Segoe UI'; font-size:9pt }.CommentSubject { margin-bottom:8pt= ; line-height:normal; font-size:10pt; font-weight:bold }.CommentText { marg= in-bottom:8pt; line-height:normal; font-size:10pt }.Footer { margin-bottom:= 0pt; line-height:normal; font-size:11pt }.Header { margin-bottom:0pt; line-= height:normal; font-size:11pt }.ListParagraph { margin-left:36pt; margin-bo= ttom:8pt; line-height:107%; font-size:11pt }.Subtitle { margin-top:18pt; ma= rgin-bottom:4pt; page-break-inside:avoid; page-break-after:avoid; line-heig= ht:107%; font-family:Georgia; font-size:24pt; font-style:italic; color:#666= 666 }.Title { margin-bottom:0pt; text-align:center; line-height:normal; fon= t-family:Verdana; font-size:14pt }span.AsuntodelcomentarioCar { font-size:1= 0pt; font-weight:bold }span.CommentReference { font-size:8pt }span.Followed= Hyperlink { text-decoration:underline; color:#800080 }span.Hyperlink { text= -decoration:underline; color:#0000ff }span.Mencinsinresolver1 { color:#605e= 5c; background-color:#e1dfdd }span.TextocomentarioCar { font-size:10pt }spa= n.TextodegloboCar { font-family:'Segoe UI'; font-size:9pt }span.UnresolvedM= ention { color:#605e5c; background-color:#e1dfdd }</style></head><body><div= class=3D"Section_1"><div style=3D"clear:both"><p style=3D"margin-left:35.4= 5pt; margin-bottom:0pt; line-height:normal; widows:0; orphans:0"><span styl= e=3D"height:0pt; display:block; position:absolute; z-index:-65537"><img src= =3D"data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAUDBAQEAwUEBAQF= BQUGBwwIBwcHBw8LCwkMEQ8SEhEPERETFhwXExQaFRERGCEYGh0dHx8fExciJCIeJBweHx7/2wB= DAQUFBQcGBw4ICA4eFBEUHh4eHh4eHh4eHh4eHh4eHh4eHh4eHh4eHh4eHh4eHh4eHh4eHh4eHh= 4eHh4eHh4eHh7/wAARCARjAxoDASIAAhEBAxEB/8QAHAABAQACAwEBAAAAAAAAAAAAAAECBwMGC= AUE/8QATxABAAEDAgIDCwkECQMDAgcAAAECAwQFEQYSByExExQXQVFSU1aRkpQIFSJVYXGT0eIy= N4GzIzM2QnR1obLSFnKCGDixQ2M0RGJzg8Hx/8QAGwEBAQEBAQEBAQAAAAAAAAAAAAECAwQFBgf= /xAAzEQEBAAIBAgQEBAQHAQEAAAAAAQIRAwQSBSExURNBYXGBkbHRFDI04QYiMzWhwfBSU//aAA= wDAQACEQMRAD8A6l3xf9Nc96Tvi/6a570uIf0nUfi91y98X/TXPek74v8AprnvS4g0u65JyL/pr= nvSnfF/01z3pYSho3XJ3xf9Nc96Tvi/6a570uMNLLXJ3xf9Nc96Sci/6e570uNJNRd1yd8ZHp7n= vSd8ZHp7nvS4hrUZ3XL3xkenue9J3xf9Nc96XEJZFlrknIv+nue9Kd8ZHp7nvS45DUN1yd8ZHp7= nvSd8ZHp7nvS4xdRN1yTkZHp7nvSnfGR6e570uOUNRd1y98ZHp7nvSd8ZHp7nvS4g1CWuXvjI9P= c96UnIyNv6+570uMnsNRd1yd8X/TXPele+L/prnvS4oDUZ3XJORf8ATXPelO+Mj09z3pccoajUt= ck5GRv/AF9z3pWMjI9Pc96XDPasGom65e+Mj09z3pO+Mj09z3pcQaibrknIyN/6+570nfGR6e57= 0uKQki7rk74v+nue9J3xf9Nc96XGLqG65O+L/prnvSTkX/T3PelxpJqG65O+Mj09z3pO+Mj09z3= pcQahus++Mj0933pO+Mj0933pcYai7rk74yPT3Pek74yPT3PelxiWQlrk74yPT3Pek74yPT3Pel= xhJFlrknIyPT3PelO+cj09335ccouoltcvfOR6e778nfOR6e778uINQ3XL3xkenu+9L9mBN6J7v= Vcr5p6qZ5p7H4se3N27FPi8b6cRERERG0QzlpnLLy05e+L/AKa570pORf8ATXPelgks6jnLXJ3x= f9Nc96Tvi/6a570uIXUXdcvfF/01z3pO+L/prnvS4g1DdcvfF/01z3pSci/v/X3PelxpPaahuuT= vi/6a570nfF/01z3pcYahuuTvi/6a570nfF/01z3pcYmou65O+L/prnvSd8X/AE1z3pcYskTd25= O+L/prnvSd8X/TXPelxhqG6znIv+mue9J3xf8ATXPelxz2oajW65e+L/prnvSd8X/TXPelxBqJL= XJORfiP66570sO73/TXPelhVO8olkalrknIv7f11z3pTu9/01z3pYT2MU1Ddcvd7/prnvSxrv35= /wDrXPelhM7QxiWctejeO2fdr3pbnvSk3r3pbnvSjGpz033Vl3a96Wv3pO7Xp/8Aq1+9LBaYXR3= OSL16I/rrnvSd3vemue9LDZFsiS1nN+96a570p3e96a570sJDUTdZ93vemue9J3e96a570sA0u6= zm/e9Nc96U7ve9Nc96WEoaXdcndr3pbnvSk373pbnvSwDUTdZTfvRH9dc96XHN696Wv3pY1T1pP= Y55SV0xrLu170tfvSndb3pa/eliM6i7q92u+lr96V7te9LX70sJTZNQlrki7emdou1+9Lli5c2/= rK/elw242jdnu644TTGWd2/QA9LzAA0SiygAAQSVSSLUAVAcuPj3siqumxaquTRRVcq5Y7KaY3m= Z+yIdg4Q4F4o4sxb+ToOmxl2rFcUXKu7UUbTMb7fSmHPk5cOObzuo3hhlldYx1mRsKehjpH9X4+= Ls/wDNPAx0j+r8fF2f+bj/AB3Tf/pPzjp/Dc3/AM38mvh3jO6JOkPDtzcu8NZFdMehu27s+ymqZ= dS1TTNS0rI731PAycK728l+1NE+yXXj6ji5P5Mpfxc8uLPD+aWPxyiyjqwABAnsCewUgIBElFlB= Yk9qwk9qwqUAQSQkWAAoJKpIIACACgCUgARYkosopQH6MK1z3Oaf2aUS3T9OJa7na3n9qrrlzg5= uNuxJVJFiANKAAJPaqT2gAAAM0AFiACqk9qLPagoSIiRJNlEaYz2MWc9jCrqKqT1sWSS5NRCewJ= GkZsaY8bJYmxJhRVYzCMpSYEQAESWSSi7RjXO0MnHM7ymSxjIps56bSQntEXYRG8jktxtG/jlZN= 0tPEjKY6mOzs5WP0gOriADRKLKAABBJVJItRYjedoRtz5OXAP8A1Brn/UOpWebS9PrjudNXZevR= 1xH2xT2z9u0eVx6nqMOn47yZfJ04eLLmzmGLsfDvAUcL9B/EOsajZ5dW1DT6pmKu2za6pij7Jnt= n+EeJ9P5I/wDZnWv8ZR/sbB6Y/wB1/EP+Cra++SP/AGZ1r/GUf7H5bLnz5+i5eTP1uUfbnFjxdR= x4Y/KVu2uqmiia66oppiN5mZ2iIfn+cMCZ/wDxuN+LT+b4fSr+7XiP/Lb/APsl4jcvDvDJ1mFy7= ta+jp1fW3p8pNb29/Wrtq7G9u5RXH/6aol+LX9E0rXtPrwNXwLGZj1x10XKd9vtie2J+2Ot4f0L= XdY0PNozNJ1LJw71E7xNu5MRP2THZMfZL2F0R8Wf9ZcE4urXYopy6ZmzlU0RtEXKe3b74mJ/inX= eGcnRScky3Pf0Om63Dqd42arzZ019HlzgbW6KsWqu9pGZvONcq/aomO23V9seKfHH3S169jdPuj= W9Y6L9V3txXdw6Iy7U+OmaOuqY/wDHmj+Lx1TtzRv2bv0XhPV5dTwbz9Z5Pk9f084eXWPpW3eCO= jfRNW4Cs3dRryLXEOrW8m9pNPPtRVTainaJjx7zvP3OqcK9Hmfr3D863OtaLpeL33OHHf8Afqtz= N2Iido2pmPH5fFLaVHEHSvbzNKuaHwXfxdEw7Fq3RiVU2rlVy3TEb/0kxExzR1dXY+NxLpnGmp6= BmaRidHefhWsjW51WP6emqKJmmImiI2jx7zv9u2zx4dVzzK7zk3d+suvp+j0Xg47JrG+X0vm6RZ= 6ONTp4g1LQ9R1bR9Ly8CaObvq/VFN2Ko3iqiaaZ3jbaevbth2Dh7oiuTqev6bxHqmJh39P0/vnH= qov7UXIn9m7MzTM9yjaYmeqd339a6StZ0LWtZyta4J1PTKdWmzy1U5NVi7RNuiKdoucn0onbfaP= LL41/pTnWeMMvVI4UycvHytF+a7+JRlTVXNHPNU188UdXbt2fxbvN13JjuTy1POa9fL+7Pw+mwv= n67+rrul9GufmYdede1/QcLAqyqsTFysjJqi3l1xO0zb2pmZp6u2dnNh9FOu13NYp1DUtH0qnSL= 1FnJuZl+qmjeuImiYmKZjad42327Yfpt8Z6LY0bH4d1/g3LuYWBl15Wn2+/arVy1TXVvyVzNP0o= +3qYcQ9KF7WtM4mxMjSqaK9bv49ymqm91Y9NmadqdtvpbxT27x2u/f1uVup5fh7z6+29uXb00nn= /wBuPirom17QMDOyrmp6Nm1YEUVZdjFyKqrtqmv9mqaaqY6n6uI+jnHtcRRoGNqOl6XkYeFZuZF= 3Ny65jJrriZmaIijqiNuzbq37ZNd6U6dTzeJsn5km18+YlnHinvnfuPc/H+z9LfydT7GB0wXsji= DV8vH4Xyrk6jj2LcxiZc037XcomN4riieqd/I53LrpN2ec+30/TzdJOl3qX/3n/ZrbjfhbUuEtY= p03Uq8e7Vcs037N3Hrmq3dt1b7VRMxE+Ke2PE+HDufS/wAU3+LNfw83I0jK0yrHwaMaLeRcmuuu= Kaqp55maae3m8nifPscC8XXtE+erWhZVWnTZm/GRERy9ziN5q7ezZ9Hh5rOHG81ktePk498lnHN= x1wB6XBJCX0eH9D1biDOnB0bBu5uTFE1zbt7b8sbbz1/fCXKYzeV1FkuV1Hzh9PiLQNY4dzaMPW= 9PvYORXbi5TbubbzTMzG/V9sT7HzFxymU3jdwsuN1RJVJaRAAQAUASkACLElFlFKtMTVVFMdcy+= pZtxbtxRHi7X5tPtdU3ao+yl+xjKueV+QAywJKpIsQBpQABJ7VSe0AAABmgAsQAVUntRZ7UFSQE= oAIJPYwllXLHdmtyILsjLSTCbMjxGi+QAqbABUlFlADYBUSYZJPUg46p8TGVmd5SWL5tTyQBFSe= 0J7RNC0RvLlY0xtH2r97pjNJtZ7GLKexi0lfoAdXAAGiUWUAACCSpTRVcrpoopmqqqdoiI65kV9= vgThnO4t4mxdFwaZiq7Vvdubbxatx+1VP3R/rtD2nw3o+Dw/oeJo+nW+542LbiiiPHPlmftmd5n= 73SegjgOng/hmMnNtR88Z9MV5E+O3T202/4ds/bP2Q2M/F+Ldd/E8nbj/LP+fq/R9B0vwcO7L1r= VXykuLcbRODLmh0ctzO1ambcU7/sWo25qpj/AEj+PkfG+SP/AGa1r/F0f7HW+mXo441z8zWOM9W= z9JqxrFE102bd65NVFmn9mmImiI32+3tmXZPkj/2a1r/GUf7Hpyw4sPDLMLu7m/u4zLPLrZcpqa= umyelX92vEf+W3/wDZLxG9udKv7teI/wDLb/8Asl4jez/D3+ln93n8W/nx+w9LfJIqqnhDV6J/Z= jOiY++aI3/+IeaYetvk4cPZOg9Hdu5mUVW8jUb1WVNFVO000TEU0xP8Kd//ACd/Hc5Ol7b62xy8= Lxt5t+0dy45ppr4L1uiv9mrT78T93c6nhaP2v4va3TDqNOl9Gev5NU7TVh12af8AuuRyR/rU8Ux= 2w83+H8b8PO/V28Wv+fGPc86jTpHAvzrXam7Th6b3eaInaaoot822/wDBqWz8o7TJu0xe4ZzKKN= /pTTk0zMR920Nk8Tfuj1H/ACO5/Jl4oeXwnoeHqpneSb1Xfrup5OG4zC/J7jmnh/j/AIMprqooz= dM1GzvTzR10z2fwqpnf7ph566Jbes8FdKeuabg6He13JxbNyxVbs3abc8kXKZi59LxTG3V9ravy= YZuT0V2OffljKvcn3b/nu+TwPyf+pri7k7O8o9u1nf8A1ceHL4Hx+H1xk/Sumc+L8Lk9Lf2ai6e= 9R1HVOPO+tT0W9o9/vS3T3vduU1ztE1bVb09XW+LoXAPGWuYdOZpnD2bex6+ui7NHJTVHliatt4= +5ubjXQMXiP5TGnYGdai7i0YNF+7RPZVFEVzET9kzs7Z01dJNXR/j4GJp2n2cnNyoqqopubxbt0= U7RvtHXPXPVH2S+jh4hyYYcXDwYS5Wb+kePLpMMss+Tly8pXn6eibpD9Wcn8Sj/AJPsdDdHEPB/= SZlYn/TWRqGp2cSqi7hUXqKKqIq5KubeersmPa3F0GdJGrceZGqW9TwsLHjDot1Ud7xVG/NNW+/= NM+R8Xhb/AN1XEX+Cj+XZY5Ou58py8PPjPKb+f0+reHS8WPZycdvnWvemi1xLxp0k4GJHC+Tp+p= V6dTTaw671FdVdNNdyrniY2jbt6vsbz0XRdTsdB9OhXcSunUo0avH7hMxv3SaJiKd+ztav6f8Ai= XP4S6adJ13TbWPcybGkUxTTfpmqieau9TO8RMT2T5W3NK4n1DK6JaeLLlrGjOnS68vkppnuXPFE= zEbb77bx5Xj6vLkvTcOpJj8vu79PMJzcm75/9PJfEnBPFHDlvHua1pF3DoyLnc7U11UzzVeTqmX= 1Y6JukKYiY4Zydp/+5R/ycnHvSfxDxtZwcfU8TTbcYl/u1rva1XTNVXZtO9c7w3FpXEvTvnYFrK= s8IaHbtV0xNEXoqt1TH20ze3j+MPsc/VdXw8eNy7Zbve7+WvN8/i4eDkysm7Ps0dq3Rrx1pmHcz= MzhrNpsW45q6qIivliO2ZimZnb7Xbvkp/vMu/5fd/3UN/dHmdxxm2cujjbRMDAuUzT3CvEuxVTc= id94mOaqYmOrr3692tOAtOxdK+U/xFh4dqm1YjFruU0UxtFM1xarmIjxRvVLxZeI59Rw8vFySbk= 3uej0zpMeLk488bdW/N1T5W37wtP/AMro/m3WnG4/lbfvC0//ACuj+bdacfX8L/pMPs8HW/6+Qk= qkvoPKgAIAKAJSABFiSysW5u3Ioj+LGX0MG13O3zT+1V/oW6ZyunPERTTFMdkCz2I5uQAAkqkix= AGlAAEntVJ7QAAAGaACxABVSe1FntSUqoARIJPVCsap8SVqMTYGW0URFXYkgVKgAAAJKLKC7AEa= GFyevZnM7Q4p7WaIAysQ2UFYrRT17k9rOI2jZZEtUBtmJKMp7GIP0AOriADRKLKAABBur5NfAHz= pqUcW6rY3wsSvbDorp6rt2P7/ANsU/wDz9zS9mbcXqJu01VW4qjmimdpmPHtLeWk9P2DpGl42ma= dwVFnFxrcW7VEah2RH/wDH2/a+b4l/EZcXw+DHdvr9nt6P4WOfdyX0ehsq/ZxcW7k5Fym3ZtUTX= crqnaKaYjeZlonL+UbYoyrtGPwrXds01zFu5Vncs1U79UzHJO2/k3l1fpE6b8vinhbI0PF0T5tj= JmIu3u+u6TNETvNMRyx29X8N/K1C+d4f4NO23qcfP5Tf7PX1fiN3Jw1urjLp2jiHhfUdE/6YnG7= 8sVWu69/c3Jv49uSN/a7R8kb+zOtf4yj/AGPNrZfRB0o2+AdMzsKvRqs/vq9Tc5oyO58u0bbfsz= u9fWeHY4dLlx9Pj62fP93Dp+ruXPM+W+j1Trmm42s6NmaVmc/e+XZqs3eSdquWqNp2ny9bWvgD4= E8uq/Ex/wAXWZ+UfY9U7nx0f8D/ANR9j1TufHR/wfF4uj8R4Zrjln4z930uTqOk5LvOytgcOdEX= Amh5VOVY0jvq/RO9NeXcm7yz/wBs/R/0d86ojyRDz5k/KPuTTMY3CdNM+KbmbvHsih0bjTpk4x4= ksXMSnIt6Xh1xy1WsOJpmqPtrn6Xs2hqeFdd1GW+X87ds3rum4sf8n/Edr+U1x9i6rdt8J6RkRd= sY1zumbdoq3pquR1Rbjy7ds/bt5Gjo7YWeveZYv1HS9Nj03FOPF8Tn5subPvye5runTq/AVWlRd= 7jOZpncIucu/Jz2+Xfbx7btM4/yb6ovUTf4sibW/wBKKMHaqY+zevqa4sdLfSDYsUWbXEFym3bp= immO4W+qIjaP7rPwwdInrFc/At/8XxOHw3run3OLOTf/AL2fT5Os6Xl13426/wDe71RiWdB4C4M= osxcpxNL06zMzVcq658czPlqqmf4zLSnyfNZr4h6Z+ItauU8k5mLduRTvvy090o5Y/hG0NQ8TcW= 8ScS1UzrmsZWbTR10266tqKZ8sUx1b/bs4+FuJda4XzrmdoebViZFy3NqquKKat6ZmJ264nxxDt= xeEZ4cPJLlvPJzz6/HLkxsmscW9+MtexOHvlM6bm512LOLcwaLF25V2UxXFcRM/Zvs7R03dGt7j= 6zgZemZ1jHzcSKqY7tv3O5RVtPbETMTEx5PG8w63rOs8W65aytWzO+s27FFmm5VTFPVv1R1R9rd= mgcC9N2h4VOFpvE+Fbx6Oqi3XkzcimPJHNRO0fZDh1HS3pvhZzkmOcmvP0rpxc/xu/Hstxtdr6C= ejjWuA8jVLmq5eBfjMot00d7V1TtyzVvvzUx5XxuFv/dVxF/go/l2Xd+jDTePNPozrnHGtYudNf= LGPRZiNqIjfmmZimnt6vL2POvH/ABrnYHTBruv8L6hFmquvuFN+immuKqaaaaZ23iYmJmjtebp8= OXq+flm5bcfWenyd+XLDg48PKyS+nzfb+Vr+8fB/yq3/ADbrcnR1ixrnQTgadj3qKZytJrxornr= imqaaqJ3+6XlHiviTWuKNRo1DXM2rLybdqLNNc0U07URMzEdUR46p9r9vCvHPFfDGLXi6JrN/Fx= 66uabW0VUb+WIqidv4Pqc3hnJn0nHxSzux/J4ePrMMefPOzyyd403o31HgTjvhnM4ru6dcwL+pU= 26ZtXZqjmjrpmrmpjaN9noDpEscb38DGjgjM07Gvxcmb85dO/NTt1cvVMf6PI/FfG/FHFOPYx9d= 1SvLt2K+e3E26aeWrbbf6MQ+lp3Spx/gYdvEx+JMmbVunlo7pTTcmI8m9UTMufUeHdTz3DkyuNy= n5NcPV8PF3Y4y6v5vTvRvj9IVi7mTxxnabk0TTR3tGLG0xPXzb/Rj7HRuGv8A3WcRf4Cn+XZain= ph6RfWK5+Bb/4vjY3HPFOPxRkcTWdUqp1bIo7ndyO50b1U7RG2223ZTHi8Tnx+E88vJb2zumvL0= +X0dM+u4rMZN+V35u//ACtv3haf/ldH82604+vxVxLrXFOfbz9dzaszIt2otUVzRTTtREzO3VEe= OZfIfa6Lhy4ODHjy9Y+b1HJOXluc+YkqkvU4oACACgCUgBETMxEdcyRY5sS13S7vMfRp65fScdi= 3Fq3FPj8bkYt25ZXdSexFnsRGQABJVJFiANKAAJPaqT2gAAAM0AFiAJKqT2pISKgCJEmdoYLVO8= ozWoCoi7CO0BQAEFmEGgATSSiygAJM7QKxrliySXNpjsKbCoGxEbzsC0x17sl26tk2dJNM0AQiS= iyiwr9ADo4gA0SiygAAQSVSSKgCoAFIkhIFAASUWUAACBPYE9grOxdrs3aL1qrlroqiqmfJMdju= nhZ6RPWfJ/Ct/wDF0iBz5OHj5P58Zfu1hyZ4fy3TtWsdI/HGq4dWJncSZtdiuJiuiiYtxVE9sTy= xG8OprKLx8WHHNYST7GWeWfnldpPasJPasOjAAgkhIsABQSVSQQAEAFAEpB+vAtbz3WqOzsfmtU= TcuRRHjfUopiimKaeyGbWcrpkAy5pPYiz2IAAAkqkixAGlAAEntVJ7QAAAGaACxBJUVWJKz2pII= lU7QrCe1KsQBGl8SL4kEURlArEXYRUAAmEVJhGoJsoIxYzO8s6p6mGyWrEAZa2mwu6ShEZUx40p= jeWe2zWMLUVjPau7TOyUWexAJTZQRzC7G0t7jGqgobi6qSiyhuLqgBuGqJKpJLF1UAXujOqAFsW= SpISHdDVADuiaqSjKWJ3RdUAO6ElCewJ7Dui6pAQHdGdVJRlKHdFkrGe1YSe1YXuhqgondE1WMh= PaLLF1QBe6JqiSqSd0NVADuhqoAd0a1QIiZ7ImXNi2Krl3aaZ5Y656kuUTVfpwbXJRz1R9Kr/4f= pXlq82fYctXmz7HPujld1BeWrzZ9hy1ebPsO6GqxnsRlNNW37M+xOWrzZ9h3Q1UF5avNn2HLV5s= +w7oaqJLLlq82fYk01ebPsO6ElYjLlq82fYctXmz7Gu6LqsRly1ebPsOWrzZ9id0NVik9rPlq82= fYxmmrf8AZn2HdDVQXlq82fYctXmz7Dui6qC8tXmz7Dlq82fYm4mqgvLV5s+w5avNn2L3Q1UF5a= vNn2HLV5s+w7oarGe1GU01b/sz7E5avNn2L3RrVYyxZ8tXmz7Dlq82fYz3Q1XHMI5OSrzZ9ictX= mz7DcXzY+JGXLVH92fYctXmz7DuhqsWUdhy1ebPsOWrzZ9h3Q1RJZbVebPsJpq82fYbhqsBly1e= bPsOWrzZ9h3RfNiLy1ebPsTlq82fYlsWbJRZpq82fYlVNXmz7DcXVYTO8i8tXmz7Dlq82fYxuNa= rFJZ8tXmz7EmirzZ9ibhqsU2ZctXmz7Fpoqmf2Z9huGimNoWexeWrzZ9hNNXmz7G9w82GyM+Wrz= Z9hy1ebPsO6M2VhC7MuWrzZ9hy1ebPsO6GqwGU01ebPsTlq82fYu4WV3LaPIbR5Afzzuvu/X6ht= HkNo8gHdfc1DaPIbR5AO6+5qG0eQ2gDuvuagbQB3X3NQ2jyG0eQDuvuahtHkAO6+5qG0eQ2jyAd= 19zUNo8htHkA7r7mobR5DaPIB3X3NQ2jyG0eQDuvuahtHkNo8gHdfc1DaPIbR5AO6+5qG0eQ2jy= Ad19zUNo8htHkA7r7mobR5DaPIB3X3NQ2g2jyAd19zUNo8htHkA7r7mobR5DaPIB3X3NQ2jyG0e= QDuvuahtHkZWrdV25Tbt0TXXXMU000xvMzPZDFtLoC4T+c9Yq4hzLe+Lg1bWYn+/e8v/jHX98wd= 19zUbS6L+FLXC/C9nGu26Ks2/8A0uVXy9fNPZT91MdXtnxu1dzt+ZT7GQzu01GPc7fmU+w7nb8y= n2MhDUY9zt+ZT7DudvzKfYyA1GPc7fmU+w7nb8yn2MgNRj3O35lPsO52/Mp9jIDUY9zt+ZT7Dud= HmU+xkBqMe52/Mp9h3O35lPsZAajHudvzKfYdzt+ZT7GQGox7nb8yn2Hc7fmU+xkBqMe52/Mp9h= 3O35lPsZAajHudvzKfYdzt+ZT7GQGox7nR5lPsO52/Mp9jIDUY9zt+ZT7DudvzKfYyA1GPJR5lP= sYXKaOyKKfY5ZnaN3DPaGowm3R5lPsOSjzKfYzF3TUcfJR5lPsOSjzKfYz2Q3TUYdzo8yn2HJR5= lPsZmxumow5KPMp9idzo82n2MxN01GHJT5tPsTko82n2ORNjdNRx8lPm0+w5KPNp9jM2XdNRx9z= p82n2JyUebT7HIhumo4q6aKaZqmmnq+x+KqKaqpmaY6/sfqyat55I8Xa4Jg3VkjjmijzY9jGaKY= /ux7HJMB3VdRxclPmx7E5KfNj2OWYYzGy919zUcfc6ZnaKY9j99mzRbtxTy07+PqcWJb3q55jqj= sfrTuqajDko82n2JyU+bT7GewbpqOPko82n2HJR5tPsZ7IbpqMOSnzafYclHm0+xmkwbpqMeSjz= afYnc6PNp9jNDdXUeRAFQAAAAAAH1OGtOs6rl38OubkX5xrleNFEx9K5THNFM9XXExEx98w+1HC= Vq/puj14mTcqzci9at5turblsxe3m1MeP9mmZnfywg6iO10cO6dqHcJ0fIv101apXh3ZuVRPLan= rt3OqI7aYrmf8At8THUuH9Pxa9UzLdzKr0y1jWr2FcqmmKrlV2YiiKp226trm+3mSDqw7ti8H4F= 7Vs6xXmXreNXZtTptczG927ep5rVNU7dnVVE7bdcOvaxplrT9K0u9VXX33mW671dEz1UUc3LR1e= WeWqfu2B8pyV2L1Fm3frs3KbV3fudc0zFNe3btPj2djyNL4e0m1hWNYualczMmxRfuVY00RRYpr= jenqqjeudtpmN6fvTA4ep1KjQLGNkXIr1HIvWpquTHLRTTNP0ojxdUzM9YOsjvOtcH4WPpObk2J= vY1zFo56Kr2oYt6MiN4iYii3VzUzt1xH0uztcFjQuGqMzR9OycjUqsrU7FmvntTRFGPVcjaN4mN= 6+vr6pjaPHIOmuS3YvXLNy9RZuVWrW3dK4pmYo3naN58W8uw2dF07T9Mv6jrdeVdpjMrxLFnFqp= pmuqjbnqqqqiYpiN426pmfscHeOm3tN1nL0+9mTZxqbE2qbvLTMzVVtVFUR1Tt17T1eXYHwR3vT= uC8fM0vn711LHvTiVX6b+Res0UzVFE1bRZmeeaZ22iqJ+3Z8m5pugaXgafOrVajfy82xGRMY1VF= FFiiqZin9qJ552jfb6P3g+PlaXqGNkVY93Fud0os036opjm5bdVMVRVO2+0bTE/Zu/E73xTg42X= xRqFNGRem1j6JZu2q6foTXy49vbmjr6p8cPk3NN0DTMDT51evUb2Xm2IyJjGmimmxbqmYp/aiee= do32+j94OvWrF+7bu3bVm5XRaiKrlVNMzFETO0TM+LrnZxu4anw7p2De1mjHysq9YxMHGybVW8U= Tc7pNuZ5o27PpztHi6u1ycVY+jZN/h/FwdP1C1dv4did6LlN2qaJmqNooiinmr+3eN/IDpb9Go4= eRp+XVi5VEUXaaaapiJieqqmKo7PsmHauJOFLGDoF3U7OPmYldi/Rbqt5OVZuzXTVv17W+uiYmI= 6pjx9vU+Xx9/ae9/wDsY/8AJoB8Edov6Zw9pNGFj6zVqV7LybFF+5OLVRTRYprjemNqoma52mJm= N6Y8W7l/6a0zByNdjVMvJuWdM7lVanHiIm/TXP0e3fl3iYnx7dfaDqQ7NewOHcDCxcjUKdTruZ1= NV61Zs3KI7hZ56qaZqqmn6dX0Z6oin+D5/FWnYemalbsYGRdyMe5j2r1Fy5Ty1Tz0RV2eLt7OsH= yQFAAAAAAH7tA0vK1rWMbS8Kjnv5FcUU+SI8cz9kR1vWPDWkYug6Hi6Thx/Q49EUxM9tU+Oqftm= d5a4+T9wn3lptfEuba2yMqJoxoqp66LXjq/8p/0j7W2EoAIAAAAAAAAAAAAAAAAAAAAAAAJM9QM= a53nZiswgJMCkwCBsAkwjJNgQ2XZAQU2BE2UBiwuTFNMy5H571XNVtHZAOGevrYzDPZBphMMZhy= TCbA4yImqYiO2Wcw5ce3t9Of4COWimKaYpjxKAgbAKiMiYBjsjJAQ2XZAeQgGkAAAAAAfq0rOv6= bqeNqGNMd2x7lNyjfsmYnfafsfYs8Xaja1XU9Qos40V6ham3Vb5Z5LUdlM0Rv1TTEbR5HXQH1tD= 17M0fE1DGxqLVVObZ7lXNcTM0dUxzU+SraqqN/tllmcQ52Vw1iaBci13tjXJrprin6dX7UxTM+O= Imqrb/ul8cB9m/xHn3dK0zT9rVFOnVzXbu0xPPVO+9PNO/Xy7zt5N3JqHEuRnann51/AwaqszG7= 3i3NuZosR1bTbiZ+jMbdv2y+EA7Bj8T1RiY1nO0jTdRu4tHJYv5NNfPRTHZTPLVEVRHiiqJfkt6= 9nWqNO7h3Ozc0+9Xes10U9fNVMT1x2bdUdWz5Qg+3qev28vFvWbGh6VhV5ExN67Yt1TVVtO+0c1= UxR1+bEOCrW8mdU07UO5Wu6YFFmi3TtO1UW9tt+vx7db5YD7uJxJeooy7GZp+Hn4mTfnInHvxXy= 27k9tVE01RVT5O3r2hwZOuXbtrPs28PExrWbFumbdmiaabcUTvHL1+2Z3mXyQHaqeNMiMic35n0= yc+qz3G5lTTXNddPJydnNyxO3jiIfkxeJaqcHGxc/SNO1LvSnlxrmRTXFVuneZ5foVRzRvM9VW/= a+AA+9qHFGbm6rmajdx8am7l4kYldNFM0000xRTTvEb9U7Ux9j72j2tX1DQ8DbSNF121jW5i1cu= 3uW5ixzTPJc2rp6u2Y5t42nt8ToZvIO3cacQxd13V6MOce/Zy8axi3LtFO1MzbijeaNurbmo6vs= fhtcU5Nr5qu0YOH33pkRRaydq+au3G/0Ko5uWY+lPXtv9rr4D72dxJ3fScjTMXR9OwMfIrouXO4= RXNU1UzvE81dUzt19nY4c3Xr2XGf3bCw6q8y3Zom5NuZqtRbiIiaJmeqZimN/K+OA7BjcT1Ri41= rP0fTdSuYlMUWL2TTXz00x2Uzy1RFUR4oqiX5MnXs/Kp1PvqaLtzUq6K71cxtMTTVvG23VEeL7n= yhR3fh+1qufoGJbt6No+uWcfm7n3a9y3cWOaZ5atq6Z5d96o33jr++HyOkDMt5vEdVVu7j3e5WL= NmqvHiItTVTbpirk26uWJ3iNvFDr+4gAKAAAADs3Rrwxc4q4osYExMYtv+lyq46trcdsffPZ/F1= qmJqqimmJmZnaIjxvTnRFwrHDHC9EZFG2oZe13J37aerqo/hH+syg7hYtW7FiixZopot26Ypopi= NoiI6ohmCAAAAAAAAAAAAAAAAAAAAAAAAAnasoCJMMgRhsjNJgVibLsgIKbAibKAxGSbAibKA47= tXLT1dsvzOa5VzVbsJjcWMNkmGUxsgrHZGeyTAMaaZqqiH6YjaNoY2ado3ntlybCVE2XYEYjJJg= EAATZQVEZGwPJfzXqX1fl/g1fkfNepfV+X+DV+T2ILtHjv5r1L6vy/wavyPmvUvq/L/Bq/J7EDY= 8d/NepfV+X+DV+R816l9X5f4NX5PYgbHjv5r1L6vy/wAGr8j5r1L6vy/wavyexA2PHfzXqX1fl/= g1fkfNepfV+X+DV+T2IGx47+a9S+r8v8Gr8j5r1L6vy/wavyexA2PHfzXqX1fl/g1fkfNepfV+X= +DV+T2IGx47+a9S+r8v8Gr8j5r1L6vy/wAGr8nsQNjx3816l9X5f4NX5HzXqX1fl/g1fk9iBseO= /mvUvq/L/Bq/I+a9S+r8v8Gr8nsQNjx3816l9X5f4NX5HzXqX1fl/g1fk9iBseO/mvUvq/L/AAa= vyPmvUvq/L/Bq/J7EDY8d/NepfV+X+DV+R816l9X5f4NX5PYgbHjv5r1L6vy/wavyPmvUvq/L/B= q/J7EDY8d/NepfV+X+DV+R816l9X5f4NX5PYgbHjv5r1L6vy/wavyPmvUvq/L/AAavyexA2PHfz= XqX1fl/g1fkfNepfV+X+DV+T2IGx47+a9S+r8v8Gr8j5r1L6vy/wavyexA2PHfzXqX1fl/g1fkf= NepfV+X+DV+T2IGx586EODL2pcQ/Oup4ly3iYExVTTdomO6Xf7sdfijt9j0GCAAAAAAAAAAAAAA= AAAAAAAAAAAAAmygiC7IKACaTZJhkBtgjOYYzAqJsoCCpsA4707Rt5WcztG7hqnmncGCbMtkFRj= MeRnskgwmNlt081W3i8auW3Ry0/eG12FBGJsswgIKbAxmEZAMRdkAADb6AAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAmk2FAQJgFABEmGMwzQNsBlM= MauqNxWF2fE4phnPlQGAymEmAY7IyNtwKKd5+5ypTTyxsoImzIQYi7IomyMgGJsuyAgqTAJsjIB= +4AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= TSbCkggbAo4rk7zt5HJVO0OKRGKMjYVhsMk2BjMLRT17rt1so6gCYAEFTYAAEmEZCDFNmWyKIjJ= JgE2TZkgP2gAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAGwlU9QmnHXO8opMCsZhGQDE2WYQCmPGyAE2RkAxF2QBNlAQVJgBFATZGSIImzLZy= xZjbrlRygAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAMZ61nyAlYzCbM02DbBNmcwmwrFYgATYUBA2AE2UBiMk2BAAJhFAQXZIiZmIBnZp3nm= 8jmSmNoiIUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAkJBAAABNCbKAxmEZpsKwF2AQ2AEFNgQABNlAYjJNgRyWqf73sYUxvOzniNo2AAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAT= ZQRBdk2FAAABNITCgbYbIzmEmBWIuyAEwAIKmwALTG8gztxtG/lZAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAJomEUBAmAUAAAET= ZJhkBthsjPZJgViKgGzkojaGNEbyzAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAE0kwKBtA2BQATQACTDHZmRALEbQAKAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAGwCIKmwbABRUhQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA0JsoIACgAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAwvXrVi3Ny9dot0RMRzV1REdfVHXLKJiY3i= YmPsBRpTI6dadJ4p1PSNZ0Sa7GLl3LNF/Fr+ly01TEb01ds9XlhtnhnWsHiLQ8bWNNrrqxcmmaq= JrpmmeqZiYmPviXo5ul5eGTLOeVefh6ri5rccL5x9Ifg4i1fB0HQ8zWNSu9yxMS1N25V49o8UeW= Z7Ijyy8809PnHeuajkRwnwVRl4tqeqmjHvZFymnxTXNE7Rv93ted6HpUab4R6SOkO/wvr2ra5wD= mTlYE48YeFaw79mvJ56qor25oqmeWIieqPvbP4R1PL1rhvB1TO0y9peTk2ue5iXt+ezO/7M7xE/= 6QD6oAAAA6ZwVxfrWu8U6zpGocI52kYuBVVTYzb3PyZURXNMTTvREdcdfVMu5gAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA6H= 0/9XRRrH3W/wCZS1d8lTPzbnFOpYVzLv14sYM1xZquTNEVRXTG+3ZvtM+1tD5QH7p9Y+61/Mpan= +Sj/bXU/wDLp/mUPt9NJfDeT7/s+L1Ns8R4/t+7XfSN/b7X/wDMb/8Avl6f6BP3UaL/ANlz+bW8= wdI39vtf/wAxv/75en+gT91Gi/8AZc/m1vX4v/R8f4fo8vhX9Xyfj+r5nyn67tHQ1q/c9+uuxFW= 3k7tQ/N8lXGwrPRDh3samju9/JvV5Mx2zXFc0xv8A+MUu+cc8PYvFfCmoaBl1TRbzLU0RXHbRV2= 01fwmIl5w0Lg7p36P72XpvC9uqvCuXOea7NVi5auTtEc0Rc66Z2iInqjsfmX6RuP5SWRkYnQ/q9= /Fv3bF2mqztXbrmmqP6Wnxw0px1x1ruH0dcDcO4us5Gn287Ai/nZlNdU3Jpm5NMb1R9LaNpmYjr= nqdtytL6YeKOi/inSeLcG7kZt2rEnTrXLYomra5M3OujaOyKe3+D83FvRHxRqfR9whmafi2Y13R= sTuORgX5omLkc81RETP0ZmJ36p6pif4SV8/ottcMf9W2q9L6StY1jNpxsiqnEvYl23Rc2s17/AE= qqto2jef4OsdHfCOvcXcDa7xNTxlqWJVpXdJixz11Rc5bfP+1zRt5OxsrgLT+P6eILdGqdGPDmj= 41WPeorzMTFtUXaJm1VEbTFczG87R2eN+roT4L4m0Hop4r0fVtKuYudmxe73tVV0zNzms8sdcTM= dvV1g6JHSjxTidAGLFGpXqtTyNUuYFObVVvdps0W6a52q7eb6cRv27fb1u58G9C3Elm/pOt6nx7= qFWRRXayr+L9OumZiYqmjmmvr8m+z4ei9DnEmqdCd3RM7FjTtcxdXuZmLbvV0zTcom3RTNMzTM7= b7T/GmH3uD9W6fMLJ0rSdT4aw7mBauWrGRk3OSq53KJiKqpmLm0zFPj2B8fouy72dxx0o4epa5f= xMOLOVR3e5emacWmblcc8bz1bR1+Lsa+12rhnC03IyNF6WtczM+zTNVi1Vi37dNyqPFzc3V97Ym= j9GHFmZqfSRYycKcC1rMXO8b9y5TNN2e790pidpmYiYiPF43WMbgvpNxOE7nDc9GGh3t7ddrv+q= zZqyfpTP0ouc/bG/VP2QDefyfuIdS4l6L9O1DVr038yiq5YrvVdtzkq2iZ+3bbefG7+178nrQNX= 4a6NcbStbwqsPMoyLtdVqqqJmImreJ3iZhsIQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAB0L5QH7p9Y+61/Mpan+Sj/AG11P/Lp= /mUNsfKA/dPrH3Wv5lLU/wAlH+2up/5dP8yh9zpv9t5fv+z4nU/7jx/b92u+kb+32v8A+Y3/APf= L0/0Cfuo0X/sufza3mDpG/t9r/wDmN/8A3y9P9An7p9F/7Ln8yp6vF/6Pj/D9Hm8K/q+T8f1d6n= qiZedMr5R+qUalk4ePwZRkTYu1UTNGVVMzETtvtFD0VV+zP3PMvyVIielXineP/wAvc/nw/Mv0j= tfR/wDKCwtc4lsaHr2iVaPXk1xatXovc9MVzO0RXExE0xPZv/8A673Y6QLN3pRu8Cxo2bTct0c3= fs7dyn+ji5//AHt97SnyxMDDw+LNA1bFppt5uTZuU3pp6pmLdVHJVP2/SmN/sjyOw4nF2s4/ykM= 3Cy9VzPmjHwO714ndZm3G2HTXP0ezt3n7wb/fF454go4W4WzdduYd/NpxaaZmxZ/br3qinq9u7z= 1whe6V+lvM1TW9N4sr0PT7F7udu3TcqooiZjfkpiiOuYjbeZ8sfw/BwrxVxfRwB0j9+8S6jk5ml= 9627F+ciqZtz3eqmqaZnrjfYG6Nd6TZwuiCjpAx9Fu/TqimMPIuclUb3Zt9cxE+Tfsdt4H1qriP= hHS9drx4x6s7HpvTairmijeOzfxvNnHOPxNrvyedD4py+JMm7jW6KreZjXa6qpya5yqqaKpnfae= WNu3yO59EnC3FOH0a5GrZfHdWPp2dokxh03K6qaNPmdpi5vM7RyxE9m3aDfLXXS30k3uBta0DT7= Wk286NWuVUVV1Xpo7ntVRHZtO/7f8Ao0VxHq+u6Lpd3UNN6b41bJsTE04tu7diq51xHVvvE7dvW= /b0o6/l8UaV0V65n8vfWTVd7tNMbRVVTet0zO3i35d/4g9WwEdgAAAAAAAOPKv2sXGu5N+5TbtW= qJrrqqnqppiN5lqDI6c7FN+5TY4druWoqmKK6svlmqN+qZjknb7twbjGmPDrT6sz8b+g8OtPqzP= xv6DQ3ONMeHWn1Zn439B4dafVmfjf0GhucaY8OtPqzPxv6Dw60+rM/G/oNDc40x4dafVmfjf0Hh= 1p9WZ+N/QaG5xpjw60+rM/G/oPDrT6sz8b+g0NzjTHh1p9WZ+N/QeHWn1Zn439BobnGmPDrT6sz= 8b+g8OtPqzPxv6DQ3ONMeHWn1Zn439B4dafVmfjf0GhucaY8OtPqzPxv6Dw60+rM/G/oNDc40x4= dafVmfjf0Hh1p9WZ+N/QaG5xpjw60+rM/G/oPDrT6sz8b+g0NzjTHh1p9WZ+N/QeHWn1Zn439Bo= bnGmPDrT6sz8b+g8OtPqzPxv6DQ3ONMeHWn1Zn439B4dafVmfjf0GhucaY8OtPqzPxv6Dw60+rM= /G/oNDc40x4dafVmfjf0Hh1p9WZ+N/QaG5xpjw60+rM/G/oPDrT6sz8b+g0NzjTHh1p9WZ+N/Qe= HWn1Zn439BobnGmPDrT6sz8b+g8OtPqzPxv6DQ3ONMeHWn1Zn439B4dafVmfjf0GhucaY8OtPqz= Pxv6Dw60+rM/G/oNDc40x4dafVmfjf0Hh1p9WZ+N/QaG5xpjw60+rM/G/oPDrT6sz8b+g0NzjTH= h1p9WZ+N/QeHWn1Zn439BobnGmPDrT6sz8b+g8OtPqzPxv6DQ3ONMeHWn1Zn439B4dafVmfjf0G= hucaY8OtPqzPxv6Dw60+rM/G/oNDc40x4dafVmfjf0Hh1p9WZ+N/QaG5xpjw60+rM/G/oPDrT6s= z8b+g0NzjTHh1p9WZ+N/QeHWn1Zn439BobnGmPDrT6sz8b+g8OtPqzPxv6DQ3ONMeHWn1Zn439B= 4dafVmfjf0GhucaY8OtPqzPxv6Dw60+rM/G/oNDc40x4dafVmfjf0Hh1p9WZ+N/QaG5xpjw60+r= M/G/oPDrT6sz8b+g0NzgAAAAA6F8oD90+sfda/mUtT/JR/ttqf+XT/Mob+4x4fxeKOHcnRM27dt= WMjl5qrUxFUbVRV1bxPkdI4f6HNM4fy6svReI9dwb9dHJVXauUb1U777T9Hs3iH1On6rix6TPhy= urb+z5nUdNyZdXhzYzyjz10lYmVa46127dxr1FFWoXppqqomImOeevdvjoA404bq4N03hy5qdqx= qePTXE2b30OfeuqY5Znqq6pjqjrd2x9A13Hp5aeLcnKjs5czDtVx/HlimZ9r4mrdHuHqE1TqOh8= OahNf7Vyzj14V3fy81M17z7Hbn6/i6jinFnPT5z+8n6uPB0PJ0/LeXC+vyv8Aau/z+zO3kePuFs= bpW4I4s1bVOH+DtTuV5ddy3NV7TbtdM0Tc5omNtvJD0boGi8R8O/0Wn5t/P0+jaO8tQuxXXTH/A= Nq9HX1ebXG32x2u4Yt6MixTd7nctzVHXRXTtVTPkmHyM8ZjfK7j62GVs85p5a0/gjpL6UOPcPV+= NdOyNOwrE003a71nuEU2qZmrkt0T1zM7z19fb1y7hPCer5XyndTz7+jZ9OiZOHVY777hVFmYqxI= omIr227d4+9volht5i4Sx+lfoiy9S0fTeErmvadk3u6W7lqzXcpmY6oriaOumZiI3ifJH8et9He= Jquu8DdKFjF07IvajlTiVd62bc1V80366qqYp7err9jbes9FXSBm6tmZWN0q6li2L9+u5bsUxc2= t01VTMUxtc8UTs7b0P9HWH0eaRlY9vOuZ+bm3IuZWTVRyc0xvyxEbztEbz2zPXMiuhU8H8Q6h8l= TG4bt6ZkW9XtxNzvO7R3O5PLk1V7bVbdc09ceXqfF0mx0i8T9Eef0fZPCOZpVWFp9vvbIvW67Xf= U27tE9y+lERvNO/j8TdfGHEN7S8/TdOwaYuZGVeib21qq7Niz171zRT17TVy079nX9jrXEPSHqO= JViWsTAt0XYirvqquO6UTVG9M00RExM/SouxEztvyfbDth0+eetT1cc+fDHe/k0Dd4f4ijg2dB8= DOZTqMUck6rTjX5u7xVvzbbTHXHV5H39b4P4qu8IdGOPb4c1Wu9gXMicuiMWuarG+RTMc8bfR3j= r6/E3TgdIFWNodjO1ixNXdJqtzcs2uWnulNO88sTVPNTO1W09XZG0Tu57XHU5teDp+Djz39k12o= m7VEdx5eeablUde+30K9t+36Plje3p+SfI+Ph7u8x2AODqAAAAA+XxXreLw9oOVq2XMclmjemnf= aa6v7tMfbMg1r8oPizvbEo4Xwrv9LfiLmXMf3aP7tP8Z6/uj7WjX7Na1HK1fVcnUs25Ny/kXJrr= mZ/0j7Ijqj7IfjUAFAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA= AAAAAAAAAAHtABkAAAAAAAAAAAAAAfE1DhrAzdcjWK6rlOR3CLFcRFNVNdMTVMdVUTtMc1XXTtP= 0pftnR9Jmqap0zDmZneZmzTvM9fX2fbPtl+4a78vdnsx9n5K9L02uzTZr0/EqtU1TXTRNmmaYqn= tnbbtnefaWNM06xei9ZwMW3ciZmK6LVMTE9fj2+2fbL9YndfddQARQAAAB586eeLJ1bXI0LDuTO= HgVTFzaeq5e8fu9n37tp9LPFVPC/C9y5ZriM/K3tYseOJ266v4R/rs8wVVTVVNVUzMzO8zPjWCA= KAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAPaAD= IAAAAAAAAAAAAAAAAAAAAAAAA85/KByb93j6uxcu1VWrGPbi1RM9VO8bzt98tdgoAKAAAAAAAAA= AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAP/9k=3D" width= =3D"794" height=3D"1123" alt=3D"" style=3D"margin-top:-36.95pt; margin-left= :-121.25pt; position:absolute" /></span><span style=3D"height:0pt; display:= block; position:absolute; z-index:-65535"><img src=3D"data:image/png;base64= ,iVBORw0KGgoAAAANSUhEUgAAANIAAAAqCAYAAADGWAU2AAAABHNCSVQICAgIfAhkiAAAAAlwSF= lzAAAOxAAADsQBlSsOGwAAB29JREFUeJzt3D1MU+8XwPFvS2mpWENaQbSAhYpgQUQxYDFoNCbqo= JPgRKJGdGFwc5IBFzcXXEwMGEUkYUBFZFFDghEEMUWRl1IKBkUggBJukfL2Gwz9UwRp4fLiP89n= 4/o8555zbk/vbSUobty4MYMgCMt28+ZNhXK9kxCE/wdikARBBmKQBEEGYpAEQQZikARBBmKQBEE= GYpAEQQZikARBBmKQBEEGYpAEQQZikDa43NxccnJyVhTj0KFD5Ofnc+DAgRXFlSOXa9euceXKlR= XF2IjEIP0DFArFhom7Wrn861TrncC/Jj09nSNHjnDr1q01OV9BQcGGiTt/z1r3YiMTdyQ/hYSEs= GnTpvVOY0MQvfgfn+9Iubm5gPe70vXr1xkdHeXOnTsA7Ny5k0uXLlFdXY3FYlnV9a9evfojx7i4= OI4ePUpoaCgqlYqRkRFqamqor68Hfj+fu1wu3G43ERERBAQEMDQ0RFVVFXa7fckYubm5hIWFAZC= fnw/A7du3GR4eBuDcuXOYzWa0Wi3T09MMDw/z5s0bGhsbvc4/MTFBREQECoWCnp4eXrx4wZkzZw= gPD2dmZobe3l5KSkqQJMmz5+7duz7VqFarycrKIioqCrVajcvlwuFw/NGr+XHVajXnz58nKiqKw= MBAXC4XHR0dJCcnU15eTmNjo9eexXoRFhb21/x8sVQf5+Y/OTlJZGQkdrudsrKyJWtYLT7fkb59= +4Zeryc4OBiA/fv3o9Fo0Ov1qNVqABITE5mcnKSurm7V1y8kJSWFHz9+UFFRQWlpKQAZGRlea7Z= v345CoaC0tJSXL1+yZcsWjh075lOMgoICamtrAcjLyyMvL88zRNnZ2VgsFlpbW7l//z5VVVUolU= pOnjzJtm3bPPHDw8MZGxvjwYMH2Gw2TCYT2dnZuN1uiouLqa+vJzIykhMnTiyrxszMTKKjo7HZb= BQWFtLY2Mju3bsXu6xe+0wmEzabjaKiIhobG4mLi1t0/WK98OUa/I2vfQTYunUrbreboqIiGhoa= /K5BTj7fkT59+sS+fftITU3l9evXxMfH09/fT2hoKFarlerqanbs2MHg4CCSJK36+oU8evTI6+f= Y2FhSUlJQq9W43W4AXC4XhYWFANjtdmJiYjAajX7FmM9oNBITE0NraytPnjwBwOl0MjAwQHZ2Nh= kZGZSVlQEgSRKPHz8GoKuri9jYWFQqFUVFRQA4HA4sFovn3d6fGnU6HWazmdbWVp4/fw5Ad3c3w= cHBpKSkLBgPwGAwePZVVFR4cltqn7/5Lda/Wf70EWBqaoqHDx/KXsNy+DxI7e3tjIyMEBUVBfx+= Z29rayMgIMBzzGAw0NLSsibrF7Jr1y6sVit6vR6tVktQUBBKpRKDwUBvby8AIyMjXntGR0cJDAz= 0K8ZC5w0ICKCzs9PruNPpRJIkQkJCvM43169fv5iZmfnjmEaj8bvGqKgoVCoVTqfTa09/f/+Cse= bGVKlUdHV1+bXP3/wW69/cvb72EbyvpZw1LIdf39r19fURHh6O2Wxm8+bNNDQ0oNFoiI6OJikpi= aCgIGw225qtn8toNJKZmcnY2BidnZ0MDAyg1+tJS0vzWjf/RTv3Z19jzKdU/n5Cnpqa+uu/L3T+= xY4tZKn8goKCAJiYmPDap1L9/TLP7hsfH/drn7/5LcWfPs5fJ1cNy+XXt3Z2ux2dTsfBgwcZHh6= mr6+P5uZmdDodFouFnz9/er0jrPb6ufbs2YNWq6WyspKnT5/y9u1bdDqdX83wJcbsi37Lli2eY0= 6nk+npacxms9dak8lEcHAwg4ODfuWx3Px6enqYmZnBZDJ57Zv76LqQr1+/evL1Z9/8Xqz0Gqykj= 8utQS5+jWtdXR3Hjx/3PIsCtLW1IUkS0dHRf7zIV3O9wWDg6tWrOJ1OSkpKPLf55ORkJEkiISGB= mJgYf8rzKcbslwuHDx+ms7MTp9NJV1cX3d3dxMfHc/bsWZqamjyf7cbHx6mpqfErj+Xm53A4+P7= 9OwkJCUiSRHt7O4mJiX+8uObr6Oigt7eXxMREJEnCbrf7tG9+L2Y/u/p6DeZfw5X0cbk1yMXv/0= fq7+9Ho9HQ1NTkdUyr1Xq+Ql7L9bPevXvH58+fiY2NJScnh4SEBNrb2/2qzZcYtbW1fPnyhdTUV= LKysjyPFMXFxTgcDhISErh48SKnTp3C7XZTXl5OX1+fX3msJL/KykqGhoawWq1cuHABs9nMhw8f= loxdWVnJ4OAg6enpnn2zj9HT09ML7pnfi+bm5hVfg5X0cTk1yEUh/hyXsJjTp09jtVq5d+8e3d3= d653OsqxFDeLPcQl/FRERgSRJ/+wQwdrVIH7XTgDg8uXLDA4O0tLSQmBgIElJSRiNRp8eCzeK9a= xBDJIAwMePH0lLS2Pv3r0olUpGR0d5//49z549W+/UfLaeNYhBEoDf35gu9qtX/4r1rEF8RhIEG= YhBEgQZiEESBBmIQRIEGYhBEgQZiEESBBmIQRIEGYhBEgQZiEESBBmIQRIEGYhBEgQZiEESBBmI= QRIEQRA2hv8ACiH269WaWwIAAAAASUVORK5CYII=3D" width=3D"210" height=3D"42" alt= =3D"" style=3D"margin-top:56.2pt; margin-left:-73.7pt; position:absolute" /= ></span><span style=3D"height:0pt; display:block; position:absolute; z-inde= x:-65536"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAXIAAAB= bCAYAAABu8A5DAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAF2RJREFUeJ= ztnX+wXVV1x9e22I4/ora2b4qNWlOH2lixEyeWGYcOQ5u+MpRhmChiBoqayiSIClIkWH4TWyJoM= EZAI4JEBFMRBQQDiPxQCPKjaVQSEkICgZCQkIQEkmdC8ukfa928ffc7+/y4777kJW99Zt7cd/bP= tfc5d91z1jlnf0Ucx3Ecx3Ecx3Ecx3Ecx3Ecx3Ecx3Ecx3Ecx3Ecx3Ecx3Ecx3Ecx9n/AB6mnT5= LPwJ4FHgF2ArcB5wCXJXUz5YDLoja3Qocl9S9Nul7Tg17JwCPAduALcAtmXI9wOXAE8Am4E5LPx= pYBPze6t8J9ET1XqCYn5bY1GPtvGzzcGfD/CqbVgMbI1suqJonx3FGEMAo4L/NQTwIjLH0J4CVw= GTgSOBr5uSuTupXlrM8gOXAqKT+RGADcHRNe58ocLLXJGWOAVZY3u+Ay4DxwGjgeXOYk4CHrMwD= Vu+ojBMHmFJi0z0F5a+ok19lU9RGb1TXHbnjOO2gZ4QAP4rStgOXJ+WmAN9J0irLoY78N+gZ6U0= F/S+paecX0LPVQ4GLzfkR1wfGoT8kO4FvJvUvs/LP2fbnbXsXcBxwBXC9zUePlbkZWFti08eBnw= OHW3ubrM37auaX2hT1447ccZw8GUe+GFgFfKSibmU5c+QPADPM8Z+W5Nd15L3J9q/N7seitPss7= ZcF9W+xvGdtu8ccJiRXGlGdVcAdJTYdlGwvsvauqplfyyZ35I4z8nhNF9r4dxFZJyJzgZ8Bhw6y= nIQQzhSRX4jINGBsrhwwF1ifOsEQwvy0SftshUbGi8gHLe2v0DP29cBMS9tsn2+29l4QkVct7Q0= FdnxERP5CRG4vGdNSK3sYcIOIjBWRhSGEyXXym9rkOI5TSNEZeZR3np2VvmKOKNdGtlzrjNz+H4= XGyu+P8mudkRf0uR5YEW1fHJ21ngh8y/7fDpyAxqC3t86I0XBKi9kF7c8DXqxpy8KorT7gsjr5d= W3yM3LHcUopc+RRmWvRuHN6VlxZLnbktn0MsBn4sm03duTAbPQJj2OjtLk2jp1R2kuWdoNtfxVY= Z87zOct7FTiioI/lwN017ekFvo/+kAG8XDe/jk3uyB3HKaXIkQPzCsrdj4YrRjUplzpyS/sv9MZ= fb1NHjj4dsx44M0mfEzm7XktbZdsDHh8E7rW8/y3Im2A/SGdFaY/SzvaCeicDOyz/Qx3kF9rkjt= xxnFIyjnwFA2/U3WQOuqdJuSJHbum3Ab9t4sjRm4G/A6bb9mjgh+jTIcfRf6PwbMtvOfKvJ+18A= z3r3Uzx2fi1wKa6diV1VwIbmuaX2eSO3HGcUoAvmYN4ADjY0ragoYVp6CN9F5mDeTCpW1kOmAUs= bbUdpY8CllHyeF+BrXczkK1Rfus57MfQOHkf+jjiGLPvEvRRSNAwxomZfhYTxfFL7LkHfazyZvR= K4Qw0fDKzZn6lTTZP50fjvYbkeXzHcUYw5N/snIfePHwKDQVsQp+HHpvULy1H+00+GPgI4VHAk0= na9WjoZHySPodilkdlxgC/MOe5HXgci6MD89E3JJegz4yPzszJeBvLhTXmbw76QtNO9G3TpcD5D= fIrbUJfGEp5rso2x3GcPQYwYW/b4DiO4ziO4ziO4ziO4ziO4ziO4ziO4ziO4ziO4zhObWhXngG4= Lcl/Jcq7tkZ7E4DbgZca2HAI8Aj6NuhWMsvGMgSKQzVsO4n+Z+TXA18dbJtONcBMm+/sKplR2QH= HHHApun7NmKG1dM8wVONBl5Z+Mv3eDwXAp6yv3wMvkmgbWJnr0ZcMtwI3N61v5cYCPwHWom9Knz= 5UYxo20C/VBnBHeqCgr76/jL5NWPgCTVL+JnN6r1aVjeosRF+7PwKYjr44Uyat1jXFoQq7DkZfL= joBXehrsR1Ehwy2bad7dHLMObuXu9hq36UhdeTW1yL0DfAj6X8De0ZUZo59978AnIq+IX5d3fpW= 7hjgWfsx+AFw/FCOa1iBKu70kWhJWt5Y4KGG7c2t+6UCPomuj/KpKO0Os2d8pk5XFIdq2NYT/3g= BZ9nBM7Eb7XcTdGmEHSRvfKJXFMstr89+tMd1sd/vAGus/a3A3CjvWjsr2mE/rnPL2hqkHbWPuX= 0B9O3i7MlMl/vatAcc+TlEgjLoG9gvAY9EaRuAe6LtW+07Prpm/XH069uWCuLst6ArFm5m4Bn5V= dR4VT2pM6eBI7/cnOPRUdpFlnZRpk5XFIeaYnPxf0PR9mAADkIvu5cB65K8tegVz2HAZ+0gr1xD= pma/37X2voyGx04EPhPlPwNcaH3fZz/YU7vRd4EttY+54Q66ts4iYMEe6m/dUDvyTL+LMXUv4HT= 7zsdr8F9oaYX+J65v2/PRpTBOHXrrhyn2JdyJSZBF6UWSab12ZrcNDTU8DkyK8ps48ktsZ30lSj= vH0i7L1ImFKuabsxob5S9JypfaW8PG8ea0NpBZZCtTbzq6hsod9sOzHY3tXVInv0E/t9mY/id25= MC55jx7o7Qf0+D+RUW/G4FLa5Y9Mf2ilpQ9HPgpsNm2Wyta3mvbv7Xt56I6u485298/oz1mPqhj= oMLe263dFaiYyeQo71izdyt6ovSTGsdFuj7RvILxDGjX0j9v9R9B1+zfYGW+BXwGXZRtB+0OcB2= 6PtKjZsta7CQKDXMsQq+Al6FXdRfn+m84b6swXV30JAng3Cj/JEu7rkb9HvR+3kqzazt6pXhOU7= v2eWwCno22Pwt8PykzCj3TWoDGqs60g+UFLAxBM0f+ITSetQYNs3zE2obkTDuqU1txqI69NWx8I= PpSbaFm3I3++ONT6KqHx5it29DFwkrza/bxKTuAj2egI78O2JiU/yrqGHsGtlYf9L4Bdsy8jN5U= eho4OVN+ppX/ZI22WzHvXbY9Af3RaDnysdZvzpHfShQz78YxUGLrSagTnmT74FeYI0edyzJUPWs= 88E2bg9Z69Nn9bvUWZMaTa/drtg9A48Sz0B/FhbaPfmh9tQS/z7P21qE3EaegDvoJOzaPQr+XoM= 59YlX/DeZtCvBMtD3P2jgpSjvR0m6sUf9MK7sA9SEn2/59mRL5yf0S+s+Ez7XtOxm4AuEMK3Nkl= DbL0mbbdqPLXOBsdIW/HegXdCnqMAvv0NNAcaiOvTXs6wFOQZekhSiOV6PuRtrVkqZaG3Pq5Ndo= /0nsPgEDHfnNwAtJ+fOt/cMK+ixjatLO2Zb+I/Qm9UTUGT0jCWiMczXRWWCNcV2FOXLbXoU5ctu= +m4wjt+3dMfNuHAMldh6NOr2bSBZ/o3956JQFNY6L3Y68YDzZdi1/KbAwmZsd0XZPPHaS0Ar9+g= QtgfDlwMN1xtVg3hbSfuXSWtk0joOfamnX1Kjf2p/xGf2lllb7B2a40ZH4cgjhIhF5VkQ+jDrwn= SGEh5Ni77bPWB3nFvs8sMN+p4cQDgwhvFZETheR0SLyQAjhqZr1bxKR2SJyEskyud2wN4TwQghh= dgjhMBFZLCaUXJM2FaEQwhUislNE3lozP4t96d8gIp/JFNkqIq9N0l4nIrtE5NG4z1DNFUk7Lcd= wQwjh9hDCjSJyl4i8rcCOm0TkABH5j6oxRWxrULaIvuj/jo4B4OrEUQ249xJC+ImITBORMSJyC/= Ag/TeT3yEiqwvm8hBpvt/j8ZS1m45TrN2WUHlL4DuLjWm7iLzFknYkRar6LwUVsLk1hBCHcVtLW= cdXSG+3zydq1G+JmB8QpbXCPfusiHlHjty4TUTeKyIXikiRhucq+4yf3HijfQ7qJiOqNDRTRDZJ= 3jkVEkL4oog8ICJfSbK6be8GEVnZsM7ugwu9PP0DEVnRID/HOBH5cxFZBSAiHxaRPzWnM0n0R/l= NtKsNHSQiL4YQtjQcQ8oi+/xglPZ6iRwOGtJ4UETeJSKfDiHU0j8tIT2u0x+pHB0dAyGETySO6j= 2ZcrNCCO8XkRNEnVzrGHxeRHpIYvH0X211ut+r2h0U1u4fSn5uOu7fzvKfDCGcHaeHEGaIyIsi8= oEo+b0iskX0JK20vqiv2i4i8Y/JO+3zERlp2GXXRmBpSf4a9NGf89EnEhYAT0dlbkXjsHVjyb3o= jZnV6CV06eN9NFAcqmNvTRvHoLHF1WQei8zUW4vG6k5CQxC/NXt66uQ3tDENrYxGQ1S/tjn+vM3= DgJhjJ9i+WomGVU5BX+C5x/JG2eXvGjp4pt+Ohzi0sgSN+05Ab7attB+sTZbfdsxF25O6dQxk7J= yGxsWnojHlJcCvLG8sGrZYjT66eih6Y/qUGsfFEjuWz0BDQ/F4ytoda/P0FPo00yj0BusuzPHSH= 8b5sc3Nc+iN2qlofHkZ8ISVHWf5cagm23/FXH2X9sdTx6Lvp5wc5b+CxrdPR+Pb1zaofyt6M3Z6= NKcLZaSCxvtmleQfhz76sx29QfMY/WLHN9DOZPRu+ACBYyv/WTQ2vtb6PaioXFS+E8WhrL2WX2g= fGqN72b4EW1A1pYlR/nj0ptnTZF4SsnE9Ygd+H/ri08QG+dm5K+jremBNknaufeFetbHcTZdk4t= AbrSvof4b8XvqVoaZQzLKa8zab9pj3l2wfbAFuRJ+yWIo+opYec6lIdm/VMTCIOZhmti63tpcQX= QGhL9QtRZ+UWY89nVVjv3/b7HwUvQ+RjifX7tNRuefRp7piZifb16E/Dr+jX+HrDvolH9dauW3A= iqpxlczTXPqfPop5Pil3C/1Pwvygg/rz0R+DPvT7WvukyxlmsIcVh9AzsmMzeWuJbmo1zd+fqZi= 3y+lQ/HpfYCTvd6c+g4mR7/OEEAa8oToUoGeW3xaRh0II8wryJ4jeXPwTirU4S/P3V6rmzXiXJD= e59hdG6n53nH0O9PI3ZlmT/JEIGmvfYpfFi/b0ldWewPe74ziO4ziO4ziO4ziO4ziO4ziO4ziO4= 7RAX2SI2Un/kpzTu9jPfiW9JbJnxjRc5w19i24bBasZoivo3QusjtKG5TiqoAPpwqT+gLkYpD0/= sqd6pkZppXJtRWPYV/eHkwF9hbeldTkbfRX9PHRpzh3AlL1tozP8sBOAwrd/0Rd9XgVe3NN2dRs= GKSPX7blAl5i9MtqulGsb7BicfQT6l6+NF6dprTF8+16wZ4/JXDnNsf3zs4oy8/cHRy6y+/Xwjp= 1gt+YCXTslJ0xeKtc22DE4e4cDqotU8jr73NmFtmqDrgNylegSrM4wJOjSxv9SUayvIn9fYrBj6= cpchBCWisg/Z7LTpWaHxAZnz9LxK/roqmFzRJf83CEiP0zyi6SrNkYx9rusXGuxno0US2/l5LHu= F5H3icjfW/0ZVnczGr/fQIW8WJGNlj4NlaxagK6kthldSCrbHroI12PoQjzb0JUED86MqWhuKvt= s2Ed2LkrmNDe2TmTBcnN7KLrAUx+qSvS2qE7ROArH3O0xFoy5TJat8jijnuxcdi4yNlVJv1X2af= wRBXJtBf3V3h915sQZJtAfWolZBkxLyuUknq5GHfcz9Mu9jcKWoGSgVFVWHsvyY5mrXjuwvoQuq= fkoJTeOSmz8GroaHPZ5Obqc6TIKVG2srZayzf1Wdjb9moV15bdeKeuzYR/Zuaia08z4GsmCVczt= YjRufiwqu7UJCycUjKNszF0dYzLeMlm2sn5jGbk6snPZucjYVSUJWKfPrFxbwRjq7o8f5ObEGYb= Q78gvR8+AdxGtAxyVK5Ou6kXXe26dVfUS3SilXaoqK49l+W0yV5Z2svXTV/GlqJLBWkm7bNVtwP= pMWzPtQC5c2Iia8ltlfTbpo2wuqua0ZL5qy4KVjHGVfcZ6i21x4WSuSsfc7TFGbVbWz/SbyshlZ= efo/y5l5yLTb5X0W5XUXZVcW5kUXtUxWOu753SfTkMru0IIZ4rIvSLyURKdRimReAohzBddre4M= K/t3IYQro7q7Y3QV8lgDAH4uIheJqqfcnytXZaPlp7HEXRLJYCW8XUT6QgjPZvLrym+V9dmkj+x= cNJ3TiCayYIVjFJGHLD++2ZbGZOPt0jEPwRhr1W94nOV4v32WzUURHUv+FVEg15ZSa390aU6cDh= nsMraTRWWXzqVdhadK4mmuiBxu/6cOoo0Seaw2UEHlfxCR40MIH5Pqm6DdlMFaIyJvBj5eo2yn/= dbuo2ou6s7pICgco+g9DRGRf0vSczfds2Me6jHm6ndwnOVk51oSenXnorAMxdJvtaXuqJZriync= Hx3MidNlaj+1gj4l0lLleSfQE0J4CrhQRGaJyHzgeyJyo4hcIyKfEJFLgXeKyC9F5Cyxs48Qwte= BzwFXi8g5SVcHishr7AB7h4gcJSLfE9WV3CJ60LXYKSJvBc4QkSNED+D3W59/LSJ/CIzK6E5mbb= QfpVE6bMaIyDrRM57XAYcXaEp+R0QmichFwOtF5DER+biIbAshnJaMKdfvwrI+G/bRk5sLEfl0x= ZwOAFXzeYuIbEeVmZ6P+wshfD+6KhstIpdmxniX5X8ODcs8Lrqe+JuAbaLaifE4smMWkT/u5hiT= 8U4rqV82ty3bjw8hfE9EXhGRd1l45h9Fz/D/DBXC+KiIHFs2FyEvfvw+C8msEpELRGStiMywvGy= fIYS3iJ44/Y3tr/VWf2kI4T+tfjqGOvvj0NycZL57zt6CgW92xnqX16XpVEg8oTe+bkvSUqmqqy= iXx4plrj6E3pTrQy+FZ1leVjwiZyP6FEaLp2mXBCu8/EVjlU+ZnRswvcuCMRXKb9Xps0Efp+Xmg= grJsczYOpEFy83tmehN0x3oTbd7bEyXZOYqN+bs/s6NkRrScdZ2do5K+l2T2D6ZEtm5qrkosa1K= +q2qzzK5tjpSeAP2R9m+KDuuHMdxOoYS6bjhDi795hQwoqXenJEF9aTjhi249JvjOM6+Cy795ji= O4ziO4ziO4ziO4ziO4ziO4ziO4zgRwMPAcYNsY5y9nHDXINsZlNTWYKGhJFbT8pk29uqYHcfZx0= GXzdxBRomkQTsz0TfoegbZzoiTqRqJY3Ycp4ugS6zuQBeTr/1yAok8G/Bj4Ogu2TTiZKpG4pgdx= +kC6ALza4F59nLCldW1dOEtYBHJGuJdtGvOSHNqI3HMjuO00+kr+meLyFIRmS66ZGWR6MMXzGn/= BhWA6BORJ6Vdnm0e9aWk6spYxTb0ogv/bEMXb3qcgUur1q5TNCb61WrScUxEFyfqQ9Vmzk/62F2= eejJvLqXlOE73QFc/a0lf/cIc6tSkTGs1uLW0r84Wy7M1kfaqI2MVy1SNQiXlFgBHoivNbQBeIK= 9wUlqnZExt44jGudyc9gXoanHYD0M67lJpOWrKizmO49QCOBVYHG2fiJ4tD1AFMUf2cJLWJs9GM= ympKhmr2JHPMOd4ZJQ/y9JmZ9qvrFM0pnQctr2ZdkmtZYntafmVVEjLUUNezHGckUcnoZWPich7= zLkhKpQQROQDDJTTSqXLiqgt7dWQd9tnrEB0i30eOIg6uTGl65T/UkTGAyegiio9oivX5cqXSsv= hUlqO42Ro5MiBXhH5SxH5YKLFOFPUSZ02SHvqyJnVlbFaZZ8To7Q32mdO1qqTOjm+ISKbReQK+3= tGRM5r2IaIuJSW4zhdwmLGS1AVl1FJ3jhUBWYLcBYaax6Hqt4sTMousTDDGRbKuNVCM5OszgYLo= ZwMHAJcCcyM6j6LxssvtnAEqHSWRG0dj6q6rwFeAs5H484LgKdLxlhaJzempO/WjdFFwDUlfcXj= Ptj6XQqMsfl7EFVyPxy4Br3JOQ2YYvOwxcrtHnOD3ek4zkjEnFuLVKLtedq5Dr0hCBrzXhGVjeX= Zakt7Wd2sjBUDZaomA8cBi62tbejTML0V48zWKRlT0TjuYyAbgC8WlF8f/T9A5o0G8mLd2+OO4z= gjGPSs+h5U0aWVdjD6+OKv9qZtjuPsfxywtw3YT5khIn8rIv8EiIg8LSKHiMi/isigljRwHMdx9= gDoS00Poirlr6Kx7sXAWXvbNsdxHMdxHMdxHMdxHMdxHMdxHMdxHMdxHMdxHMdxHMdxHMdxHMdx= HMdxHMdxHMdxHMdxHMdxnH2R/wfcXFc692flrgAAAABJRU5ErkJggg=3D=3D" width=3D"370"= height=3D"91" alt=3D"" style=3D"margin-top:-21.2pt; margin-left:196.75pt; = position:absolute" /></span><span style=3D"font-family:'Times New Roman'">&= #xa0;</span></p><p style=3D"margin-left:35.45pt; margin-bottom:0pt; line-he= ight:normal; widows:0; orphans:0"><span style=3D"font-family:'Times New Rom= an'"> </span></p><p style=3D"margin-left:35.45pt; margin-bottom:0pt; l= ine-height:normal; widows:0; orphans:0"><span style=3D"font-family:'Times N= ew Roman'"> </span></p><p style=3D"margin-left:35.45pt; margin-bottom:= 0pt; line-height:normal; widows:0; orphans:0"><span style=3D"font-family:'T= imes New Roman'"> </span></p><p style=3D"margin-left:35.45pt; margin-b= ottom:0pt; line-height:normal; widows:0; orphans:0"><span> </span></p>= <p class=3D"Header"><span> </span></p></div><p style=3D"text-align:cen= ter; line-height:115%; font-size:18pt"><span style=3D"font-family:'Times Ne= w Roman'; font-weight:bold">Vitamina C como modulador del estr=C3=A9s oxida= tivo periodontal: perspectivas actuales y relevancia cl=C3=ADnica. Revisi= =C3=B3n bibliogr=C3=A1fica narrativa</span></p><p style=3D"line-height:115%= ; border-bottom:0.75pt solid #5b9bd5; padding-bottom:1pt; font-size:12pt"><= span style=3D"font-family:'Times New Roman'; font-weight:bold"> </span= ></p><p style=3D"text-align:center; line-height:115%; font-size:14pt"><span= style=3D"font-family:'Times New Roman'; font-style:italic">Vitamin C as a = modulator of periodontal oxidative stress: current perspectives and clinica= l relevance. Narrative literature review</span></p><p style=3D"text-align:c= enter; line-height:115%; font-size:14pt"><span style=3D"height:0pt; text-al= ign:left; display:block; position:absolute; z-index:1"><img src=3D"data:ima= ge/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAUCAYAAACNiR0NAAAABHNCSVQICAgIf= AhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAA2lJREFUOI21lEtoXVUUhr+197n3nNzbJN6omdTW= RmwbikVq4iMxk0ZU2oGgA1FnQcQiUhUnFqo4cGIRQUGd+KDY+Jp25ouiGCOxElqjhba0URPzsPQ= muY9zzj1nLwcnuU1iQ0f+mzXZe///Wv/aiy1cBV/83NNOPr/VWHunqO5OVNuNlQVjmZCGjCVhcP= HR3q8XrsaVNUITu/KSlu7LFeSpNNZ+57RTjDTvqFM1IvNiGXWJvD/9x8yXB/efizYU/Hy8/0W/a= A/Xq43r1P3nOCNIFsW2XLleTd648Z/863v3nkjWCL59dp/fWSsfzOXNkShKacvfgnMRlXjqqqIr= wr5vkihyhxbT+K2ne082AAzADZXyPj+wL8ehQ1NH700v0N35OAroutW0rxDF6rUUvddaJfdwM9H= wqYFSa0GO1SrpfucUVUXEZCQcqQtZ0VEU1QTPtmAkDygiEBTsTxq6hx65fWTOy7l0exjKgGrGcj= To2/oKS9EUZ2aPcf/Oo1iTI9UGqFJrzDF5+Sv+Wvg+y+IEVXaGibsbOO5hGBSkbUUQdRT9zaQuB= hE6Ct2MT7/D9OIIVnw6Ct3csfk52oNtTMwcBbE0YteeC7we4LinSI9Z03dBNUVxTdu1eI7FcBIj= HvPVU1Tjv7nn5sNMXv6WSjyFiIg17AAwqpRW9fqayNkiM0tjqDrag67mDCi0ARiB6gaTsSEEg4h= tusj2qGeCIr9dW0JR3PKrR2zreIDURZTrZ7NTBYdeBPAU+cY59zxCkFlXjHiI2GY1pZbtRMkC1g= ZcX9hFV+lBTs98SDWexYjFGqkldT0J4EkY/ZovBb+klbQ/G1zDYvQntXgWFC5VJ9hSGmRLaRCnC= ZeqE3x34SXK9XMY8bK+BvZ8JUzGAEQV+Wy87xm/xbwZ1lwewGmCIIhYnCZXjKvDaQNrfIzkAKXY= Zl11wR16omfkyHIP0RB/2CV8GrRkNldbNmKbYU2enC0uV6bkfUNUd8P1ury3ktQADO05UV6azx1= IE/dRULDomjGSVXEFhVbrXMoncTV99smBH5ZW327igzP3trY2ONCyyQ6FtbRLUw2yZ8p+FwARif= yCvRDV048rcfXdoT3j5fXp1+BVxdx2um+HGnuX9egX4dY01U0iVK2R80nMaELy42O7R39fz/1f8= C/hZ5YvjpSKGwAAAABJRU5ErkJggg=3D=3D" width=3D"20" height=3D"20" alt=3D"" st= yle=3D"margin-top:25.6pt; margin-left:189.15pt; position:absolute" /></span= ><a href=3D"https://crossmark.crossref.org/dialog?doi=3D10.33262/anatomiadi= gital.v9i3.3715" style=3D"text-decoration:none"><span style=3D"height:0pt; = text-align:left; display:block; position:absolute; z-index:0"><img src=3D"d= ata:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAEBAQEBAQEBAQEBAQEBA= QEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQH/2wBDAQEB= AQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQE= BAQEBAQH/wAARCAAxADADASIAAhEBAxEB/8QAHQAAAgICAwEAAAAAAAAAAAAAAAgFBwYJAgMKBP= /EADQQAAEFAAEDAgQDBQkAAAAAAAIBAwQFBgcAERIIIRMUIjEJFUEjNVFhkRYkMnR1gbO04f/EA= BsBAAEFAQEAAAAAAAAAAAAAAAABAgYHCAMF/8QAMBEAAgIBBAAEAwYHAAAAAAAAAQIDBAUABhES= BxMhMRQVYQgWIkFx0RdDUWKBsfD/2gAMAwEAAhEDEQA/APc3xtT1drx/irW0EptjZ5TP2E+a/If= J+ZNm1UWTLkvErv1OOvumZ9uwoqqgCIogpkF9Bxedp7G9uDhVlVUxHp9jYTprjESHDjATj8h95x= 4QBtoBUlJV/Tsnv1W/Ftz48bYAPIvoxuZH7/bxpYSfZf5ov39l/j+vVB+rKHK5Iz+c4rYuZlPG1= l3COwehkifMNRZkYY8WYJEPxYSyHRkOtoqKRx2O3dQQSj+5N1YLZ+NTN7itTVcSt7G0Zpq1eS3Y= WXJ5CrjqwirxkPK7WLcQ6qQVHZm4Uc6f8BmchDbr4CimQzC0btmjTnmWtBYkqVpbBSWdyBEvEfJ= JILKCEPYaUnmf8Tbj3J2j1fgsdWTq9l1xtm71FhYRTsgDuKyIFNEUpiRDX3bcfNp8k/xst9x7x/= Ef4nuE01sxB3WLqWq90wB61ytjYOyoAEXisiTS2BjKejt90VxWXVcQe6A26f09avvxK81lcL6jo= eIycWNX1tFxrj2I0JrwB50fGejs6R4ihvSJbyOPyJBJ5uvman29kTHfw7M3Sa71V4nN6KAxaUlt= Qb2HZw5IoTbkd7F3bYl3L6gdadNt5hxvs8w+20+0QONASR6TxVqpvL7srt2i+KXKrjGuNPY+Zkd= hGbRfzVrJKCS6weSwCAJ2LEHWyqP2Brtr7L03jxL4ybnj8QV2DZ3193YsRgG2OjQUJL3yBqbV/m= z1ZHjFYXhkkclxKY2H4T648smC2NDWaXPOwbSmt4jMyusIcp02JMZ4fIDFUdXsSIqiYL2NsxIDE= SEkThsM/SRMpo5cRr5aTFpLSTHktSZAOx32IL7rLzTgvCTbrbgCQGKoQqndPfrXn6Kb6zwew5r4= El2D86owehWxzDjxd1ar5s2VGlNdvL9mj3jXzPhACCkh6Wqiil3J6NlcoWQ1A+ffzoLdPuv618j= v/X+Xdf6e9nZGr8DbaAv2UxxzRu3oWjmRZI+f7gjDt+o/rrB+0s6+5MHTyUtf4a0ZLNLIV1PZK9= /HzvTuIhH8sWYZTECefKKEk88mmeOrVQ4/xI+YfRk88K+6+3apiJ7+/bv/AA/2+3WG8uBLdYpdP= X9nZWanDJMUVVUWVdaeB1URFXwbfYBDVEJUBzzVOwKqY9h7hW8blhM0EWs9UCq/oIhBZRV9kXv2= RO6onun2+/UHXc38XX9g5SVfIGQtrH8wWnKsh3tbJku2BNWbqwBjtySJ6QTNNbEjYoSGNbYKKr8= m/wCNX+Ie0It+7Qy+2Zbb0Zb0Ub0b8ahnoZGpPFcx91RwfxVrkEE3orEhCvUg8asHAZh8HlqeTS= FbKV2lWeBjws8E8TQTwkn27xSOvPB4LAgEjjSbct+hvP8Aq39TcfnXcbEqzj+syeZqAyVDIcj6a= 4tqs5rk+NZTXBFKmq/vDYC5GWRKmtq6jLkMUF1cgyvoyy3pq9QOf51wGhVcNVV2rCfiLN4pF7El= WOdsIcGPn5aoX5sy7KfbZ+DMNqRHEkddkyBEl6aKdlav5pyXV2b1O6X1OAw6nwAQi7oqIjjZtAp= p9H7RW07IgD26j62oztg/NkzNGl+VPKeiWALMBwIcmIDbr8acXx3nGnGW3WnHmiUEFt1slUgcTq= j6lfxdqEU5fCnbd/c5yEFmTe77shi29anhKc5WXGCP55GkvQu+NjJILmNJ1BVl0f8Ax3zy4Cbbl= fxPzFXZU20LGzTshcGXC4SzUaq0K95Dj3yEfcNDlXfz0VeA6xM0TQHpNp9E/d8pcxayvkU9lyLf= EFdXSwcakxq2HLkvvIomiEjSyH2YzJqCI8EE3W1IDQlbrVWnlmdEPknZaS0H7/dVhPJ2/qv6p9v= v1UWe2uevqaut8xcVVvRT4oSaqwqpkaXWy4SkrbUiFJjG5HfjEiIIPMKTRL7CRIncu3QW6u5+6H= zTsVRYp3FUVF7w3k7Ivt7L9v8A3rVUt65dMdi8K6WjBXjmSqH+FV4YI4mFcS8yiHmPlBIe/XjuS= 3J1jvbmCpbax64ihLYswxzWrDW7QQWrM1qzJZlmsCMLH5srzMzBAFXjgenqaWz1oLuRqYJPGAu0= MOKpNl4uCDkEGyIDT2AxQl8SUV8STy7L27dInL4RrYtPx9kOUOVeLCynC0Wuq6aAWbhUlrY56j4= +3NPDl7Gwm3rjqWzlVNS9ktQUjUzn9nLazbgB8yiVrMU9/HjVkCK++DT0SJHjPNOm22409HbFl5= l1syEgcacAmzAhQgIVEkRUXpYubfT/AEXLUvUXUXeW1Da32bsqtqtT8ikZ385k4nYYaDdTRerH7= kvkqraWRrDiWkeI9IZjPOsGoELnDXvgce3p+eqnc41pMtGprS59TeP2BX1nhKSthWxWV1D5Jnld= 57JN0+wg1OpGVeUUK6dFIT7RSTonCB2f5RWLQJlxcaROM8Dt9WVnz3i9bF5PwGjYdo3nhdpKWNl= oWZqruVQz5V/aMV1a81YNuaWsup86xtm/yiQ3KcZqppnDy/TDiZ0uTPlckbRZ91oc5pdXNYXDRn= dHZZLTQtTnS8GssLWfbr5sBiO6maGqWwiqfzqvSl+YWCj+kDjhmHKiPci7ScU1uwCXJlLiVdfOa= GDcB1wW80LRnHseN8vaL8RtxJ0hqfHskmRLKS0rlKgeo5PP7fX6f9zpSe3vwf8AA+n7a6Mv6bs1= NSgwtDzlip8OBncu6sKgSQOnv85WVeJgyaKU1B1JslhJBUErQV7UeOsiPbXaTDkqiyHbfZdMsIk= HNTK2GARocSnkRIsZoFBpiOzENpllsR7CjbYCICKIn0oiJ0j3HnA+F422VZs6PT2yy6+nk1kiAE= fH1EC5kTGhakWNymeoKiTPNFQpEWDIfOFBlGTsYARAbRiLHQxHIE1puQ0bjsV9psBdbIjccbIAA= BE1IjMlQQFEVSJURE7qnTT7nj2/LSAADgDjT0XH72s/9Qnf9t7qN6Ojo0aOjo6OjRo6+mD+8K7/= AD8X/lHo6OlX3H6j/ejX/9k=3D" width=3D"48" height=3D"49" alt=3D"Interfaz de u= suario gr=C3=A1fica, Aplicaci=C3=B3n Descripci=C3=B3n generada aut= om=C3=A1ticamente con confianza media" style=3D"margin-top:56.75pt; margin-= left:394.5pt; border-style:none; position:absolute" /></span></a><span styl= e=3D"font-family:'Times New Roman'; font-style:italic"> </span></p><ta= ble style=3D"width:403.75pt; margin-bottom:0pt; padding:0pt; border-collaps= e:collapse"><tr style=3D"height:3.4pt"><td style=3D"width:4pt; padding:0pt = 5.4pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:center= ; line-height:normal; font-size:10pt"><span style=3D"font-family:'Times New= Roman'; font-size:6.67pt; font-weight:bold; vertical-align:super">1</span>= </p></td><td style=3D"width:158.45pt; padding:0pt 5.4pt; vertical-align:top= "><p style=3D"margin-left:7.1pt; margin-bottom:0pt; text-indent:-7.1pt; tex= t-align:justify; line-height:normal; font-size:10pt"><span style=3D"font-fa= mily:'Times New Roman'">Lizbeth Tatiana Aguayza Rodas</span></p></td><td st= yle=3D"width:10.45pt; padding:0pt 5.4pt; vertical-align:top"><p style=3D"ma= rgin-bottom:0pt; text-align:center; line-height:normal; font-size:10pt"><sp= an style=3D"font-family:'Times New Roman'"> </span></p></td><td style= =3D"width:187.65pt; padding:0pt 5.4pt; vertical-align:top"><p style=3D"marg= in-bottom:0pt; line-height:normal; font-size:10pt"><span style=3D"font-fami= ly:'Times New Roman'">https://orcid.org/0000-0003-4629-9602</span></p></td>= </tr><tr style=3D"height:29.55pt"><td style=3D"width:4pt; padding:0pt 5.4pt= ; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:center; lin= e-height:normal; font-size:10pt"><span style=3D"font-family:'Times New Roma= n'"> </span></p></td><td colspan=3D"3" style=3D"width:378.15pt; paddin= g:0pt 5.4pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:= justify; line-height:normal; font-size:10pt"><span style=3D"font-family:'Ti= mes New Roman'">Universidad de Cuenca (UCUENCA), Cuenca, Ecuador.</span></p= ><p style=3D"margin-bottom:0pt; text-align:justify; line-height:normal; fon= t-size:10pt"><span style=3D"font-family:'Times New Roman'">Estudiante de pr= egrado de la Carrera de Odontolog=C3=ADa</span></p><p style=3D"margin-botto= m:0pt; line-height:normal"><a href=3D"mailto:tatiana.aguayza@ucuenca.edu.ec= " style=3D"text-decoration:none"><span class=3D"Hyperlink" style=3D"font-fa= mily:'Times New Roman'; font-size:10pt">tatiana.aguayza@ucuenca.edu.ec</spa= n></a><span style=3D"font-family:'Times New Roman'; font-size:10pt"> </span= ></p></td></tr><tr style=3D"height:3.4pt"><td style=3D"width:4pt; padding:0= pt 5.4pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:cen= ter; line-height:normal; font-size:10pt"><span style=3D"font-family:'Times = New Roman'; font-size:6.67pt; font-weight:bold; vertical-align:super">2</sp= an></p></td><td style=3D"width:158.45pt; padding:0pt 5.4pt; vertical-align:= top"><p style=3D"margin-left:7.1pt; margin-bottom:0pt; text-indent:-7.1pt; = text-align:justify; line-height:normal; font-size:10pt"><span style=3D"font= -family:'Times New Roman'">Andrea Soledad Carvajal Endara</span></p></td><t= d style=3D"width:10.45pt; padding:0pt 5.4pt; vertical-align:top"><p style= =3D"margin-bottom:0pt; text-align:center; line-height:normal; font-size:10p= t"><span style=3D"height:0pt; text-align:left; display:block; position:abso= lute; z-index:2"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAA= ABQAAAAUCAYAAACNiR0NAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAA2l= JREFUOI21lEtoXVUUhr+197n3nNzbJN6omdTWRmwbikVq4iMxk0ZU2oGgA1FnQcQiUhUnFqo4cG= IRQUGd+KDY+Jp25ouiGCOxElqjhba0URPzsPQmuY9zzj1nLwcnuU1iQ0f+mzXZe///Wv/aiy1cB= V/83NNOPr/VWHunqO5OVNuNlQVjmZCGjCVhcPHR3q8XrsaVNUITu/KSlu7LFeSpNNZ+57RTjDTv= qFM1IvNiGXWJvD/9x8yXB/efizYU/Hy8/0W/aA/Xq43r1P3nOCNIFsW2XLleTd648Z/863v3nkj= WCL59dp/fWSsfzOXNkShKacvfgnMRlXjqqqIrwr5vkihyhxbT+K2ne082AAzADZXyPj+wL8ehQ1= NH700v0N35OAroutW0rxDF6rUUvddaJfdwM9HwqYFSa0GO1SrpfucUVUXEZCQcqQtZ0VEU1QTPt= mAkDygiEBTsTxq6hx65fWTOy7l0exjKgGrGcjTo2/oKS9EUZ2aPcf/Oo1iTI9UGqFJrzDF5+Sv+= Wvg+y+IEVXaGibsbOO5hGBSkbUUQdRT9zaQuBhE6Ct2MT7/D9OIIVnw6Ct3csfk52oNtTMwcBbE= 0YteeC7we4LinSI9Z03dBNUVxTdu1eI7FcBIjHvPVU1Tjv7nn5sNMXv6WSjyFiIg17AAwqpRW9f= qayNkiM0tjqDrag67mDCi0ARiB6gaTsSEEg4htusj2qGeCIr9dW0JR3PKrR2zreIDURZTrZ7NTB= YdeBPAU+cY59zxCkFlXjHiI2GY1pZbtRMkC1gZcX9hFV+lBTs98SDWexYjFGqkldT0J4EkY/Zov= Bb+klbQ/G1zDYvQntXgWFC5VJ9hSGmRLaRCnCZeqE3x34SXK9XMY8bK+BvZ8JUzGAEQV+Wy87xm= /xbwZ1lwewGmCIIhYnCZXjKvDaQNrfIzkAKXYZl11wR16omfkyHIP0RB/2CV8GrRkNldbNmKbYU= 2enC0uV6bkfUNUd8P1ury3ktQADO05UV6azx1IE/dRULDomjGSVXEFhVbrXMoncTV99smBH5ZW3= 27igzP3trY2ONCyyQ6FtbRLUw2yZ8p+FwARifyCvRDV048rcfXdoT3j5fXp1+BVxdx2um+HGnuX= 9egX4dY01U0iVK2R80nMaELy42O7R39fz/1f8C/hZ5YvjpSKGwAAAABJRU5ErkJggg=3D=3D" w= idth=3D"20" height=3D"20" alt=3D"" style=3D"margin-top:0.45pt; margin-left:= -0.3pt; position:absolute" /></span><span style=3D"font-family:'Times New R= oman'"> </span></p></td><td style=3D"width:187.65pt; padding:0pt 5.4pt= ; vertical-align:top"><p style=3D"margin-bottom:0pt; line-height:normal; fo= nt-size:10pt"><span style=3D"font-family:'Times New Roman'">https://orcid.o= rg/0000-0002-4443-6864</span></p></td></tr><tr style=3D"height:29.55pt"><td= style=3D"width:4pt; padding:0pt 5.4pt; vertical-align:top"><p style=3D"mar= gin-bottom:0pt; text-align:center; line-height:normal; font-size:10pt"><spa= n style=3D"font-family:'Times New Roman'"> </span></p></td><td colspan= =3D"3" style=3D"width:378.15pt; padding:0pt 5.4pt; vertical-align:top"><p s= tyle=3D"margin-bottom:0pt; text-align:justify; line-height:normal; font-siz= e:10pt"><span style=3D"font-family:'Times New Roman'">Universidad de Cuenca= (UCUENCA), Cuenca, Ecuador.</span></p><p style=3D"margin-left:7.1pt; margi= n-bottom:0pt; text-indent:-7.1pt; text-align:justify; line-height:normal"><= a href=3D"mailto:andrea.carvajal@ucuenca.edu.ec" style=3D"text-decoration:n= one"><span class=3D"Hyperlink" style=3D"font-family:'Times New Roman'; font= -size:10pt">andrea.carvajal@ucuenca.edu.ec</span></a><span style=3D"font-fa= mily:'Times New Roman'; font-size:10pt"> </span></p></td></tr></table><p st= yle=3D"text-align:center; line-height:115%; font-size:12pt"><span style=3D"= font-family:'Times New Roman'; font-style:italic"> </span></p><p style= =3D"margin-bottom:10pt; line-height:115%; font-size:10pt; background-color:= #ffffff"><span style=3D"font-family:'Times New Roman'"> </span></p><p = style=3D"margin-bottom:10pt; line-height:115%; font-size:12pt; background-c= olor:#ffffff"><span style=3D"font-family:'Times New Roman'"> </span></= p><p style=3D"margin-bottom:10pt; line-height:115%; font-size:12pt; backgro= und-color:#ffffff"><span style=3D"font-family:'Times New Roman'"> </sp= an></p><table style=3D"width:437.15pt; margin-bottom:0pt; padding:0pt; bord= er-collapse:collapse"><tr><td colspan=3D"7" style=3D"width:151.1pt; padding= :0pt 5.4pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:c= enter; line-height:115%; font-size:10pt"><span style=3D"font-family:'Times = New Roman'"> </span></p></td><td colspan=3D"2" style=3D"width:264.45pt= ; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padd= ing:0pt 5.4pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-alig= n:right; line-height:normal; font-size:10pt"><span style=3D"font-family:'Ti= mes New Roman'; font-weight:bold">Art=C3=ADculo de Investigaci=C3=B3n Cient= =C3=ADfica y Tecnol=C3=B3gica</span></p><p style=3D"margin-bottom:0pt; text= -align:right; line-height:normal; font-size:10pt"><span style=3D"font-famil= y:'Times New Roman'">Enviado: 14/04/2026 </span></p><p style=3D"margin-bott= om:0pt; text-align:right; line-height:normal; font-size:10pt"><span style= =3D"font-family:'Times New Roman'">Revisado: 12/05/2026 </span></p><p style= =3D"margin-bottom:0pt; text-align:right; line-height:normal; font-size:10pt= "><span style=3D"font-family:'Times New Roman'">Aceptado: 23/06/2026 </span= ></p><p style=3D"margin-bottom:0pt; text-align:right; line-height:normal; f= ont-size:10pt"><span style=3D"font-family:'Times New Roman'">Publicado: 15/= 07/2026</span></p><p style=3D"margin-bottom:0pt; text-align:right; line-hei= ght:115%; font-size:10pt"><span style=3D"font-family:'Times New Roman'; bac= kground-color:#ffffff">DOI: </span><a href=3D"https://doi.org/10.33262/anat= omiadigital.v9i3.3715" style=3D"text-decoration:none"><span class=3D"Hyperl= ink" style=3D"font-family:'Times New Roman'; font-weight:bold">https://doi.= org/10.33262/anatomiadigital.v9i3.3715 </span></a><span> </span><span style= =3D"font-family:'Times New Roman'"> </span><a href=3D"https://doi.org/= 10.33262/anatomiadigital.v8i4.3568" style=3D"text-decoration:none"><span st= yle=3D"font-family:'Times New Roman'; text-decoration:underline; color:#056= 3c1; background-color:#ffffff"> </span></a></p></td></tr><tr style=3D"= height:3.5pt"><td colspan=3D"7" style=3D"width:151.1pt; padding:0pt 5.4pt; = vertical-align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-s= ize:10pt"><span style=3D"font-family:'Times New Roman'; color:#0000ff"> = 0;</span></p></td><td colspan=3D"2" style=3D"width:264.45pt; border-top:0.7= 5pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.4pt; v= ertical-align:top"><p style=3D"margin-bottom:0pt; text-align:justify; line-= height:115%; font-size:10pt"><span style=3D"font-family:'Times New Roman'">=  </span></p></td></tr><tr><td style=3D"width:52pt; border-top:0.75pt s= olid #000000; padding:0pt 5.4pt; vertical-align:top"><p style=3D"margin-bot= tom:0pt; text-align:justify; line-height:115%; font-size:10pt"><span style= =3D"font-family:'Times New Roman'"> </span></p><p style=3D"margin-bott= om:0pt; text-align:justify; line-height:115%; font-size:10pt"><span style= =3D"font-family:'Times New Roman'">C=C3=ADtese: </span></p></td><td style= =3D"width:10.35pt; border-top:0.75pt solid #000000; padding:0pt 5.4pt; vert= ical-align:top"><p style=3D"margin-bottom:0pt; text-align:justify; line-hei= ght:115%; font-size:10pt"><span style=3D"font-family:'Times New Roman'">&#x= a0;</span></p></td><td colspan=3D"6" style=3D"width:337.8pt; border-top:0.7= 5pt solid #000000; padding:0pt 5.4pt; vertical-align:top"><p style=3D"margi= n-bottom:0pt; text-align:justify; line-height:115%; font-size:10pt"><span s= tyle=3D"font-family:'Times New Roman'"> </span></p><p style=3D"margin-= bottom:0pt; text-align:justify; line-height:115%; font-size:10pt"><span sty= le=3D"font-family:'Times New Roman'">Aguayza Rodas, L. T., & Carvajal E= ndara, A. S. (2026). Vitamina C como modulador del estr=C3=A9s oxidativo pe= riodontal: perspectivas actuales y relevancia cl=C3=ADnica. Revisi=C3=B3n b= ibliogr=C3=A1fica narrativa. Anatom=C3=ADa Digital, 9(3), 40-62. </span><a = href=3D"https://doi.org/10.33262/anatomiadigital.v9i3.3715" style=3D"text-d= ecoration:none"><span class=3D"Hyperlink" style=3D"font-family:'Times New R= oman'">https://doi.org/10.33262/anatomiadigital.v9i3.3715</span></a></p><p = style=3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-size= :10pt"><span style=3D"font-family:'Times New Roman'"> </span></p></td>= <td style=3D"border-top:0.75pt solid #000000; padding:0pt; vertical-align:t= op"></td></tr><tr><td style=3D"width:52pt; padding:0pt 5.4pt; vertical-alig= n:top"><p style=3D"margin-bottom:0pt; text-align:center; line-height:115%; = font-size:10pt"><span style=3D"height:0pt; text-align:left; display:block; = position:absolute; z-index:23"><img src=3D"data:image/jpeg;base64,/9j/4AAQS= kZJRgABAQEAYABgAAD/2wBDAAEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEB= AQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQH/2wBDAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQE= BAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQH/wAARCAAiAEEDASIAAhEBAx= EB/8QAHQAAAgMBAAMBAAAAAAAAAAAAAAcGCAkFAQIDBP/EAD0QAAEEAgECBAIFBg8AAAAAAAQCA= wUGAQcIAAkREhMhFDEVFiJxgQoaUWGR0zZBUlNXWHWTlZehsdHW8P/EABwBAAEEAwEAAAAAAAAA= AAAAAAgAAQMEAgUGB//EADYRAAIBAgQCBQoGAwAAAAAAAAECAwQRAAUSIQYxEzJBUXEHIjM0YXS= BkbGzNVOCobLRhMPw/9oADAMBAAIRAxEAPwDaOudw/ZPM/t483Jm1VqLoVw1PSIZAlgo8pKhNnv= TT6yGzxGXnVHQpYL0WpbTg8k+rKn0+VTeWMqdbnYf3ruHcWt9yRe1Nh2fYItDsNVCqr9rkHZqUj= A5aNlnzhfpo7Dsweyt4dhbbcicZgRKPTF9FvKk5yd4H+/bs7nX6qVRv9MTWetDPydX+A/JPGfbP= 1so2cfjETn6P1eP/ALw6JHjPh7Jcl4c8p1Jl1BBBFlfF2TU9CSokkpopqaJpEhkk1SIHYvqs24Z= l6tgBn4Nz/N834l8n1ZX1s00tdw/mT1e+hKho5qkRmVVsrlAFKlgTqUP1rkz3mrUbNzI7oOs+F1= o2hfKDout6MkdrT0HRJ1+vnWqcyQchvK3U4eDMIYfREfCuyARqY4EWYyG2y+Wt/HX2ZpbXPbrvv= B6g69uW9piubO5PyktPkzO3zRGsKCrdbYeFsoEdCsDW+sJEFS6muyOR2EkLJfwVjJCsIsR3AOHO= stmbX1dyNY5Wi8N95UwIus1zZJVgrkSzYoNtBjj8RgOxz1faLKDbmTmXlClvNERcoSBKgljOsZY= gVI4UH7mVpC4XznvG8pWuPe75DaC7ELH0+UEIijYGEjCKMUdWLOYFEM4zGkSCjiPiHvCQVjIuG2= 0qWOhKkRm5CgAFQNiQNJN/bfbs7D3YJjCz1l3jrxuOZsMrTde6DjaDHg7OlYWCsnIOuMb0l4nXt= bsU8ybnU4iHZlpUqiC9dwZtD2RI1wiQbdKDHSS91tWd3Lb6TdJWDkPx2rtD1PyD1xs3YWuLnS77= izyTwerq07aJtmVgHwRSAcuhpYHZS6425l8sfLeHkJJyx3NadoArWR88JrjkHX8aqnQ9ihRkJK6= E1dO3ePithQE5CLEY3Clpi6PMx6ZrK21hngoKDZcjsJHELeThnmdsykuVzhtQ7htts6F4oa527T= JiPchxosrYdc2hV2a5Kn5dzNqcrTcUGM+/klvEmhSsq8zo3o5cymEF+qLb3Pn6uR7Lc7+OFhLTv= NTl3vHiZtTeM3xtjtWcdJ7Td7t9WvVc3cqM2wqMEBI+rh0azGxKjYIqZdaQseTaZw8Ey6kpDK21= NqXELX3OtscdtXanzGV3jzZa0zxz05f2w9p8qoCK3vYR5nXMFNSqCKvKMJn5+deLcOHCkFh4NtL= 7X0gwGp0xDGW7q3t6bMM0ZYdL0vn8Vszi1ZKBeNd02rDUek2SPhouXXIAR6hr5DzLpsympSGXWU= hsHjj5cDVG4QEwykZlPba7PVXgSHJ5fK6ma3AvWsNSaQsj2z9S6ytTcxM0bX8XraLeo07epH4+m= y1kAhmix42snszKZFWVCyJKhA/hWAhvuQAWuAA97eaBe9t9vgdh2YWIB+cgag/oGvn+LQv73o6W= H5tvBf1tH/8AK4b/ALn0dS2pe9vmfZ/3xPdssVI4H5xjt3dzpOfnmk0jw/DE1jw9vHPv88e3v9/= t1oV+Trq8KTyT8ffP1rovhjH9jzmPn4Y/T4/d8v4uopw57fvKXTmkOTeidz6PshNf5FRFficWHW= WxdNSMxW24dR2CHHI60XOFCdU9g1DjbjZRGEZZUhQ6vUwtD/4k8O+RnBI22SWmpU6YqdxlIl+w6= 03fr5hgyQRG4y00RH7F0hadq4hjEClGoYMKqJMVheU5kwmGkoKT7/xzxTkGZ0/lGy6izKmnlzzi= PLM0yueOTpKWohpKeJJB0sYcxtcuqiVUDNYXAFyNHBnDue5XWcDZjWZXVQwZPldbR5hEYmFRA9R= JOYyUdk1qRIjExs1lJ22Nux3laRV9l7b7bOv7nGIl6jduTrVWs8U4QQImSg506mx0qEsoN4ctjB= IRDzOXhiGX2vNlbLzbiUqxQDkLq3XPBvn5Y9Z8aoJEdrLZvBffEntHWBE5PzdckUxmsNszzTM0t= 6XcmGBHT6ZXjMfDywkgKl0j4EwVmRd9TbHkRxO113Ea9rIfb5G29NWbV8tIWSJCrErDRskzLSjA= gjp0bZMx0uFKAtZjmiI8iPXHTIXmaVNRsOa58C3HtOdobjTp4bbhQ9h2le7puDWto1TL7E2BaB7= BbIKo2+LVEzTFceVGsgCHPi+klMgWCaQhDOBkqwG8SO+Pino10OTqUOhQWKm7bHUCQbDfa4uNiR= Y4JSORZUWRCSrjUpIKmx7wbEeBAI5EbYo3ovmFy12G5qLjJxGh9D67C1dwx1vuK8SuyI64y0fn6= YhYF4auVEIOTKkciBDzUaww7IknvL9Mxw2V9ZDDRKV1xya3Vyi3Nom8OwWoYvfF84K8hTWdgGQl= tyBDoq20Nt1nMQNCCWvEfmJLhoR1xzLwRElmTMW+k9sbDYrTz5icILTRbXqqJ41cdOUNzmqHoKv= 6tzvfSnImi6fkpqCiFHRkfTbxHTUQ4qYfAFAjZAySjxgWDRzBw8p8I5lLL64acA4DjTqPSW9uRc= nNQO0NKcf9oUe5VwSTj5eqRVNvFtvV9m2JPEaAabK2GKCthQRJEPKPBPksZSE0V4oeeyuthZQWY= 6VVVDOzG9ha5LajYabXuRbuDu6orO7BEUFmZiAqqNyWJ2AA3JOwG5xTbhnvTeXGbtiUHYczvfRG= tKVYL0bWdOfWjV2xbxNNGv7C2c7d4WZiaSSbJ2KWm5EVg2tuRMeONExYhrclh595hzCQ2lzs2by= x13I682WbSbU9pnmrxCIrmwKRTrrr4GzQtzk7E8pk2m35gWyRJsaTFKQpwwYZJOH14YbfEbGPNu= OZxE4KVmnxWm2d+cjSYOwXGC2prCMAuo6ndEz0POSahJOmJfjBm6oxZsX86ZeKdZPanomETZBTH= cgCmGTCD4N8JhV2oojktuTaVsuW1tIXOZkbBcoGyXaXvGq5eYj6fAKdKro5jq2VSBQk+AZlBocZ= GMKaICHDdyqZoJUHSNTygMxKkRED0ix2FuQButztqv2G+Ka5lQMzIKuAsukMusXBZBIBY730HUR= zAvcC2Nu/Sa/kJ/Z0dfb0UfzJ393j910dU9Dd37j+8WOnh/MX9/69o+eJNn2Tjw9vteH4eKfbr3= +fm8ffwznGPu8Fe33dHR1GOs36fpjCPmPFfouPyPYx4te2PZft7fL7Of8AnP7c9ddPyx92P9ujo= 6deQ8B9MTry+X8Vx56qlzLSlejpZtScKQ7c9UNOoVjGUONObSpyHG3E58cLbcRnKFoVjKVpzlKs= ZxnOOjo6t0PrlL7xD9xcUM2/Da33ab7T4UQWv6FKHxUhJUioyJ7MXDYZNOrUMWW1hjIa2MNkkBO= PN+it1xTXlXj01OLUjy5WrOZlG6+oQ2zUTY9IqDEyuzlFql2a1DNSaiktj+UlR6AklZIT51+V7L= uXMedXgr7WfE6Ot03of8Vftx445PWF9+X+Yxcjo6Ojrnx2fD/Xjssf/9k=3D" width=3D"65" = height=3D"34" alt=3D"editorial1.png" style=3D"margin-top:47.15pt; margin-le= ft:4.85pt; position:absolute" /></span><span style=3D"height:0pt; text-alig= n:left; display:block; position:absolute; z-index:-4"><img src=3D"data:imag= e/png;base64,iVBORw0KGgoAAAANSUhEUgAAADcAAAAmCAYAAABgUQN4AAAABHNCSVQICAgIfA= hkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAB+BJREFUaIHtWH1sU9cV/533nr9iJ7HjJCQB2iRAK= VC2wSjthIDQVprGtjI0JdoQVKOtOk0Tk2gLK1NFXFVo6qjKCh0t3QYd3drNrGgqU+nHSlBpYRsB= VqawNnylIQ1JSOz4I/HHe++e/WE7OPZz4jj5k5/0/OR7zz33/O4795xzL2GKsa+11fTjJUvUAy1= XrXHFUmk1m6yF6tp99J9dvYEIzy6t4IaVDVpzA3Qi4nzHU6ETG2Gz96RtRX3dtrVLqrevePa9ul= BM8goy3TFhRQSAgYGhoW6LUPm2shKfo9S+NxQOXIiponPG/GDgUFOTPp4apRASRvC2sfnQsU/Wn= TUFfwRg+5e+gKyS3aFDlBSuVSmJkIx2XxxKIL5MIgxWOpS3fR01v2vwtJw+7lkVHWu0VPjEo3Gs= tfVrbd1Dv1LFlDoDiAgghiYIMR3OrqD20LWBob8F48OPPPjcx8VjjZ0Scpv2f1Tx387gLwMRdk2= FviyQBFCSKAjhOJf1R2lnZzC0ofEFry3XsEmTO9By1do9ZFp/bVD7BtP4e5gBgDn5IMeT6qfR8m= nQWLL1R6QdPcPlq71er2w016T33Jtnehd0+UKbdWZbYmXHAQN2qxJz2qQ/9fgj541ERPJ938KaD= a3tX9YMqajWBJCKf6l5BFB6I6Tu+Etf7WcA2jL1TIrchpc/rfy8t98TjIiZyIcYAAJDE7jhchTv= +/f2+06PJVvv8exZ88NNNQeP/e/pT7vCD6uCTaDE1yQAYKaIhrn+4NCju9+5+NTPVs+JpY8v2C0= 37X7H0n6995vXg+oDE4khTARigCTO6ZSpx+PxiO9/1d3VUDv9qWVzyv+qyJLOKbdNElSZ0B2IPv= jBha66zLkKJMfUPmydHVbpeZ3Zmrkfphqb19YNypLucZrF5URISYISmzyq0+3X/eoij4dH8SmIX= IPnuH0wInYPRrVKIglEU5ZRcuI7yxwd5SWWo7LE8cw+VYcc17U1R3HUkd4+Yau8zLLFpG7uDmrL= eGoLnDHRtGBB3G2XDykSDWbPS4jotBTAqIJhwuRO/vE/y68GxFZBZMkrOk4h5te7LwPsTyaImyC= GxjQjEOSi9OYJkdvmPVvR1h3aH1bhGF966tG8en6fWYuFjJY0prOpusZdzMwj3XmT87axuTukP9= feNzQzc+UYySQrBFRIIoeKSYOIxD1zq4UsZ7slg3D3rIqfvHrmzEh6y5vc4Q8/uefEZ/7vqoKUz= MMEpSoJggj4Bp6dDIHxMLd2GiSDAEZgnPjXefOrZ2625UWuwdNSfrYruE3VRXmyyDNQDtQ6LUd+= ++jS/QVbngccJglGe50AKBbFVX/9Sv5uuWHne3aLQ94cF9L9ApSjEGEUW+S+b9897RcTOUwWAm0= M7UIg/wql0euV+4V54aWe4Y1xHebM/tReU4iH68rMW86F2z4v1Oh8MeAPQRgUDQxCdaUr7KquH+= kc+8v1VJVd80dfigtUG4Z9BmQCXDbpWGRYvJ3P6XiyOHWhE7rIjlkEwr0Lb7/ygOvrI51jkgtG8= WRIlb8ixnAFq8xd1SXmHcebGwLp7TNLS+Cym+F2WEaeMocF5Q4znEUm4bQqE3bfDy5zaWeYbXqm= QZwIKAePXzrc1EQjC5zzVPDih91rdx09/1NVkClXriYQXMUWtltNW9fuORWte+Nc2wvrFu0AgG8= tqu0tctgfV1kqTR+jA1AkDsX02MU/T5DcwfdPztQhuWCQxEuspqEyC0ZdOxiSO9By1fnr98/vVX= W2J4J87g98za/O6BqMTycwhjTpGIAdAPDzNXeGmPndZ57JrtGam8GFBJ5hVVquC3JmdTAQiw5fC= LA8ynuyyD22r9X0h1Mdzf0RMY0lGeOZQBDEIGIGIMSoVUgSyNLg8eRDZTQ27v+o4vTF4Pd0wY7k= kTXNBnB5sfXwvFoldC5tzChjGr1e2V1Z9IMOX+wRQXLCG8cqHwmGOW+qsfX3HxfLcvGWmM4rOXu= tYFXIV2SRT7y2cVVut/RfcU0/EuraoglySMbBERJzjCAi6evCEGBIYOLwSGOjV55fAduw2TSp03= 6V1eo82xtZf8Uf3hDVYEldEiUmZhB04bZbTlSZKSsNjUzcuK+19FJH7xODUXkWG8R9ZoZEwBy3y= dtxI/y6nqFEByBJRQOptlluxR2ReadguTpzoQQb7OKkjMDNPsGMHpUr9H5tts7kMHIlsyT3O23K= 7jeeWOl780kDco1erxzoCC0PavI6ARQZMAOB4TBL3XOnl21vefr+jkwRAOhM/2PTSnTYlupkutM= o+empi5CUl6VNOiLPgCZS3p8mkEziMnGsqsT0+ixHxWkiykp+CgDoPbdV+4aHd8U1uI2MBhiKLG= NxvXPXgN3cbSxjAJKQc9NSxjuHTK5uBvG8KvupWeXOF/c+vCBsJKM8tq/V9IXP/3xfSK3XkXSgr= PKG4LSI9lAs8taRpqVZx/yctrFhsJwAEp828ctIncAVibF4puMfNaXmhyq/eKsv12jFF4vee9En= 1upCJgBstFIWhVDlLNrz+F3Lrh2ZgGmcuOcqmB1zwh2ZARDDQoxim9K2Yl7Vb15av/CV8cYrJMQ= qocZflmGcqgUAp8nsdznUv69aRVq+htmEFtJJew0QNYVdH0nQIKCwwDSrhMV3VAdicf1dpUy+sK= fxruBL6wtSegu3cAu3cAtZ+D8xrVXPnmihogAAAABJRU5ErkJggg=3D=3D" width=3D"55" he= ight=3D"38" alt=3D"" style=3D"margin-top:9.25pt; margin-left:12.6pt; positi= on:absolute" /></span><span style=3D"font-family:'Times New Roman'"> <= /span></p></td><td style=3D"width:10.35pt; padding:0pt 5.4pt; vertical-alig= n:top"><p style=3D"margin-bottom:0pt; text-align:center; line-height:115%; = font-size:10pt"><span style=3D"font-family:'Times New Roman'"> </span>= </p></td><td colspan=3D"6" style=3D"width:337.8pt; padding:0pt 5.4pt; verti= cal-align:top"><div style=3D"border-top:0.75pt solid #000000; border-bottom= :0.75pt solid #000000; clear:both"><p style=3D"margin-bottom:0pt; text-alig= n:justify; line-height:115%; padding-top:1pt; font-size:10pt"><span style= =3D"line-height:115%; font-family:'Times New Roman'; font-size:8pt">ANATOM= =C3=8DA DIGITAL, es una Revista Electr=C3=B3nica, Trimestral, que se public= ar=C3=A1 en soporte electr=C3=B3nico tiene como misi=C3=B3n contribuir a la= </span><span style=3D"line-height:115%; font-family:'Times New Roman'; font= -size:8pt"> </span><span style=3D"line-height:115%; font-family:'Times= New Roman'; font-size:8pt"> </span><span style=3D"line-height:115%; f= ont-family:'Times New Roman'; font-size:8pt"> formaci=C3=B3n de profesional= es competentes con visi=C3=B3n human=C3=ADstica y cr=C3=ADtica que sean cap= aces de</span><span style=3D"line-height:115%; font-family:'Times New Roman= '; font-size:8pt"> </span><span style=3D"line-height:115%; font-family= :'Times New Roman'; font-size:8pt">exponer sus resultados investigativos y = cient=C3=ADficos en la misma medida que se promueva mediante su intervenci= =C3=B3n cambios positivos en la sociedad.</span><span style=3D"line-height:= 115%; font-family:'Times New Roman'; font-size:8pt"> </span><a href=3D= "https://anatomiadigital.org" style=3D"text-decoration:none"><span style=3D= "line-height:115%; font-family:'Times New Roman'; font-size:8pt; text-decor= ation:underline; color:#0563c1">https://anatomiadigital.org</span></a><span= style=3D"line-height:115%; font-family:'Times New Roman'; font-size:8pt"> = </span><span style=3D"line-height:115%; font-family:'Times New Roman'; font= -size:8pt; text-decoration:underline; color:#0563c1"> </span></p><p st= yle=3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-size:1= 0pt"><span style=3D"line-height:115%; font-family:'Times New Roman'; font-s= ize:8pt">La revista es editada por la Editorial Ciencia Digital (Editorial = de prestigio registrada en la C=C3=A1mara Ecuatoriana de Libro con No de Af= iliaci=C3=B3n 663) </span><a href=3D"http://www.celibro.org.ec" style=3D"te= xt-decoration:none"><span style=3D"line-height:115%; font-family:'Times New= Roman'; font-size:8pt; text-decoration:underline; color:#0563c1">www.celib= ro.org.ec</span></a></p><p style=3D"margin-bottom:0pt; text-align:justify; = line-height:115%; padding-bottom:1pt; font-size:8pt"><span style=3D"font-fa= mily:'Times New Roman'"> </span></p></div></td><td style=3D"padding:0p= t; vertical-align:top"></td></tr><tr style=3D"height:23.65pt"><td style=3D"= width:52pt; border-bottom:0.75pt solid #000000; padding:0pt 5.4pt; vertical= -align:top"><p style=3D"margin-bottom:0pt; text-align:center; line-height:1= 15%; font-size:10pt"><span style=3D"height:0pt; text-align:left; display:bl= ock; position:absolute; z-index:-3"><img src=3D"data:image/png;base64,iVBOR= w0KGgoAAAANSUhEUgAAAE0AAAAcCAYAAAAk2zLiAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAO= xAAADsQBlSsOGwAAE1VJREFUaIHtmVl4VFW2x3/7nFNThspMCIEQQgIIBBRkaIYWkEFQQbG9Aa+= EQRlUtBlaBZtPbMBuVGznDuA1eMMgiHyIAsokqJhIEpFJgiaoCVAhQAKVpFJVp6rOvg+VFAkCfr= 7f9XJS+5y19lr/vaa9InRdl2fPnSVgGAgBCBAIgiQbH42/hQDZuEbz7wAhkciggGYkpQzKRSDl1= feimTwZZG8Simwp4dptAVAQIVktXrXY/homrm4i5NUPZUszmtlD0CYpMQIGHVLTUFQFUVl5Vs54= bBaj77kbiXH9PRotESL4bDJdIhv/aHy2xOu3JJsZKiUGEmkYgEBTlOsbLq41vEkvgTQkhiExBCi= KQAjRUg3RwoiW/FIBKQlII2iPAEUoIV4hQAqJlBJFKOzdtZd/Lv0X6ekd0epdDbRvn0pCQsJvQW= syLiDRdR8ejwevruP3+1EUBU1TCQ8Lw2Q2Y9JUhPI7qEmQUqDrOpcvX+ZKrZP6ujqEULDb7URHR= 2G3R2Exm2h0ebhGJ8Mw8Pv9XL7sxFlbS63TiTQk9ig7UfYo7NFRWK3WRl3kb0ATQhAIGNTUXKHW= 6aS2rg5d1wmz2bBHRRETE43NZkPTtNDeAkFax478/PMvQdCQEiHUkMDmYEkJXreO48w5Thw/Tll= ZGZcuVuNqcGExW7BH2WnXLpnumZl0SO9AdEw0iqqFTqr5wSJBGgaXLl6ioKCAY98fxe/3Y7XaMA= wDt7uBSHsE/fr/iR639iAqOhpFDXqPbIxNw5A4rzg5duQYBQcLqK+vJ8wWhqIqeL1eFEWh5209G= TBoEHHxsaA0BkAoQiQet4cffzjFvr1fcOnSJWw2GyaTCY/bQ0AGyEjvyB1D7qBtSjuESQt6umwC= 30AIgQZNYSFC+afxNc4rTvbt3sPX+7/C4/EQGxtL69atiYiIQNd1ampqKCr8jvxvCkhNS+X+v4y= nU5fOKKoIRmzQxxEyKPtSVTW5772H1+Nl3LhxDB8+HLPZjKqqOJ1OtmzZwhd79lFaVsp94+8jJj= 4WTVwN25qaGj7Zuo1fT5czcMAAsrKyiIuLw2QycfHiRQ4cOMC2bds4efwkUx6ZQuvk1qFYNQBXv= Zuv93/Jns9307dvX555+hnatm1LWFgYNTU1HD9+nLVr17LynVU8PHkSnbp2QTGrhHJSE1KlpaXy= zXfe5s9D/9wYnsE4djrreG/V//DD8ROktk9l4sSJjBs3jpiYGCwWC4Zh0NDQwKlTp8j5z384ePA= giqYw5dFp9O7TO5hjaAIM6l31vPbKv5GG5P333ycjI4P6+noWL15Mp06dmDNnDnV1dRz8+iB/X/= R3OqSnMv7B8YSFhwPgdrvZ+tFWyk6VsWTJEoYOHUpERATV1dXk5+dzzz334PF4KC0tZcb0GXh0L= /MXzCM8IhwhBD6fj2++/IatH21l/vy/kZ09ifDwcOrq6vD7/URERGAymbhw4QILFy7km/xvmP3U= bDqkp4GAwoJDDPvzMEaNGsXVY5QilAK8bg/vv7uGI4eP0L9vPz7avJk5c+bQpUsXkpKSiIuLIyE= hgZSUFIYOHcp7ubm88MI/EIZg1TsrKTlxEimbPDZYVQ8cOEB5eTm5ublkZmYSFhaGy+Xi4MGDfP= HFF0gpiYqKYsTIEcyfN48jh4/gqDgXShOOsw6++uIrxowZw6BBg4iMjOTixYts2LCBV155hcLCQ= qSUdO/endw1uVyoqmLXZ7tCKafKUcWnH3/K1KmPMGvWLGw2G+vXr2f8+PGMGjWKRx55hIMHD9Km= TRtWrFhB+5T27Ph0B676ekLGNLpbi5IlEcgA7PlsD8WFRfTs0YN169eTnpGBzWZDUZRQjmnKMya= TiZiYGGbOmsmKf7+K1+Nldc5qrtQ4g+egQIO7ge0ff8rMGTPp2bMnqqricrm4ePEi06dPJysri+= LiYgDMZjNjx42jR2YPPt32KboeIBCQfPLxJ9TX17Nq1SomTZrE3r17GTFiBEuWLMHhcDBr1ixOn= TqFpmnccsstPProo+z+bDcetxfDkBQVFRNlt/P4YzOxWMxs376dOXPmcP78edq0acOhQ4eYMGEC= hw8fJjExkeeff56ff/4ZxzlHs8i8FrTGYlV1vort23dgt9vZvHkz8fHxSCnx+/34/X4Mw2hWKCS= BQADDMFAUhQkTJvDEE09QU13D3l27wB/ACARwOBzofp2p06aiqsGic+bMGbKzs5k/fz5Tp05l/P= jxjTlVYLfbGTJkKJWVVcF9AwEqfiln4cKFLFu2jIqKCrKysigtLWXatGns2bOHrVu30rNnz6BRi= sLEiRPxeLw4Kh24GlycPv0zw4ePIMoehdfrJScnh9jYWDZs2MDOnTvZuHEjAAsWLACgY8eOxMXF= cfbcWQSisQflWk+TSAH5Bfk0uN089de/0rZtWwKBABcuXKC4uJjCwkLOnDlDIBDA6/VSVlZGfn4= +x48fx+l0IoTg6aefJioqikMFh6i94kQIcDe40RSN1PapwV6q0VsNwwiB33QYTUanp6ej6zqGES= AQ8KP7fPTt25eZM2eyf/9+Xn31VQYNGsQHH3xAVlYWu3fvpqysjLq6OqSUdO7cGSkldbV1eHWdW= qeTrt26opk0fD4fFouFzMxMkpOTAejUqRNWq5WjR4+i6zoWixnNpOF2e5BG86Zdol3FTOLTdX48= WYKmKGRPmoRhGDgcDubOnUtJSQkmk4nExERWr15NcXExS5cuDXnH6NGjWbRoEfHx8QwcOJADX+6= n8kIV9viYxv4s6JUQrKpmsxm73Y6qqkgpadOmTTNVgiAKRaAIJdh0ChHqDxMSEpgyZQqjR4+mqK= iIvLw8Fi1aRKtWrRg7diwPPvgg7dq1I3ibUEIHFQgEEEIQHh7OsmXL8Pv9xMXFoSgKgUAglHIg2= N40XUNa3nNky/B01dfjdDppm9yW+Ph4fD4fb7/9Nvn5+Tz22GO88cYbJCUl0dDQwMKFC/F4PLzx= xhvMnj2buLi4kKjBgwej6zoXL14ECVHRURiGwQ8//BDyrNatWzN79mzCw8NRVZV33303lLQNw6C= kpASr1YqiKKiaSkREOCdOnGiKCWpra1m/fj3R0dFkZ2djsVgwmUzs2rWLyZMnM2vWLBRFCVX7mN= hYioqK8Hp1hBCsXLmSxYsXU1JSQk1NDcXFxbjdbgYMGIDZbMbj8eDxeIiMjEQRollwimaehsTtb= sDt9tAmLRlFUfD7/RQXF2O32xk2bBhdunShV69e6LpORUUFY8aMYfDgwfTv3z/kPYqi0K1bNwIB= g7raOpCSVq1aEREZwepVq8nMzMRisRAREUFycjImkwm3202PHj1CYXuh6gL79++nXbt2mE0mpID= UDml8/vnnZGdn07p1a2pqatixYwd5eXl4vV7S09NZtmwZ8fHxbN68mddff51IeyQJreIxmU107t= yJgwe+5sKFKlI7pNKvXz+2b9/OlClTyMjIoKioiLi4OJ577jl8Ph9HjhzB5WogJaV9s6ZfAUSTp= wVxVFUFVVHweDyhMLJYLOi6jtfrJRAIcPr0aXw+H6qqUl9fj8/no7a2lsrKSnRdR0qJy+VCCIHJ= pKEgsNos/OW/HuDDjz7ks88+a1FMmvZp+u1yudi48QNKy0q5Z9xYVE1FUQT3jr2HijMVrM3Lw+V= ykdy2LWvXruWFF14gLS2NdevW0a9fP9LT0+nVuzd+I8C9943FYjGjKoLb+/YmgGTJkqW43W6ysr= JYsmQJcXFxlJWVMXToUHJzc+nduzdnz57lH0v+QcdOHUlsnRi6mzaRFopNICwsnPCIcBwOB36/H= 5PJRHZ2Nk888QRz584lPT2dffv28eabbzJkyBAKCwuZMWMGVVVVNDQ08PHHH2M2mzl06BCaphEd= FR2aEvTt15cTR08wZ84chBCMGjWK5ORkHnroIbxeLwB1dXWsW7eO1994nTvuHEpim0QQEkVAq6R= ERtw1kpyVOVhtVqZNe4SkpCSGDRtGamoqbdq0wev1snvvHubNncutvXoxZOiQoD8ogpj4WCb890= RWvZPDU0/9leXLl5Odnc2ECRMIBAKoqorVauXHH39k+vTp6F6d+8ePx2y1tJiCAKhPPjX7hcKiQ= lI7pKJpKke++56ff/mFMWPGkJKSQlpaGsnJyRQUFIT6oaysLEaPHk1paSnHjh0jMjKS1157jZSU= FACWLl3K5SuXGX33aKKjo4Nep6jcdlsvTpedJicnh6LiIrp3z2T48OH06dOH4uJipj/6KB9u+ZA= hw4dw1913YbaaG71QoKoKySltkTLAqpWr2bFjB4mJrbFYrZhMZo4dO86zCxbw1ltv0alzJ2bNmo= lm1lBU0TTCID4hgXZt2/H+mvfZsGEDYRHhREZGovt8nHM4ePnll5g3bz6BQIAFC54hPiEWoQQnJ= +fOnqND+/akp2cgSkt/lG++8zaDhw1BSoPi/EOsfHslQ+8cxsaNGzGbzQD4fL7GkDM1qzBGKFQ1= TcMwDAoLCxl25zDS0juy4O8LsIVZr6ZQqeDz6hQVFbF71x4c5xyoioJEYhgB0jMyuPveu0nvnIF= mNjWb7V1Nw37dR+mPP7Hzk52UlpaimTSQAsMwSEpK4s6Rw+nTpy8WixlDbWpjBFIYSAmqVDh/pp= KtWz/m5A8n8fl9KELB5/MRlxBH//79GDliJBH2CALCQApQpeBQ/iGG3TGEUaNGB8NTSok0JBJBl= 65dSUpOYteuXXz00Uc88MADWCwWzGZzs4TY6KaqGmpWDcPg/PnzzJ8/H03TuPveuzFbbc2GkMEs= YLKY+dPAAfS87VauOJ24PR6EENhsVqJjYjGbtcZ7K82mg1eBM5lMdOvendQOHalz1eNucGMYBrY= wG/aISGw2K6oSvGQr8mrVE6HppqR12ySmPzaD2ro66uvq8fl9aKpKTEwM0VH2IB5IBKA0zWGbtS= OalJJ6Vz0Xqqowm0zYbGFMmpLNv1e8xtPPPE1iYiL9+/cnIiIiOJBTlFBv1iTI7/fz66+/MnfuX= L777jsGDh5It27dqL1yhYDfj9I0Gmu8qjV1PlaTBavJEsLFXVePR8rrDx6vIYmCWWiYwiIbv5d4= 3W68bncI5OaNQospb7NhaERYGE1TDL+uc+nipav8zfo0V50r5DSipKREDhw0kMjISFRVZex94+j= Vpw/FRUWsz8vDZg3jiccf54EHHiA5ORmLxdKin3I6nRw6dIjly//F90e+55auXZn6yDQCRoB3V7= 9L7WXnzSy/Pv3uBPgm736P94/u2/htfX09eXl5jBo1KuhpNdU11FTXAPDhps0kp6TQ9099sdmsr= Fvzv7z88sts2bKFQYMGkZmZSUJCAi6Xi4qKCvLz8zl8+DDOOieDh/yZcfffj81q4/01ayg58QM+= 3d9CB5PJFGqEGxoaQusul4uwsDAMw8Dlct3QXovFgtVqxeVyYbPZCAQC6LpObGwsQghqamrw+Xw= 35A+mAhuJiYk4nU6uXLmCqqpERkZSW1uL3++/IW8TadcuVJ2vJOed/zB3/lx69uxB4tN/Y9+efR= QUFFByqgSTZkLTNKSU+Hw+JMEr0EOTH6ZTl05YLVY2rF3Pt998+xvAAKKjo9m0aRPnzp3D5/ORl= 5fHpEmTePLJJ8nJyWHx4sWcPn36hgp37NiRF198kXnz5nHnnXdy6dIlLBYLDz/8MIFAgNzcXHbu= 3HlT41esWIHf7yc2NpZFixZht9t56aWXeOqppygrK2uRv64leT3QAv4A5b/8wovLlvL444+TkZH= BxOyHGDN2DOccDsrLy6msrETTNDp37kJKSgrxcXFYrWF4vR7ezVlN/jf56I2917WkaRpms5ktW7= Ywfvx4ysvLsVgs5ObmcvbsWc6cOXNDhQFsNhtpaWksW7aMU6dOoSgK9913HwsWLKChoYHExESU5= v+kuQ4NGjSIDRs2sH37djweD5MmTeL48eNMmDCBF1988aagieuBFgTOz/lz5/nnsn8xYtRIRt41= gvhWccQlJtDjtlsbiwBIaWAYwQRc9O23bNq4icrKyptu2gRceHg4drsdTdNYsmQJhYWFdOnSJXS= pv6HSQvDTTz+hqioDBgxg27ZtREZGUl1djdvtDo2ybkSKovDkk08ycOBAnnvuOdasWUNmZibl5e= WMGTOG5cuXt5i4XFf/665KQEo8DQ3s2PYJB7/8ioyMDDqmdyQxMZGIyAh8uk519WXOnDnDqZISK= s850HX9ppsBodlcq1atQgBVVFRQXV3N+fPnfxc0v9+Py+XirbfeYtOmTbhcLrZv387zzz+PEIJv= v/2WI0eO3DCvqarKs88+y65duygtLaVz587U1NRw9OhRMjIyuP322ykoKLipDuLkyZOya9euv2u= sEAJFVdBUDZPJhGEY6Lr+m5HK71F4eDj9+/dHURQcDgenT5/G7/czePBgvvzyy9895bi4OGJjYz= l79iyZmZk4HA5cLhc9evRASsmJEye4fPnyDXVSFIX27dtzyy23UF1dzZUrV/D5fJSXl5Oeno7X6= +XXX3+9Lu/OnTsZOXIkory8XE6ePPmmija/UF9v/Xrvbiarqc/7I7zXNtbN6Y/Ia95fNpfbXMaN= +FesWBGaDv8//UH6Pw/h65aldWKXAAAAAElFTkSuQmCC" width=3D"77" height=3D"28" al= t=3D"" style=3D"margin-top:0.15pt; margin-left:0pt; position:absolute" /></= span><span style=3D"font-family:'Times New Roman'"> </span></p></td><t= d style=3D"width:10.35pt; border-bottom:0.75pt solid #000000; padding:0pt 5= .4pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:center;= line-height:115%; font-size:10pt"><span style=3D"font-family:'Times New Ro= man'"> </span></p></td><td colspan=3D"6" style=3D"width:337.8pt; borde= r-bottom:0.75pt solid #000000; padding:0pt 5.4pt; vertical-align:top"><p st= yle=3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-size:1= 0pt"><span style=3D"line-height:115%; font-family:'Times New Roman'; font-s= ize:8pt">Esta revista est=C3=A1 protegida bajo una licencia Creative Common= s Atribuci=C3=B3n-NoComercial-CompartirIgual 4.0 International. Copia de la= licencia: </span><a href=3D"https://creativecommons.org/licenses/by-nc-sa/= 4.0/deed.es" style=3D"text-decoration:none"><span style=3D"line-height:115%= ; font-family:'Times New Roman'; font-size:8pt; text-decoration:underline; = color:#0563c1">https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es</s= pan></a><span style=3D"line-height:115%; font-family:'Times New Roman'; fon= t-size:8pt"> </span></p></td><td style=3D"padding:0pt; vertical-align:top">= </td></tr><tr><td colspan=3D"4" style=3D"width:101.1pt; padding:0pt 5.4pt; = vertical-align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-s= ize:12pt"><span style=3D"font-family:'Times New Roman'; font-weight:bold">P= alabras claves: </span></p><p style=3D"margin-bottom:0pt; line-height:115%;= font-size:12pt"><span style=3D"font-family:'Times New Roman'">Vitamina C, = estr=C3=A9s oxidativo, enfermedad periodontal, periodontitis, antioxidantes= .</span></p></td><td colspan=3D"2" style=3D"width:0.7pt; padding:0pt 5.4pt;= vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:justify; lin= e-height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'= "> </span></p></td><td colspan=3D"2" style=3D"width:298.35pt; border-t= op:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.= 4pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:justify;= line-height:115%; font-size:12pt"><span style=3D"font-family:'Times New Ro= man'; font-weight:bold; color:#767171">Resumen</span></p><p style=3D"margin= -bottom:0pt; text-align:justify; line-height:115%; font-size:12pt"><span st= yle=3D"font-family:'Times New Roman'; font-weight:bold">Introducci=C3=B3n:<= /span><span style=3D"font-family:'Times New Roman'"> la periodontitis es mu= ltifactorial y se manifiesta por la destrucci=C3=B3n progresiva de los teji= dos de soporte dental. Su desarrollo se ha asociado con el aumento del estr= =C3=A9s oxidativo, que resulta del desequilibrio entre la producci=C3=B3n d= e especies reactivas de ox=C3=ADgeno y los antioxidantes. La vitamina C par= ticipa en la s=C3=ADntesis del col=C3=A1geno, en la respuesta del sistema i= nmunol=C3=B3gico, neutraliza y elimina radicales libres, lo que podr=C3=ADa= influir sobre la salud periodontal.</span><span style=3D"font-family:'Time= s New Roman'">  </span><span style=3D"font-family:'Times New Roman'; f= ont-weight:bold">Objetivo:</span><span style=3D"font-family:'Times New Roma= n'">  </span><span style=3D"font-family:'Times New Roman'">analizar la= relaci=C3=B3n entre la vitamina C y el estr=C3=A9s oxidativo con la period= ontitis. </span><span style=3D"font-family:'Times New Roman'; font-weight:b= old">Metodolog=C3=ADa:</span><span style=3D"font-family:'Times New Roman'">= se realiz=C3=B3 una revisi=C3=B3n bibliogr=C3=A1fica exploratoria de la li= teratura cient=C3=ADfica publicada entre 2020 y 2026, utilizando bases de d= atos como PubMed, Scopus, ScienceDirect y Google Acad=C3=A9mico. Se incorpo= r=C3=B3 investigaciones en humanos que analizaron la relaci=C3=B3n entre la= vitamina C, el estr=C3=A9s oxidativo y la salud periodontal. Despu=C3=A9s = de aplicar los criterios de inclusi=C3=B3n y exclusi=C3=B3n se finaliz=C3= =B3 con un total de 10 estudios para su an=C3=A1lisis. </span><span style= =3D"font-family:'Times New Roman'; font-weight:bold">Resultados:</span><spa= n style=3D"font-family:'Times New Roman'"> la revisi=C3=B3n de los estudios= indic=C3=B3 que los pacientes con enfermedades periodontales presentan cam= bios en los biomarcadores vinculados al estr=C3=A9s oxidativo y, en algunos= casos, niveles reducidos de vitamina C comparados con aquellos con salud p= eriodontal. Adem=C3=A1s, la ingesta de vitamina C mostr=C3=B3 un impacto po= sitivo en ciertos biomarcadores inflamatorios y antioxidantes, sin embargo,= los resultados cl=C3=ADnicos en cuanto a la disminuci=C3=B3n de la profund= idad de sondaje y la mejora de inserci=C3=B3n cl=C3=ADnica variaron entre l= os estudios. </span><span style=3D"font-family:'Times New Roman'; font-weig= ht:bold">Conclusiones:</span><span style=3D"font-family:'Times New Roman'">= se identific=C3=B3 una relaci=C3=B3n entre la vitamina C, el estr=C3=A9s o= xidativo y el estado periodontal. A pesar de que la vitamina C tiene propie= dades antioxidantes y podr=C3=ADa servir como coadyuvante en el tratamiento= periodontal, la evidencia cl=C3=ADnica es variada, lo que indica la necesi= dad de investigaciones con m=C3=A9todos estandarizados y un seguimiento pro= longado para establecer de manera m=C3=A1s precisa su efecto terap=C3=A9uti= co. </span><span style=3D"font-family:'Times New Roman'; font-weight:bold">= =C3=81rea de estudio general: </span><span style=3D"font-family:'Times New = Roman'">Odontolog=C3=ADa. </span><span style=3D"font-family:'Times New Roma= n'; font-weight:bold">=C3=81rea de estudio espec=C3=ADfica: </span><span st= yle=3D"font-family:'Times New Roman'">Periodoncia. </span><span style=3D"fo= nt-family:'Times New Roman'; font-weight:bold; background-color:#ffffff">Ti= po de estudio: </span><span style=3D"font-family:'Times New Roman'; backgro= und-color:#ffffff">Revisi=C3=B3n bibliogr=C3=A1fica narrativa</span><span s= tyle=3D"font-family:'Times New Roman'">.</span></p></td><td style=3D"paddin= g:0pt; vertical-align:top"></td></tr><tr style=3D"height:28.2pt"><td colspa= n=3D"3" style=3D"width:98.85pt; padding:0pt 5.4pt; vertical-align:top"><p s= tyle=3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-size:= 12pt"><span style=3D"font-family:'Times New Roman'; font-weight:bold">Keywo= rds: </span></p><p style=3D"margin-bottom:0pt; line-height:115%; font-size:= 12pt"><span style=3D"font-family:'Times New Roman'">Vitamin C, oxidative st= ress, periodontal disease, periodontitis, antioxidants.</span></p></td><td = colspan=3D"2" style=3D"width:1pt; padding:0pt 5.4pt; vertical-align:top"><p= style=3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-siz= e:12pt"><span style=3D"font-family:'Times New Roman'"> </span></p></td= ><td colspan=3D"3" style=3D"width:300.3pt; border-top:0.75pt solid #000000;= border-bottom:0.75pt solid #000000; padding:0pt 5.4pt; vertical-align:top"= ><p style=3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-= size:12pt"><span style=3D"font-family:'Times New Roman'; font-weight:bold; = color:#767171">Abstract</span></p><p style=3D"margin-bottom:0pt; text-align= :justify; line-height:115%; font-size:12pt"><span style=3D"font-family:'Tim= es New Roman'; font-weight:bold">Introduction.</span><span style=3D"font-fa= mily:'Times New Roman'; font-weight:bold">  </span><span style=3D"font= -family:'Times New Roman'">Periodontal disease is a multifactorial conditio= n characterized by the progressive destruction of the tooth-supporting tiss= ues. Its development has been associated with increased oxidative stress, r= esulting from an imbalance between the production of reactive oxygen specie= s and antioxidants. Vitamin C plays a role in collagen synthesis, immune re= sponse, and the neutralization of free radicals, which may influence period= ontal health. </span><span style=3D"font-family:'Times New Roman'; font-wei= ght:bold">Objective. </span><span style=3D"font-family:'Times New Roman'">T= o analyze the relationship between vitamin C, oxidative stress, and periodo= ntal disease. </span><span style=3D"font-family:'Times New Roman'; font-wei= ght:bold">Methodology.</span><span style=3D"font-family:'Times New Roman'">= An exploratory literature review of scientific publications published betw= een 2020 and 2026 was conducted using the PubMed, Scopus, ScienceDirect, an= d Google Scholar databases. Studies in humans analyzed the relationship bet= ween vitamin C, oxidative stress, and periodontal disease were included. Af= ter applying the inclusion and exclusion criteria, a total of 10 studies we= re selected for analysis. </span><span style=3D"font-family:'Times New Roma= n'; font-weight:bold">Results.</span><span style=3D"font-family:'Times New = Roman'"> The reviewed studies indicated that patients with periodontal dise= ase exhibit alterations in biomarkers associated with oxidative stress and,= in some cases, lower levels of vitamin C compared with periodontally healt= hy individuals. Furthermore, vitamin C intake showed positive effects on ce= rtain inflammatory and antioxidant biomarkers. However, clinical outcomes r= egarding reductions in probing depth and improvements in clinical attachmen= t levels varied among the studies. </span><span style=3D"font-family:'Times= New Roman'; font-weight:bold">Conclusion.</span><span style=3D"font-family= :'Times New Roman'"> The relationship between vitamin C, oxidative stress, = and periodontal disease was identified. Although vitamin C possesses antiox= idant properties and may serve as an adjunct in periodontal treatment, the = available clinical evidence remains variable, highlighting the need for stu= dies with standardized methodologies and longer follow-up periods to more a= ccurately determine its therapeutic effect. </span><span style=3D"font-fami= ly:'Times New Roman'; font-weight:bold">General Area of Study: </span><span= style=3D"font-family:'Times New Roman'">Dentistry. </span><span style=3D"f= ont-family:'Times New Roman'; font-weight:bold">Specific area of study: </s= pan><span style=3D"font-family:'Times New Roman'">Periodontology. </span><s= pan style=3D"font-family:'Times New Roman'; font-weight:bold; background-co= lor:#ffffff">Type of study:</span><span style=3D"font-family:'Times New Rom= an'; background-color:#ffffff"> Narrative bibliographic review</span><span = style=3D"font-family:'Times New Roman'">.</span></p><p style=3D"margin-bott= om:0pt; text-align:justify; line-height:115%; font-size:12pt"><span style= =3D"font-family:'Times New Roman'"> </span></p></td><td style=3D"paddi= ng:0pt; vertical-align:top"></td></tr><tr style=3D"height:0pt"><td style=3D= "width:62.8pt"></td><td style=3D"width:21.15pt"></td><td style=3D"width:25.= 7pt"></td><td style=3D"width:2.25pt"></td><td style=3D"width:9.55pt"></td><= td style=3D"width:1.95pt"></td><td style=3D"width:38.5pt"></td><td style=3D= "width:270.65pt"></td><td style=3D"width:4.6pt"></td></tr></table><p style= =3D"margin-bottom:10pt; line-height:115%; font-size:12pt; background-color:= #ffffff"><span style=3D"font-family:'Times New Roman'"> </span></p><p = style=3D"margin-bottom:10pt; line-height:115%; font-size:12pt; background-c= olor:#ffffff"><span style=3D"font-family:'Times New Roman'"> </span></= p><p style=3D"margin-left:21.3pt; text-indent:-18pt; text-align:justify; li= ne-height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman= '; font-weight:bold; color:#767171"><span>1.</span></span><span style=3D"wi= dth:9pt; font:7pt 'Times New Roman'; display:inline-block">   = 0;   </span><span style=3D"font-family:'Times New Roman'; font-we= ight:bold; color:#767171">Introducci=C3=B3n</span></p><p style=3D"margin-bo= ttom:0pt; text-align:justify; line-height:115%; font-size:12pt"><span style= =3D"font-family:'Times New Roman'">Las enfermedades periodontales, gingivit= is y periodontitis, son condiciones multifactoriales e inmunoinflamatorias = que afectan los tejidos blandos y duros del complejo periodontal, respectiv= amente (1). La respuesta inflamatoria ante la presencia de la biopel=C3=ADc= ula dental puede provocar la destrucci=C3=B3n tisular, induciendo as=C3=AD = un ciclo continuo de retroalimentaci=C3=B3n positiva de prote=C3=B3lisis, i= nflamaci=C3=B3n y enriquecimiento de pat=C3=B3genos periodontales (2). </sp= an></p><p style=3D"margin-bottom:0pt; text-align:justify; line-height:115%;= font-size:12pt"><span style=3D"font-family:'Times New Roman'">La periodont= itis severa, puede ocasionar p=C3=A9rdida dental presentando alteraciones f= uncionales que afectan negativamente la calidad de vida de las personas; en= Am=C3=A9rica Latina y el Caribe la prevalencia de periodontitis en poblaci= =C3=B3n adulta var=C3=ADa entre el 11,6% y el 99,9%, dependiendo de los gru= pos etarios. Esta extensa variabilidad refleja una alta carga de la enferme= dad y representa un verdadero desaf=C3=ADo para la salud p=C3=BAblica. Por = ende, resulta necesario identificar factores asociados con su prevenci=C3= =B3n y progresi=C3=B3n.</span><span style=3D"font-family:'Times New Roman'"= >  </span><span style=3D"font-family:'Times New Roman'">La complejidad= de las enfermedades periodontales no solo radica en los microorganismos pe= riodontopat=C3=B3genos, sino que el hu=C3=A9sped tenga la capacidad de reac= cionar ante estos est=C3=ADmulos. Conforme a ello, actualmente existe inter= =C3=A9s por entender los procesos biol=C3=B3gicos que pueden afectar el gra= do de susceptibilidad y desarrollo de la enfermedad (3).</span></p><p style= =3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-size:12pt= "><span style=3D"font-family:'Times New Roman'">El estr=C3=A9s oxidativo es= un desequilibrio producido cuando los oxidantes superan los antioxidantes = del organismo, provocando da=C3=B1o tisular con la liberaci=C3=B3n de radic= ales libres; estos =C3=BAltimos, son mol=C3=A9culas altamente reactivas por= la presencia de electrones desapareados en su capa m=C3=A1s externa, permi= ti=C3=A9ndoles interactuar y alterar estructuras celulares (4). Los radical= es libres, junto a otras mol=C3=A9culas oxidantes, se agrupan bajo el t=C3= =A9rmino de especies reactivas, las cuales pueden ser derivados del ox=C3= =ADgeno, nitr=C3=B3geno y otros elementos (5). </span></p><p style=3D"margi= n-bottom:0pt; text-align:justify; line-height:115%; font-size:12pt"><span s= tyle=3D"font-family:'Times New Roman'">Estas mol=C3=A9culas se desarrollan = en condiciones fisiol=C3=B3gicas, as=C3=AD como, como patol=C3=B3gicas; por= ende, para atenuar su efecto a nivel biol=C3=B3gico, las c=C3=A9lulas han = desarrollado sistemas antioxidantes, tanto enzim=C3=A1ticos como no enzim= =C3=A1ticos, que ayudan a neutralizar las especies reactivas y mantener el = equilibrio redox de la c=C3=A9lula (6). Una de las fuentes celulares m=C3= =A1s relevantes para las especies reactivas de ox=C3=ADgeno (ROS), por ejem= plo, es la respiraci=C3=B3n mitocondrial (6).</span><span style=3D"font-fam= ily:'Times New Roman'">  </span><span style=3D"font-family:'Times New = Roman'">El equilibrio entre la producci=C3=B3n de especies reactivas y los = sistemas antioxidantes es importante para mantener la homeostasis celular y= la integridad de los tejidos; cuando este equilibrio se altera, pueden pro= ducirse procesos relacionados con el da=C3=B1o celular y la inflamaci=C3=B3= n. Por esta raz=C3=B3n, los sistemas antioxidantes han adquirido importanci= a en el estudio del estr=C3=A9s oxidativo y sus efectos a nivel biol=C3=B3g= ico (6). </span></p><p style=3D"margin-bottom:0pt; text-align:justify; line= -height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'"= >La vitamina C o =C3=A1cido asc=C3=B3rbico, es una vitamina hidrosoluble co= n funciones bien establecidas en diversos procesos fisiol=C3=B3gicos; adem= =C3=A1s de su reconocida funci=C3=B3n como antioxidante y cofactor en la s= =C3=ADntesis de col=C3=A1geno, la vitamina C ha despertado inter=C3=A9s por= sus propiedades inmunomoduladoras y sus potenciales beneficios terap=C3=A9= uticos en enfermedades del sistema inmunitario (7). Tiene efectos directos<= /span><span style=3D"font-family:'Times New Roman'">  </span><span sty= le=3D"font-family:'Times New Roman'">sobre</span><span style=3D"font-family= :'Times New Roman'">  </span><span style=3D"font-family:'Times New Rom= an'">las</span><span style=3D"font-family:'Times New Roman'">  </span>= <span style=3D"font-family:'Times New Roman'">c=C3=A9lulas</span><span styl= e=3D"font-family:'Times New Roman'">  </span><span style=3D"font-famil= y:'Times New Roman'">inmunitarias,</span><span style=3D"font-family:'Times = New Roman'">  </span><span style=3D"font-family:'Times New Roman'">ya = que desempe=C3=B1a</span><span style=3D"font-family:'Times New Roman'"> = 0; </span><span style=3D"font-family:'Times New Roman'">un</span><span styl= e=3D"font-family:'Times New Roman'">  </span><span style=3D"font-famil= y:'Times New Roman'">papel</span><span style=3D"font-family:'Times New Roma= n'">  </span><span style=3D"font-family:'Times New Roman'">crucial</sp= an><span style=3D"font-family:'Times New Roman'">  </span><span style= =3D"font-family:'Times New Roman'">en</span><span style=3D"font-family:'Tim= es New Roman'">  </span><span style=3D"font-family:'Times New Roman'">= la</span><span style=3D"font-family:'Times New Roman'">  </span><span = style=3D"font-family:'Times New Roman'">regulaci=C3=B3n</span><span style= =3D"font-family:'Times New Roman'">  </span><span style=3D"font-family= :'Times New Roman'">de</span><span style=3D"font-family:'Times New Roman'">=   </span><span style=3D"font-family:'Times New Roman'">la</span><span = style=3D"font-family:'Times New Roman'">  </span><span style=3D"font-f= amily:'Times New Roman'">producci=C3=B3n</span><span style=3D"font-family:'= Times New Roman'">  </span><span style=3D"font-family:'Times New Roman= '">y</span><span style=3D"font-family:'Times New Roman'">  </span><spa= n style=3D"font-family:'Times New Roman'">la</span><span style=3D"font-fami= ly:'Times New Roman'">  </span><span style=3D"font-family:'Times New R= oman'">actividad</span><span style=3D"font-family:'Times New Roman'"> = </span><span style=3D"font-family:'Times New Roman'">de</span><span style= =3D"font-family:'Times New Roman'">  </span><span style=3D"font-family= :'Times New Roman'">las</span><span style=3D"font-family:'Times New Roman'"= >  </span><span style=3D"font-family:'Times New Roman'">citocinas,</sp= an><span style=3D"font-family:'Times New Roman'">  </span><span style= =3D"font-family:'Times New Roman'">mediadores</span><span style=3D"font-fam= ily:'Times New Roman'">  </span><span style=3D"font-family:'Times New = Roman'">clave</span><span style=3D"font-family:'Times New Roman'">  </= span><span style=3D"font-family:'Times New Roman'">de</span><span style=3D"= font-family:'Times New Roman'">  </span><span style=3D"font-family:'Ti= mes New Roman'">la</span><span style=3D"font-family:'Times New Roman'"> = 0; </span><span style=3D"font-family:'Times New Roman'">inflamaci=C3=B3n</s= pan><span style=3D"font-family:'Times New Roman'">  </span><span style= =3D"font-family:'Times New Roman'">y</span><span style=3D"font-family:'Time= s New Roman'">  </span><span style=3D"font-family:'Times New Roman'">l= as</span><span style=3D"font-family:'Times New Roman'">  </span><span = style=3D"font-family:'Times New Roman'">respuestas</span><span style=3D"fon= t-family:'Times New Roman'">  </span><span style=3D"font-family:'Times= New Roman'">inmunitarias; puede adem=C3=A1s</span><span style=3D"font-fami= ly:'Times New Roman'">  </span><span style=3D"font-family:'Times New R= oman'">modular</span><span style=3D"font-family:'Times New Roman'">  <= /span><span style=3D"font-family:'Times New Roman'">el</span><span style=3D= "font-family:'Times New Roman'">  </span><span style=3D"font-family:'T= imes New Roman'">equilibrio</span><span style=3D"font-family:'Times New Rom= an'">  </span><span style=3D"font-family:'Times New Roman'">entre</spa= n><span style=3D"font-family:'Times New Roman'">  </span><span style= =3D"font-family:'Times New Roman'">las</span><span style=3D"font-family:'Ti= mes New Roman'">  </span><span style=3D"font-family:'Times New Roman'"= >citocinas</span><span style=3D"font-family:'Times New Roman'">  </spa= n><span style=3D"font-family:'Times New Roman'">proinflamatorias</span><spa= n style=3D"font-family:'Times New Roman'">  </span><span style=3D"font= -family:'Times New Roman'">y</span><span style=3D"font-family:'Times New Ro= man'">  </span><span style=3D"font-family:'Times New Roman'">antiinfla= matorias,</span><span style=3D"font-family:'Times New Roman'">  </span= ><span style=3D"font-family:'Times New Roman'">contribuyendo</span><span st= yle=3D"font-family:'Times New Roman'">  </span><span style=3D"font-fam= ily:'Times New Roman'">as=C3=AD,</span><span style=3D"font-family:'Times Ne= w Roman'">  </span><span style=3D"font-family:'Times New Roman'">a</sp= an><span style=3D"font-family:'Times New Roman'">  </span><span style= =3D"font-family:'Times New Roman'">una</span><span style=3D"font-family:'Ti= mes New Roman'">  </span><span style=3D"font-family:'Times New Roman'"= >respuesta</span><span style=3D"font-family:'Times New Roman'">  </spa= n><span style=3D"font-family:'Times New Roman'">inmunitaria</span><span sty= le=3D"font-family:'Times New Roman'">  </span><span style=3D"font-fami= ly:'Times New Roman'">equilibrada; siendo que, al</span><span style=3D"font= -family:'Times New Roman'">  </span><span style=3D"font-family:'Times = New Roman'">suprimir</span><span style=3D"font-family:'Times New Roman'">&#= xa0; </span><span style=3D"font-family:'Times New Roman'">la</span><span st= yle=3D"font-family:'Times New Roman'">  </span><span style=3D"font-fam= ily:'Times New Roman'">producci=C3=B3n</span><span style=3D"font-family:'Ti= mes New Roman'">  </span><span style=3D"font-family:'Times New Roman'"= >de</span><span style=3D"font-family:'Times New Roman'">  </span><span= style=3D"font-family:'Times New Roman'">citocinas</span><span style=3D"fon= t-family:'Times New Roman'">  </span><span style=3D"font-family:'Times= New Roman'">proinflamatorias,</span><span style=3D"font-family:'Times New = Roman'">  </span><span style=3D"font-family:'Times New Roman'">como</s= pan><span style=3D"font-family:'Times New Roman'">  </span><span style= =3D"font-family:'Times New Roman'">la</span><span style=3D"font-family:'Tim= es New Roman'">  </span><span style=3D"font-family:'Times New Roman'">= interleucina 6</span><span style=3D"font-family:'Times New Roman'">  <= /span><span style=3D"font-family:'Times New Roman'">(IL6)</span><span style= =3D"font-family:'Times New Roman'">  </span><span style=3D"font-family= :'Times New Roman'">y</span><span style=3D"font-family:'Times New Roman'">&= #xa0; </span><span style=3D"font-family:'Times New Roman'">el</span><span s= tyle=3D"font-family:'Times New Roman'">  </span><span style=3D"font-fa= mily:'Times New Roman'">factor</span><span style=3D"font-family:'Times New = Roman'">  </span><span style=3D"font-family:'Times New Roman'">de</spa= n><span style=3D"font-family:'Times New Roman'">  </span><span style= =3D"font-family:'Times New Roman'">necrosis</span><span style=3D"font-famil= y:'Times New Roman'">  </span><span style=3D"font-family:'Times New Ro= man'">tumoral</span><span style=3D"font-family:'Times New Roman'">  </= span><span style=3D"font-family:'Times New Roman'">alfa</span><span style= =3D"font-family:'Times New Roman'">  </span><span style=3D"font-family= :'Times New Roman'">(TNF=CE=B1),</span><span style=3D"font-family:'Times Ne= w Roman'">  </span><span style=3D"font-family:'Times New Roman'">y</sp= an><span style=3D"font-family:'Times New Roman'">  </span><span style= =3D"font-family:'Times New Roman'">al</span><span style=3D"font-family:'Tim= es New Roman'">  </span><span style=3D"font-family:'Times New Roman'">= mismo</span><span style=3D"font-family:'Times New Roman'">  </span><sp= an style=3D"font-family:'Times New Roman'">tiempo</span><span style=3D"font= -family:'Times New Roman'">  </span><span style=3D"font-family:'Times = New Roman'">promover</span><span style=3D"font-family:'Times New Roman'">&#= xa0; </span><span style=3D"font-family:'Times New Roman'">la</span><span st= yle=3D"font-family:'Times New Roman'">  </span><span style=3D"font-fam= ily:'Times New Roman'">s=C3=ADntesis</span><span style=3D"font-family:'Time= s New Roman'">  </span><span style=3D"font-family:'Times New Roman'">d= e</span><span style=3D"font-family:'Times New Roman'">  </span><span s= tyle=3D"font-family:'Times New Roman'">citocinas</span><span style=3D"font-= family:'Times New Roman'">  </span><span style=3D"font-family:'Times N= ew Roman'">antiinflamatorias,</span><span style=3D"font-family:'Times New R= oman'">  </span><span style=3D"font-family:'Times New Roman'">como la = interleucina 10 (IL 10), la</span><span style=3D"font-family:'Times New Rom= an'">  </span><span style=3D"font-family:'Times New Roman'">vitamina</= span><span style=3D"font-family:'Times New Roman'">  </span><span styl= e=3D"font-family:'Times New Roman'">C</span><span style=3D"font-family:'Tim= es New Roman'">  </span><span style=3D"font-family:'Times New Roman'">= puede</span><span style=3D"font-family:'Times New Roman'">  </span><sp= an style=3D"font-family:'Times New Roman'">ayudar</span><span style=3D"font= -family:'Times New Roman'">  </span><span style=3D"font-family:'Times = New Roman'">a</span><span style=3D"font-family:'Times New Roman'">  </= span><span style=3D"font-family:'Times New Roman'">mitigar</span><span styl= e=3D"font-family:'Times New Roman'">  </span><span style=3D"font-famil= y:'Times New Roman'">la</span><span style=3D"font-family:'Times New Roman'"= >  </span><span style=3D"font-family:'Times New Roman'">inflamaci=C3= =B3n</span><span style=3D"font-family:'Times New Roman'">  </span><spa= n style=3D"font-family:'Times New Roman'">excesiva</span><span style=3D"fon= t-family:'Times New Roman'">  </span><span style=3D"font-family:'Times= New Roman'">y</span><span style=3D"font-family:'Times New Roman'">  <= /span><span style=3D"font-family:'Times New Roman'">el</span><span style=3D= "font-family:'Times New Roman'">  </span><span style=3D"font-family:'T= imes New Roman'">da=C3=B1o</span><span style=3D"font-family:'Times New Roma= n'">  </span><span style=3D"font-family:'Times New Roman'">tisular (8)= .</span></p><p style=3D"margin-bottom:0pt; text-align:justify; line-height:= 115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'">Por otr= a parte, sus propiedades antioxidantes le permiten eliminar las especies re= activas de ox=C3=ADgeno</span><span style=3D"font-family:'Times New Roman'"= >  </span><span style=3D"font-family:'Times New Roman'">(ROS)</span><s= pan style=3D"font-family:'Times New Roman'">  </span><span style=3D"fo= nt-family:'Times New Roman'">y</span><span style=3D"font-family:'Times New = Roman'">  </span><span style=3D"font-family:'Times New Roman'">neutral= izar los radicales libres,</span><span style=3D"font-family:'Times New Roma= n'">  </span><span style=3D"font-family:'Times New Roman'">reduciendo<= /span><span style=3D"font-family:'Times New Roman'">  </span><span sty= le=3D"font-family:'Times New Roman'">as=C3=AD el estr=C3=A9s oxidativo y li= mitando la inflamaci=C3=B3n. Al mantener el equilibrio, la vitamina C puede= ayudar a proteger las c=C3=A9lulas del da=C3=B1o oxidativo y modular y las= v=C3=ADas de se=C3=B1alizaci=C3=B3n inflamatoria (7)(8). De esta manera, l= a vitamina C contribuye a proteger las c=C3=A9lulas frente al da=C3=B1o oxi= dativo y favorece el mantenimiento de la homeostasis tisular. </span></p><p= style=3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-siz= e:12pt"><span style=3D"font-family:'Times New Roman'">La vitamina C es un m= icronutriente esencial para la salud periodontal, al participar en tres fun= ciones indispensables: s=C3=ADntesis y maduraci=C3=B3n del col=C3=A1geno, m= odulaci=C3=B3n del sistema inmunol=C3=B3gico e inflamatorio y un potente an= tioxidante frente al estr=C3=A9s oxidativo (9). El periodonto depende en gr= an medida del col=C3=A1geno, puesto que constituye un componente fundamenta= l en la matriz extracelular periodontal, la enc=C3=ADa, cemento radicular y= hueso alveolar (10). La vitamina C se caracteriza por ser un cofactor de l= as hidroxilasas de prolina y lisina, enzimas necesarias para formar col=C3= =A1geno tipo I y III; su deficiencia genera escorbuto, afectando los tejido= s gingivales por alteraci=C3=B3n de la s=C3=ADntesis de col=C3=A1geno y oca= sionando sangrado gingival espont=C3=A1neo y ulceraci=C3=B3n de la mucosa o= ral (10).</span></p><p style=3D"margin-bottom:0pt; text-align:justify; line= -height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'"= >En cuanto a la modulaci=C3=B3n inmunol=C3=B3gica, la quimiotaxis y fagocit= osis de neutr=C3=B3filos; mejora la funci=C3=B3n fagoc=C3=ADtica de los mac= r=C3=B3fagos y fortalece la l=C3=ADnea de defensa inmunitaria de los linfoc= itos T, finalmente la vitamina C act=C3=BAa como antioxidante primario fren= te al estr=C3=A9s oxidativo, neutralizando </span><span style=3D"font-famil= y:'Times New Roman'; text-decoration:underline">Especies Reactivas de Ox=C3= =ADgeno (ROS)</span><span style=3D"font-family:'Times New Roman'"> evitando= da=C3=B1os en el ADN y membranas celulares. Esto favorece a disminuir la i= nflamaci=C3=B3n evitando que la enfermedad periodontal progrese (11).</span= ><span style=3D"font-family:'Times New Roman'">  </span><span style=3D= "font-family:'Times New Roman'">Por lo tanto, estas funciones han despertad= o un creciente inter=C3=A9s cient=C3=ADfico sobre el posible papel de la vi= tamina C en la prevenci=C3=B3n y control de las enfermedades periodontales.= </span><span style=3D"font-family:'Times New Roman'">  </span></p><p s= tyle=3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-size:= 12pt"><span style=3D"font-family:'Times New Roman'">Aunque las enfermedades= periodontales han sido ampliamente estudiadas, todav=C3=ADa existe inter= =C3=A9s por comprender los factores que influyen en su desarrollo y severid= ad.</span><span style=3D"font-family:'Times New Roman'">  </span><span= style=3D"font-family:'Times New Roman'">En este contexto, la vitamina C ha= generado inter=C3=A9s por sus caracter=C3=ADsticas inmunomoduladoras, anti= oxidantes y su papel fundamental en la s=C3=ADntesis de col=C3=A1geno. De l= a misma manera, se ha reconocido el estr=C3=A9s oxidativo como un mecanismo= vinculado con el da=C3=B1o tisular periodontal y progresi=C3=B3n de la enf= ermedad. No obstante, la evidencia disponible presenta resultados variables= sobre esta relaci=C3=B3n entre la vitamina C, el estr=C3=A9s oxidativo y l= as enfermedades periodontales, as=C3=AD como sobre el posible beneficio en = la suplementaci=C3=B3n como coadyuvante terap=C3=A9utico. Por ello, surge e= l inter=C3=A9s de integrar y analizar la literatura disponible para compren= der la participaci=C3=B3n de estos factores en la salud periodontal y su po= sible aplicaci=C3=B3n dentro de estrategias preventivas y terap=C3=A9uticas= en periodoncia.</span></p><p style=3D"margin-bottom:10pt; text-align:justi= fy; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times New= Roman'">Por lo tanto, el objetivo de esta revisi=C3=B3n bibliogr=C3=A1fica= fue analizar la relaci=C3=B3n entre la vitamina C y estr=C3=A9s oxidativo = con la periodontitis.</span></p><p style=3D"margin-left:21.3pt; margin-bott= om:10pt; text-indent:-18pt; line-height:115%; font-size:12pt"><span style= =3D"font-family:'Times New Roman'; font-weight:bold; color:#767171"><span>2= .</span></span><span style=3D"width:9pt; font:7pt 'Times New Roman'; displa= y:inline-block">      </span><span style=3D"font-f= amily:'Times New Roman'; font-weight:bold; color:#767171">Metodolog=C3=ADa<= /span></p><p style=3D"margin-bottom:0pt; text-align:justify; line-height:11= 5%; font-size:12pt"><span style=3D"font-family:'Times New Roman'">La siguie= nte revisi=C3=B3n bibliogr=C3=A1fica narrativa fue desarrollada bajo los li= neamientos de la declaraci=C3=B3n </span><span style=3D"font-family:'Times = New Roman'; font-style:italic; text-decoration:underline">PRISMA (Preferred= Reporting Items for Systematic Reviews and Meta-Analyses)</span><span styl= e=3D"font-family:'Times New Roman'">, con el prop=C3=B3sito de identificar,= analizar y sintetizar la evidencia cient=C3=ADfica disponible sobre la rel= aci=C3=B3n entre la vitamina C, el estr=C3=A9s oxidativo y la periodontitis= . </span></p><p style=3D"margin-bottom:0pt; text-align:justify; line-height= :115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'">Se rea= liz=C3=B3 una b=C3=BAsqueda electr=C3=B3nica en las bases de datos PubMed, = Science Direct, Scopus y Google Acad=C3=A9mico. Los t=C3=A9rminos se relaci= onaron con la vitamina C, estr=C3=A9s oxidativo y periodontitis. La estrate= gia incluy=C3=B3 los siguientes t=C3=A9rminos y operadores booleanos: (vita= min C OR =E2=80=9Cascorbic acid=E2=80=9D) AND (=E2=80=9Coxidative stress=E2= =80=9D) </span><span style=3D"font-family:'Times New Roman'; font-style:ita= lic">AND (=E2=80=9Cperiodontal disease=E2=80=9D OR periodontitis OR "period= ontal diseases")</span><span style=3D"font-family:'Times New Roman'">. Los = t=C3=A9rminos descriptores MeSH utilizados para PubMed fueron: </span><span= style=3D"font-family:'Times New Roman'; font-style:italic">("Periodontitis= "[MeSH] OR "Periodontal Diseases"[MeSH]) AND ("Oxidative Stress" [MeSH] OR = antioxidants) AND ("Ascorbic Acid" [MeSH] OR "Vitamin C").</span><span styl= e=3D"font-family:'Times New Roman'"> Para reducir sesgos y excluir factores= se utilizaron los operadores booleanos NOT (diabetes OR c=C3=A1ncer </span= ><span style=3D"font-family:'Times New Roman'; font-style:italic">OR =E2=80= =9Ccardiovascular disease=E2=80=9D OR pregnancy OR obesity OR smoking OR to= bacco OR =E2=80=9Csystemic disease</span><span style=3D"font-family:'Times = New Roman'">=E2=80=9D). </span></p><p style=3D"margin-bottom:0pt; text-alig= n:justify; line-height:115%; font-size:12pt"><span style=3D"font-family:'Ti= mes New Roman'">Se incluyeron publicaciones en idioma ingl=C3=A9s publicada= s entre 2020 y 2026, que se llevaron a cabo en adultos humanos y examinaron= biomarcadores de estr=C3=A9s oxidativo y/o vitamina C en relaci=C3=B3n con= las enfermedades periodontales. Se tomaron en consideraci=C3=B3n metaan=C3= =A1lisis, revisiones sistem=C3=A1ticas, ensayos cl=C3=ADnicos controlados y= estudios observacionales. Se eliminaron los estudios que se llevaron a cab= o en pacientes con enfermedades sist=C3=A9micas o condiciones que podr=C3= =ADan modificar los resultados como el embarazo, diabetes mellitus o tabaqu= ismo; as=C3=AD como publicaciones en otros idiomas e investigaci=C3=B3n in = vitro. </span></p><p style=3D"margin-bottom:0pt; text-align:justify; line-h= eight:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'">L= a selecci=C3=B3n de los estudios se efectu=C3=B3 en dos fases: revisi=C3=B3= n de t=C3=ADtulos y res=C3=BAmenes seguida de una lectura completa de los a= rt=C3=ADculos potencialmente elegibles. Inicialmente se identificaron 81 ar= t=C3=ADculos, procedentes de la base de datos seleccionadas, se procedi=C3= =B3 a eliminar los 15 art=C3=ADculos duplicados, se excluyeron art=C3=ADcul= os no compatibles con el tema de investigaci=C3=B3n 36. Posteriormente, los= art=C3=ADculos seleccionados fueron analizados a texto completo para verif= icar el cumplimiento de los criterios de inclusi=C3=B3n y exclusi=C3=B3n. C= omo resultado de este proceso se incluyeron 10 art=C3=ADculos en la s=C3=AD= ntesis cualitativa final, los cuales sirvieron de base para el an=C3=A1lisi= s de la relaci=C3=B3n entre la vitamina C, estr=C3=A9s oxidativo y la perio= dontitis. </span></p><p style=3D"margin-bottom:0pt; text-align:justify; lin= e-height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'= ">La informaci=C3=B3n fue organizada en una matriz elaborada en Microsoft E= xcel. Se registraron autor, a=C3=B1o de publicaci=C3=B3n, variables de estu= dio, dise=C3=B1o metodol=C3=B3gico, tama=C3=B1o de muestra, caracter=C3=ADs= ticas de poblaci=C3=B3n, biomarcadores evaluados, niveles de vitamina C, pa= r=C3=A1metros periodontales y resultados. </span></p><p style=3D"margin-bot= tom:0pt; text-align:justify; line-height:115%; font-size:12pt"><span style= =3D"font-family:'Times New Roman'">No se requiri=C3=B3 aprobaci=C3=B3n de u= n comit=C3=A9 de =C3=A9tica ni consentimiento informado debido a que se fun= dament=C3=B3 exclusivamente en la revisi=C3=B3n de literatura cient=C3=ADfi= ca previamente publicada. Sin embargo, se respetaron los principios de inte= gridad cient=C3=ADfica y adecuada citaci=C3=B3n de las fuentes consultadas.= El proceso de selecci=C3=B3n de estudios se resume en la </span><a href=3D= "#fig1" style=3D"text-decoration:none"><span class=3D"Hyperlink" style=3D"f= ont-family:'Times New Roman'; font-weight:bold; text-decoration:none; color= :#000000">Figura 1</span></a><span style=3D"font-family:'Times New Roman'">= .</span></p><p style=3D"text-align:justify; line-height:115%; font-size:12p= t"><span style=3D"font-family:'Times New Roman'"> </span></p><p style= =3D"margin-bottom:0pt; line-height:normal; font-size:12pt"><span style=3D"h= eight:0pt; display:block; position:absolute; z-index:3"><img src=3D"data:im= age/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAACACAYAAABOUyafAAAABHNCSVQICAgI= fAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAErNJREFUeJztnXu0HVV9xz83D29CTGIeEAgxvWK= ighKLBS3hYUBjqNTYqFEsCEakilgXYKWNBLXtqo/6WBhjsEDxhU1qCk2rXS5qDfRhi8KyNFUaoX= WlLJRiSQVplwTR2z++e5h99t2zzzzOnHtuzu+z1l13zuw9sx8zv9mv7/xmBBjHMIwYIzOyjUnNh= mEMFk82GtMmMxeGMeiYgRhGAjMQw0hgBmIYCcxADCOBGYhhJDADMYwEZiCGkcAMxDASmIEYRgIz= EMNIYAZiGAnMQAwjgRmIYSQwAzGMBFUN5P1IKz/utn2ucvuP7EG+/HMu936PAG8Bvg38AfDeILz= X6QEcC1wDzKxwjl7XQ8ibgXNqHvtWlL9n9S47XRkB7gZ29THNnlH1jcK3uL8Yu2l2Y7y0S/gvAu= 8CFgOfAw5vkFZZ1gFzKx7TtB5Cwnp5XcPzXUt/DQTgaKaOgWSNQM+7WD9pcOxc4G1d4jwT2A88B= JwP/HeD9MpyC/BoxWOa1ENIrF7+tOE5H2t4fB0en4Q0G9MLAzkD+DtgGzA9CFsP3AbsJH+CfAs4= CfgH4He9uFuADchyx4CL3faxLnwT8GfAF9ETOgwH+BXgb4CvotZmNvBhYB9wHfC0gngUnG+dy/8= t7hgSZSiqh7AOfGL52426I5cAf5GoF78FiJXngPsNsNUdU9QSxsoJcBhqbW4AVifKk7quIecBe4= HLUNer6BrF0o6lXxSvZzTpYi0BvgQcATwHeJC8a7ECXcxZqL/8AWAOcA+qyHmoUrMKmel++1xL5= w17LrCxIPzZwKfQTfBraCywCtjs0v0guolj8WLnOwZdhAXumHvc/1gZVhbUQ6wOfGL5mwX8AFjW= pV4yAykqzzHkBjIHjdsyA9nqHV9UToA1wGuA+cAbEuVJXdeMw4Fb0Rgvu29OLqiDWNoUpB+L15Q= nu1gzukTsxouBm4Efur9bvbATgO3uD+AbwHuA/wXucPv+g/Tgt1tXwA9/EXr6Pur+73b7HwAuAl= 4FfC0RLzzfaeip/CP3d7079nuRMpxOvB5ideCzN5K/nwIPA/c3LLff/fw/l06MonJ+15X1UhfvZ= uDlBeV5nHLX9SHgPrf9BWSIn2FiHRBJG+L1eU0kXs9o2sWaBzzF++23RtOBM1EzOgL8csO0ujGN= iU+tlcBHga+jiiyKV8Rib/sh4ImCeHOJ10O3OojlrypVylNEUTnvAy5Ercvn0ZO7V9d0BvAIxXU= Qpj2beH3G4vWMpgbybTQ2WAEsRBWdPTn+BXg76jc/FTgLFWIh6jeOAovcb9BNtRBdBFBlHOGOAV= XIEmCp2w7D70JdvzHUXJ8FnAp8E/Vvj3BpxuLF0rsdPdVWoQfB6ah/HSvDDwrqIVYHPrH8LXRxM= 4rqZVGi3KCbfKWrs1WoCzIT3ZhlyonbXg78CWrRHigoT+q6ZjwBHIW6jkvQWOIfC+oglvaRxOsz= Fq+nVBmDhOsgI6hPeCdq5naigmZ+tjaiC7ATeAYazI2jKdrsXHd759+GngLz0EXP0pqFxh9+2mE= 4wAUuL3+MDOk4l/5VLi/b0RMmjEfB+V7t4u0B1rp9RWUoqoewDnxi+ftLd86tJeslVu6MK9DEwW= o0HrkNraFkx2ctT6ycAMcDZ6MxxTsT5el2XTNe5o79IvlkQtE1iqVNJP2ieE14cgwC1QfphnGo0= 9o6iGEcUpiBGEYCMxDDSGAGYhgJmhhIXdVqP9SuRfRDyVpH/dtLRbLRY5rMYtVVrZY5rpuyty5N= lKxl8lRH/WsMFj2bxaqrWu12XBllb13qKlnL5qmO+tcYUOoYSBX1bpnjYmrOUMEK1RSnZfKTihN= Tx4Z5ClW30wrymFK6NlEkt65iNUSVLlZV9W6Z42JqzlDBWkVxmlGUH1/JGotTpI4N8xSqbquof3= 3tVB1FcqrcRnNqr6S/FmmOMnaS3+gbvROPIzlAmeNAUuhL0Y20lok34wVIIpFxBXphCjTA3Y1ul= jlenKL8+AYSi3M+EzVTRPI0nU45RVEew+N20fkm5FZyAylKO6wfKC630ZzaY5C66t3UcWUVrWUV= p5mas4yaOBaniTq2rPq3iLKKZGhZxWqIqgZSVb1b5riYmjNUsFZRnGYtUyw/oZI1FqdIHRvmKVT= dVlH/ZkrXuorkVLmNHlOli1VVvVvmuCI1p69ghWqK04wwPzElayzPRepYP0+7mai6raL+hWaK5D= ZUrIYwNa9hJDA1r2GUwQzEMBKYgRhGAjMQw0hQ1UBuIB/A7EczM6sS8bv5ZM3Od2UkLFuBHkezN= d1IqYTH0BRsL5mPZqHOjYRNB77s8vNN8qnZt6EVd2MKUXUWawu6KeagNYS9pFdyu/lkvQwZ2/xg= /yvQdOeJFfIWUwkvAW5EC2695Dw0xbopEraOXILisxK4qSDMGBwaz2I9jpyR7ULz8Uu7xE1xwJ3= nZcH+ZcC9FfMVUwlvBn6/xrm6cSPwvsj+GWi95WTyBcCMe90xv93jvBgtUddAZrq/deiiP0B3X7= ChT1afm9ACWbb/uWiVOySmvE2pi5eh7tV33e8yPmSvpVOflf29ORI3xhPAm4D/QvXwzCD8X12er= BWZAtQ1kPXAPyE3/Bcit5MneeGbge94vxejm3gt0j6Fuqg70EryC9zvU5jopnMFMoqzUFfq7aj7= dDkS7G1DrlB9MlVtxhvJ5SEvR924UPv0G+TaLP/vesrzKPD3aFy0ORJ+L3oIGANOXQO5CY0NzkY= 3AqR9wWY+WR8k98nq8zPko/VVqNV51O3zyfyy/gTYgVoO3zfwPjp9A4M0Tw97v30fsj8m7kO2aQ= visx+9oPWUYP8BcgmNMcBMxjRv5pM15CtowHseemEoJKa8TamEQYa2iGr0ogXxeQw5pPZZiIzEG= HB6aSBFvmCLfLKGHAA+DfwC8Q/jxJS3KZUwaIrZf/+8jA/ZXjANGfRa1FUMDTfs+hkDTJVpXn8d= 5LJIeMwXLMR9svrn2+9+nwi80G3f7aWVrYOEyttu6mKATwDPc9tlfciWIXv9dpzOqd7nunQ+i95= SDCckng18vGaaRn8YKjXvUmQ44WzSZLASvb9x1GRnxEgyVAYCWr2+eLIzgcY3oYd3Y/AYOgMxjC= rY+yCGUYY6BnImGoB/GXg+3T/D1U/Xmv4kwgHk6OAjdE4M9CtfY/ReIAnwq0gN8Gk6nUT4vILc6= 4sJJBtSpYu1CDlFOxpNmV5CXM06mWxBq/ujaIB+OXAQ+KWW0ou5I21LILkUfWBzNtJ0XRiJMx8t= pGYGYgLJ6tQegxyNZoSylmeEifKOyWYLnZ+KBokVd7SQ1lziX1a9molqgV7gt/jr6fQwmfF6JAE= 639t3PJruNspRewzyfdS8fwJ1IcaBv/XCQ7eZMdeaoeCwm4Aw5ga0jEtRn5vRmkSmrg3zFXMjWs= YlacxFapsCyZ+jh9KxSHpzSxB+HPBvTFRQm0CyAXVmsc5EF+cKtCoNxS47fdeaMVefKdecsXOmX= JxCvAVZ5sr5dG+fn6/QjWhZl6Sh10SAlwB/6P3u5nq0KsvJDegcb/904Nfd9gY6WxCAjyH1tdGd= nkzzjgLvJn8noshtpu9aM+bqM+WaM3bOlItTiBvICS6u733Qz1foRrSsS9KYgWxE9VIUJ3Q9CtU= FkvPR6wF+2c8i153FDORKJtaLEad2F2s5+ULXQSQxfyNq9su47CzjDtQnds6q5wA5dPsjyn+uoY= lL0n4IJB9Bcpnve/tej1TT46hL+VnUZcwwgWQN6kzzvhd1QUZRd+JWdFFibjND15oxwWFKQBg7Z= 8rFacZTkcr3KKQZOx8NnDPCfIVuRMu6JA3dkUJ/BJIjSLP2196+7IWzEfTawAXAJ71wE0jWpEoX= azm6+O9GosBP0TnwC91mxlxrhoLDbgLCmBvQIhen/jrIOOrafIiJM0phvmJuRMu6JA1dpEJ7Asn= VSNh5O/CbFH/mLeximUCyGiY1aRkTSE5tzED6gAkkpy5mIIaRwMSKhlEGMxDDSNAPNW8/GaO3Ct= ppSOy4Fy3mhQt85mJ0CDhU1LxtKGhfhDRXhwHvYaKsxVyMHpockmrethS0GUfRudA2A61xbGSii= 1EwBe1UptEs1hVohXYsEhZT3q5Dqthb6JRn34UW6F6NujBXIoNLuTA9DHV1bkCLZhnL3Lky2nAx= OgO9gOUzFzgNLRTG1jy+hLUiU5HG07xl1bzHoBZnAbnUIXvKL0WGswLJPvagL7oeQ24gc5Dvq8x= A1iA3o/OBN3j5aVtBC1IQvKkgbIy4bsoUtFOTxtO8e9D7EjOQkYD667uRWG83eknpNNSi/Ai9H3= G9iwcSOz4M/DtyHZq5JE25MP0e8ry4ls4XlfrhYvQMtCIdYz/mYvSQpB9qXv+96YeQp8UYB5FBp= LgPvWa6AHVrMvl62wralwB/joygCHMxegjStpr3djTtugo9SU9HY4KM41GrsRAJ7L5BsQtT3PHL= 0ZP8fvKP5bSpoD0JjZF+6M7rjzXMxegQ0KaaFzQIvxN1y9Z6cReh11s/hAa/672wIhemxyM3pN8= C3kn7LkbX09n9OkjeUpmL0UOXgdBiLaJz5qkppqA1esVAGMgK1EqMdotYAVPQGr1g0g1klpeJ7Z= OQvmGkmHQDMYxBxuTuhlGGugbyYrQOcQ9wHfAc2nPt+VZkzc/qFtExSvGKdx2ucumH319fC/xOz= fM19Qk8Ru/9/o6i6Wx/1m4jpkyu3MU6G31P8PlofWIJuuiv6XG+fK6lvIGsQV/gLXJoUIfdTDSQ= DT1Ooyxt+f1dhQw3m67+LfQgHEZlcu0xyALUahwX7J9Ou5qjrZQ3kPVobWV1t4gV2MFEA5ks2lY= tg4zkr8iVCsOmTK49BlmN9FDhotvP6PQTW6Tg7RZ2DnrxKMvg1cQp8s27FH2DfBf5dw1DQsXxbO= DDaOHzOnK5zBloGnobegCk0t+B9FjPc+f+AHrS70SK3sy4Yr6Kqyig2/T767MCLe5mjvaG2rdvl= RbkQrRK7nMJeaWfS1rBmwpbgm6KReiC7/HS8FuQlG/e09z/ESRmDIWCMcXxKmAzksd8EBnGEnRj= H4HGVw+S3+Sx9Gci374nujRvRQqCOUh18EovD75P4KoK6H6olkFK6VODfcOkTK7dgvwPumF8WcU= n0aD4cqTITSl4U2GPIH3VbCTwexoT5RsgP7vb0dNtB7qhQU/533MF+zkaI6wJjo0pjve6fFyEPB= LOQH3vm5H+ah+64VPp/xQpiO9E6uG7gO8g8eV/0qny9QWPVRXQ/VAtA5zszukzlMrkqgZyB+qPn= tIlXkrBWxT2GPpM9MfQRX0H8datyDfvC5C70Gz/6eiG94kpjlcCH0V6sGvcvnl03tR+Psr4Bh4n= btwhVRXQ/fD7uxC1hgcj+4dOmVzVQO4H3oX65WeibsYiOgfQKQVvKmwmGuO8Fn21Kds/g+7+fee= jccE+Lx93oi7PKeRjiJji+FQ07tnn0hlFL2ltQt2pheiGzZ7MsfQXom7SHJfWYrdvxNXPYrcd+g= SuqoDuh9/fF6IWLGRolclVp3lH0AD4RjQw3YM+OeAP4IoUvKmwmeQeQsbRDbsadQWyfdnTNvSbe= 5sLf4d3vsu84zZ5+0PF8XHuXFe5825H3byLXbxLXTr7yFuFMP3PuXR2Belu8LZPIO6ruIoCGtrz= +5uxmYndtGFTJg+k1GQB+SAb9EQeFI8pg0S/VcvDqEweSAO5CA32s/7/SXQajJHTT9XyMCqTB9J= Ano6a8XvQmsCGyc2OMcQMpIEYxqBgal7DKENVA8mkEuFf05mTjCLl7hi9V6+CplD3oIXAcOV4Pp= p18icKhl7ZOoxU6WKdQ75Q9VUkmRhFN3YZXloiTqjcbUu9OhutXi9xf1+hc3HwPCTd8KeIh1HZO= ozUHoP4i1CZgYBmnrqtHM+l09lbEaFyty316lI6FapX0/khT9Di46Zg37ApW4eRRlqsGD8mN7Qi= JeoW8oWzMYpVtD5tqlcfQKvaa1AL8s9I19SNoVa2DiN1Z7H8FiQjpUSdiW7ujJiKFjpbkLbVq8u= RzOT9xFvAWAsCw6VsHUZam8VKKVFDYirakLbVq89ARroY6avKMpTK1mGkjWnesr54YyrakDbVq4= ejSYOvodmpYyk/QzWUytZhpNcGklKijqMbKxPpxVS0oXK3TfXqLKT2PdJtP0757ubQKluHkapjk= Ol0dl3WBOEpJeo25A1lHnEVrb/Oko0t2lSvbkQG/HXgdUGYr8T1xyHDpmwdRqaU1MR87hr9ZkoZ= CJjPXaO/TDkDMYx+YmJFwyiDGYhhJDADMYwEZiCGkcAMxDASmIEYRgIzEMNIYAZiGAnMQAwjgRm= IYSQwAzGMBGYghpHADMQwEmTvgZui1zAiWAtiGIZh1OP/AUqhSnTd9m/PAAAAAElFTkSuQmCC" = width=3D"200" height=3D"128" alt=3D"" style=3D"margin-top:12.15pt; margin-l= eft:43.99pt; position:absolute" /></span><span style=3D"font-family:'Times = New Roman'"> </span></p><p style=3D"margin-bottom:0pt; line-height:nor= mal; font-size:12pt"><span style=3D"font-family:'Times New Roman'"> </= span></p><p style=3D"margin-bottom:0pt; line-height:normal; font-size:12pt"= ><span style=3D"height:0pt; display:block; position:absolute; z-index:4"><i= mg src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPYAAAAkCAYAAAC65Mf= sAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAABd9JREFUeJzt3HuMXVUVx/= HPjJ1psSBSLNYKLWAQGoXQlkCtTvzDB4gGggYpNlGxxSpqNP5jfVSNxhgfUWOCBosvICIQRf4wg= BDTmFYTFGMaY3zFAMZHFcSoURBl/GPt03vm9N47986dyTiH9U1O5py9z15n7X33b++1z753xjAt= SZJWsaz8HVtUL5IkmQ8OT9Lji+lFkiQLQwo7SVpICjtJWkgKO0laSAo7SVpICjtJWkgKO0laSAo= 7SVrIsML+gtgEn8bfcA8+guPm+Pw3Y2qOZbtxFHZixyKVh1V4F86vpY1az/nwazaOxrsxMc92j8= Kr8KkueR/T6U8vKWlX4vR59uEJyTBfKZ3AB8oxhvX4Fj4+YPkteOpQ3g3H+TiEXYtUHl6PR3HBC= DaazIdf/ZjA5/HCBbB9Afbhxkb6WaI/NDlV9KnTFsCXtjNdO4b+rvhOIeyKHbh7gHIrcJuFFTa8= zmgCGLU80T7zKWzmx69evAGvWSDb8FwzhT2Gr2IPzuly/2m4RS4Vh+WwsEdpuOVi1N2O7zTypoS= I9+NlJW0PLsLDuATHY7dOyLoBXxId+B4Rjm3BrfgR3ouVPXw5W4zy38NJs/gxaPmHRCOtwLZyvr= 3kbRId9bxS5macXLP3aO28WU+lXt/AQSHWSdE+PxezWzWT9apXZaNb20ziE/gutmJdSX8fXtCl7= stxFW4v1xvwZZyJr5f09V3KwefMnCXqxzG1+/7dKDctlie3idD7TY38X+GPOLfHc5MBmMuMXX14= 94nQc7KWf6LopCuFOO/D6pL3M50Z+0ozQ9Zbi83zyvVaEQmsF2v4a4rdJseJjn96sf0VIZZ+fgx= S/gQdYY+LWbgS9o9L3kaxhnwP9tZs7q7Vq1nPdfgmni7CzgPYjKuFyC7BJ/v4NVvbnFvuezIu1h= F2L87GD2rXN5e6vbzY2IPXzmJjNp7tyFC8YgLXiQGlzlvwzhGf+0Rj5Bn7g6LjPyhmmfqIvAkfw= j9K3nrdX4bsxUdr16/EL/Drcj0lZtr7xSx/tQj7m79Em8JdpexfcceQfvQq/6faPY/jd7Xrai16= EP/C9bgMTxqgnlvETHUIv8Hzca8YDF6Nt4mBspdflc+92uZ+ERldjh/igS4+1VlTnlGxDb8VA84= /i4+TXcox+Izdj8fwNUcK+yEzo6BkCEYJxf+Mt+MzItys27xcdLLq2N/DxiO182nRkSrG8Iza9V= 8a+RVPETNdnckh/OhVvhtV+iON9MdERPDfHuXq9487chfhRDEA/B4fHsCvfm1zSIjzYRFSb+zhU= 8UyM+v7uBgMB+EqM9u3fvx9QBvK8x9spP1HtGsyB4YV9rgIA9eKEPUAbsKn8RwRVv1EfOBnlXs2= i5CT+LCOLedjIhx9Wrk+VmwVVb8R/74Q5kuLnRfrbLfVOSjC3eeJsHidWE+u7ePHIOUvFbPfGcX= WBrG1d2GtbFXmMhFOdqtX8/pesabcqDMzX4hfipD4BBEC9/OrX9tsFeH1nSKS2NylznX+YOYa+p= ji76ri++pyjPKb/VViMKsGqvFSJ+JF2VbRl+qsEZFDMkeGWWPX97H3lbTlQtzTJR9eJMLIA2KdV= /H+kn4GrqjZOke8JJoW68/VNTt3i7X5bp3O0GSbEMU1eCveIWa8Xn4MWv4K8SJvl3iXsEus2SeK= r2/ET8Use3Sxtb1Wr6ku9YRXiPXzXcXHU0R77i337Ct/e/nVr202iXB/P67Vacs9QkBNVohBpYo= ibqz5u612flGvxpuFrY7sM8/Ct3GD2DvvFrZ/Vr48G5aRtruSjrC7ramXIjvFltf/CyfJ7a65kM= IekTWi3Y6f7cYlwnJ8UbwJX2yeKZYQpyy2I0uQFPYIrNBowJawUux2zPdXSodlh/zW2Vw53C/Hy= kn+M8MkWfrkPzNMkjaTwk6SFpLCTpIWksJOkhaSwk6SFpLCTpIWksJOkhaSwk6SFpLCTpIWksJO= khZSfaU0SZIWkTN2krSQZbPfkiTJEmIM/gchIV16fMtQoAAAAABJRU5ErkJggg=3D=3D" width= =3D"246" height=3D"36" alt=3D"" style=3D"margin-top:8.86pt; margin-left:240= .82pt; position:absolute" /></span><span style=3D"font-family:'Times New Ro= man'"> </span></p><p style=3D"margin-bottom:0pt; line-height:normal; f= ont-size:12pt"><span style=3D"height:0pt; display:block; position:absolute;= z-index:12"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAD4A= AAASCAYAAAADr20JAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAAEtJREF= UWIXt07EKACAIAFED//+XaxIKxFoi0nuzg4coAgD/6KeD7eYWD8zhYVvmcOM2Vgg3S6tuhtOqcH= G3US8v8lK2o4ZKvi0AYAB5cwcL2DgZQAAAAABJRU5ErkJggg=3D=3D" width=3D"62" height= =3D"18" alt=3D"" style=3D"margin-top:3.62pt; margin-left:195.07pt; position= :absolute" /></span><span style=3D"height:0pt; display:block; position:abso= lute; z-index:16"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgA= AAB8AAACJCAYAAADUkeNnAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAABd= RJREFUeJztnHtQVFUcxz8rkChoyUNMMBYVUBQRQVJ8YmpYJoOihqhpmmPZMMk4jKmZj0nFnILKc= hzNcUwtQRx8jQ8mYUhUIkVNjVTExAeCC8vLhWV3+8O88tI4V3bN5v5mduaePXO+n/M7e8/vvO5e= FY3N1MR3LWWqxyXMCW2S+fDCUuB63Ebwr7KvmIUWHdi9UQVaWQL8OO1WZqM1owIWhTc0Ba7AFbg= CV+AKXIErcAWuwBW4+eFV5WVUlNyjouQehfl5fDYxVKi8tVzwgQ3xXMj4GSc3dwAqSzUUXhNbbs= mGX/71BNEbd2BrZw+AvrqaQ5u+FtKQ3ezhMYspzM+T0iaTkdLCO0Iasj3/adUSqu9X0bpNWwCqy= rRobt9k2op15oc7ubkTtSwOaxsbACq1WpLWLhfSUGGh9flDq7NJoJLtOUBhfh7XL5zFytoaD78A= HDp1FiovdMMZavXS9cXj6WyMmUNZcRF6nY6DG+LJzcoUggt5nvT5SsKiY7G1s+fY9u+Z88VGXNR= dAfB7LZTNsfPwDgputp6Q58Mj3+HaudMA1OpraOfoJOVpbhWgq6wQkRPz3EXdDRd1NwBGzZjLrt= VL8QoKpqJEQ2byTsLnLxKCP9XdXlxwnas5vwGg7t1X+gmeZC12tzu5uUuxHR6EWJvWrZtdXgiuu= XNL6k53GgwiVVot8bMnC7WeEDxrfzKhsz8EYNXEUILDJ2P9wgNPK0o0IlLi8IdggEkLlzM4IkpK= Gw0GPANeFYLLHtXUvv4c2vSNlP7j1HF6Dx1hGXhKQhydu3tL6W59AzjwXbxl4EajAa/+A6V0RYm= Gm5cvCWnI7mojps4iJSEO3+GjuF9eRmbyToZOnm4ZeK/BITi5uZP/ew6YTITHLMbN28cycAAXdd= d6Ua1Gp+MFW1vzw6vKyyjIvYjRUAtAbU0NF4+nM2lh82czsuEpCWuwe7EDZ48dZkhEFOWaYjwDx= fq5bPjVM9nEbk+hnYMjHn4BuLh7kPbjViEN2V2t95AQ0nZuJXBMGBm7tnFqfzIXfkkT0pA9pNbo= dBTdyMfVswd3/8onLycbtW9fOnk0OkWqZ3WHVNme372ex/n0VAA6vqKmvVNH2ti3E9JQwquwKeG= 1bnj9/87hTu1NYsjEKOw7OFp+Dlerr2HPl6uZtmKd5edw59JSGR+zGIBLJzLq5alatUJz56YQXM= jzYW9P5+S+3Ti83Jnz6amcST0o5WmL7nJ0ywbemreg2XpCng8aH4l3UDCqf6KyQa+XPkajUUQKE= PRcpVLh5u2Dm7cPU5auIXBMmJRnMplo7+AoBJcdXgeMi2hUMb8RZtwEVNZq8IzXaj2Dh9UXsrIi= 4PWxloEvHze8XrpGpyNx7TIhDeFRLTcrk4zEHwBYGzVO+r6qTIvvsJHmhXsHBePeqw+Hu6gZ+8H= 8OjkqrKzF5GSN57Z29oRFx8opWs+UkwZhU04antuTBtnNPj5mEUc2ryfhvUisrG0oyL0o3P1kw/= fEr8bVy4f88zkAdPXrx771zW/yp4KXFRfRZ/ijcFqpLUVz24wTyLo2YuosTu5NAuDP7JNk7NpGS= NS7QhpPtd9edOM6BbkXMBqMuHr1+NeNAWjB/XbnLu44d3m0324ymVCpVE8oUd+E4GXFRY/Nq63V= 8+28GSzZfcQ88CWhA/EdNhKb1rYYDQaunsnCM3AAoKKytAQ3754icmLwN+Z+JM3jEuM+JXrjDun= Ap1JbStb+ZCG4UFerO4EsvnmDtu1fktKVpSVkHdgjBJd9w42e+T47Vn6MX8hoDHo9J/YmMnjCFM= vAu/n3x7mLmiuns6g2GYlY8AlqX38hDaFmbxg+2zs502/0mwwMm4Ta1184vAp5fnTLBhw6uT4x3= 2xL5JY2Ic9HzZzLoAmRj80X3Zl4pk8OPL9PCClwBa7AFbgCV+AKXIErcAWuwBW4Am8Ra/gf9Gfu= ubRl2MS/41vMmtL+T7xzwJIVaPS2hYbW0hVpkvM37BBxB+7XNmQAAAAASUVORK5CYII=3D" wid= th=3D"31" height=3D"137" alt=3D"" style=3D"margin-top:-30.48pt; margin-left= :7.07pt; position:absolute" /></span><span style=3D"font-family:'Times New = Roman'"> </span></p><p style=3D"margin-bottom:0pt; line-height:normal;= font-size:12pt"><span style=3D"font-family:'Times New Roman'"> </span= ></p><p style=3D"margin-bottom:0pt; line-height:normal; font-size:12pt"><sp= an style=3D"font-family:'Times New Roman'"> </span></p><p style=3D"mar= gin-bottom:0pt; line-height:normal; font-size:12pt"><span style=3D"font-fam= ily:'Times New Roman'"> </span></p><p style=3D"margin-bottom:0pt; line= -height:normal; font-size:12pt"><span style=3D"height:0pt; display:block; p= osition:absolute; z-index:19"><img src=3D"data:image/png;base64,iVBORw0KGgo= AAAANSUhEUgAAAA4AAAAkCAYAAAC5fwuBAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADs= QBlSsOGwAAAENJREFUSIljYCAM/mMTZCJCI1YwqnFU46jGUY301MiIRQxrqYauB5tGfJrh6qnqV= Fy2oqgl20ZC4D8Wm2lr4yigKwAAyOYGMa8lU3kAAAAASUVORK5CYII=3D" width=3D"14" hei= ght=3D"36" alt=3D"" style=3D"margin-top:10.15pt; margin-left:104.25pt; posi= tion:absolute" /></span><span style=3D"font-family:'Times New Roman'"> = ;</span></p><p style=3D"margin-bottom:0pt; line-height:normal; font-size:12= pt"><span style=3D"font-family:'Times New Roman'"> </span></p><p style= =3D"margin-bottom:0pt; line-height:normal; font-size:12pt"><span style=3D"h= eight:0pt; display:block; position:absolute; z-index:5"><img src=3D"data:im= age/png;base64,iVBORw0KGgoAAAANSUhEUgAAAMgAAAAoCAYAAAC7HLUcAAAABHNCSVQICAgI= fAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAABbhJREFUeJzt23uoXUcVx/HPiUlu0zRptcbEap8= QVNTQ2lJja1Co2PggtooaDa3aJD6qoChiRaMFUVELPkClpj6L+Ci1+oeIVjTUxEJRCFKK6D9VQa= 0Fi1XEYvX6x5rJ2efk7H3PK7mJrC8c7tl7Zs9ea/b8Zq2Zs28Pi5IkGUVvZf2yrGYkyYnFkaCxY= jmtSJITnRRIknSQAkmSDlIgSdJBCiRJOkiBJEkHKZAk6SAFkiQdpECSpIMUSJJ0kAJJkg5SIEnS= waQC+YJ4kWsRD+MefBiPndGOt2DbjG0cDx6H9+DKObZ5PHxfgz3YfQzaPg3vxapj0HZlBV6B7+D= WMcr24inzuvkkr7uvwgfLp4dz8V18fF7GLMFWnHGc7jWK1+MRbF9GG6bhSjyAN8253VX4PJ4353= abPAYfwzdxCRbGKLtAjMvNU96zBoEjB5OwRwikshs/ntKQSTgF37O8AiF8P9kEAq8zf4Fch9fOu= c1h3oiviCg4Sdlm3Ga6ZcQRgcyyBlnAFuzCj4bKtonBfBAvapzfjjsbBizi2bhBP21ZjU/gJ7gM= 55Tz+7ADD+FqPA1fEg/+HhFSt+IO/ALvw9qO9pq01RnlxyNj+roVt+NXYmD2Rpw7c8j3et2wD4q= /X8YzxYz5AxHBq/378GscKG3AhWImvQtnD9k9bV9VFnB9sWMp+5p8zuDzb37WDdVdhxvxG/y0tL= 9pjDL4Lf6MSzt8GItpIkh16H6RdqxulD9ZPKy1YtDejw0iV31YhL8n4PtCHHsNpi2XisFzKl5m8= CHdpx9B7tAXGJwlItm5Yk10c7Gjq73KqDptftzQsLWtzjkiJ95Y/D0kBs7wubcP+d7mA3y7+PuS= Yuc+XFvKNuOzYtBejZvK9XcVu84QM22NILP0VeVC3N047rJvWi4vPpwnBPFp4dtSZZW34p1T3Hc= uKdYGMftsHSrf4eiZ4bkiX7wVF2G9eGDPL9fcqD9INgrx7BYPsklTID0xY55Zjl9d2qlsEQO2q7= 3KqDptfjQF0lbnVSKyNRl1jkHf23zoiWj/e33/d4lnUVmHa8Ts/5li275G+U59gczSV5Xt4hlWl= rKvMkkEeTH2N46fgXvHKKvsFH0xKXNJsR4UM+Cn9AdpbfM14qHWz0H8R3TOO8rxvfhZueZfjesf= EI49JMLmRR1O/LNx3MMTG8d/LeV/GaO9Ufds86NJW50Vjt7ZG3WOQd/bfID/4h8jrici2X78ER8= q59YbXNDSj/Sz9FVlpcHMocu+Jtcb7K/m5+9DdR8UkbeO07/hD2OUVR7Fv8ewqZVJBbJCzCxniU= XzIXwLn8TTxa7GYdEJW0qdi0VK0RPp2HWl7CYhmp6YuR5f7nGZCN8/FBHn4sb9H8Xp5fvpYtu1/= l/9z8VgfWG57wvEtvRzOtqrjLpnmx9NW9vq/BJvFgNstVin/G7EuU1D7bX5UGfXjcXnnojgG8r3= y0UufrdIX08V65y9xf81Il16P145Y19V/mRwjdFl37QcFmK9RqSxV+HrY5RVNjlaNBMzSYrV/B3= kQDm3IESyWMrhCrEYPyRyWaKjvmowpH5UCKYeX4JnibTtIG4RnVz5QGn3qWLxuSjy+lrnCpFb3y= dSoTVLtFdpqzPsx66Grdta6lReKnLkO0udUefeMOR7mw/wjUbdnY3vO3C+eB77SzsHyt+dQjQ34= 20ieq+fsa8qpwhR1qjYZd8snIeviXT63foT4lJlRHo1zSJ9pjXItJxmcJdnFV4uZp3k5GSPmOBO= RM42h21ejp9ArsW7RDqxUqRpdfszOTlZwBfFztWJxJNEinj+lNcvi0A24SMidzwsdlhmfUUlWX7= Wih2xY/mqyaTsNv2v6CyTQJLkZGEu27xJ8n9PCiRJOkiBJEkHKZAk6SAFkiQdpECSpIMUSJJ0kA= JJkg5SIEnSQX37MX9NT5IRZARJkg5SIEmSJMl0/A+sMIaT747FogAAAABJRU5ErkJggg=3D=3D"= width=3D"200" height=3D"40" alt=3D"" style=3D"margin-top:5.76pt; margin-le= ft:43.99pt; position:absolute" /></span><span style=3D"height:0pt; display:= block; position:absolute; z-index:6"><img src=3D"data:image/png;base64,iVBO= Rw0KGgoAAAANSUhEUgAAAPgAAAAuCAYAAAAFttQ5AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAA= OxAAADsQBlSsOGwAACClJREFUeJztnXuMHVMcxz93d7u7tVtVa9luiiWRKiVVpdoqolQprVcU9a= iq5z/4A/WoNhoETeoRr5a2lHjFK5SwDQ2tR1NsRKTxjyIq2iBUUGWvP35nMufOnjN35t7d7t7Z3= yeZdGfmnN+c+c38Zn5nzvne5oA8iqJkkVxN8EevNkNRlO6i4IVd1VutUBSl59EAV5QMowGuKBlG= A1xRMowGuKJkGA1wRckwGuCKkmE0wBUlw2iAK0qGSRvgS5CZMnngd2A9cAcwpMTjXwVMLLFuf8b= 22xHAy55yuwM3AiftjEaVSCW0saJJMxd9ADDfLDlgX+BV4J6E9Y8CdkvVOgX8fssBHfiv4SxgOz= ClZ5rVLcyi77exkshbS+o3+A7gB8vQt8DrwOgEdeuBm1IeT4n3Wx44JqbuCuDO7m5QN7OCvt/Gi= qWcPngdcCgwE3gnsm8i8BqwFjjZbJsHTAN+Bc4AmoC5hKnZCGAZcDGS+g9H3lyvABuAW4AGoBa4= F3gXGA/s42jbCGA5cAjwHPAWkm3gseniKOAl4AvgCkJBjqv+cOBx448lwHvA/sY3XwC3W/VHA88= CY4H3gReANrOv1vhpI7DGHKuY3/4x/04E1gFPAcOs89geOa/otUniz7T+iPO/C7uNLh8oZZBWLj= qHMAXYhKRYtdb+YcgFCm78TUCz2fcVYap5GYWp2SvG5liz3gqsRm6MIcBjxu6RyA22CzAd9w35g= rE11ZSbB1wUYzPKPki/di8kUNeZ8r76T5rjTTfnfQPwIHCAKfcV0GJsf2bKHgYMBG4Glpp9BwAP= IQ/PM4BFCfxWb+yNMOd6PfCodS5zrbKuazOZ4v5M6w+f/33YbfT5QElGQYoOpQX4fCRoN9D1CTs= tcpA8cLTZZ9+oAAsIL2wOeWo3mfUZZn/AocgNuRewCrgUucFcVAHfWceaadrtsxmVy56DZBJR4u= p/SRjEk4FbrXKrCANnEOKTarO+N/LBstrafyHyRn3AbIvzWxDgAU3AT4TZmR08rmtzGsX9mdYfP= v/7sNsIbh8oySirD26zFbgGuI8wKAOb5yE3fbCs9dj4O9KwP631HDDUWv/F7N8CnIukrMuRN2GU= TuAPx3afzShVuEcG4upvs7bHPTT/jqzvQILiP+QNuxTYDCxMYcOmBrk2nY59rmvzOsX9mdYfedz= +T0JSHygJSBvgVchTvhV5c6wDngcWAwcjX9k7gKuRp3k9cDiS1gH8Cww2f+eQt/EeZn0wMmQS/A= jFh8jNONnYOQHp344DRgFvAyuN/SiDjO3dzXGazeKzGQ3IT4ErkZu9Fum3tsTUb0AeckEQNJml2= tq3B4WMQ1L0GUi/GWAC8DXwEbAnkt4W81sn8tAbacrPRroHrrKua3M2xf2Z1h+NuP3v+mGRaBt9= PlBKJE2Kbo+DrzHb6pAgz5v9AJOAduQBMN2qf5vZfiBwiWVrDDLclkf6es2WndVIijoXCYjRSLd= gLfJhq5muPGvZPtf6e5rHpotTkY9g7aZOgKv+MusYU6y/r0OCN1hvQB6CeeByJK1fiAQEwH6IX5= can6wx/8b5DWQs/C3jk0sI0/2ZVtlg3Dx6bZL4M60/4vwfJdpGnw+UZJTdB1fKIwjw6mIFFaUEu= q0PrpRG8L1CJ/woOwV9g+88gi/eBSmUonQjmqIrSobRFF1R+gsa4P2POmS0o7ZYQaXyKSXAe1vi= 2RPHd9msQ4aE2sqw24gIRQaUYaMYE5C57+/R9RyqgLOQoceVZtt24A1k/F3pB/T1PnhvSUwPR+Z= rl8oA4BHg2O5pjpMmZHJJHTLGvN7aVw3cjYg9xpgyAQ3IOLi9TckGFfWRrR5RPlXikNJs4PwePo= adgbUSilZAJtKswD+RZzGFE1aUbFBWgLsknj5ZYLux/aJZv8isT8ItJ3XJFu+wGuuSSoLMHGun8= MSG45cdRmWPLps+SWlSGWSdqTskZT2AhyPnYi+DPHWGIZJUW9CyGVGqfWyO3RKpcwGielOyRVkB= HpUqxskC6xHZ4kizXo0Etk9O6pOBxkklGxEl1v7IvOVVhHJTl+zQJXu8JmIzTlKaVAY5CplLTcp= 6pRDMjMsDTyPnOwGZVtqGBPv9dJVdHk84tVjJDmWn6AsIg6GYLHAc4Y3chtyMPjmpTwYaJ5WsRj= 4eHQbsiqSkx1llo7JDn+zRthknCU0qg5xi2hKQRj5Zyht8IJL1dCAP0VMoTNdHIvPebcYjGgIlW= 5Q9Dm5LFX2yzIBPkBuuBgmQHfjlpD9RXLYYPf5/SEBca2x8CXxg9rlkhz7Zo20zThJa7HwDaigc= hkpaD0TtlfMs2zx1/kKUXcvNsbYi3YHg+v4GfB+p0wD8nLBNSoWSNsCj0j6fLDOQBXYCbyJvlF/= MNp+cdDxu2WKcVDKH/KLMbGNvERL04JYd+mSPts04SWmx8w34kcI+dtJ65dCKdEs+R3z8K5K9NA= CnA89Eyg8FvunG4yt9lDQpelSqmEQW2IC8YW1cclKfbDFOKpkj/LmkYLkLeXD5ZIdR2aNLfumTl= CaVQdYjD5chKeulZZRp40bCbwwBbYhUdSPyM041kbqLif/BRqUyqahhsmI0En6FB+njn4m8LXub= OUhm0RfZFXm4+obQlMolU3PRzwQOQtLrGsLUd0tvNsqwEukmTO3thjg4Eel2/NXbDVF6nkp+g7c= gv6ndYZZ5lP6/rPQEDcgX+Z6cqpqWOuAJdBZbVslUiq4oSiGZStEVRYlBA1xRMowGuKJkGA1wRc= kwGuCKkmGC2U36JV1RMoi+wRUlw/wPnoJwzOCz5noAAAAASUVORK5CYII=3D" width=3D"248"= height=3D"46" alt=3D"" style=3D"margin-top:3.94pt; margin-left:239.88pt; p= osition:absolute" /></span><span style=3D"font-family:'Times New Roman'">&#= xa0;</span></p><p style=3D"margin-bottom:0pt; line-height:normal; font-size= :12pt"><span style=3D"height:0pt; display:block; position:absolute; z-index= :13"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAD4AAAASCAYA= AAADr20JAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAAEtJREFUWIXt07E= KACAIAFED//+XaxIKxFoi0nuzg4coAgD/6KeD7eYWD8zhYVvmcOM2Vgg3S6tuhtOqcHG3US8v8l= K2o4ZKvi0AYAB5cwcL2DgZQAAAAABJRU5ErkJggg=3D=3D" width=3D"62" height=3D"18" = alt=3D"" style=3D"margin-top:-0.03pt; margin-left:193.27pt; position:absolu= te" /></span><span style=3D"font-family:'Times New Roman'"> </span></p= ><p style=3D"margin-bottom:0pt; line-height:normal; font-size:12pt"><span s= tyle=3D"height:0pt; display:block; position:absolute; z-index:20"><img src= =3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAA4AAAAkCAYAAAC5fwuBAAAAB= HNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAAENJREFUSIljYCAM/mMTZCJCI1Yw= qnFU46jGUY301MiIRQxrqYauB5tGfJrh6qnqVFy2oqgl20ZC4D8Wm2lr4yigKwAAyOYGMa8lU3k= AAAAASUVORK5CYII=3D" width=3D"14" height=3D"36" alt=3D"" style=3D"margin-to= p:6.22pt; margin-left:104.72pt; position:absolute" /></span><span style=3D"= font-family:'Times New Roman'"> </span></p><p style=3D"margin-bottom:0= pt; line-height:normal; font-size:12pt"><span style=3D"font-family:'Times N= ew Roman'"> </span></p><p style=3D"margin-bottom:0pt; line-height:norm= al; font-size:12pt"><span style=3D"height:0pt; display:block; position:abso= lute; z-index:7"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAA= AMgAAAAsCAYAAAAgjfcKAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAB7d= JREFUeJzt3XuMHlUZx/HPLr1KKWCB1loKklSpYq0i2oKoCUbrbQkkarHeCsV6SzAajZdUiASNdw= IRRYyVauItiMagQbyUSjEhBTeNkqYkChov1SgGjaJc1j+eM7zzTmdm9333XXe3Pd/kze7MnHne5= 5yZ55znnPPbdghjMplMHUNzil+m1Y1MZmbx2KAxPJ1eZDIznRwgmUwLOUAymRZygGQyLeQAyWRa= yAGSybSQAySTaSEHSCbTQq8B8gWxiTKGB3AHrsCxk/TjrTh7kjYmwxn49jR+/0JswUXT6EOmgV6= kJnNxafoM4SR8Bx+fAr/qWIdjBmxzCKOmV3LzEhzA1mn0IdOhGAR6HkEewu9LRu7D9/CsgbnWzA= K8fwrsjuH5U2C3F27Ge6fZh0wNk5mDzMcabMIPK9fOxndxG15aOr8Bt+hE6Biei/eJXhTm4RP4C= c7EynR+G0ZwP87DanwJbxSp3lPECHMj9uCDOLLFXpn/lvzejR1Ygb8mHxdgY/p90zh+rsMN2CtG= hKFUdhv2YWcqA2vFCLwLJ1Z86rcuRIf1NdG2u/BNnFzyu+pLtS1Pa/C3Sp0/bW02K+k1tdii83L= fizeJhipYIRr3SPHS3ovjsUjMW07BCbhJPMCL8R8RPPAc8WI9Dufqfgnu1kmxbtQJMFiOH4m071= hcm/xos1ewINlancq9B59PfhYPe1iklsXDrrO7UsxllqZ67k6+rMJnRadyHj6Zzu9KbXQMvqyTY= k2mLnBX8vuZYn7zAVyXrtX5Um3LujJ11PnT1mazhcdSLPoLkEvFS7/Hwb3LiO4RYgzPwxH4inho= i8UL8cJ0z2U6AbJUBM9F4kUpUw6QIdHDLUnHr0l2CtaI4GyzV1AESMESMScY1nnYRd2Lh11n99W= iF67jKLxe9LZXiXbaVrq+USdAJlOX4rvGRJsTo9MDpeOqL9W2rCtTR5M/TW02W+h7DlLmL7gEV+= pu2GFcIBq9+NyGR3AN3pmOf4mfpXseLN1/QLws92O7CKimSvyrdDyEJ5SO/5au/3mC9srMSfV7t= OZaMVrW+TmsfkVvhejB/4DL07nFooeusz3ZujxYOX5IBNgjDb5U27KuTB0TfVbzGs7PeOaMX6SL= YdFTLBc9xG58A5/Bx7BfrAjtEL39fjxNNOBvRDp2oXhQBUOiJzouHZ8perqbxdB9On6Rrj2Mo/H= 39PPxpTrcLpahbxCpy4vS8foWewWPipfvNPw6+Xh1unYfTk3XV4vgP5B8qNq9VSxa3IpfiZTlHp= yV2uLneGUqvxefEj3wqEhP3o0/TbIuZdbjTjEi7Ujn6nyptmVdmTqanlVTm32/xdcZSy8pVnkfZ= Gc6N18EyVi6DueIyfhukZsSgXC97tTro+JlLI6fLSaY68Qo80WRyhV8KNk9VUxux0TOX5Q5R+Tu= d4uJ/8Jx7JU5Az9I5TbrpCObxcR1qwjwrWJ+1WT3FeKlviX5A09K7XVdquPO9HOjeAmvxTvE6Lp= 4AHWZm9rmzWKkvlzMAZt82am7LZv8rdLkT1ObzRYmNQfpl0W6V7Tm4nwxemQGSxEgR4xXMFPLQO= YgvXI+nipSqTmitzleDMOZwVLMCQe9qXpY8v8aQZbhIyLfHhUrOJOVqGQOpliR60oTMj0xLSlWJ= jNbmJYUK5OZdeQAyWRaOBwDpE5aP18sy548oO9YJISVcwdkr8pZ+Gn6VOtynFg23qt7B/tiIWvJ= 9Eieg8QG16Benrn4HF4wIHtVloiNw/lCrnJH6dqQEB2OiM2/63WU1qeIvaNVU+TXoUSepE8hF+K= 1U2i/POov1xEhEkF+V6nMBny6dH0VvuXwzBx6oe8AqZOY10nb6yTfTTLoNmm2Gvu9SLOrfizRLa= 0vylRl5UVdt+Pp+LrYZT9pnPaZn+wUy9e92LjGwSLP4nNUTfkV+LBuRe+5OpISQuazq3Lf1Zrl6= 5mg7wCpyqLrpO1r1Uu+m2TQbdLsOvs3VXxokmbXSc8v0S2tb5KVE4E6hpcLndE2vGGc9lkrpCMF= /diYCMVO+Ri+qiN6fJ3QxRU8WdS3/G8vvx3vGoAPhzJ9B0hVFl0nbd+mWfJdJ4Nuk2Y3SecnIs1= ukp5fphMgTbLyIRHEv9XZjd6UfG5jg5DxF/Rio9cRZKEQC47qTNRHdPRwRMCOVu7bqFm+ngn63g= epyqLrpO33mPgO+Tzt0uwm6fxEpNlN0vPy9zXJygmF7z8nWI+CObql3b3YeJvuepY//6gp/2+h+= t2uI8vfL1LWorNZiR9X7ntYtHFmAvQaIFVZ9Kh4sGvEyHC60Fa9RaRM80TvtiyVL2TQy0V+foVO= b75e9IplaXad/WdolmafoCPNvrPBj7K0/nYRgC9O9gtZedFrL03fNaSjHWv7ryL+qHuO0Y+NXlg= uUsxC8r4vfV4mOocLxKS8zDL8bkDff1jQS4rVJDGvStvrJN/Uy6CP1izNrrNf9aFNml31Y7NuaX= 1hvyorJxYOirIbS7+PtLTPAhGsxcjVj43xWJt83SfmW9U/u32imJfswatq7r9K/KlsppkZtcx7q= Emzt4il3pnIifIy70SYUQGSycw0slgxk5kIOUAymRZygGQyLeQAyWRaKPYS8kQ9k6khjyCZTCaT= yWQyA+d/0FZK49KM3L8AAAAASUVORK5CYII=3D" width=3D"200" height=3D"44" alt=3D"= " style=3D"margin-top:1.06pt; margin-left:42.59pt; position:absolute" /></s= pan><span style=3D"height:0pt; display:block; position:absolute; z-index:14= "><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAD4AAAASCAYAAAA= Dr20JAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAAEtJREFUWIXt07EKAC= AIAFED//+XaxIKxFoi0nuzg4coAgD/6KeD7eYWD8zhYVvmcOM2Vgg3S6tuhtOqcHG3US8v8lK2o= 4ZKvi0AYAB5cwcL2DgZQAAAAABJRU5ErkJggg=3D=3D" width=3D"62" height=3D"18" alt= =3D"" style=3D"margin-top:7.3pt; margin-left:192.45pt; position:absolute" /= ></span><span style=3D"height:0pt; display:block; position:absolute; z-inde= x:8"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAP4AAAAsCAYA= AABFYAV1AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAABedJREFUeJzt3X2= sHGUVx/HP1r7RAtIiUKlQSkJKQyC8CBZMwx80FoVI4K82DSi0TRUxgESFYMGYKImaaEzA+I4x8Q= WjSIgRhBhUKglgQggpIMZQxUhBwQBBEOjyx3mGnV13b/d2771745xvMrk7OzPnOWf2+c1zzjOze= 1toS5KkUcwtf1tj9SJJkpngrUF+zji9SJJkPKTwk6SBpPCTpIGk8JOkgaTwk6SBpPCTpIGk8JOk= gaTwk6SBpPCTpIGk8JOkgaTwk6SBpPCTpIGk8JOkgaTwk6SBpPCTpIFMVvjfFN/pbeMF3I/PY8m= IfnwUa0e0MW6W4tNYP+T+g2LeD1uweYr8gv1xDeZNoc1+LMcvautbsWqa20z2kcn8As88XF+WFl= aID/qL0+BXP9bgoBlqa7J8GK/i7BHtrMdubBvVocI8fB1nTpG9QbTwGdxVe+9o0T+Omea2k+GoB= u32ZEf81/D3mpFduB0nT51vA1koRq3Zys34whTYuROfmgI7FRfi9/jtFNrsx9m6RQ9/wSfFecmy= chYxyoexACdgE37ds20tbsO9eH/t/apztGvLe3C1Too8H1/Cb3AGjizvb8cH8TzOx2p8Fx8SJcc= qkRHcigdxLRZPYK+XXp9/VPy7p7TV1p3ZrMHP8LAYnVtixK/4VzlmITaU15vKtoN7YoYTxej4Ox= zR005vTBOdpzoLcCl+VdZX43s4Hj8u76/ofzrcpPtzqi8H9Ox7GN6Gp/rYeQJP47QB7SRjYrI/t= rlFpwM8KVLc+bXt7xIiXSzE+CQOEXXmCyL9OxS/FKLfqjtFPk0IaRHO092hd+qk+rfqXDjgcNwt= OvISfKP4MZG9iXxeKeYvPidS1c3FhmLj56LDH40dpc2ra3EcqiP8OaI8qoTfG/MSIfhVJb6bi8+= DYtrbeao4EffV1m8pPp1TjtuOi/ocNxla4tzMETV+76gPH8MnRmwnGZ19TvUrPis69j/xGP5b23= ayEMtLZdsK0aH/I0bUt+MVPCsmsr6FG2rH7xIj+0Y8gL8O8OECPI4/l/W1YrTeJbKCG0WHHMZeP= 5+XlzgXiY77Hbxc9l9TYtkt0tn3ljbrPFN7vUenRNIn5rVCMI/j37hjLzG1hoxrWbFZsQF/Exeq= l4vv8/scx/Aj/rri+54Bdojs56gJticzzCip/rO4HF8VqWvd5kbROavlXrwhOtMVZf0RUXsSF4K= K3aKDPi/S0pMGtN/WEaLSzjtr68+V7c8MYW+Qz4vwaIlvfc/++3Inoy6yeswHirS8d99BMTHceZ= rb0+YecXEbhkt1n4/68mJtvw3iItQWqf46nUyn4nUxP5TMEiYr/Dki/TxcfLA78BN8BceJGeSHR= Kc5oexzikiHW6IsuKRs+7K4GLREyvyO0sYZIkW9Ez8ox1e8LjIG5e9SnZ8I/4MQ7/tKu+vE7cfT= J7BX0c/nU/Fx/BBXihH6zHIO/oiPCLHNFyPzsp44CEEcW87XalE6fKBPzA+L9P90kQUdKWbIlwy= Iqb2X81TxD901/AGl3aXFh0PKMsrPq1cZSEuUTHeX1/UL2zKRaSSziMnU+PX7+PeU9xYI8bfLdj= hLpH87RP1JdIbv604ZbxAXgmr93SLtXiNG3G+LjllxXbF7rJgIa4tau9rnLNHxdop6e7+92KvT6= 3MV68GiFq98rO69nyvq8rvKsZv67HOxmHjcJi5628Q8wsU9MRMj532ijr9MZEYHDojJkHEtxJ90= spNqwrKtM+HYFiXDVDCoxv+anNybDdS1N2P/SWd/3TP880SdftgMtd9UtoiL67g4Aj+Vt/NmA2M= R/kW4SqS3c0X6W90GS6aPBWJi8pwxtL1clCErx9B28r+MRfjLxIMcD5Vlu9Ef9U2GY7G4QzHdj+= z2slk+tTebeEv4rfIiR90k+f8n/3dekjSZFH6SNJAUfpI0kBR+kjSQFH6SNJAUfpI0kBR+kjSQF= H6SNJAUfpI0kBR+kjSQ6pHdJEkaRI74SdJAUvhJ0jzyS3lJ0kTeBLhoV1FEPTXYAAAAAElFTkSu= QmCC" width=3D"254" height=3D"44" alt=3D"" style=3D"margin-top:0.7pt; margi= n-left:237.35pt; position:absolute" /></span><span style=3D"font-family:'Ti= mes New Roman'"> </span></p><p style=3D"margin-bottom:0pt; line-height= :normal; font-size:12pt"><span style=3D"height:0pt; display:block; position= :absolute; z-index:17"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSU= hEUgAAAB8AAAD4CAYAAAAU7z0DAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOG= wAABQFJREFUeJzt3X9M1HUcx/HnwcGdEMcPRfFHeqSImAxNUkSZmWWoW84puXJzupnhLLPW1Mpq= rDKbszJXmVuYc6hTxFTUZW3g/FGQprZkc4lBknhCdwfCedxx0B/OG+eh3eerd7n5/vzF5/vd5/X= 4vrnvfb6f723ffXX4t85utt2rprtdJ5hot+bNP0IF+7h++OcnLwRFW5o5xO8AwkIB3y47LGhaAA= cQUvzWJrjgggsuuOCCCy644IILLrjgggsuuOCCCy644IILLrjgggsuuOCCCy644IILLrjgggsuu= OCCCy644PcDrr+bwZaai9SeO0u4Xk9yxmgSkvopjddcedXxI2x6fRHNjQ24nU4ObvyM85UnlDI0= V15WVMiiTzbRx/wIABmTc/lm+RJSx2QHnKG58na3i5ievbx96+U6nK0tShmaK396fj47P3qXoWO= yabFZOVGynZmvvaWUoeMunmNprKul+swpAMwjRtJ7UDI6ne6OY7o8TKNTqry5scGnH2mMIi0rB4= D2djcfzn6GVbsPB5ynhK/KHUf6xKeIMBjp8HioPl1JSmYWoKPVbmNAappKnBo+LX8ZuQtfBmDXx= ++xdNM2+pgHA9DaZKeytEQJVzrbb8IAjX9fIsoU5+232m1UHtijhGs+26csWMy2998kY9IUPG43= P+3bxYRZL4QGHzzqcRIfNnPh10raOjuY/cY7mNNHhQYHMPVK5LEp0719l9NJpNEYfNxxrZm681V= 0eNoBaHe5qDp+hOdWFgQf37t+DdGx8Zwt+56c2XO5Zm0kJXOsUoZmvPr0SZYX7SUmoSfJGaPpMy= iZ8h1blDI0X1hG5EyifPsWMqfO4OjOrVSUlnDuWLlShua53eV00nCphv4pw7j6Vw0Xz5zEnD6Sp= GS/ByF9mua5vWuLMBhoczj4eV8xPWJMDB//BKYul9hAmuZ/e1lRIT98u5EIgxHXdQe71xZQd75K= KUNz5RX7i1ny5VZvtaljJ7B7bQEL1mwIOENz5ZPnvYTH7fb2290ubJZ6pQylygtXvOLTr9i3i+i= 4BACaG68yLX9Z8HBLzQUWb9iMPiLCb19YuJ4oU2zw8JU7Dt5xmeRuayPCYAgObrPUe28MrvzpOy= c4mpr4bOEcpblCCa8sLfEuKFbn5ZI9cw76yBuVttisKlHqeNeVTN6KAnLy5nr7HR4PKaPVLizab= 5dOHPENCg9n/KznQ4OnZeVgv+V7vefT1UoZmme4o8VFHN78FT1iTAC4HK3YLPVKdy2a8d4Dzcxf= vZ5w/Y0IR7Od7R+8rZShdEmtr/4D13UHnZ0dPotFS001iQOTCQv770+x6yVV6TPXhen45eB39B0= 81Gd7fFJ/KvYX42huUolTO+HO/HiIJ+e9iCEq2md7pNHI8OyJlBUVBg8/dfgAsb0Su90XHRfPb+= WB3yQq4/2GDKXhUm23+yw1FzH17B08fNyMPEq/WOd3ANYrlzn09Xoypz6rhCt91YZl5dBis7Ju/= iwGpqUTn9SX1iY7546VMz3/VWVc0+q1xW6l9vezXLP+Q5QplgGpw0no2z+gsXe9en0oLoFHJ0zS= MtSnPbg/fwouuOCCCy644IILLrjgggsuuOCCCy644IILLrjgggsuuOCCCy644IILLrjgggsuuOC= CCy644IILLvgDh9/62tL/vXLvE4/dvFD1nrXusu+L19SG8gD8XtDbtQXrIPysfwFv6XpPkauYtQ= AAAABJRU5ErkJggg=3D=3D" width=3D"31" height=3D"248" alt=3D"" style=3D"margi= n-top:-61.98pt; margin-left:6.95pt; position:absolute" /></span><span style= =3D"font-family:'Times New Roman'"> </span></p><p style=3D"margin-bott= om:0pt; line-height:normal; font-size:12pt"><span style=3D"height:0pt; disp= lay:block; position:absolute; z-index:21"><img src=3D"data:image/png;base64= ,iVBORw0KGgoAAAANSUhEUgAAAA4AAAAkCAYAAAC5fwuBAAAABHNCSVQICAgIfAhkiAAAAAlwSF= lzAAAOxAAADsQBlSsOGwAAAENJREFUSIljYCAM/mMTZCJCI1YwqnFU46jGUY301MiIRQxrqYauB= 5tGfJrh6qnqVFy2oqgl20ZC4D8Wm2lr4yigKwAAyOYGMa8lU3kAAAAASUVORK5CYII=3D" widt= h=3D"14" height=3D"36" alt=3D"" style=3D"margin-top:6.71pt; margin-left:105= .86pt; position:absolute" /></span><span style=3D"font-family:'Times New Ro= man'"> </span></p><p style=3D"margin-bottom:0pt; line-height:normal; f= ont-size:12pt"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAP= 4AAACQCAYAAAAoaNZ7AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAGSFJR= EFUeJztnX3QHVV9xz8PSSQQQkhCDHmBRiDGWElJJaUGC0GMkbYGwpvRUIKUl/JSxmilVkO1Q5VK= W4rhRZsinUm1pKRAaGUcCgLTsRhaysSImIDNIINagZQCZQCTIf3jdw577rm/s3d37+7z3Pvc32f= mmefevedtf7tn9+zu+e53CNiLYRgDxVj3f2hEW2EYxnDw5kl+n5FshWEYI4N1fMMYQKzjG8YAYh= 3fMAYQ6/iGMYBYxzeMAcQ6vmEMINbxDWMAsY5vGANI2Y5/CzL7Zy/wU+Bu4ENdtuFK4LAuyxhuf= g+JwdsLpE2t35WujENqbJdhFKbsXP21wJnAOGCpy39k3Y2KeH/D5VdhPcU6fh6bsY5vDB/+pL23= m6H+buBeYAcwu45WJZgIXNJg+VV5rYYyXq2hDMMoTTcdfyLwUeTM/4Ng+XLgQWAjMMstWwn8O9k= R5zq3/GL3fb77vj9yJr0FWOyWrQVWuHRzkLPk48ClwF1uHZa5Ou8BTg7aopWntW+TK/8q4GPu80= L328nAfchB7uhELHa53wHWufwTlfUDOBH4V+AGYExUTpn1MIyuqDLU9x14AzAv+O1IZGcfj3T2q= 4HpyM48FVgE3B+Vt56sYywBzgAmAb/jlo0DHg3Sj0fuL/hRxuFIJ57s2vJE0Ka4PK19uLzrgVOA= 9yKdc8iV81WkE5+KXJd71pEN9Q8n6/gTgMdcnnj9pgP/DLwVeAfwc7Khfpn1MIwqdD3UPws4Cdm= BfxwsXwjchAxhb0U60IvAM8B+yJnxIFplwOGQeSdwNnLv4I5E3buB/3VlAvwGckZ+AbnsuBk4Nl= Ge1j5c3k8CHwamAQ8gAToWGWG87P5flWjTc8HnV4CfJdbvBNeOZ4Htrh5PmfUwjK7oZqh/P/Cfw= Opg2RjgfUjHHgJ+HdnxbwOuRc5+l5MeZTwN/C5y1vs75GBRhIODz88DexLljVfa5zkQ+DdkJDDV= LdsHOVDVxYHAW4LvcRyKrkfRuBiGSrfP8f8cGXqeigxDvwdchlyLHwB8EBmqL0ZGCe8HvhPkH4O= MGia778cjj77+HjmjH4J0jilIp8V9PiAoYwtwAbAA6VjHB3XE5f1MaR/ATOR+xVfc341I598KXO= TSTwjSj43avQeYiwzlF7hYjFPW7zHkHsKRbj0OdunKroc9CTC6psw1fvgcf41bdnywbCryqG8Lc= r36NmTH/maQZjvZDaqLguXjgaOA30Ku6T9JdklwA3KmOxAZcu9FrrE9pwOPIKOQpcFyrby4fX69= HnefP+fK3+y+r3Zlfw05QACcH7TbjwiuQG7aLUau9x9U1m8IucfwCPBx14btwXqWWQ/DKMve4K/= xd+5NRq5fPROBVQ3XaRhGO7U8xy/KGcgw2F/fvgO5ZjUMYwRp+ox/KPBl5PHUvcgzecMwhp83z/= hD7oNdMxrG6MfesmsYg0w36rynkJl7C3LSDyF3yzclfi+jctPQlG/zkUdy49qTjwh56sOm4nMH2= VOKXmUp8OlhqmsO8qi0bn4bedLyt2RzMC5BZmH2PFWm7K5CnmtfBmxzn1PMIr1jQz0qt5BlZNNl= +4Em4jOe8h1/uBWQKxieg/N04OvIDeY6mYnMrNwP+DwywQpXz+00K1yrStd39X+BTE3dhDxjntk= hbR51qNxC7kGm2PYLTcRnd8n0I6GAvJPy7azCHyFTrZ+sudz/Bh5Gpn8/iuhHcPV8HvjDmuurla= odf5z7W4asqJ+bnlKXgcw134ZM/EndTNwPmQ24HfgbsskxmkJOU75p9W9CNswiZCbcn7jl33X5L= 3XfN9AqBsKVtRf4lPu+mUyMo7U1Vg5eErUxtX5QLD7Qri7MU+79KjIN+XMdyogVkFoav/5FlZEp= RaZWdmobpdKn4hjHYrZbnx3u90714PLvVf7Oj9K9gWyn+YgG5J7gt++7envxrP8mVYb6G5EZZne= TTc5Jqcu86OUwMnXae4LyQpXbAuQIPQH4M0REk6eQC5VvqfonuM+LkLkEjyI7ykGu/dNd/jPI5u= h7ZiE7+iT3/Tiy6zetrbFyMG6jlqdMfDR14RLalXtjkHswC108HnXrniojVkCmVIxFlZF5ikyt7= NQ2SqXX4ogSi5OAa4K68+qpwmFkB4aV0W/XIgfFXqKrmXv+DTwxq2k9Kl4BnIPs2OE17Erg3OB7= uGPj0n8c2UBLXRkfRGcdWadK1R/v1JtcHb4tXmR0XqKOy5AdClpnIGptHUP7tXXYRi1PmficSev= G24LsfJuRHd7fa4nbcTvZOmtlxDHS0mjlpmI+Hrmuno0cHB4lG8UUqT/cRqm2xHFEicWZwGeCcv= Pq8RQ943smuThsiZZ/Fr2fjCSNzdxLqctCxiJSXY25wF8iw9OvuGVlFHJF6g+5Bxliz0HOkBp3I= J1xMq3yW62tnSiSJy8+mvqxiHLvjQ5lFKknhRbzPEVmmbJT6VNxjGPxOu2juE5cGNQV/t2cSP8i= cpn4k2j5FESG3pPU2fFT6rI9wAzk6D8duV57yOWJVW7vRa4Lt7vl+5JWyMXKt1T9k5GNsL8rb6r= 7DqJ9fwg5OsdHbM9Pgf9BXiq6PViutTVWDsZt1PKUiY+mftSUe1ORg+VEZZ21MmIFpJYGZf1SMc= 9TZGpl520jLb0WR5RY7KJ1NJlXT1WGgF8D/iVa7i99epZu1XkhKXXZB5Cd5DZaX18Vq9ze6dJdi= QyTbkLOYJpCLla+per3r9XaAHzRfQ6Hq0cDX+iw3gtov17T2vpPtCoH4zam1q9ofKBdXagp98J1= vsZ9/m5QrqZQDBWQqTRFlZF5ikyt7E7bKE6fiqMWi+uBd7lyOtVThsXIKHEL8Pu0Ppqch0xT7zW= GVZ3X67yN7BreqIdeUmTORA4YRwxTfXOREceMYaqvDNbxHUPIIzd7o029XIDcLPWKzEW03xgdTg= 5HngwMBxeSjZB6Dev4yBD1O8j1olEvpsjsTUydZxgDSCV13iyyI8ZxwfIFwfI6r+OaEPDUSR0WW= FoZ/WgpNlooG/umbNA6taOWfaTsUP8SZFbWpGDZIcgsqbqpW8BTN3VYYDVpozVS1mO9aHnWFHVs= v07xqiueXU3g+T/kcYj2OK9u6hbw1E0dFlhN2WiNlPVYr1qeNUW3269TvBqJZ9UJPBuQCRWpO7V= 5Yh3QxR6aKCRkOAU8efXVYYGVKiNud9E4aTGIhTfa+tyKPIt+l8vvnY82IpoBfyZL2Y5psSsq+E= lZk5XdTp6tLl6nI2Knz5LduyoiOIoFVam2QLV9oGi84n2g0++V7dXKDvXPcf9nISt3EK1D/TwrK= E8s9kiJQkZKwJOqrw4LrEtzyojbXSROqRjE89K19Rnnyj/Grf8DSMeZgMxxPyVRJzmxKyL4SbW5= ynbyzEQ63JFIbO9HntgUFRxBsX2m6j5QNF5xOzr9voTi9mpvDvXHdkiYx08QqeUfIEc+T2gF9QK= ZFdSOIE1sg+WtrW5y3x9W6tuGyH8vAE4Dvk27xdXmIH14mZBq007k0uU/XLr/IpuBpdV3ApkF1r= OkLbDi9d6JCEoAXsopI253kTj9MCcGIdr67EbeB/CIS7MVMUB9BbFGe0uiTly+VOxCyrS5ynbyv= I7E6kfu+zeQTjcj0f44tlBsn3mNavtA0XjF7ej0e7hvFbZX63au/reQ4VR886GsWKaIcGO4BTxa= fXVYYK2h9Y1FZUZcWpyKxqCIQEh7tFtWVNNtm8tupxSvIwewbtqvtaXqPtAUlezV6hDpXEOrf16= eFZQnFntoQoyRFvBo9dVhgfUjZENpZcTtLhKnVAxi4U1KVDTR5Rvj2jIF6SBT3feUYCcVuyKCn1= Sbq2ynkKOQs/wU5Lr44Zz2dxJUpdpSdR8oGq+4HZ1+r2yvVuaM4wUfoTAG4N3IUdWTEut4NLFHL= MQYaQFPqr46LLBSZcTtLhInEjGAVuGNtj7fcOVvQkYivu4VweeFiTrzYldE8JNqcxWhFUhHugv4= EjKqWd4hZnFsi+4zVW3QisZLa0fe72Xs1RqZstsrb7U1BpOppO9vGEIjL+IYjhcnGkYKP5Tet1N= CQxhUkY4xehhPdja7qUPaQcZEOoYxgFQS6RiGMUqo2vHnYJZEhtHXlL3GN0siw+hPunqcdx3tc+= /rIBx9LKdV4HAU8tJEwzCqU/lxnlkSGcYoocwZ3yyJDKN/qXzGn4Iomjyh4ugldMVRGUuip5EDx= 7lkiiPPLrIpoIZhdEHZjv8yZklkGH1P2Y7/OGZJZBijgrJ39c2SyDD6k64e55klkWH0J13Lcs2S= yDD6DxPpGMYAYiIdwxhkrOMbxgBStuOvQ5+Mo71Xr1v60VeujvZ16xkIzagn9wE+gbymez0wLfj= NFJR9SNmbe2vITDVAdoDjO+Sp6v3VpK9cL9ONZ2BT6sljEceb/YE/JjOmAFNQ9gtd3dWPO34nJl= LiRf8RtzKYHT90ECpLU+rJkBm0T6YyBWXvU9vLNsfSKpzRfLxi769diF8aZJcOE4MyivrKge5TF= rehjO9biOY1l5cvbl8RX7qUP1+Mtg5arJtUT4Y85/5CTEHZZ1Q544c7SKjWW0K7j1fs/XU4Wcef= gBgU+I6f50sGxbzNwjb4d9gX9X0L0bzmOuWLPc86+dJpdUDrGT/l/Raup4910+pJz9uB85TlpqD= sbbo+469Gnv2/hVbvsJ3A2cjNvtTwPjxTvIL4uXlOIPMl206+r1zoU7aDVp8134afI29dfRU5A/= uOVURVuM2V6b3mxhbIF/veeV+6l9B96bQ6Yrz3XLwOWqybVk96TkRmU8aYgrJP6Haovxvxz/NU8= vEK6ORLFqP5lIVtuByxTKrim1bEa64M2kSpInWkvN+0WA+HevIk4E50Y0dTUPYJVTt+2KEnI7Y+= Q+g+XrH31x5kh5+ODHUnkZ2F8nzJinqbhW3Ygej651DM9y1E85rLy6f53nXypdPqiD0DU95vWqy= bVk8uQkYpz7qyY72GKSj7iDLX+Knn+P7FmCkfr9hL7QrkBt5i5Hr/Qbc8z5esqLdZ3Iayvm8ezW= vu9px8cfs20NmX7jSljouD3/31uLYOqVg3pZ5cTus2f53W0YUpKHufRrzzjN5guNWTYArKfsE6/= ihnONWTYArKfsHUeYYxgJg6zzAGGev4hjGAlO34t5BdJzyF3C1ekJN+CLmLvCnxe7dKNE0NNx95= Jh5PVOlF/NOKx4AvoE/gaQJN+Vhn+qJlVlUyLgU+PYz1jUrK3txbC6xCnk9fhjzXnZCTfhbpjg/= dKdE0ltE697+XORr4FPJMfwOtUtemKat8HCmlpKbsXEF/HNh7ja6n7P4CmXq6CXmePLND2jy0GW= DdcA8yg60fOAIZOT2PKB5j4UuTvNpw+jqYiGj9Y+5EZo0aFana8ce5v2XAk2Tz7TW1nOdsZHSwh= vRThJRa7WRkXv69yFkSiqv18hRqWrmpdSiidCujBPwY8I/AbcjZNJV/M3K5dClwF8VUf6myUsrH= VNxT6bXyNbUgieXxtkvljZWdWr1F4qHtK9q21+IQt63TfpDXB3qKKkP9jciMubsRsQyk1XLTELH= NYWTqu/cE5YVKNE2tNg/4KnL0PxW5VvMUUeulFGpauakyyCnHk1LR5eVbhczKy8s/HlH5eblrEd= WfVlae8lGLe156rfwltKsFyVkebrtUmljZqdVbJB5xfal9SotD3La87Zm3//QCXU3gWUu2s4asp= lXRdQUyfJ1G6zX+SsQbzxO/dGIaMl33CeQmzjlk89Nj1pFtzFT98c6zydWhlZsqg5xyPGfSGtgt= BfKFHT+Vfwzt02yfCj7/FdIxw/K0ss5CRhmejbRes8dxz0uvlX8YMjo5g9Z7Pqnl4bZLpYljl4r= RU0EaLR5xfXn7VByHuG152zNv/+kFansRR4ymlosZi/jjaWhqtX0oriEvUr8nVW6ZMkJSKrqiVM= 2vTcDSyspTPmpxz0uvlZ9SZhZRbBZVdRaJUZEJaaltr8Uhbtt4JV9I1f1nWKmz46fUcnuQOdyzk= eHjcuAhlydWomlqta3II685yBHXH6mLqvVSCjWt3FQZ5JTjSanoUvmGXDxmus+p/FPcd4LvnVR/= Wll5ykct7nnptfI1tSCJ5fG2S+WNlZ1avUXiEdeX2qe0OMRtm0d6P8jbf3qOMkP98Dn+GuV3TS0= H8AEkKLeR3UgBGRaFSjRNEbcfMoR6BPga2ROEomq9PIWaVm5qHYoo3cooAVcF7f9iTv7NLs0697= 2I6m+hUlae8jEV91R6ra0ptaC2PN52qbzQruyM6y0Sjz+lfV/Rtr0Wh2OitnXaD1L7Ty9gc/UNY= wCxufqGMchYxzeMAcQ6vmEMINbxDWMA6ceOX0XR14S6zDD6mpF89VZVT70qir5B9eEzDE9jM/fK= kFJeFaGKom8k1GWG0ZNU6fh1Kdpi5VWsQtsnp9yQPP85TV2WSp9SiBnGqKTMUL9ORVssdohVaHn= ldlL0QVpdlkq/BF0hZhijhTeH+mVf9XQscmZ+2f3fjEx99B52L5B52O2g1bsNdO82z27E9+0Z9z= 30xovLDdmGvA/A+8992y0/gcyH71kyH75U+p3I1FSobuttGH1B2aF+3Yq2ThQpN+U/l1KXpdJ36= /tnGH1D2Y5fp6ItVl7FKrRUuUUUfZBWl6XSpxRihjEqKfs4r05FW6i8ilVoqXKLKvpSarRU+jyF= mGGMBkydZxgDiKnzDGOQsY5vGAOIdXzDGECqdvw5yB33pvgQ2dtJL0Em8xiGUSNl7+pPB76OPA9= vgkmISYLv+HOB28lm9BmGUY2u3qt/Hc2aBHwE+DCt7yM/Cri+wToNYxCorM6bjQzz/bTZIrZS62= k90vi/85W07wR+SLvf3vddvXbWN4waKNvxvVjGcy7ZbLvfRK7N4ym9F5IZIIR/N0fpxiBqv62Ju= p8Efrlkew3DUCjb8acgQhpPKMJ5CV2EU/SMvxSR36bYRfZudcMwuqCsOu9lZL59GS50f534CPCt= aNlE4Eb3eQrS+Q3DqIEyN/cOQzTunrcihoVehHM/9dz4W0G72eA3sWt8w+iGynr8p8m8yB9Dzsa= /hLyc4xnkpRZ3Ijfp6mQechnxTKeEhmEUo+zjvJmI0u2IBtqiMReRys4YpvoMY7TS1XN8kJl0F9= fZohwuJDOQNAyjOibLNYwBxGS5hjHIWMc3jAGkbMe/hew6YRfywsq/IHu/vudK5NFfFc5C3qV/H= PDuimU0SRk7rpTd13zkRZ+pNw5rdZaNZzfbIC5nuO3HytY5h+bUoqFSFEaRWrTszb21yNto90Xu= 8H8CeJ36OumvIC++vA9YXlOZeVSx8Spjx6XZfS1DJif1CyNhP1a0zibVorFSFPpbLdrVXf21yEs= qQ65CAtRvTKTaO/RvpXhHCM0/+pUy6zvcdTapFtWUotC/atHavfPuAFYir7y+2BU+3/2WZ021HB= nWbwRm0Vntp1lq3Uo2qeg+4GrkLLARmWXod564Lmi38UrVAbodV167UqTSrkRe++03znVueRxP6= GxjdkOUJy+uKUuxvPXVYhm3aZf7DHLw20s2yqlSpxa3JtWiKaUojBK1aB1n/NmunEPd9/VkO90S= dGuqI5Gdejyy019NvuVWylJrHGK9dYzL8wDyWu4JwGeAUxJ1QbuNV6qOlB1XXh5PeMbPK/9BRAe= xCJn6HBLGs6iN2T8EefLiqlmK5a2vFstUm3zHn4DM9PQdv2ydqbidBFwTxClvPcswBvio+6xNHw= e4FjkY9RO1n/Gnuf/Pu/+hm+1O4GxEfRcOqxci77R/FTlrn0i+2i+01NpBZqm12+V7xOXZCvwAe= AX4MeKmo9WlkaojtOPaTmbHlZenTPkvItOR90POlAfROrcijGdsY3ZVotzJQZ68uG5z6b2l2NgO= 66vFUmvTc0GeVxDbMk/ZOlNxa0ot2kkpCn2uFi07Vz/F6cBfo1tRe2uq0xDzjFUu3RjgfbRu4E5= 3uYtYamkTkrS6ytRxIK1Dz3iUVMZCTEv7GnAbchaZAlyu1OEpamP2Rk4bQuYiZ+jryeKWt75aLM= 9NtKmuOkGPW1Nq0U5KUehztWjVM/4ByJl0BrAGGQr5a9IxtFpcpaypvgdchlwrHYDYceVZbqUst= aYgG2WCq/tgt2zI5T84URe023il6kjZceXlgXa7r1Taccj9j7OQpww+vxbPIjZmJyBnP58nL66a= pVje+mqx1Nq0B+ng0127JgVllK0zFbfHab1xmreeZVhN9sKY09z3G6M08Utp+o4y1/jhc/y9yDX= Ul2i9pr0o+H08+dZUZyIbdSMyH7+T5ZZmqbXBpduEHIR83SuCzwuVujyhjVeqjpQd11BOHmi3+0= qlHYfIjn3a7WQ3QuN4Qmcbs+uiPHlxTVmK5a2vFkutTVcgN+sWI9f7D3ZRZyrG1yM3dumwnlXRr= vHnAV/ustyRoGuRjlEvk5HrWM9E5JLI6IypRYtjHb/HuAA4j8zaexGtBwIjH1OLFsM6fo9xKDJ0= fAIZEq8Y2eYYoxST5RrGAGKyXMMYZKzjG8YAYh3fMAYQ6/iGMYBYxzeMAcQ6vmEMIP5xnmEYA4S= d8Q1jALGObxiDh03YM4xB5P8BWsFuS+pQZE8AAAAASUVORK5CYII=3D" width=3D"254" heig= ht=3D"144" alt=3D"" style=3D"margin-right:9pt; margin-left:9pt; float:right= ; position:relative" /></p><p style=3D"margin-bottom:0pt; line-height:norma= l; font-size:12pt"><span style=3D"height:0pt; display:block; position:absol= ute; z-index:9"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAA= MgAAAA0CAYAAADPCHf8AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAB/pJ= REFUeJztnXmsX0MUxz+/1/faV93UWlXakobaQq0tDUGsSVFBaaguNLYQYlcVglgSVKyltogtsUS= oLTR2IiIi1kQqYm0oJXZ9/vjOuPO77955v/u79/X9yvkkv+TdO3NnzsydM3Nm7jl5NaALwzCyqL= X7P/pUDMNoLf5dNNr6UgrDaHVMQQwjgimIYUQwBTGMCKYghhHBFMQwIpiCGEYEUxDDiGAKYhgRT= EEMI4IpiGFEKKogtyI/lS5gBfAmcCkwvKQcJwCTS5bR16wFnA3sW0FZA4E5wOwKyjJKUsSbtwOY= 7341YDTwKHBlL8iVxS7AmquorqIcC/wO7FdBWfsC3wBzKyjLKI5fBAqvIH8CXwSFfAY8DkyoTLR= 8OoFzV0E9zXIncFlFZT0NnFVRWUYJyuxBBgDbANOBZ1Jpk4HHgJeB/YP7+wHPkmhoF7AzcA6Jad= IfuAp4HpgEbOzuzwOmAMuBQ4DxwCJgBjL1NkMrzCPAW8D5wKBIeWnSMns5H3Lpx7jrvVyZ84APg= SWuXtAK4vnO5e8Eprm/pwdtzHp+W7QivwhslJKvTNsmAPehvn4ReBAYE5El3bdb5cibRZZMsb5o= eYoGTM0hGdxLkWnRP0gfhTpzEBq0S4F1gcFo37IJsB7wBHphx1FvmuyETIs1gIOof+nvk5hYj5A= oGMBI4Dlk9g0HbnFyxMqLyTwKuBkNDoB+SIlqwDjgBjRJHAJc7fKcE7RjPZJB0YbMUj8osp4fjg= bvZq6Nd5KYWGXaBvC2k2U7tL85D1gYkSXdt3ntzSJLplhftCL/mljQnILMR4P+LbrPJlOoXyG6g= N3QALsHvaShaADs4Z65iGRgrY+UZzYaGCGhgtTQjLa2uz7ClePZBg30WHk9yTwRrRygGbcjeGYI= cDSaKRe4e6GCQDIoQP0WDor081PQoPdMI1GQMm3zdXWhdwBanVYE12lZ0n2b194s8mSK9UWr0fQ= eJGQZcCpwLfUd2QYciTrZ/14G/gZuBE5z1+8BL7lnfgue/wYNjuXAHUih8hrxS3BdAzYIrr936d= 82UF6ezG+gVaPd3fvT5R+FZuAvgUty5MvCr7RZzw9FM3RW/jJtg/r+BbVjKXonWbKk+7ZIext9f= /1z7rcURRWkDc0KI9Fs8ArwAHANsCWaYd8BTkSzXCewPTKrasgcm+XSrkYvqIZmnXVcHZOQLf40= WnG2D+r/Cxjm/h6GjlZ92PCraJDv4+rdGx1LT4yU58mTeSXwJHAAGpSeXYGPgdeQ+bBGRjtAhxi= bu/4aj47ED8h5/l1kbk5EZtDGwAXAYSXbFuLLPgK4O9KWdN9m5ckj7/3l9UXLU8TECr+DLHH3Bi= Al6XLpoI3ss0iBDnL3asBd1JsxlyOF8dc7oA3lLmgGvw2Zcp4LXbmbo81sF/BwkGcvZKu/j8ydg= T2UF5IlM2hfcloq71jX/oVO5iVoMPt2+G86M9Emdy6aHOa68rKe3wHNvK+hPcbJrt6hFbStw8l1= PFq5L0F7wry2LKG+b/PkzSJPpry+aEVK7UGaZTD1J1odwFQ06xq9i1eQfj1lNICK9iBFmQpsgUy= QdjSzrIvsaKN38XvEVv3I2tKsqhVkBPqQ9o77zaO8i4rRM53Um7VGz/SJiWUYqwt9YmIZxmqHKY= hhRDAFMYwIVShIFXEQYTzIjuj8vZG8WXXnxZYUjbFoJP9g5GHcEclTlhnA68jFI/1hrQ04FPXXP= e7eccify6iIspv0Y6kuDqKGTrgalalI3UVjLHrK3wHcBOzeYHnNsDVy/uuPlH4FsKlL6wdcAdyP= Ptp5N5VN0EfUcb0o13+dyk+x5lONgoC+HBeRqUjdMygWhBTLPws4qkBZVbCAZLU8Hjl8DszINw6= 56ZsJ3RylTrGyYj1+byAPNBYP8kdQxivIZ2iUu7d2Km+67qz0vBiLZmIyPAOQ79Zidz0eOeZtjW= b0xcg1PYsb6e457H9Dcp7x+BCDIci792PgBVf3iCDfJ8DXaPUxSlJkts6L9QjdvMvGg/gPW+ORU= 9yZKC6DjLyk6k6nx2IsisZkhGyLfKY8DzqZD3QyzyNxk6+K4SQu77s6OccgZbmO7jEaJwGnVyzD= /4WmV5AJwMXAz2jmHU33DWFenl/RqjIMuV8vQ+bBQuS0mOYD5HK9CA3gtkheTzp9MlqxPgJ+AJ4= K0j5BynU4cAqJnZ+XP2SEy+OZBnyOVrxfgE/Jd+dudgWZirymQX34EZp8fkLtTpuZ35FEDRpN0o= y7e1bcRCN5Go0HSdOOlGllA3nT6bEYi6IxGWmZwvsr0YTQCCdS3zfh76ecZ/ZEyvqju16GzDn//= n5EChryF0n8itEkRRUkL24ijIMoGw+yEjkwboXMlVnA9S4tnben61iMRdGYjJCvqN9jDHH1ruVk= 8I6YVfxru92cnF+gk7NJqI+Xowi/QcDBwL2p50bQXWmMJih6ipWOm5hO9ziIMvEgoG8hi9FKM5P= ETXtmKm+67nQ65MdYNBOT4elEg9Y7W94X1Dst+HtKfjc2xIF0N8NmuLQx6ADjQ7RPa089uwDbpD= eLxYNUwByk3K3IRtgxbxn6REGOAc4giQcZiU6IVtf/sDsAuB3N8q3Ehuir+ti+FmQ1pk8U5L8YD= zIIHb32pqtJUWZjX9HLYvEghhHB4kEMoxFMQQwjgimIYUQwBTGMCKYghhHBFMQwIpiCGEYE779j= 30IMIwNbQQwjgimIYUT4B/JaV2b+CxqcAAAAAElFTkSuQmCC" width=3D"200" height=3D"5= 2" alt=3D"" style=3D"margin-top:1.22pt; margin-left:44.45pt; position:absol= ute" /></span><span style=3D"font-family:'Times New Roman'"> </span></= p><p style=3D"margin-bottom:0pt; line-height:normal; font-size:12pt"><span = style=3D"height:0pt; display:block; position:absolute; z-index:15"><img src= =3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAD4AAAASCAYAAAADr20JAAAAB= HNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAAEtJREFUWIXt07EKACAIAFED//+X= axIKxFoi0nuzg4coAgD/6KeD7eYWD8zhYVvmcOM2Vgg3S6tuhtOqcHG3US8v8lK2o4ZKvi0AYAB= 5cwcL2DgZQAAAAABJRU5ErkJggg=3D=3D" width=3D"62" height=3D"18" alt=3D"" styl= e=3D"margin-top:-2.86pt; margin-left:192.59pt; position:absolute" /></span>= <span style=3D"font-family:'Times New Roman'"> </span></p><p style=3D"= margin-bottom:0pt; line-height:normal; font-size:12pt"><span style=3D"heigh= t:0pt; display:block; position:absolute; z-index:22"><img src=3D"data:image= /png;base64,iVBORw0KGgoAAAANSUhEUgAAAA4AAABUCAYAAACyXQZAAAAABHNCSVQICAgIfAh= kiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAAFBJREFUWIXt1zEKACAMQ9Hq/e9cB0FQohVRp5+x9J= GuNYvjapg3oAwQCAQCgUAgEAgEAoHAmiRm8gsfjYIr3Pavnjpr7XaPG6O4aH7bSL6mAHGmBpFaO= OXbAAAAAElFTkSuQmCC" width=3D"14" height=3D"84" alt=3D"" style=3D"margin-to= p:11.25pt; margin-left:105.6pt; position:absolute" /></span><span style=3D"= font-family:'Times New Roman'"> </span></p><p style=3D"margin-bottom:0= pt; line-height:normal; font-size:12pt"><span style=3D"font-family:'Times N= ew Roman'"> </span></p><p style=3D"margin-bottom:0pt; line-height:norm= al; font-size:12pt"><span style=3D"font-family:'Times New Roman'"> </s= pan></p><p style=3D"margin-bottom:0pt; line-height:normal; font-size:12pt">= <span style=3D"font-family:'Times New Roman'"> </span></p><p style=3D"= margin-bottom:0pt; line-height:normal; font-size:12pt"><span style=3D"font-= family:'Times New Roman'"> </span></p><p style=3D"margin-bottom:0pt; l= ine-height:normal; font-size:12pt"><span style=3D"height:0pt; display:block= ; position:absolute; z-index:11"><img src=3D"data:image/png;base64,iVBORw0K= GgoAAAANSUhEUgAAAMgAAAA4CAYAAAC4yreHAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAA= ADsQBlSsOGwAABz5JREFUeJztnHuIVUUYwH93Xd31sZrvzcemguiWSmaUWlJg1GaxomGtLdWmhi= VB/lVGmUZUUFIhZA97KAX2oFSixKxY8kWiIRJmBmFFDw0VLCLT3P745njmjnNm99xz967W94PD3= jlnHt98c755nW82B7SgKIqPXHn0o0PFUJSzi9ODRllHSqEoZztqIIoSQA1EUQKogShKADUQRQmg= BqIoAdRAFCWAGoiiBFADUZQAaiCKEkANRFECqIEoSgA1EEUJkNZAXkY8HVuAY8AO4HGgd0Y57gG= mZMwjK1lk6AM8AFyXoZyuwDxgboEyFEoa2YtJW/Tti1MBbAKGtYNMXtKcB+kMLDFXDrgAWAc81Q= 5y+ZgInFeistLQBBwH6jLkcR1wEJhfDIFS0ER22UvJBGBUO5cRDQKUtxLR5QTwEzDYZPA98AEwu= 5jSJVAJPAjcUYKy0rIK6SyysBG4H6lnKVlFdtlLya5SFpZlDVIBjAMagY+dZ1OA9cAW4Hrrfh0y= PLZY1+XAIuIhvgvwNPAZMBmoMfcXA/XAUWAGUAu8hhjMDqRXmQisBXYCDwHdA/nZ9HVkqAVeB8Y= CbwEbiF+iicB7wB6kt48Omx238jts6lYJNJjfjZ5yAC5GRuHPgaGOXL76+HD1HZLfhy17F0TX+4= BmI4OLT/euDFE7v2vS3G7CUzlTD7428ukqSR9p65uKtEdu5xG/3AeQIbqL9XwIouDuiOIOAP2BH= si6ZQQwAPgQMY67yB/iL0NevG7AdPJf6L3EU6y1xAYGMAj4BFFMb+AlI0covwhXhndM3jeYdIuR= Bq4B3gcGmnpsJV5/LbLSDyA2kDJkStroKac3YhijTL1WEU+xkurj4tP3+gT5k7BlHwk8j3SAM4B= lnviu7n0yDAFeBMaYOJ0QI8p59OBrIzdOSB9J7VUop6dYUJiBLEFe+p2c2cPUkz9CtABXIgp6Ax= gP9ERehqtNmqXEihiIGM9cRCk2toHkkF6urwnfYvKJGIc0VCg/G1uGMuAHq6xGU++bSZ7i2S8Zx= AaCSdvoKaee/Je+gdhAkurjHo/26XtKgvxJuLJXAbchPfpyT3xX90ltPon4RR2GrGEjltJ6m9tx= QvpIaq9COW0gWaZYvwH3Ac8RKyrKczYieHRtAf4BVgALTfgrYLNJ85eV/iDyohxFhs3xgUr8aYV= zwPlW+Ih5fqiN+dkynAL+8MQpo/Adu2iUtcvpifTUvnhJ9fHJ5Op7M37528IQYCXwM/BYQhxX90= lt/gVirOXm3gkrTVva3I4T0kdSe2UmrYGUIRY+COkdtwJvA88CFyE9xG5gAWLhlciuwwikgk3AH= PNsGWI0OaQH6WfKmIzMyzciI84Eq/yTQC/zuxeyRRltNGxDGulaU+41yLb0pEB+Ea4MVSbcxzzr= b65dwN1IA3ZBGr/akx5kA2O00VUtsh0+zYm3B5lKTEK2eWuAh4FZgfq4I75P32MT5Pf9cw5X9iu= A/cB2ZKrYzZPG1X1Sm58CPjL1PhIo09fmbpyQPpLaqyj/jCTNFMv+DtJs7lUgRtJinoMsxDYhBj= Td3MsBq8kfhp9EDCYKXwpcgkzbtgCvIBWNeMTkOxpZ2LYga4IozlRknroXmTZ0bSW/iDsdGdZY4= Qbrdz1wI7Ju2GTKAxnS7elNlOcOZMrUZP7Od8rB5L8dmVPfi4ywPQP18eHqOyS/iyv7cKRtVxoZ= my1ZI5J077Y5yLpkoZPe1bevjdw4IX2kqW9byLQGKZQe5O9odQZmIpavKGcTRVmDpGUmcCEyZJY= TD4OHSiiDoqSmVCNINfAEMl/djezeZHVRUZT2oEOmWIpyrtAhUyxFOedQA1GUAIUaSA/EcbBzax= ELpCtwE/CM51k/ZEt0D/HXaZDvCe3t5an8D0m7BukMvABc1Q6yRNQh++9rnPs5xEmuHvlYtRrZQ= wf5MLUO8SVSlCxkWqTPAW4tqjh+xnCmgYwCviQe+erIH2VGIt6jOnVUslDwIr0CcSnYYMJtdTNe= YRXqXlUJZf3tuTca8eE6ZcI/kv+V91vgV8Q7VFEyk9ZAahGHs6Mm/CjiRlGDjCzb8E+9FpDvyGZ= fv6covwo5axFxAnG5tn1u9iG+PYqSmbQGUg18Y4UbkF58K+JZ+R35Z0MiChlBfBwj/9BQN+Br8q= eJhynheWXlv01aAykn3wDa6mZcrBFkP7Io72TCNcCnTpyT5LtVK0rBpDWQX8hfY7Snm3EfxBXFP= i+xz1zTzLPZxEc6I6qRUU1RikKaXaxKpBePfKiK7WYcMdnKq9l5Nhh4EznNOMuTdjm6SFeykfnI= 7ZyiilM8hqLbvEp2MhlIBfAqckD+bGIwchpteEcLopzzZPbm7Y4coG8vV5NCmIt+RVeKg7q7K0o= AdXdXlLagBqIoAdRAFCWAGoiiBFADUZQAaiCKEkANRFECqIEoSgA1EEUJEP13bv2arigedARRlA= BqIIqiKEph/AsLft7ZK75AUQAAAABJRU5ErkJggg=3D=3D" width=3D"200" height=3D"56"= alt=3D"" style=3D"margin-top:1.25pt; margin-left:44.46pt; position:absolut= e" /></span><span style=3D"font-family:'Times New Roman'"> </span></p>= <p style=3D"margin-bottom:0pt; line-height:normal; font-size:12pt"><span st= yle=3D"height:0pt; display:block; position:absolute; z-index:18"><img src= =3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAB8AAABTCAYAAABnNNwuAAAAB= HNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAABLJJREFUaIHtmn9MlHUcx1/HHb+F= +HE3HF2BirI0/BFqKU6ihDGbfxAaK8rUzCwcFYHLJMwsi9YcZJZjVmsrXVo0TByrVXMV1vkj21J= j/gACDALujuPuODyO6w/nszsP2H0fuDO3e2+33ed59rxf389z3+fz/X6f+yrwlHOEYxMlxWiBL6= EjMq9/8RfYjesBf+/kRZ/QiueneDQgyB/g0byDfEbzogF+hd+oADwAD8ADcK901Wajt6MNp1Nsf= FLJBV7+4zS9HX8zOyuHz7aVcZsmgfhELVmF67z2kJ358bqDpGUu43zjMWZmZLJiUyknGw4LeciG= K5VK/vr1Z04crWN2Zjbdrc0sf+Z5/8AffqmcyJhY8ssqiIyJxWa1EDs5UchD9m8eEhZOdLyGi6d= +Q6lSMWVOOnGCcNmZn/vlGDUlGzD1dGO32Ti6t4omXaOQh+zMf/z8YzbsqiEheSoAcx7M5aPNRa= QuXOy1h+zMh+xXiYpXS7H+Sjs2i1nIQ3bm2Ws2cvCtCmYsXIzZoKex9gB5L74i5KFgHBPInvZWL= p05BUDy3XOln2AsucxiFbIzB1Brk1Brk6TY6XSiUCjGuMJdQnBTT/eo54aG7HxQtIbyr771Dbw8= dxFpmcsIDg1j2OHg0u86ps+/D1BgMRrQpt4lYicGX77xBXLXbwLgUOU2imv2k5A8DQBLnxHdkVo= huNCjdh0M0NPRRkR0jBRbjAZ09V8LwWV3uJy1z7J/xxbmZOXgsNs5fvgQS/If8w982rwFaO5I5u= JpHYPOYVaWvkpy2jz/wAGi1RruyXlIiu2DgwSHhvoGru+8Io1cnc3uBcna10fV+gKhQiUE1x2pl= TrdzlW5LM4rQBVyLVOzQS9iJQ537e2PvLydJSsLpXjY4WB6+r1C8HHVdjlyre2yh1Sbxez2sRgN= VD/9qJCH7N6+OXMuCVNSiNEkADBg6Sc8Mso/8KUFq1mxqZTQ8AgA2pvOYR8cFPKQfdtXllVIYID= oeA1H9rwr5CE78z3PPekWd7e1uPV+n8Lbms5S+mktk2LjAAhSqggJC/MP/O3vT3ocs/abiIiK9g= 3839bmUc9ZTUZ2rV3lu/L6Rn62W0l1lc/La8GWHWTkj1xIHENDzBBYMIDgo+YKbm86R8O+96W4S= dfIrIxM38FdVVddSWJKqhRPm5tO/YdV/oEPDzuYsWCRFJsNejounBfykP2oPfD4U9RVV5J2fzYD= /SYaaw+wtGC1f+CzlmSh1ibR8ucZcDrJK9mKNnWmf+AACclTvVqfjaZxvQqz9pswG3oxG3rparn= Mm6tyha6XnXn93irO/vSDtFC0GPV0NYvNhGTDL5w4TnHNfsIiJwHXps0N+3YLeci+7XklW+lquS= zFTucwxq5OIQ/ZmX+xs5zBAas0obCa+tD/08ETr3s/oZANV2uTKHytElVwMACWvj6+fGe7kIfQb= f/GZZq0rnI3oeERKFXBKFXBRMer0dyZNMbVnhLK/LtP9hI3+fYxz68oKvXa76a+bxfKPHvtxlHH= cwB9Z4cQ/NZcLk2EAvAAPAAPwAPwWx9+4y6hm5659I/MCPuXJkwjef8vdoX5swEe++Fc5atGeLD= +A6JqiOU0u5EEAAAAAElFTkSuQmCC" width=3D"31" height=3D"83" alt=3D"" style=3D= "margin-top:-16.54pt; margin-left:10.55pt; position:absolute" /></span><spa= n style=3D"font-family:'Times New Roman'"> </span></p><p style=3D"marg= in-bottom:0pt; line-height:normal; font-size:12pt"><span style=3D"font-fami= ly:'Times New Roman'"> </span></p><p style=3D"margin-bottom:0pt; line-= height:normal; font-size:12pt"><span style=3D"font-family:'Times New Roman'= "> </span></p><p style=3D"margin-bottom:0pt; line-height:normal; font-= size:12pt"><span style=3D"font-family:'Times New Roman'"> </span></p><= p style=3D"margin-top:12pt; margin-bottom:10pt; text-align:center; line-hei= ght:115%; font-size:10pt"><a id=3D"fig1"><span style=3D"font-family:'Times = New Roman'; font-weight:bold">Figura 1.</span><span style=3D"font-family:'T= imes New Roman'"> </span><span style=3D"font-family:'Times New Roman'; font= -style:italic">Diagrama de flujo PRISMA para la selecci=C3=B3n de estudios = incluidos en la revisi=C3=B3n bibliogr=C3=A1fica</span></a></p><p style=3D"= margin-top:12pt; margin-left:21.3pt; margin-bottom:10pt; text-indent:-18pt;= line-height:115%; font-size:12pt"><span style=3D"font-family:'Times New Ro= man'; font-weight:bold; color:#767171"><span>3.</span></span><span style=3D= "width:9pt; font:7pt 'Times New Roman'; display:inline-block">  &= #xa0;   </span><span style=3D"font-family:'Times New Roman'; font= -weight:bold; color:#767171">Resultados </span></p><p style=3D"margin-botto= m:0pt; text-align:justify; line-height:115%; font-size:12pt"><span style=3D= "font-family:'Times New Roman'">Las investigaciones evaluaron la relaci=C3= =B3n entre vitamina C, estr=C3=A9s oxidativo y enfermedad periodontal media= nte diferentes dise=C3=B1os y procesos metodol=C3=B3gicos, como ensayos cl= =C3=ADnicos aleatorizados, estudios transversales, estudios de casos y cont= roles, revisiones sistem=C3=A1ticas y metaan=C3=A1lisis. Las poblaciones es= tudiadas incluyeron pacientes periodontalmente sanos, con gingivitis y peri= odontitis. La evaluaci=C3=B3n cl=C3=ADnica periodontal se realiz=C3=B3 prin= cipalmente mediante </span><span style=3D"font-family:'Times New Roman'; te= xt-decoration:underline">Profundidad de Sondaje (PD</span><span style=3D"fo= nt-family:'Times New Roman'">), </span><span style=3D"font-family:'Times Ne= w Roman'; text-decoration:underline">Nivel de Inserci=C3=B3n Cl=C3=ADnica (= CAL)</span><span style=3D"font-family:'Times New Roman'">, </span><span sty= le=3D"font-family:'Times New Roman'; text-decoration:underline">Sangrado al= Sondaje (BOP</span><span style=3D"font-family:'Times New Roman'">), </span= ><span style=3D"font-family:'Times New Roman'; text-decoration:underline">= =C3=8Dndice de Placa (PI</span><span style=3D"font-family:'Times New Roman'= ">), </span><span style=3D"font-family:'Times New Roman'; text-decoration:u= nderline">=C3=8Dndice Gingival (GI</span><span style=3D"font-family:'Times = New Roman'">), recesi=C3=B3n gingival, p=C3=A9rdida =C3=B3sea alveolar y se= veridad de la periodontitis.</span></p><p style=3D"margin-bottom:0pt; text-= align:justify; line-height:115%; font-size:12pt"><span style=3D"font-family= :'Times New Roman'">Los biomarcadores antioxidantes e inflamatorios fueron = evaluados en saliva, </span><span style=3D"font-family:'Times New Roman'; t= ext-decoration:underline">Fluido Crevicular Gingival (GCF</span><span style= =3D"font-family:'Times New Roman'">), suero y plasma sangu=C3=ADneo mediant= e ensayos ELISA, pruebas de capacidad antioxidante total, m=C3=A9todos colo= rim=C3=A9tricos y an=C3=A1lisis espectrofotom=C3=A9tricos. Algunos estudios= analizaron la suplementaci=C3=B3n sist=C3=A9mica o aplicaci=C3=B3n local d= e vitamina C como terapia periodontal coadyuvante no quir=C3=BArgica, combi= n=C3=A1ndola con </span><span style=3D"font-family:'Times New Roman'; text-= decoration:underline">Fibrina Rica en Plaquetas (PRF</span><span style=3D"f= ont-family:'Times New Roman'">), antioxidantes complementarios o enjuagues = bucales. De la misma forma, se observ=C3=B3 heterogeneidad en los m=C3=A9to= dos de evaluaci=C3=B3n, biomarcadores analizados y tiempos de seguimiento c= l=C3=ADnico entre las investigaciones seleccionadas. </span></p><p class=3D= "ListParagraph" style=3D"margin-bottom:0pt; text-indent:-18pt; line-height:= 115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'; font-st= yle:italic"><span>3.1.</span></span><span style=3D"font-family:'Times New R= oman'; font-weight:bold"> </span><span style=3D"font-family:'Times New Roma= n'; font-style:italic">Asociaci=C3=B3n entre niveles de vitamina C y severi= dad periodontal</span></p><p style=3D"margin-bottom:10pt; text-align:justif= y; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times New = Roman'">Los estudios reportan que los pacientes con periodontitis presentar= on menores concentraciones de vitamina C en comparaci=C3=B3n con individuos= periodontalmente sanos (2)(12). La disminuci=C3=B3n de vitamina C fue iden= tificada en saliva, suero sangu=C3=ADneo y fluido crevicular gingival (2)(1= 2). Hashim et al. (2) observaron diferencias significativas entre las conce= ntraciones de vitamina C en saliva y GCF 3,16 =CE=BCg/mL y 4,55 =CE=BCg/mL,= respectivamente; (</span><span style=3D"font-family:'Times New Roman'; fon= t-style:italic">p </span><span style=3D"font-family:'Times New Roman'">=3D = 0,022), mientras que Assaf & Rabi (12) reportaron niveles s=C3=A9ricos = significativamente menores de vitamina C en pacientes con periodontitis est= adio IV en comparaci=C3=B3n con estadios menos avanzados (</span><span styl= e=3D"font-family:'Times New Roman'; font-style:italic">p </span><span style= =3D"font-family:'Times New Roman'">< 0,05), sugiriendo una relaci=C3=B3n= entre la deficiencia de vitamina C y la progresi=C3=B3n de la enfermedad p= eriodontal (12). Por lo tanto, los hallazgos identificaron una relaci=C3=B3= n inversa entre los niveles de vitamina C y la gravedad de la enfermedad pe= riodontal (2)(12), como se muestra en la</span><span style=3D"font-family:'= Times New Roman'; font-weight:bold"> </span><a href=3D"#tabla1" style=3D"te= xt-decoration:none"><span class=3D"Hyperlink" style=3D"font-family:'Times N= ew Roman'; font-weight:bold; text-decoration:none; color:#000000">Tabla 1</= span></a><span style=3D"font-family:'Times New Roman'">.</span></p><p style= =3D"margin-top:12pt; margin-bottom:0pt; line-height:115%; font-size:10pt"><= a id=3D"tabla1"><span style=3D"font-family:'Times New Roman'; font-weight:b= old">Tabla 1</span><span style=3D"font-family:'Times New Roman'">. </span><= span style=3D"font-family:'Times New Roman'; font-style:italic">Asociaci=C3= =B3n entre deficiencia de vitamina C y enfermedad periodontal</span></a></p= ><table style=3D"width:101.36%; margin-bottom:0pt; padding:0pt; border-coll= apse:collapse"><tr style=3D"height:32.85pt"><td style=3D"width:8.72%; borde= r-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt= 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:cent= er; line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New = Roman'">Autor/ A=C3=B1o</span></p></td><td style=3D"width:15.98%; border-to= p:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.7= 5pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:center; = line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New Roma= n'">Estudio y muestra</span></p></td><td style=3D"width:12.58%; border-top:= 0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75p= t; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:center; li= ne-height:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'= ">Condici=C3=B3n periodontal evaluada</span></p></td><td style=3D"width:11.= 1%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; pa= dding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-a= lign:center; line-height:115%; font-size:9pt"><span style=3D"font-family:'T= imes New Roman'">Tipo de evaluaci=C3=B3n de vitamina C</span></p></td><td s= tyle=3D"width:13.12%; border-top:0.75pt solid #000000; border-bottom:0.75pt= solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-= bottom:0pt; text-align:center; line-height:115%; font-size:9pt"><span style= =3D"font-family:'Times New Roman'">Par=C3=A1metros periodontales evaluados<= /span></p></td><td style=3D"width:8.96%; border-top:0.75pt solid #000000; b= order-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top">= <p style=3D"margin-bottom:0pt; text-align:center; line-height:115%; font-si= ze:9pt"><span style=3D"font-family:'Times New Roman'">Variable</span></p></= td><td style=3D"width:14.42%; border-top:0.75pt solid #000000; border-botto= m:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D= "margin-bottom:0pt; text-align:center; line-height:115%; font-size:9pt"><sp= an style=3D"font-family:'Times New Roman'">Resultados</span></p></td><td st= yle=3D"width:15.14%; border-top:0.75pt solid #000000; border-bottom:0.75pt = solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-b= ottom:0pt; text-align:center; line-height:115%; font-size:9pt"><span style= =3D"font-family:'Times New Roman'">Hallazgo</span></p></td></tr><tr style= =3D"height:13.3pt"><td style=3D"width:8.72%; border-top:0.75pt solid #00000= 0; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:t= op"><p style=3D"margin-bottom:0pt; line-height:normal; font-size:9pt"><span= style=3D"font-family:'Times New Roman'">Hashim et al. (2025)</span></p><p = style=3D"margin-bottom:0pt; line-height:normal; font-size:9pt"><span style= =3D"font-family:'Times New Roman'">(2)</span></p></td><td style=3D"width:15= .98%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; = padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; line= -height:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">= Estudio transversal; n=3D43 participantes distribuidos en periodontalmente = sanos (n=3D13), grupo periodontitis leve (n=3D9), grupo con </span></p></td= ><td style=3D"width:12.58%; border-top:0.75pt solid #000000; border-bottom:= 0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"m= argin-bottom:0pt; line-height:115%; font-size:9pt"><span style=3D"font-fami= ly:'Times New Roman'">Salud periodontal / Periodontitis</span></p></td><td = style=3D"width:11.1%; border-top:0.75pt solid #000000; border-bottom:0.75pt= solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-= bottom:0pt; line-height:115%; font-size:9pt"><span style=3D"font-family:'Ti= mes New Roman'">Salival y GCF</span></p></td><td style=3D"width:13.12%; bor= der-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0= pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; line-height:1= 15%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">PD, CAL, = BOP, Vitamina C salival y GCF</span></p></td><td style=3D"width:8.96%; bord= er-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0p= t 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; line-height:11= 5%; font-size:9pt"><span style=3D"font-family:'Times New Roman'"> </sp= an></p></td><td style=3D"width:14.42%; border-top:0.75pt solid #000000; bor= der-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p= style=3D"margin-bottom:0pt; line-height:115%; font-size:9pt"><span style= =3D"font-family:'Times New Roman'">Vitamina C en GCF: 4,55 =C2=B5g/mL vs sa= liva: 3,16 =C2=B5g/mL (p=3D0,022). En saliva, las medianas de vitamina C fu= eron 4,7172; </span></p></td><td style=3D"width:15.14%; border-top:0.75pt s= olid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; verti= cal-align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-size:9= pt"><span style=3D"font-family:'Times New Roman'">Los niveles salivales mos= traron diferencias significativas seg=C3=BAn la severidad periodontal (</sp= an><span style=3D"font-family:'Times New Roman'; font-style:italic">p</span= ><span style=3D"font-family:'Times New Roman'">=3D0,000136), mientras que l= os niveles de </span></p></td></tr></table><p style=3D"margin-bottom:10pt; = line-height:115%; font-size:10pt"><span style=3D"font-family:'Times New Rom= an'; font-weight:bold"> </span></p><p style=3D"margin-bottom:10pt; lin= e-height:115%; font-size:10pt"><span style=3D"font-family:'Times New Roman'= ; font-weight:bold">Tabla 1</span><span style=3D"font-family:'Times New Rom= an'">. </span><span style=3D"font-family:'Times New Roman'; font-style:ital= ic">Asociaci=C3=B3n entre deficiencia de vitamina C y enfermedad periodonta= l (continuaci=C3=B3n)</span></p><table style=3D"width:100%; margin-bottom:0= pt; padding:0pt; border-collapse:collapse"><tr style=3D"height:34.55pt"><td= style=3D"width:8.44%; border-top:0.75pt solid #000000; border-bottom:0.75p= t solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin= -bottom:0pt; line-height:normal; font-size:9pt"><span style=3D"font-family:= 'Times New Roman'">Autor/ A=C3=B1o</span></p></td><td style=3D"width:15.6%;= border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; paddi= ng:0pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; line-heig= ht:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Estud= io y muestra</span></p></td><td style=3D"width:12.12%; border-top:0.75pt so= lid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertic= al-align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-size:9p= t"><span style=3D"font-family:'Times New Roman'">Condici=C3=B3n periodontal= evaluada</span></p></td><td style=3D"width:10.68%; border-top:0.75pt solid= #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-= align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-size:9pt">= <span style=3D"font-family:'Times New Roman'">Tipo de evaluaci=C3=B3n de vi= tamina C</span></p></td><td style=3D"width:12.62%; border-top:0.75pt solid = #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-a= lign:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-size:9pt"><= span style=3D"font-family:'Times New Roman'">Par=C3=A1metros periodontales = evaluados</span></p></td><td style=3D"width:9.56%; border-top:0.75pt solid = #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-a= lign:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-size:9pt"><= span style=3D"font-family:'Times New Roman'">Variable</span></p></td><td st= yle=3D"width:14.68%; border-top:0.75pt solid #000000; border-bottom:0.75pt = solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-b= ottom:0pt; line-height:115%; font-size:9pt"><span style=3D"font-family:'Tim= es New Roman'">Resultados</span></p></td><td style=3D"width:16.3%; border-t= op:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.= 75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; line-height:115%; = font-size:9pt"><span style=3D"font-family:'Times New Roman'">Hallazgo</span= ></p></td></tr><tr style=3D"height:110.15pt"><td style=3D"width:8.44%; bord= er-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0p= t 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; line-height:no= rmal; font-size:9pt"><span style=3D"font-family:'Times New Roman'"> </= span></p></td><td style=3D"width:15.6%; border-top:0.75pt solid #000000; bo= rder-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><= p style=3D"margin-bottom:0pt; line-height:115%; font-size:9pt"><span style= =3D"font-family:'Times New Roman'">periodontitis moderada (n=3D12) y grupo = con periodontitis severa (n=3D9)</span></p></td><td style=3D"width:12.12%; = border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; paddin= g:0pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; line-heigh= t:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'"> = </span></p></td><td style=3D"width:10.68%; border-top:0.75pt solid #000000;= border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top= "><p style=3D"margin-bottom:0pt; line-height:115%; font-size:9pt"><span sty= le=3D"font-family:'Times New Roman'"> </span></p></td><td style=3D"wid= th:12.62%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000= 000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt;= line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New Rom= an'"> </span></p></td><td style=3D"width:9.56%; border-top:0.75pt soli= d #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical= -align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-size:9pt"= ><span style=3D"font-family:'Times New Roman'"> </span></p></td><td st= yle=3D"width:14.68%; border-top:0.75pt solid #000000; border-bottom:0.75pt = solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-b= ottom:0pt; line-height:115%; font-size:9pt"><span style=3D"font-family:'Tim= es New Roman'">0,8743; 2,0600 y 3,4907 para los grupos sano, periodontitis = leve, moderada y severa, respectivamente (</span><span style=3D"font-family= :'Times New Roman'; font-style:italic">p</span><span style=3D"font-family:'= Times New Roman'">=3D0,000136). En GCF, las medianas fueron 4,9625; 4,4719;= 0,3270 y 4,9625, respectivamente (</span><span style=3D"font-family:'Times= New Roman'; font-style:italic">p</span><span style=3D"font-family:'Times N= ew Roman'">=3D0,062)</span></p></td><td style=3D"width:16.3%; border-top:0.= 75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt;= vertical-align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-= size:9pt"><span style=3D"font-family:'Times New Roman'">vitamina C en GCF n= o mostraron diferencias significativas (</span><span style=3D"font-family:'= Times New Roman'; font-style:italic">p</span><span style=3D"font-family:'Ti= mes New Roman'"> =3D0,062)</span></p></td></tr><tr style=3D"height:110.15pt= "><td style=3D"width:8.44%; border-top:0.75pt solid #000000; border-bottom:= 0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"m= argin-bottom:0pt; line-height:normal; font-size:9pt"><span style=3D"font-fa= mily:'Times New Roman'">Assaf & Rabi et at. (2022)</span></p><p style= =3D"margin-bottom:0pt; line-height:normal; font-size:9pt"><span style=3D"fo= nt-family:'Times New Roman'">(12)</span></p></td><td style=3D"width:15.6%; = border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; paddin= g:0pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; line-heigh= t:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Estudi= o transversal: n=3D25 pacientes con periodontitis distribuidos en pacientes= con periodontitis estadio II (n=3D2), periodontitis estadio III (n=3D11) y= grupo con periodontitis estadio IV (n=3D12)</span></p></td><td style=3D"wi= dth:12.12%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #00= 0000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt= ; line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New Ro= man'">Periodontitis estadio IV / controles</span></p></td><td style=3D"widt= h:10.68%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #0000= 00; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; = line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New Roma= n'">S=C3=A9rica </span></p></td><td style=3D"width:12.62%; border-top:0.75p= t solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; ve= rtical-align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-siz= e:9pt"><span style=3D"font-family:'Times New Roman'">PD, CAL y vitamina C s= =C3=A9rica</span></p></td><td style=3D"width:9.56%; border-top:0.75pt solid= #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-= align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-size:9pt">= <span style=3D"font-family:'Times New Roman'">Vitamina C s=C3=A9rica</span>= </p></td><td style=3D"width:14.68%; border-top:0.75pt solid #000000; border= -bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p st= yle=3D"margin-bottom:0pt; line-height:115%; font-size:9pt"><span style=3D"f= ont-family:'Times New Roman'">Estadio II: no se registr=C3=B3 deficiencia d= e Vit C. En el estadio III se identificaron 5 pacientes con deficiencia de = Vit C, mientras que en el estadio IV se registraron 5 pacientes con deficie= ncia de Vit C. </span></p></td><td style=3D"width:16.3%; border-top:0.75pt = solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vert= ical-align:top"><p style=3D"margin-bottom:0pt; line-height:115%; font-size:= 9pt"><span style=3D"font-family:'Times New Roman'">Los pacientes con period= ontitis estadio IV presentaron niveles s=C3=A9ricos significativamente meno= res de vitamina C en comparaci=C3=B3n con los estadios menos avanzados (</s= pan><span style=3D"font-family:'Times New Roman'; font-style:italic">p </sp= an><span style=3D"font-family:'Times New Roman'"><0,05).</span></p><p st= yle=3D"margin-bottom:0pt; line-height:115%; font-size:9pt"><span style=3D"f= ont-family:'Times New Roman'"> </span></p></td></tr></table><p style= =3D"margin-bottom:10pt; line-height:115%; font-size:10pt"><span style=3D"fo= nt-family:'Times New Roman'; font-weight:bold">Nota:</span><span style=3D"f= ont-family:'Times New Roman'"> elaboraci=C3=B3n a partir de los estudios in= cluidos en la revisi=C3=B3n (2)(12). Abreviaturas: PD: profundidad de sonda= je; CAL: nivel de inserci=C3=B3n cl=C3=ADnica; BOP: sangrado al sondaje; GC= F: fluido crevicular; Vit C: vitamina C; =C2=B5g/mL: microgramos por milili= tro; </span><span style=3D"font-family:'Times New Roman'; font-style:italic= ">p</span><span style=3D"font-family:'Times New Roman'">: valor de signific= ancia estad=C3=ADstica; n: n=C3=BAmero de participantes; vs: comparado con.= </span><span style=3D"font-family:'Times New Roman'">    </s= pan></p><p class=3D"ListParagraph" style=3D"margin-bottom:0pt; text-indent:= -18pt; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times = New Roman'; font-style:italic"><span>3.2.</span></span><span style=3D"font-= family:'Times New Roman'; font-weight:bold"> </span><span style=3D"font-fam= ily:'Times New Roman'; font-style:italic">Efecto terap=C3=A9utico de la vit= amina C como coadyuvante periodontal</span><span style=3D"font-family:'Time= s New Roman'; font-style:italic">  </span></p><p style=3D"margin-botto= m:10pt; text-align:justify; line-height:115%; font-size:12pt"><span style= =3D"font-family:'Times New Roman'">Los estudios evaluaron la vitamina C com= o coadyuvante de la terapia periodontal no quir=C3=BArgica y regenerativa, = mostrando resultados variables. Se observaron diferencias favorables en el = nivel de inserci=C3=B3n cl=C3=ADnica a los 3 meses (</span><span style=3D"f= ont-family:'Times New Roman'; font-style:italic">p </span><span style=3D"fo= nt-family:'Times New Roman'">=3D0,029) y disminuci=C3=B3n en el dolor posto= peratorio a los 2 y 3 d=C3=ADas (</span><span style=3D"font-family:'Times N= ew Roman'; font-style:italic">p </span><span style=3D"font-family:'Times Ne= w Roman'">=3D 0,021 y </span><span style=3D"font-family:'Times New Roman'; = font-style:italic">p </span><span style=3D"font-family:'Times New Roman'">= =3D 0,001) (13). Adem=C3=A1s, se observ=C3=B3 reducci=C3=B3n de la recesi= =C3=B3n gingival y de la profundidad del defecto radiogr=C3=A1fico en defec= tos intra=C3=B3seos tratados con =C3=A1cido asc=C3=B3rbico y PRF (</span><s= pan style=3D"font-family:'Times New Roman'; font-style:italic">p </span><sp= an style=3D"font-family:'Times New Roman'">< 0,05) (14). Por el contrari= o, no se observaron beneficios cl=C3=ADnicos adicionales significativos sob= re los =C3=ADndices de placa, =C3=ADndice gingival y sangrado al sondaje (<= /span><span style=3D"font-family:'Times New Roman'; font-style:italic">p</s= pan><span style=3D"font-family:'Times New Roman'"> > 0,05) (15). De la m= isma manera, la suplementaci=C3=B3n con vitamina C no produjo mejoras adici= onales significativas en la capacidad antioxidante total s=C3=A9rica y sali= val (</span><span style=3D"font-family:'Times New Roman'; font-style:italic= ">p</span><span style=3D"font-family:'Times New Roman'"> > 0,05) (16). P= or otro lado, se report=C3=B3 que la suplementaci=C3=B3n combinada con vita= minas C, D, y E mostr=C3=B3 mejoras en la profundidad de sondaje y sangrado= al sondaje, as=C3=AD como un incremento de los niveles s=C3=A9ricos de vit= amina C (17). La </span><a href=3D"#tabla2" style=3D"text-decoration:none">= <span class=3D"Hyperlink" style=3D"font-family:'Times New Roman'; font-weig= ht:bold; text-decoration:none; color:#000000">Tabla 2</span></a><span style= =3D"font-family:'Times New Roman'"> presenta los resultados de cada estudio= .</span></p><p style=3D"text-align:justify; line-height:115%; font-size:10p= t"><a id=3D"tabla2"><span style=3D"font-family:'Times New Roman'; font-weig= ht:bold">Tabla 2.</span><span style=3D"font-family:'Times New Roman'"> </sp= an><span style=3D"font-family:'Times New Roman'; font-style:italic">Efecto = terap=C3=A9utico de la vitamina C como coadyuvante en el tratamiento period= ontal </span></a></p><table style=3D"width:100%; margin-bottom:0pt; padding= :0pt; border-collapse:collapse"><tr><td style=3D"width:12%; border-top:0.75= pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; v= ertical-align:top"><p style=3D"text-align:justify; line-height:115%; font-s= ize:9pt"><span style=3D"font-family:'Times New Roman'">Autor/A=C3=B1o</span= ></p></td><td style=3D"width:16.02%; border-top:0.75pt solid #000000; borde= r-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p s= tyle=3D"text-align:justify; line-height:115%; font-size:9pt"><span style=3D= "font-family:'Times New Roman'">Dise=C3=B1o y muestra</span></p></td><td st= yle=3D"width:12.32%; border-top:0.75pt solid #000000; border-bottom:0.75pt = solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"text-ali= gn:justify; line-height:115%; font-size:9pt"><span style=3D"font-family:'Ti= mes New Roman'">Intervenci=C3=B3n terap=C3=A9utica</span></p></td><td style= =3D"width:13.68%; border-top:0.75pt solid #000000; border-bottom:0.75pt sol= id #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"text-align:= justify; line-height:115%; font-size:9pt"><span style=3D"font-family:'Times= New Roman'">M=C3=A9todo / tipo de evaluaci=C3=B3n</span></p></td><td style= =3D"width:13.68%; border-top:0.75pt solid #000000; border-bottom:0.75pt sol= id #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"text-align:= justify; line-height:115%; font-size:9pt"><span style=3D"font-family:'Times= New Roman'">Par=C3=A1metros cl=C3=ADnicos evaluados</span></p></td><td sty= le=3D"width:15.54%; border-top:0.75pt solid #000000; border-bottom:0.75pt s= olid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"text-alig= n:justify; line-height:115%; font-size:9pt"><span style=3D"font-family:'Tim= es New Roman'">Resultados cl=C3=ADnicos principales</span></p></td><td styl= e=3D"width:16.76%; border-top:0.75pt solid #000000; border-bottom:0.75pt so= lid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"text-align= :justify; line-height:115%; font-size:9pt"><span style=3D"font-family:'Time= s New Roman'">Hallazgo cl=C3=ADnico</span></p></td></tr><tr><td style=3D"wi= dth:12%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #00000= 0; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; fo= nt-size:9pt"><span style=3D"font-family:'Times New Roman'">Sherif et al. (2= 025) (13)</span></p></td><td style=3D"width:16.02%; border-top:0.75pt solid= #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-= align:top"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font= -family:'Times New Roman'">Ensayo cl=C3=ADnico aleatorizado; (n=3D45) pacie= ntes con periodontitis estadio II distribuidos en tres grupos: PMPR+I-PRF+v= itamina C (n=3D15), PMPR+I-PRF(n=3D15) y PMPR solo (n=3D15) </span></p></td= ><td style=3D"width:12.32%; border-top:0.75pt solid #000000; border-bottom:= 0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"l= ine-height:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman= '">IPRF + vitamina C como coadyuvante periodontal</span></p></td><td style= =3D"width:13.68%; border-top:0.75pt solid #000000; border-bottom:0.75pt sol= id #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height= :115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Evaluac= i=C3=B3n cl=C3=ADnica periodontal y seguimiento postoperatorio a 3 meses</s= pan></p></td><td style=3D"width:13.68%; border-top:0.75pt solid #000000; bo= rder-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><= p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'Tim= es New Roman'">CAL,</span><span style=3D"font-family:'Times New Roman'">&#x= a0; </span><span style=3D"font-family:'Times New Roman'">PD, BOP,</span><sp= an style=3D"font-family:'Times New Roman'">  </span><span style=3D"fon= t-family:'Times New Roman'">PI</span><span style=3D"font-family:'Times New = Roman'">  </span><span style=3D"font-family:'Times New Roman'">y dolor= postoperatorio</span></p></td><td style=3D"width:15.54%; border-top:0.75pt= solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; ver= tical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span style= =3D"font-family:'Times New Roman'">Mejor nivel de inserci=C3=B3n cl=C3=ADni= ca (CAL) a los 3 meses en el grupo PMPR+I-PRF/VitC (p=3D0,029). No se obser= varon diferencias intergrupales significativas para BOP, PD, CAL, GM, PI ni= par=C3=A1metros radiogr=C3=A1ficos a los 3 o 6 meses (</span><span style= =3D"font-family:'Times New Roman'; font-style:italic">p</span><span style= =3D"font-family:'Times New Roman'">>0,05). Menor dolor postoperatorio a = los 2 y 3 d=C3=ADas (</span><span style=3D"font-family:'Times New Roman'; f= ont-style:italic">p</span><span style=3D"font-family:'Times New Roman'">=3D= 0,021; </span><span style=3D"font-family:'Times New Roman'; font-style:ital= ic">p</span><span style=3D"font-family:'Times New Roman'">=3D0,001). </span= ></p></td><td style=3D"width:16.76%; border-top:0.75pt solid #000000; borde= r-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p s= tyle=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'Times = New Roman'">La incorporaci=C3=B3n de vitamina C en I-PRF redujo el dolor po= stoperatorio y mostr=C3=B3 una mejor=C3=ADa transitoria del CAL a los 3 mes= es; sin embargo, no aport=C3=B3 beneficios cl=C3=ADnicos periodontales adic= ionales sostenidos frente a PMPR o I-PRF solos. </span></p></td></tr></tabl= e><p><span> </span></p><p style=3D"text-align:justify; line-height:115= %; font-size:10pt"><span style=3D"font-family:'Times New Roman'; font-weigh= t:bold">Tabla 2.</span><span style=3D"font-family:'Times New Roman'"> </spa= n><span style=3D"font-family:'Times New Roman'; font-style:italic">Efecto t= erap=C3=A9utico de la vitamina C como coadyuvante en el tratamiento periodo= ntal (continuaci=C3=B3n)</span></p><table style=3D"width:100%; margin-botto= m:0pt; padding:0pt; border-collapse:collapse"><tr><td style=3D"width:12.6%;= border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; paddi= ng:0pt 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; line-heig= ht:normal; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Aut= or/A=C3=B1o</span></p></td><td style=3D"width:16.2%; border-top:0.75pt soli= d #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical= -align:top"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"fon= t-family:'Times New Roman'">Dise=C3=B1o y muestra</span></p></td><td style= =3D"width:12.92%; border-top:0.75pt solid #000000; border-bottom:0.75pt sol= id #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height= :115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Interve= nci=C3=B3n terap=C3=A9utica</span></p></td><td style=3D"width:13.14%; borde= r-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt= 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><= span style=3D"font-family:'Times New Roman'">M=C3=A9todo / tipo de evaluaci= =C3=B3n</span></p></td><td style=3D"width:13.38%; border-top:0.75pt solid #= 000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-al= ign:top"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-f= amily:'Times New Roman'">Par=C3=A1metros cl=C3=ADnicos evaluados</span></p>= </td><td style=3D"width:16.36%; border-top:0.75pt solid #000000; border-bot= tom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style= =3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New = Roman'">Resultados cl=C3=ADnicos principales</span></p></td><td style=3D"wi= dth:15.4%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000= 000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; = font-size:9pt"><span style=3D"font-family:'Times New Roman'">Hallazgo cl=C3= =ADnico</span></p></td></tr><tr><td style=3D"width:12.6%; border-top:0.75pt= solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; ver= tical-align:top"><p style=3D"margin-bottom:0pt; line-height:normal; font-si= ze:9pt"><span style=3D"font-family:'Times New Roman'">Elbehwashy et al. (20= 21) </span></p><p style=3D"margin-bottom:0pt; line-height:normal; font-size= :9pt"><span style=3D"font-family:'Times New Roman'">(14)</span></p></td><td= style=3D"width:16.2%; border-top:0.75pt solid #000000; border-bottom:0.75p= t solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-h= eight:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">En= sayo cl=C3=ADnico aleatorizado; (n=3D20) paciente con periodontitis estadio= III grado C distribuidos en grupo prueba (OFD+AA/PRF; n=3D10) y grupo cont= rol (OFD+PRF; n=3D10)</span></p></td><td style=3D"width:12.92%; border-top:= 0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75p= t; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span s= tyle=3D"font-family:'Times New Roman'">PRF + =C3=A1cido asc=C3=B3rbico en d= efectos intra=C3=B3seos</span></p></td><td style=3D"width:13.14%; border-to= p:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.7= 5pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span= style=3D"font-family:'Times New Roman'">Evaluaci=C3=B3n cl=C3=ADnica perio= dontal y regeneraci=C3=B3n tisular</span></p></td><td style=3D"width:13.38%= ; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padd= ing:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size= :9pt"><span style=3D"font-family:'Times New Roman'">CAL, PD, RD y par=C3=A1= metros radiogr=C3=A1ficos </span></p></td><td style=3D"width:16.36%; border= -top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt = 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><s= pan style=3D"font-family:'Times New Roman'">Ganancia de CAL: 4,25 =C2=B1 1,= 27 mm. Reducci=C3=B3n de recesi=C3=B3n gingival: 0,80 =C2=B1 0,74 mm (</spa= n><span style=3D"font-family:'Times New Roman'; font-style:italic">p</span>= <span style=3D"font-family:'Times New Roman'">=3D0,010). El grupo AA/PRF mo= str=C3=B3 una mayor reducci=C3=B3n de la profundidad del defecto radiogr=C3= =A1fico (2,29 =C2=B1 0,61 mm; </span><span style=3D"font-family:'Times New = Roman'; font-style:italic">p</span><span style=3D"font-family:'Times New Ro= man'">=3D0,014). </span></p></td><td style=3D"width:15.4%; border-top:0.75p= t solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; ve= rtical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span style= =3D"font-family:'Times New Roman'">La incorporaci=C3=B3n del =C3=A1cido asc= =C3=B3rbico al PRF mejor=C3=B3 la reducci=C3=B3n de la recesi=C3=B3n gingiv= al y el relleno radiogr=C3=A1fico de los defectos intra=C3=B3seos en compar= aci=C3=B3n con PRF solo. </span></p></td></tr><tr><td style=3D"width:12.6%;= border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; paddi= ng:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size:= 9pt"><span style=3D"font-family:'Times New Roman'">Ozmeric et al. (2025) (1= 5)</span></p></td><td style=3D"width:16.2%; border-top:0.75pt solid #000000= ; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:to= p"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:= 'Times New Roman'">Ensayo cl=C3=ADnico multic=C3=A9ntrico; (n=3D51) pacient= es con gingivitis, distribuidos en tres grupos: enjuague con fenoles (n=3D1= 3);CHX (n=3D19) y CHX+VitC (n=3D19)</span></p></td><td style=3D"width:12.92= %; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; pad= ding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-siz= e:9pt"><span style=3D"font-family:'Times New Roman'">Enjuague con clorhexid= ina 0,12% + vitamina C</span></p></td><td style=3D"width:13.14%; border-top= :0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75= pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span = style=3D"font-family:'Times New Roman'">Evaluaci=C3=B3n cl=C3=ADnica period= ontal durante 14 d=C3=ADas</span></p></td><td style=3D"width:13.38%; border= -top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt = 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><s= pan style=3D"font-family:'Times New Roman'">PI, GI y BOP</span></p></td><td= style=3D"width:16.36%; border-top:0.75pt solid #000000; border-bottom:0.75= pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-= height:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">P= I (d=C3=ADa 14): Fenol 0,28 =C2=B1 0,59; CHX 0,08 =C2=B1 0,23; CHX+VitC 0,1= 3 =C2=B1 0,21. GI: 0,19 =C2=B1 0,18; 0,04 =C2=B1 0,41; 0,06 =C2=B1 0,11. BO= P: 0,05 =C2=B1 0,06; 0,01 =C2=B1 0,19; 0,03 =C2=B1 0,05, respectivamente. N= o se observaron diferencias significativas entre grupos (</span><span style= =3D"font-family:'Times New Roman'; font-style:italic">p </span><span style= =3D"font-family:'Times New Roman'">> 0,05). </span></p></td><td style=3D= "width:15.4%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #= 000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115= %; font-size:9pt"><span style=3D"font-family:'Times New Roman'">La suplemen= taci=C3=B3n con vitamina C no mostr=C3=B3 beneficios cl=C3=ADnicos adiciona= les significativos frente al tratamiento convencional.</span></p></td></tr>= <tr><td style=3D"width:12.6%; border-top:0.75pt solid #000000; border-botto= m:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D= "line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New Rom= an'">Nisha et al. (2023) (16)</span></p></td><td style=3D"width:16.2%; bord= er-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0p= t 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt">= <span style=3D"font-family:'Times New Roman'">Ensayo cl=C3=ADnico aleatoriz= ado; (n=3D105) participantes distribuidos en tres grupos: sujetos </span></= p></td><td style=3D"width:12.92%; border-top:0.75pt solid #000000; border-b= ottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p styl= e=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New= Roman'">NSPT + vitamina C 500 mg/d=C3=ADa</span></p></td><td style=3D"widt= h:13.14%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #0000= 00; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; f= ont-size:9pt"><span style=3D"font-family:'Times New Roman'">Evaluaci=C3=B3n= cl=C3=ADnica periodontal y an=C3=A1lisis s=C3=A9rico antioxidante (TAOC-FR= AP)</span></p></td><td style=3D"width:13.38%; border-top:0.75pt solid #0000= 00; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:= top"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-famil= y:'Times New Roman'">PD, CAL, PI, GI, BOP y TAOC s=C3=A9rico y salival</spa= n></p></td><td style=3D"width:16.36%; border-top:0.75pt solid #000000; bord= er-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p = style=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'Times= New Roman'">PD: 3,56 =C2=B1 0,62 =E2=86=92 2,19 =C2=B1 0,44 mm; CAL: 5,16 = =C2=B1 0,41 =E2=86=92 3,18 =C2=B1 0,23 mm; PI: 2,46 =C2=B1 0,13 =E2=86=92 0= ,55 =C2=B1 0,12; </span></p></td><td style=3D"width:15.4%; border-top:0.75p= t solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; ve= rtical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span style= =3D"font-family:'Times New Roman'">La NSPT mejor=C3=B3 significativamente l= os par=C3=A1metros cl=C3=ADnicos periodontales y la capacidad antioxidante = total; sin </span></p></td></tr></table><p style=3D"text-align:justify; lin= e-height:115%; font-size:10pt"><span style=3D"font-family:'Times New Roman'= ; font-weight:bold">Tabla 2.</span><span style=3D"font-family:'Times New Ro= man'"> </span><span style=3D"font-family:'Times New Roman'; font-style:ital= ic">Efecto terap=C3=A9utico de la vitamina C como coadyuvante en el tratami= ento periodontal (continuaci=C3=B3n)</span></p><table style=3D"width:100%; = margin-bottom:0pt; padding:0pt; border-collapse:collapse"><tr><td style=3D"= width:11.54%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #= 000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115= %; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Autor/A=C3= =B1o</span></p></td><td style=3D"width:17.52%; border-top:0.75pt solid #000= 000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align= :top"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-fami= ly:'Times New Roman'">Dise=C3=B1o y muestra</span></p></td><td style=3D"wid= th:11.9%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #0000= 00; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; f= ont-size:9pt"><span style=3D"font-family:'Times New Roman'">Intervenci=C3= =B3n terap=C3=A9utica</span></p></td><td style=3D"width:13.18%; border-top:= 0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75p= t; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span s= tyle=3D"font-family:'Times New Roman'">M=C3=A9todo / tipo de evaluaci=C3=B3= n</span></p></td><td style=3D"width:12.32%; border-top:0.75pt solid #000000= ; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:to= p"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:= 'Times New Roman'">Par=C3=A1metros cl=C3=ADnicos evaluados</span></p></td><= td style=3D"width:15.2%; border-top:0.75pt solid #000000; border-bottom:0.7= 5pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line= -height:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">= Resultados cl=C3=ADnicos principales</span></p></td><td style=3D"width:18.3= 4%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; pa= dding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-si= ze:9pt"><span style=3D"font-family:'Times New Roman'">Hallazgo cl=C3=ADnico= </span></p></td></tr><tr><td style=3D"width:11.54%; border-top:0.75pt solid= #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-= align:top"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font= -family:'Times New Roman'"> </span></p></td><td style=3D"width:17.52%;= border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; paddi= ng:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size:= 9pt"><span style=3D"font-family:'Times New Roman'">periodontalmente sanos (= control) (n=3D35), pacientes con periodontitis tratados con NSPT (n=3D35) y= pacientes con periodontitis tratados con NSPT m=C3=A1s suplementaci=C3=B3n= de vit C (500mg/d=C3=ADa durante 3 meses) (n=3D35)</span></p></td><td styl= e=3D"width:11.9%; border-top:0.75pt solid #000000; border-bottom:0.75pt sol= id #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height= :115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'"> <= /span></p></td><td style=3D"width:13.18%; border-top:0.75pt solid #000000; = border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"= ><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'T= imes New Roman'"> </span></p></td><td style=3D"width:12.32%; border-to= p:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.7= 5pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span= style=3D"font-family:'Times New Roman'"> </span></p></td><td style=3D= "width:15.2%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #= 000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115= %; font-size:9pt"><span style=3D"font-family:'Times New Roman'">GI: 2,38 = =C2=B1 0,16 =E2=86=92 1,12 =C2=B1 0,18; BOP: 59 =C2=B1 0,55 =E2=86=92 28,14= =C2=B1 16,63 (basal=E2=80=9312 meses). Los niveles s=C3=A9ricos y salivale= s de TAOC aumentaron despu=C3=A9s del tratamiento periodontal, sin diferenc= ias significativas entre NSPT y NSPT + vitamina C (</span><span style=3D"fo= nt-family:'Times New Roman'; font-style:italic">p</span><span style=3D"font= -family:'Times New Roman'">>0,05).</span></p></td><td style=3D"width:18.= 34%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; p= adding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-s= ize:9pt"><span style=3D"font-family:'Times New Roman'">embargo, la suplemen= taci=C3=B3n con vitamina C no mostr=C3=B3 beneficios cl=C3=ADnicos ni antio= xidantes adicionales significativos</span></p></td></tr><tr><td style=3D"wi= dth:11.54%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #00= 0000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%;= font-size:9pt"><span style=3D"font-family:'Times New Roman'">Jaafer et al.= (2025) (17)</span></p></td><td style=3D"width:17.52%; border-top:0.75pt so= lid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertic= al-align:top"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"f= ont-family:'Times New Roman'">Estudio prospectivo; (n=3D120) pacientes con = periodontitis moderada a severa distribuidos en grupo control (SRP; n=3D60)= y grupo experimental (SRP+VitC, D y E n=3D60)</span></p></td><td style=3D"= width:11.9%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #0= 00000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%= ; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Vitaminas C,= D y E + SRP</span></p></td><td style=3D"width:13.18%; border-top:0.75pt so= lid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertic= al-align:top"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"f= ont-family:'Times New Roman'">Evaluaci=C3=B3n cl=C3=ADnica periodontal y an= =C3=A1lisis s=C3=A9rico antioxidante</span></p></td><td style=3D"width:12.3= 2%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; pa= dding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-si= ze:9pt"><span style=3D"font-family:'Times New Roman'">PD, CAL, BOP y vitami= na C s=C3=A9ricos de vitamina C, D y E</span></p></td><td style=3D"width:15= .2%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; p= adding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-s= ize:9pt"><span style=3D"font-family:'Times New Roman'">PD: 5,3 =C2=B1 0,7 = =E2=86=92 3,5 =C2=B1 0,5 mm; CAL: 4,9 =C2=B1 0,8 =E2=86=92 3,7 =C2=B1 0,6 m= m; BOP: 46,2 =C2=B1 9,8% =E2=86=92 20,3 =C2=B1 7,2%; Vitamina C s=C3=A9rica= : 0,8 =C2=B1 0,2 =E2=86=92 1,5 =C2=B1 0,4 mg/dL (basal=E2=80=933 meses). </= span></p></td><td style=3D"width:18.34%; border-top:0.75pt solid #000000; b= order-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top">= <p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'Ti= mes New Roman'">La suplementaci=C3=B3n antioxidante combinada se asoci=C3= =B3 con mejoras en los par=C3=A1metros cl=C3=ADnicos periodontal y un incre= mento de los niveles s=C3=A9ricos de antioxidantes</span></p></td></tr></ta= ble><p style=3D"margin-bottom:10pt; text-align:justify; line-height:115%; f= ont-size:10pt"><span style=3D"font-family:'Times New Roman'; font-weight:bo= ld">Nota:</span><span style=3D"font-family:'Times New Roman'"> elaboraci=C3= =B3n a partir de los estudios incluidos en la revisi=C3=B3n (13)(14)(15)(16= )(17). Abreviaturas: AA: =C3=A1cido asc=C3=B3rbico;</span><span style=3D"fo= nt-family:'Times New Roman'">  </span><span style=3D"font-family:'Time= s New Roman'">BOP: sangrado al sondaje; CAL: nivel de inserci=C3=B3n cl=C3= =ADnica; CHX: clorhexidina;</span><span style=3D"font-family:'Times New Rom= an'">  </span><span style=3D"font-family:'Times New Roman'">FRAP: pode= r antioxidante reductor f=C3=A9rrico; GI: =C3=ADndice gingival;</span><span= style=3D"font-family:'Times New Roman'">  </span><span style=3D"font-= family:'Times New Roman'">GM: margen gingival;</span><span style=3D"font-fa= mily:'Times New Roman'">  </span><span style=3D"font-family:'Times New= Roman'">I-PRF: fibrina rica en plaquetas inyectable; NSPT: terapia periodo= ntal no quir=C3=BArgica; PD: profundidad de sondaje; PI: =C3=ADndice de pla= ca; PMPR: remoci=C3=B3n mec=C3=A1nica profesional de placa; PRF: fibrina ri= ca en plaquetas; RD: profundidad de recesi=C3=B3n gingival;</span><span sty= le=3D"font-family:'Times New Roman'">  </span><span style=3D"font-fami= ly:'Times New Roman'">SRP: raspado y alisado radicular; TAOC: capacidad ant= ioxidante total.</span></p><p class=3D"ListParagraph" style=3D"margin-top:1= 2pt; margin-bottom:0pt; text-indent:-18pt; text-align:justify; line-height:= 115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'; font-st= yle:italic"><span>3.3.</span></span><span style=3D"font-family:'Times New R= oman'; font-weight:bold"> </span><span style=3D"font-family:'Times New Roma= n'; font-style:italic">Biomarcadores de estr=C3=A9s oxidativo asociados con= periodontitis</span><span style=3D"font-family:'Times New Roman'; font-sty= le:italic">  </span></p><p style=3D"margin-bottom:10pt; text-align:jus= tify; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times N= ew Roman'">Los estudios relacionados con biomarcadores oxidativos reportaro= n alteraciones en el equilibrio oxidativo-antioxidante en pacientes con per= iodontitis. Los biomarcadores evaluados incluyeron marcadores y respuestas = inflamatoria periodontal (18)(19)(20). Adem=C3=A1s, se observ=C3=B3 una red= ucci=C3=B3n significativa de los niveles de sulfiredoxina despu=C3=A9s de l= a terapia periodontal no quir=C3=BArgica (</span><span style=3D"font-family= :'Times New Roman'; font-style:italic">p</span><span style=3D"font-family:'= Times New Roman'">=3D0,004) (18). Por otro lado, se report=C3=B3 un increme= nto del estado oxidante total y una disminuci=C3=B3n de la capacidad antiox= idante total en pacientes con periodontitis (</span><span style=3D"font-fam= ily:'Times New Roman'; font-style:italic">p</span><span style=3D"font-famil= y:'Times New Roman'">=3D0,001) (19). Asimismo, se identific=C3=B3 una dismi= nuci=C3=B3n de taurina y un incremento de TNF =E2=80=93 =CE=B1 en pacientes= con periodontitis, evidenciando una asociaci=C3=B3n entre inflamaci=C3=B3n= periodontal y desequilibrio oxidativo (20). Los resultados se=C3=B1alan un= a relaci=C3=B3n entre el estr=C3=A9s oxidativo, la respuesta antioxidante y= la inflamaci=C3=B3n periodontal (</span><a href=3D"#tabla4" style=3D"text-= decoration:none"><span class=3D"Hyperlink" style=3D"font-family:'Times New = Roman'; font-weight:bold; text-decoration:none; color:#000000">Tabla 3</spa= n></a><span style=3D"font-family:'Times New Roman'">).</span></p><p style= =3D"text-align:justify; line-height:115%; font-size:10pt"><a id=3D"tabla4">= <span style=3D"font-family:'Times New Roman'; font-weight:bold">Tabla 3.</s= pan><span style=3D"font-family:'Times New Roman'"> </span><span style=3D"fo= nt-family:'Times New Roman'; font-style:italic">Biomarcadores de estr=C3=A9= s oxidativo asociados con enfermedad periodontal</span></a></p><table style= =3D"width:100%; margin-bottom:0pt; padding:0pt; border-collapse:collapse"><= tr><td style=3D"width:11.1%; border-top:0.75pt solid #000000; border-bottom= :0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"= margin-bottom:0pt; text-align:center; line-height:normal; font-size:9pt"><s= pan style=3D"font-family:'Times New Roman'">Autor/</span></p><p style=3D"ma= rgin-bottom:0pt; text-align:center; line-height:normal; font-size:9pt"><spa= n style=3D"font-family:'Times New Roman'">A=C3=B1o</span></p></td><td style= =3D"width:17.2%; border-top:0.75pt solid #000000; border-bottom:0.75pt soli= d #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-botto= m:0pt; text-align:center; line-height:normal; font-size:9pt"><span style=3D= "font-family:'Times New Roman'">Dise=C3=B1o y muestra</span></p></td><td st= yle=3D"width:13.96%; border-top:0.75pt solid #000000; border-bottom:0.75pt = solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"margin-b= ottom:0pt; text-align:center; line-height:normal; font-size:9pt"><span styl= e=3D"font-family:'Times New Roman'">Biomarcador oxidativo evaluado</span></= p></td><td style=3D"width:14.88%; border-top:0.75pt solid #000000; border-b= ottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p styl= e=3D"margin-bottom:0pt; text-align:center; line-height:normal; font-size:9p= t"><span style=3D"font-family:'Times New Roman'">M=C3=A9todo / tipo de eval= uaci=C3=B3n</span></p></td><td style=3D"width:13.18%; border-top:0.75pt sol= id #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertica= l-align:top"><p style=3D"margin-bottom:0pt; text-align:center; line-height:= normal; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Par=C3= =A1metros relacionados</span></p></td><td style=3D"width:14.8%; border-top:= 0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75p= t; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:center; li= ne-height:normal; font-size:9pt"><span style=3D"font-family:'Times New Roma= n'">Resultados principales</span></p></td><td style=3D"width:14.88%; border= -top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt = 5.75pt; vertical-align:top"><p style=3D"margin-bottom:0pt; text-align:cente= r; line-height:normal; font-size:9pt"><span style=3D"font-family:'Times New= Roman'">Hallazgo principal</span></p></td></tr><tr><td style=3D"width:11.1= %; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; pad= ding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-siz= e:9pt"><span style=3D"font-family:'Times New Roman'">Dixit et al. (2025) (1= 8)</span></p></td><td style=3D"width:17.2%; border-top:0.75pt solid #000000= ; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:to= p"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:= 'Times New Roman'">Estudios de casos y controles; (n=3D41) participantes di= stribuidos en individuos periodontalmente sanos (grupo control; (n=3D20)) y= pacientes con periodontitis cr=C3=B3nica (grupo caso; (n=3D21)); evaluados= antes y despu=C3=A9s de (NSPT)</span></p></td><td style=3D"width:13.96%; b= order-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding= :0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9p= t"><span style=3D"font-family:'Times New Roman'">Sulfiredoxina (Srx)</span>= </p></td><td style=3D"width:14.88%; border-top:0.75pt solid #000000; border= -bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p st= yle=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'Times N= ew Roman'">An=C3=A1lisis de biomarcadores oxidativos en fluido crevicular g= ingival posterior a terapia periodontal no quir=C3=BArgica (NSPT)</span></p= ></td><td style=3D"width:13.18%; border-top:0.75pt solid #000000; border-bo= ttom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style= =3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New = Roman'">Estr=C3=A9s oxidativo y respuesta periodontal</span></p></td><td st= yle=3D"width:14.8%; border-top:0.75pt solid #000000; border-bottom:0.75pt s= olid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-heig= ht:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Srx: = 0,532 =C2=B1 0,23=E2=86=920,366 =C2=B1 0,10 ng/mL tras NSPT (</span><span s= tyle=3D"font-family:'Times New Roman'; font-style:italic">p</span><span sty= le=3D"font-family:'Times New Roman'">=3D0,004).</span></p></td><td style=3D= "width:14.88%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid = #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:11= 5%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">La terapia= periodontal redujo biomarcadores asociados a estr=C3=A9s oxidativo e infla= maci=C3=B3n periodontal.</span></p></td></tr><tr><td style=3D"width:11.1%; = border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; paddin= g:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9= pt"><span style=3D"font-family:'Times New Roman'">Mohideen et al. (2023) (1= 9)</span></p></td><td style=3D"width:17.2%; border-top:0.75pt solid #000000= ; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:to= p"><p style=3D"line-height:115%; font-size:9pt"><span style=3D"font-family:= 'Times New Roman'">Revisi=C3=B3n sistem=C3=A1tica y metaan=C3=A1lisis; 42 e= studios incluidos para s=C3=ADntesis cualitativa y 24 estudios cuantitativo= de TOS y TAC en pacientes con periodontitis y controles sanos</span></p></= td><td style=3D"width:13.96%; border-top:0.75pt solid #000000; border-botto= m:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D= "line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New Rom= an'">TOS y TAC</span></p></td><td style=3D"width:14.88%; border-top:0.75pt = solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vert= ical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span style=3D= "font-family:'Times New Roman'">Evaluaci=C3=B3n s=C3=A9rica y salival de ca= pacidad antioxidante y oxidativa</span></p></td><td style=3D"width:13.18%; = border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; paddin= g:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9= pt"><span style=3D"font-family:'Times New Roman'">Estr=C3=A9s oxidativo sis= t=C3=A9mico y salival en periodontitis</span></p></td><td style=3D"width:14= .8%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; p= adding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-s= ize:9pt"><span style=3D"font-family:'Times New Roman'">TOS salival: diferen= cia global 1,784 =C2=B5mol H=E2=82=82O=E2=82=82 Eq/L (</span><span style=3D= "font-family:'Times New Roman'; font-style:italic">p</span><span style=3D"f= ont-family:'Times New Roman'">=3D0,001). TAC s=C3=A9rico: disminuci=C3=B3n = global -2,049 mmol Trolox Eq/L (</span><span style=3D"font-family:'Times Ne= w Roman'; font-style:italic">p</span><span style=3D"font-family:'Times New = Roman'">=3D0,001).</span></p></td><td style=3D"width:14.88%; border-top:0.7= 5pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; = vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span styl= e=3D"font-family:'Times New Roman'">Los pacientes con periodontitis present= aron incremento de estr=C3=A9s oxidativo y disminuci=C3=B3n de capacidad an= tioxidante.</span></p></td></tr></table><p><span> </span></p><p style= =3D"text-align:justify; line-height:115%; font-size:10pt"><span style=3D"fo= nt-family:'Times New Roman'; font-weight:bold">Tabla 3.</span><span style= =3D"font-family:'Times New Roman'"> </span><span style=3D"font-family:'Time= s New Roman'; font-style:italic">Biomarcadores de estr=C3=A9s oxidativo aso= ciados con enfermedad periodontal (continuaci=C3=B3n)</span></p><table styl= e=3D"width:100%; margin-bottom:0pt; padding:0pt; border-collapse:collapse">= <tr><td style=3D"width:10.88%; border-top:0.75pt solid #000000; border-bott= om:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style= =3D"margin-bottom:0pt; text-align:center; line-height:normal; font-size:9pt= "><span style=3D"font-family:'Times New Roman'">Autor/</span></p><p style= =3D"text-align:center; line-height:115%; font-size:9pt"><span style=3D"font= -family:'Times New Roman'">A=C3=B1o</span></p></td><td style=3D"width:17.52= %; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; pad= ding:0pt 5.75pt; vertical-align:top"><p style=3D"text-align:center; line-he= ight:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">Dis= e=C3=B1o y muestra</span></p></td><td style=3D"width:13.74%; border-top:0.7= 5pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; = vertical-align:top"><p style=3D"text-align:center; line-height:115%; font-s= ize:9pt"><span style=3D"font-family:'Times New Roman'">Biomarcador oxidativ= o evaluado</span></p></td><td style=3D"width:15.16%; border-top:0.75pt soli= d #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical= -align:top"><p style=3D"text-align:center; line-height:115%; font-size:9pt"= ><span style=3D"font-family:'Times New Roman'">M=C3=A9todo / tipo de evalua= ci=C3=B3n</span></p></td><td style=3D"width:12.96%; border-top:0.75pt solid= #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-= align:top"><p style=3D"text-align:center; line-height:115%; font-size:9pt">= <span style=3D"font-family:'Times New Roman'">Par=C3=A1metros relacionados<= /span></p></td><td style=3D"width:15.08%; border-top:0.75pt solid #000000; = border-bottom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"= ><p style=3D"text-align:center; line-height:115%; font-size:9pt"><span styl= e=3D"font-family:'Times New Roman'">Resultados principales</span></p></td><= td style=3D"width:14.66%; border-top:0.75pt solid #000000; border-bottom:0.= 75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"tex= t-align:center; line-height:115%; font-size:9pt"><span style=3D"font-family= :'Times New Roman'">Hallazgo principal</span></p></td></tr><tr><td style=3D= "width:10.88%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid = #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:11= 5%; font-size:9pt"><span style=3D"font-family:'Times New Roman'">D=C3=B6nme= z et al. (2025) (20)</span></p></td><td style=3D"width:17.52%; border-top:0= .75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75pt= ; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span st= yle=3D"font-family:'Times New Roman'">Casos y controles; (n=3D40) participa= ntes distribuidos en grupo control periodontalmente sanos (n=3D20) y grupo = con periodontitis generalizada estadio III grado B (n=3D20)</span></p></td>= <td style=3D"width:13.74%; border-top:0.75pt solid #000000; border-bottom:0= .75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style=3D"li= ne-height:115%; font-size:9pt"><span style=3D"font-family:'Times New Roman'= ">Taurina y TNF-=CE=B1</span></p></td><td style=3D"width:15.16%; border-top= :0.75pt solid #000000; border-bottom:0.75pt solid #000000; padding:0pt 5.75= pt; vertical-align:top"><p style=3D"line-height:115%; font-size:9pt"><span = style=3D"font-family:'Times New Roman'">Evaluaci=C3=B3n s=C3=A9rica de biom= arcadores inflamatorios y antioxidantes</span></p></td><td style=3D"width:1= 2.96%; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000;= padding:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font= -size:9pt"><span style=3D"font-family:'Times New Roman'">Inflamaci=C3=B3n p= eriodontal y estr=C3=A9s oxidativo</span></p></td><td style=3D"width:15.08%= ; border-top:0.75pt solid #000000; border-bottom:0.75pt solid #000000; padd= ing:0pt 5.75pt; vertical-align:top"><p style=3D"line-height:115%; font-size= :9pt"><span style=3D"font-family:'Times New Roman'">Taurina disminuida (p= =3D0,009). TNF-=CE=B1 aumentado (p=3D0,004). AUC taurina=3D0,739.</span></p= ></td><td style=3D"width:14.66%; border-top:0.75pt solid #000000; border-bo= ttom:0.75pt solid #000000; padding:0pt 5.75pt; vertical-align:top"><p style= =3D"line-height:115%; font-size:9pt"><span style=3D"font-family:'Times New = Roman'">La disminuci=C3=B3n de taurina se asoci=C3=B3 con inflamaci=C3=B3n = periodontal y alteraci=C3=B3n antioxidante sist=C3=A9mica.</span></p></td><= /tr></table><p style=3D"margin-bottom:10pt; line-height:115%; font-size:10p= t"><span style=3D"font-family:'Times New Roman'; font-weight:bold">Nota:</s= pan><span style=3D"font-family:'Times New Roman'"> elaboraci=C3=B3n a parti= r de los estudios incluidos en la revisi=C3=B3n (18)(19)(20). Abreviaturas.= Srx: sulfiredoxina; NSPT: terapia periodontal no quir=C3=BArgica; TOS: est= ado oxidante total; TAC: capacidad antioxidante total; TNF-=CE=B1: factor d= e necrosis tumoral alfa; AUC: =C3=A1rea bajo la curva; H=E2=82=82O=E2=82=82= Eq/L: equivalentes de per=C3=B3xido de hidr=C3=B3geno por litro. Trolox Eq= /L: equivalentes de Trolox por litro. </span></p><p style=3D"margin-left:21= .3pt; margin-bottom:10pt; text-indent:-18pt; line-height:115%; font-size:12= pt"><span style=3D"font-family:'Times New Roman'; font-weight:bold; color:#= 767171"><span>4.</span></span><span style=3D"width:9pt; font:7pt 'Times New= Roman'; display:inline-block">      </span><span = style=3D"font-family:'Times New Roman'; font-weight:bold; color:#767171">Di= scusi=C3=B3n</span><span style=3D"font-family:'Times New Roman'; font-weigh= t:bold; color:#767171">  </span></p><p style=3D"margin-bottom:0pt; tex= t-align:justify; line-height:115%; font-size:12pt"><span style=3D"font-fami= ly:'Times New Roman'">El presente estudio evidenci=C3=B3 una relaci=C3=B3n = entre la vitamina C, estr=C3=A9s oxidativo y enfermedades periodontales. Lo= s estudios analizados reportaron que los pacientes con periodontitis presen= taban alteraciones en los sistemas antioxidantes y aumento en los biomarcad= ores inflamatorios y oxidativos en comparaci=C3=B3n con individuos periodon= talmente sanos (19)(20). De la misma manera, se observ=C3=B3 que la disminu= ci=C3=B3n de los niveles de vitamina C tend=C3=ADa a asociarse con una mayo= r severidad periodontal, lo que sugiere una posible relaci=C3=B3n entre el = estado antioxidante del organismo y la progresi=C3=B3n de la periodontitis = (2)(12). Mohideen et al. (19) identificaron niveles significativamente alto= s de </span><span style=3D"font-family:'Times New Roman'; text-decoration:u= nderline">Estr=C3=A9s Oxidativo Total (TOS</span><span style=3D"font-family= :'Times New Roman'">) y menores niveles de </span><span style=3D"font-famil= y:'Times New Roman'; text-decoration:underline">Capacidad Antioxidante Tota= l (TAC</span><span style=3D"font-family:'Times New Roman'">) en pacientes c= on periodontitis (19). De la misma forma, Hashim et al. (2) y Assaf & R= abi (12) reportaron concentraciones m=C3=A1s bajas de vitamina C en suero, = saliva y fluido crevicular gingival en pacientes con mayor severidad period= ontal (2)(12). Estos hallazgos sugieren que el desarrollo de la periodontit= is podr=C3=ADa asociarse con un desequilibrio entre los mecanismos oxidativ= os y antioxidantes del organismo. </span></p><p style=3D"margin-bottom:0pt;= text-align:justify; line-height:115%; font-size:12pt"><span style=3D"font-= family:'Times New Roman'">Buzatu et al. (9) reportaron que los niveles bajo= s de vitamina C se asociaron con un mayor riesgo de periodontitis (OR=3D1,5= 2; IC95%:1,49=E2=80=931,55), lo que respalda la posible participaci=C3=B3n = de este micronutriente en la progresi=C3=B3n de la enfermedad, aunque desta= caron una elevada heterogeneidad metodol=C3=B3gica entre los estudios inclu= idos (9).</span></p><p style=3D"margin-bottom:0pt; text-align:justify; line= -height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'"= >Adicionalmente, Rosa et al. (21) indicaron que una mayor ingesta diet=C3= =A9tica de vitamina C se relaciona con mejores condiciones periodontales, o= bservando que los individuos con consumo m=C3=A1s elevado presentaban menor= frecuencia de periodontitis y menor inflamaci=C3=B3n gingival (21).</span>= </p><p style=3D"margin-bottom:0pt; text-align:justify; line-height:115%; fo= nt-size:12pt"><span style=3D"font-family:'Times New Roman'">Estos resultado= s coinciden con Mi et al. quienes en un metaan=C3=A1lisis observaron que un= a mayor ingesta de vitaminas antioxidantes se asociaba con una menor frecue= ncia de enfermedades periodontales, sugiriendo que el estado nutricional po= dr=C3=ADa influir en la respuesta inflamatoria periodontal (11). Por lo tan= to, estos hallazgos respaldan que la vitamina C participa en mecanismos bio= l=C3=B3gicos relacionados con la protecci=C3=B3n periodontal, aunque la nat= uraleza de esta asociaci=C3=B3n todav=C3=ADa requiere mayor investigaci=C3= =B3n cl=C3=ADnica (11). </span></p><p style=3D"margin-bottom:0pt; text-alig= n:justify; line-height:115%; font-size:12pt"><span style=3D"font-family:'Ti= mes New Roman'">La posible explicaci=C3=B3n biol=C3=B3gica de esta relaci= =C3=B3n puede encontrarse en las funciones antioxidantes e inmunomoduladora= s atribuidas a la vitamina C. De forma similar, Ustianowski et al. (22) sos= tienen que esta vitamina participa en la s=C3=ADntesis de col=C3=A1geno, la= regulaci=C3=B3n de la respuesta inmunitaria y la neutralizaci=C3=B3n de es= pecies reactivas de ox=C3=ADgeno, mecanismos que podr=C3=ADan contribuir a = la protecci=C3=B3n de los tejidos periodontales. As=C3=AD como Van der Veld= en (23) sostuvo que la vitamina C contribuye al mantenimiento de la integri= dad del tejido conectivo periodontal y a los procesos de reparaci=C3=B3n ti= sular. Por ello, una disminuci=C3=B3n de sus niveles podr=C3=ADa favorecer = una mayor susceptibilidad frente al da=C3=B1o oxidativo y la destrucci=C3= =B3n de los tejidos periodontales observados durante la progresi=C3=B3n de = la enfermedad. </span></p><p style=3D"margin-bottom:0pt; text-align:justify= ; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times New R= oman'">Los biomarcadores evaluados en los estudios seleccionados respaldan = la participaci=C3=B3n del estr=C3=A9s oxidativo en la fisiopatolog=C3=ADa p= eriodontal. Dixit et al. (18) identificaron niveles elevados de sulfiredoxi= na en pacientes con periodontitis activa, observando una disminuci=C3=B3n p= osterior a la terapia periodontal no quir=C3=BArgica (18). Adicionalmente, = Mohideen et al. (19) reportaron un incremento del estado oxidante total y u= na disminuci=C3=B3n de la capacidad antioxidante total en pacientes con per= iodontitis, evidenciando un desequilibrio entre los mecanismos oxidativos y= antioxidantes (19). Tambi=C3=A9n D=C3=B6nmez et al. (20) dieron a conocer = que los pacientes con periodontitis presentaban concentraciones reducidas d= e taurina y niveles aumentados de TNF-=CE=B1 en pacientes, adem=C3=A1s de a= sociaciones entre estos biomarcadores y par=C3=A1metros cl=C3=ADnicos como = la profundidad de sondaje y la p=C3=A9rdida de inserci=C3=B3n cl=C3=ADnica = (20). En conjunto, estos hallazgos respaldan la participaci=C3=B3n del estr= =C3=A9s oxidativo en la fisiopatolog=C3=ADa periodontal y sugieren que dive= rsos biomarcadores oxidativos podr=C3=ADan reflejar la actividad inflamator= ia y la progresi=C3=B3n de la enfermedad (18)(19)(20). </span></p><p style= =3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-size:12pt= "><span style=3D"font-family:'Times New Roman'">En cuanto a los efectos ter= ap=C3=A9uticos de la vitamina C, los estudios incluidos mostraron resultado= s heterog=C3=A9neos. Sherif et al. (13) hallaron que la utilizaci=C3=B3n de= fibrina rica en plaquetas inyectable suplementada con vitamina C produjo u= na reducci=C3=B3n temprana del dolor postoperatorio y una mejora del nivel = de inserci=C3=B3n cl=C3=ADnica a los 3 meses (</span><span style=3D"font-fa= mily:'Times New Roman'; font-style:italic">p</span><span style=3D"font-fami= ly:'Times New Roman'">=3D0,029), en pacientes con periodontitis estadio II = (13). De la misma manera Elbehwashy et al. (14) identificaron una mejor res= puesta cicatricial y una mayor reducci=C3=B3n radiogr=C3=A1fica de defectos= intra=C3=B3seos observando una disminuci=C3=B3n promedio de 2,29 =C2=B1 0,= 61 mm en la profundidad del defecto radiogr=C3=A1fico (</span><span style= =3D"font-family:'Times New Roman'; font-style:italic">p</span><span style= =3D"font-family:'Times New Roman'">=3D0,014) cuando el =C3=A1cido asc=C3=B3= rbico fue incorporado al PRF. De la misma manera Jaafer et al. (17) report= =C3=B3 que la suplementaci=C3=B3n antioxidante combinada con vitamina C, D = y E se asoci=C3=B3 con mejoras cl=C3=ADnicas periodontales, observando una = reducci=C3=B3n de la profundidad de sondaje 5,3 =C2=B1 0,7 mm a 3,5 =C2=B1 = 0,5 mm, una disminuci=C3=B3n del sangrado al sondaje de 46,2 =C2=B1 9,8 % a= 20,3 =C2=B1 7,2 % y un incremento de los niveles s=C3=A9ricos de vitamina = C de 0,8 =C2=B1 0,2 mg/dL a 1,5 =C2=B1 0,4 mg/dL tras 3 meses de seguimient= o. Estos resultados coinciden con Sherif et al. (13) y Elbehwashy et al. (1= 4) quienes obtuvieron beneficios cl=C3=ADnicos asociados al empleo de vitam= ina C como coadyuvante terap=C3=A9utico. Sin embargo, debido a la administr= aci=C3=B3n conjunta de varios antioxidantes resulta dif=C3=ADcil atribuir l= os efectos alcanzados exclusivamente a la vitamina C (17). </span></p><p st= yle=3D"margin-bottom:0pt; text-align:justify; line-height:115%; font-size:1= 2pt"><span style=3D"font-family:'Times New Roman'">Por otra parte, Nisha et= al. (16) mencionan que la terapia periodontal no quir=C3=BArgica mejor=C3= =B3 significativamente la capacidad antioxidante total y los par=C3=A1metro= s cl=C3=ADnicos periodontales; sin embargo, la administraci=C3=B3n sist=C3= =A9mica de vitamina C (500mg/d=C3=ADa) no aport=C3=B3 beneficios adicionale= s significativos respecto a la terapia periodontal convencional sola (16). = Esto podr=C3=ADa atribuirse principalmente al efecto de la terapia periodon= tal no quir=C3=BArgica, m=C3=A1s que a la suplementaci=C3=B3n con vitamina = C. De la misma manera Fageeh et al. (1) en una revisi=C3=B3n sistem=C3=A1ti= ca que incluy=C3=B3 seis ensayos cl=C3=ADnicos aleatorizados, se=C3=B1alaro= n que la suplementaci=C3=B3n con vitamina C no produjo mejoras cl=C3=ADnica= mente significativas en la profundidad de sondaje ni en el nivel de inserci= =C3=B3n cl=C3=ADnica en pacientes con periodontitis. Los autores destacan q= ue las diferencias en las dosis administradas, las v=C3=ADas de aplicaci=C3= =B3n y los periodos de seguimiento entre los estudios reportados, dificulta= n la comparaci=C3=B3n directa de los hallazgos y limita el establecimiento = de conclusiones definitivas sobre la eficacia de la vitamina C como coadyuv= ante del tratamiento periodontal (1). Ozmeric et al. (15) hallaron que un e= njuague con vitamina C present=C3=B3 resultados semejantes a los de la clor= hexidina, donde no se encontr=C3=B3 diferencias significativas en el contro= l de placa, gingivitis o sangrado gingival (</span><span style=3D"font-fami= ly:'Times New Roman'; font-style:italic">p </span><span style=3D"font-famil= y:'Times New Roman'">> 0,05) (15). Estos resultados mencionan que los ef= ectos cl=C3=ADnicos de la vitamina C podr=C3=ADan ser m=C3=A1s evidentes en= la modulaci=C3=B3n inflamatoria temprana que en la regeneraci=C3=B3n perio= dontal profunda. </span></p><p style=3D"margin-bottom:0pt; text-align:justi= fy; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times New= Roman'">Un aspecto relevante identificado durante la revisi=C3=B3n fue la = diferencia entre los hallazgos experimentales y la evidencia cl=C3=ADnica d= isponible. Aytekin et al. (24) utilizando un modelo experimental de periodo= ntitis en ratas, demostraron que la aplicaci=C3=B3n local de vitamina C red= ujo la p=C3=A9rdida =C3=B3sea alveolar, la p=C3=A9rdida de inserci=C3=B3n y= la expresi=C3=B3n de biomarcadores relacionados con el estr=C3=A9s oxidati= vo y la destrucci=C3=B3n tisular. Estos resultados sugieren un potencial ef= ecto protector de la vitamina C sobre los tejidos periodontales. Sin embarg= o, los beneficios observados en modelos animales todav=C3=ADa no han sido r= eproducidos de forma consistente en estudios cl=C3=ADnicos realizados en hu= manos, por lo que persisten interrogantes acerca de su verdadero impacto te= rap=C3=A9utico en la pr=C3=A1ctica cl=C3=ADnica.</span></p><p style=3D"marg= in-bottom:10pt; text-align:justify; line-height:115%; font-size:12pt"><span= style=3D"font-family:'Times New Roman'">Los hallazgos de esta revisi=C3=B3= n presentan algunas limitaciones. Primero, los estudios incluidos presentar= on dise=C3=B1os metodol=C3=B3gicos diversos, tama=C3=B1os de muestras varia= bles y diferentes estrategias de administraci=C3=B3n de vitamina C. Segundo= , los biomarcadores evaluados no fueron uniformes entre las investigaciones= , lo que dificulta la comparaci=C3=B3n directa de los resultados. En conjun= to, la evidencia disponible sugiere que la vitamina C podr=C3=ADa contribui= r al equilibrio antioxidante y a la modulaci=C3=B3n de la respuesta inflama= toria periodontal, particularmente durante etapas tempranas de la enfermeda= d. Sin embargo, los beneficios cl=C3=ADnicos observados contin=C3=BAan sien= do inconsistentes y no permiten recomendar su utilizaci=C3=B3n como tratami= ento periodontal independiente. Actualmente, la terapia periodontal convenc= ional contin=C3=BAa siendo el tratamiento de elecci=C3=B3n (25)(26)(27), mi= entras que la vitamina C podr=C3=ADa considerarse un complemento potencial = cuya utilidad cl=C3=ADnica requiere ser confirmada mediante ensayos cl=C3= =ADnicos aleatorizados con nuestras muestras m=C3=A1s amplias, seguimiento = prolongado y metodolog=C3=ADas homog=C3=A9neas.</span></p><p style=3D"margi= n-left:21.3pt; margin-bottom:10pt; text-indent:-18pt; line-height:115%; fon= t-size:12pt"><span style=3D"font-family:'Times New Roman'; font-weight:bold= ; color:#767171"><span>5.</span></span><span style=3D"width:9pt; font:7pt '= Times New Roman'; display:inline-block">      </sp= an><span style=3D"font-family:'Times New Roman'; font-weight:bold; color:#7= 67171">Conclusiones</span></p><ul style=3D"margin:0pt; padding-left:0pt"><l= i class=3D"ListParagraph" style=3D"margin-left:32.33pt; margin-bottom:0pt; = text-align:justify; line-height:115%; padding-left:3.67pt; font-family:seri= f; font-size:12pt"><span style=3D"font-family:'Times New Roman'">La literat= ura cient=C3=ADfica revisada permiti=C3=B3 identificar una relaci=C3=B3n en= tre la disminuci=C3=B3n de los niveles de vitamina C, incremento del estr= =C3=A9s oxidativo y la severidad de la enfermedad periodontal. La evidencia= mostr=C3=B3 que los pacientes con periodontitis presentan alteraciones en = los sistemas antioxidantes, aumento de biomarcadores oxidativos y reducci= =C3=B3n de mecanismos de defensa antioxidante en comparaci=C3=B3n con indiv= iduos periodontalmente sanos. De la misma forma, diversos estudios reportar= on concentraciones reducidas de vitamina C en saliva, suero y fluido crevic= ular gingival en pacientes con mayor severidad periodontal, sugiriendo una = posible participaci=C3=B3n de esta vitamina en los mecanismos biol=C3=B3gic= os relacionados con la inflamaci=C3=B3n y destrucci=C3=B3n de los tejidos p= eriodontales.</span></li><li class=3D"ListParagraph" style=3D"margin-left:3= 2.33pt; margin-bottom:0pt; text-align:justify; line-height:115%; padding-le= ft:3.67pt; font-family:serif; font-size:12pt"><span style=3D"font-family:'T= imes New Roman'">Los estudios analizados respaldan la importancia del estr= =C3=A9s oxidativo en la fisiopatolog=C3=ADa de la periodontitis. El desequi= librio entre oxidantes y antioxidantes favorece la producci=C3=B3n excesiva= de especies reactivas de ox=C3=ADgeno, contribuyendo al da=C3=B1o celular,= la degradaci=C3=B3n del col=C3=A1geno y la p=C3=A9rdida progresiva de los = tejidos de soporte dental. En este contexto, la vitamina C adquiere relevan= cia debido a sus propiedades antioxidantes, inmunomoduladoras y a su papel = esencial en la s=C3=ADntesis y mantenimiento del col=C3=A1geno periodontal.= Estas caracter=C3=ADsticas permiten considerar que niveles adecuados de vi= tamina C podr=C3=ADan contribuir al mantenimiento de la homeostasis tisular= y a la protecci=C3=B3n frente al da=C3=B1o oxidativo asociado con la enfer= medad periodontal.</span></li><li class=3D"ListParagraph" style=3D"margin-l= eft:32.33pt; margin-bottom:0pt; text-align:justify; line-height:115%; paddi= ng-left:3.67pt; font-family:serif; font-size:12pt"><span style=3D"font-fami= ly:'Times New Roman'">En relaci=C3=B3n con su aplicaci=C3=B3n cl=C3=ADnica,= los estudios incluidos mostraron resultados variables. Aunque algunos auto= res observaron mejor=C3=ADas en biomarcadores inflamatorios y antioxidantes= , as=C3=AD como beneficios cl=C3=ADnicos relacionados con la cicatrizaci=C3= =B3n periodontal, la reducci=C3=B3n del sangrado al sondaje y la mejor=C3= =ADa del nivel de inserci=C3=B3n cl=C3=ADnica, los resultados continuaron s= iendo heterog=C3=A9neos entre los estudios. Por esta raz=C3=B3n, la evidenc= ia disponible no permite establecer conclusiones definitivas sobre la efica= cia de la vitamina C como tratamiento periodontal independiente. Actualment= e, la terapia periodontal convencional contin=C3=BAa siendo la principal es= trategia terap=C3=A9utica para el control de la enfermedad, mientras que la= vitamina C podr=C3=ADa considerarse =C3=BAnicamente como un complemento po= tencial dentro del manejo integral de determinados pacientes.</span></li><l= i class=3D"ListParagraph" style=3D"margin-left:32.33pt; margin-bottom:0pt; = text-align:justify; line-height:115%; padding-left:3.67pt; font-family:seri= f; font-size:12pt"><span style=3D"font-family:'Times New Roman'">Es importa= nte se=C3=B1alar que los estudios analizados presentaron diferencias metodo= l=C3=B3gicas relacionadas con el dise=C3=B1o de investigaci=C3=B3n, el tama= =C3=B1o muestral, las dosis administradas, las v=C3=ADas de aplicaci=C3=B3n= , los biomarcadores evaluados y per=C3=ADodos de seguimiento. Estas variaci= ones dificultan la comparaci=C3=B3n directa de los resultados y limitan la = posibilidad de establecer recomendaciones cl=C3=ADnicas universales. Adem= =C3=A1s, la evidencia disponible contin=C3=BAa siendo insuficiente para det= erminar con precisi=C3=B3n qu=C3=A9 pacientes podr=C3=ADan beneficiarse en = mayor medida de la suplementaci=C3=B3n con vitamina C y cu=C3=A1les ser=C3= =ADan las dosis y protocolos m=C3=A1s adecuados.</span></li><li class=3D"Li= stParagraph" style=3D"margin-left:32.33pt; margin-bottom:10pt; text-align:j= ustify; line-height:115%; padding-left:3.67pt; font-family:serif; font-size= :12pt"><span style=3D"font-family:'Times New Roman'">Finalmente, se requier= en ensayos cl=C3=ADnicos aleatorizados con muestras m=C3=A1s amplias, segui= miento a largo plazo y metodolog=C3=ADas estandarizadas que permitan esclar= ecer el verdadero impacto de la vitamina C sobre la progresi=C3=B3n de la e= nfermedad periodontal. Futuras investigaciones deber=C3=ADan integrar simul= t=C3=A1neamente par=C3=A1metros cl=C3=ADnicos, radiogr=C3=A1ficos y biomarc= adores relacionados con el estr=C3=A9s oxidativo para comprender mejor la i= nteracci=C3=B3n entre vitamina C, respuesta inflamatoria y salud periodonta= l. De esta manera, ser=C3=A1 posible determinar con mayor precisi=C3=B3n el= papel que esta vitamina puede desempe=C3=B1ar como coadyuvante terap=C3=A9= utico dentro de la pr=C3=A1ctica cl=C3=ADnica periodontal. </span></li></ul= ><p style=3D"margin-left:21.3pt; margin-bottom:10pt; text-indent:-18pt; tex= t-align:justify; line-height:115%; font-size:12pt"><span style=3D"font-fami= ly:'Times New Roman'; font-weight:bold; color:#767171"><span>6.</span></spa= n><span style=3D"width:9pt; font:7pt 'Times New Roman'; display:inline-bloc= k">      </span><span style=3D"font-family:'Times = New Roman'; font-weight:bold; color:#767171">Conflicto de intereses</span><= /p><p style=3D"margin-bottom:10pt; text-align:justify; line-height:115%; fo= nt-size:12pt"><span style=3D"font-family:'Times New Roman'">Los autores dec= laran que no existe conflicto de intereses en relaci=C3=B3n con el art=C3= =ADculo presentado.</span></p><p style=3D"margin-left:21.3pt; margin-bottom= :10pt; text-indent:-18pt; text-align:justify; line-height:115%; font-size:1= 2pt"><span style=3D"font-family:'Times New Roman'; font-weight:bold; color:= #767171"><span>7.</span></span><span style=3D"width:9pt; font:7pt 'Times Ne= w Roman'; display:inline-block">      </span><span= style=3D"font-family:'Times New Roman'; font-weight:bold; color:#767171">D= erechos de autor (copyrigth)</span></p><p style=3D"margin-bottom:10pt; line= -height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'"= >Los autores son los titulares de los derechos de autor</span><span style= =3D"font-family:'Times New Roman'; font-weight:bold"> </span><span style=3D= "font-family:'Times New Roman'">(patrimoniales y/o de explotaci=C3=B3n) de = los contenidos de la revista (</span><span style=3D"font-family:'Times New = Roman'; font-style:italic">copyright</span><span style=3D"font-family:'Time= s New Roman'">).</span></p><p style=3D"margin-left:21.3pt; margin-bottom:10= pt; text-indent:-18pt; text-align:justify; line-height:115%; font-size:12pt= "><span style=3D"font-family:'Times New Roman'; font-weight:bold; color:#76= 7171"><span>8.</span></span><span style=3D"width:9pt; font:7pt 'Times New R= oman'; display:inline-block">      </span><span st= yle=3D"font-family:'Times New Roman'; font-weight:bold; color:#767171">Decl= araci=C3=B3n de contribuci=C3=B3n de los autores</span></p><p style=3D"marg= in-bottom:0pt; text-align:justify; line-height:115%; font-size:12pt"><span = style=3D"font-family:'Times New Roman'">Los autores declaran haber particip= ado de manera equitativa y sustancial en la realizaci=C3=B3n de esta invest= igaci=C3=B3n, bajo las responsabilidades seg=C3=BAn la </span><a href=3D"ht= tps://credit.niso.org/" style=3D"text-decoration:none"><span class=3D"Hyper= link" style=3D"font-family:'Times New Roman'">Taxonom=C3=ADa CRediT</span><= /a><span style=3D"font-family:'Times New Roman'"> para describir las contri= buciones individuales de cada autor al trabajo. </span></p><p style=3D"marg= in-bottom:0pt; text-align:justify; line-height:115%; font-size:12pt"><span = style=3D"font-family:'Times New Roman'">Lizbeth Tatiana Aguayza Rodas reali= z=C3=B3 la conceptualizaci=C3=B3n de la investigaci=C3=B3n, organizaci=C3= =B3n y ejecuci=C3=B3n del ensayo, recopilaci=C3=B3n y curaci=C3=B3n de los = datos, revisi=C3=B3n del an=C3=A1lisis estad=C3=ADstico, interpretaci=C3=B3= n de los resultados, elaboraci=C3=B3n del borrador original, preparaci=C3= =B3n de tablas y figuras, revisi=C3=B3n cr=C3=ADtica del contenido y aproba= ci=C3=B3n de la versi=C3=B3n final del manuscrito.</span></p><p style=3D"ma= rgin-bottom:0pt; text-align:justify; line-height:115%; font-size:12pt"><spa= n style=3D"font-family:'Times New Roman'">Andrea Soledad Carvajal Endara re= aliz=C3=B3 la supervisi=C3=B3n acad=C3=A9mica y metodol=C3=B3gica de la inv= estigaci=C3=B3n, brind=C3=B3 orientaci=C3=B3n durante el desarrollo del ens= ayo, revis=C3=B3 el an=C3=A1lisis y la interpretaci=C3=B3n de los resultado= s, efectu=C3=B3 la revisi=C3=B3n cr=C3=ADtica del manuscrito, realiz=C3=B3 = la correcci=C3=B3n cient=C3=ADfica y acad=C3=A9mica y aprob=C3=B3 la versi= =C3=B3n final para su publicaci=C3=B3n.</span></p><p style=3D"margin-bottom= :0pt; text-align:justify; line-height:115%; font-size:12pt"><span style=3D"= font-family:'Times New Roman'; font-style:italic">Divulgaci=C3=B3n de la de= legaci=C3=B3n a la IA generativa</span></p><p style=3D"margin-bottom:0pt; t= ext-align:justify; line-height:normal; font-size:12pt"><span style=3D"font-= family:'Times New Roman'">Declaraci=C3=B3n sobre la delegaci=C3=B3n de tare= as a IA generativa</span></p><p style=3D"margin-bottom:0pt; text-align:just= ify; line-height:normal; font-size:12pt"><span style=3D"font-family:'Times = New Roman'">Los autores declaran el uso de IA generativa en el proceso de i= nvestigaci=C3=B3n y preparaci=C3=B3n del manuscrito. De acuerdo con la taxo= nom=C3=ADa GAIDeT (2025), las siguientes tareas se delegaron a herramientas= de IA generativa bajo supervisi=C3=B3n humana:</span></p><p style=3D"margi= n-bottom:0pt; text-align:justify; line-height:normal; font-size:12pt"><span= style=3D"font-family:'Times New Roman'">- Correcci=C3=B3n y edici=C3=B3n</= span></p><p style=3D"margin-bottom:0pt; text-align:justify; line-height:nor= mal; font-size:12pt"><span style=3D"font-family:'Times New Roman'">- Resume= n de texto</span></p><p style=3D"margin-bottom:0pt; text-align:justify; lin= e-height:normal; font-size:12pt"><span style=3D"font-family:'Times New Roma= n'">- Traducci=C3=B3n</span></p><p style=3D"margin-bottom:0pt; text-align:j= ustify; line-height:normal; font-size:12pt"><span style=3D"font-family:'Tim= es New Roman'">Herramienta de IA generativa utilizada: ChatGPT (OpenAI).</s= pan></p><p style=3D"margin-bottom:0pt; text-align:justify; line-height:norm= al; font-size:12pt"><span style=3D"font-family:'Times New Roman'">Los autor= es son totalmente responsables del manuscrito final.</span></p><p style=3D"= margin-bottom:0pt; text-align:justify; line-height:normal; font-size:12pt">= <span style=3D"font-family:'Times New Roman'">Las herramientas de IA genera= tiva no figuran como autoras ni son responsables de los resultados finales.= </span></p><p style=3D"margin-bottom:10pt; text-align:justify; line-height:= 115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'">Declara= ci=C3=B3n presentada por: Lizbeth Tatiana Aguayza Rodas.</span></p><p style= =3D"margin-left:21.3pt; margin-bottom:10pt; text-indent:-18pt; text-align:j= ustify; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times= New Roman'; font-weight:bold"><span style=3D"color:#767171">9.</span></spa= n><span style=3D"width:9pt; font:7pt 'Times New Roman'; display:inline-bloc= k">      </span><span style=3D"font-family:'Times = New Roman'; font-weight:bold; color:#767171">Costos de financiamiento</span= ><span style=3D"font-family:'Times New Roman'; font-weight:bold"> </span></= p><p style=3D"margin-bottom:10pt; text-align:justify; line-height:115%; fon= t-size:12pt"><span style=3D"font-family:'Times New Roman'">La presente inve= stigaci=C3=B3n fue financiada en su totalidad con fondos propios de los aut= ores.</span></p><p style=3D"margin-left:21.3pt; margin-bottom:10pt; text-in= dent:-18pt; text-align:justify; line-height:115%; font-size:12pt"><span sty= le=3D"font-family:'Times New Roman'; font-weight:bold; color:#767171"><span= >10.</span></span><span style=3D"width:3pt; font:7pt 'Times New Roman'; dis= play:inline-block">  </span><span style=3D"font-family:'Times New Roma= n'; font-weight:bold; color:#767171">Referencias Bibliogr=C3=A1ficas</span>= </p><ol style=3D"margin:0pt; padding-left:0pt"><li style=3D"margin-left:17.= 3pt; margin-bottom:0pt; line-height:115%; padding-left:4pt; font-family:'Ti= mes New Roman'; font-size:12pt"><span>Fageeh HN, Fageeh HI, Prabhu A, Bhand= i S, Khan S, Patil S. Efficacy of vitamin C supplementation as an adjunct i= n the non-surgical management of periodontitis: a systematic review. System= atic review update [Internet]. 2021 [cited 8 May 2026];10(1):5. Available f= rom: </span><a href=3D"https://doi.org/10.1186/s13643-020-01554-9" style=3D= "text-decoration:none"><span class=3D"Hyperlink" style=3D"color:#000000">ht= tps://doi.org/10.1186/s13643-020-01554-9</span></a><span> </span></li><li s= tyle=3D"margin-left:17.3pt; margin-bottom:0pt; line-height:115%; padding-le= ft:4pt; font-family:'Times New Roman'; font-size:12pt"><span>Hashim NT, Rah= man MM, Islam MS, Padmanabhan V, Chaitanya NCSK, Mohammed R, et al. Salivar= y and GCF vitamin C levels: implications for local and systemic periodontal= defense.</span><span style=3D"line-height:115%; font-size:11pt"> </span><s= pan>International Journal of Dentistry [Internet]. 2025 [cited 8 May 2026];= 2025(1):8367922. Available from: </span><a href=3D"https://doi.org/10.1155/= ijod/8367922" style=3D"text-decoration:none"><span class=3D"Hyperlink" styl= e=3D"color:#000000">https://doi.org/10.1155/ijod/8367922</span></a><span> <= /span></li><li style=3D"margin-left:17.3pt; margin-bottom:0pt; line-height:= 115%; padding-left:4pt; font-family:'Times New Roman'; font-size:12pt"><spa= n>Carvajal P, Campos de Almeida Carrer F, Lopes Galante M, Vernal R, Barboz= a Solis C. Prevalence of periodontal diseases: Latin America and the Caribb= ean Consensus 2024. Brazilian Oral Research [Internet]. 2024 [cited 8 May 2= 026];38(suppl 1): e116. Available from: </span><a href=3D"https://doi.org/1= 0.1590/1807-3107bor-2024.vol38.0116" style=3D"text-decoration:none"><span c= lass=3D"Hyperlink" style=3D"color:#000000">https://doi.org/10.1590/1807-310= 7bor-2024.vol38.0116</span></a><span> </span></li><li style=3D"margin-left:= 17.3pt; margin-bottom:0pt; line-height:115%; padding-left:4pt; font-family:= 'Times New Roman'; font-size:12pt"><span>Sosa V, Aicardo A, Valez V. Oxidat= ive stress in saliva induced by tobacco smoke: impact on periodontitis and = perspectives with redox pharmacology. Odontoestomatologia [Internet]. 2022 = [cited 8 May 2026];</span><span style=3D"line-height:115%; font-size:11pt">= </span><span>24(39):1-14. Available from: </span><a href=3D"https://doi.or= g/10.22592/ode2022n39e307" style=3D"text-decoration:none"><span class=3D"Hy= perlink" style=3D"color:#000000">https://doi.org/10.22592/ode2022n39e307</s= pan></a><span> </span></li><li style=3D"margin-left:17.3pt; margin-bottom:0= pt; line-height:115%; padding-left:4pt; font-family:'Times New Roman'; font= -size:12pt"><span>Georgiou AC, Cornejo Ulloa P, Van Kessel GMH, Crielaard W= , Van der Waal SV. Reactive oxygen species can be traced locally and system= ically in apical periodontitis: a systematic review. Archives of Oral Biolo= gy [Internet]. 2021 [cited 8 May 2026]; 129:105167. Available from: </span>= <a href=3D"https://doi.org/10.1016/j.archoralbio.2021.105167" style=3D"text= -decoration:none"><span class=3D"Hyperlink" style=3D"color:#000000">https:/= /doi.org/10.1016/j.archoralbio.2021.105167</span></a><span> </span></li><li= style=3D"margin-left:17.3pt; margin-bottom:0pt; line-height:115%; padding-= left:4pt; font-family:'Times New Roman'; font-size:12pt"><span>Pizzino G, I= rrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative str= ess: harms and benefits for human health. Oxidative Medicine and Cellular L= ongevity [Internet]. 2017 [cited 8 May 2026];2017(1):8416763. Available fro= m: </span><a href=3D"https://doi.org/10.1155/2017/8416763" style=3D"text-de= coration:none"><span class=3D"Hyperlink" style=3D"color:#000000">https://do= i.org/10.1155/2017/8416763</span></a><span> </span></li><li style=3D"margin= -left:17.3pt; margin-bottom:0pt; line-height:115%; padding-left:4pt; font-f= amily:'Times New Roman'; font-size:12pt"><span>Mochol M, Jablonowski L, Paw= lik A, Ras=C5=82awska-Socha J, Chamarczuk A, Lipski M, et al. The role of v= itamin C in selected autoimmune and immune-mediated diseases: exploring pot= ential therapeutic benefits. International Journal of Molecular Sciences [I= nternet]. 2025 [cited 8 May 2026];26(19):9375. Available from: </span><a hr= ef=3D"https://doi.org/10.3390/ijms26199375" style=3D"text-decoration:none">= <span class=3D"Hyperlink" style=3D"color:#000000">https://doi.org/10.3390/i= jms26199375</span></a><span> </span></li><li style=3D"margin-left:17.3pt; m= argin-bottom:0pt; line-height:115%; padding-left:4pt; font-family:'Times Ne= w Roman'; font-size:12pt"><span>Wintergerst ES, Maggini S, Hornig DH. Immun= e-enhancing role of vitamin C and zinc and effect on clinical conditions. A= nnals of Nutrition and Metabolism [Internet]. 2006 [cited 8 May 2026];50(2)= :85-94. Available from: </span><a href=3D"https://doi.org/10.1159/000090495= " style=3D"text-decoration:none"><span class=3D"Hyperlink" style=3D"color:#= 000000">https://doi.org/10.1159/000090495</span></a><span> </span></li><li = style=3D"margin-left:17.3pt; margin-bottom:0pt; line-height:115%; padding-l= eft:4pt; font-family:'Times New Roman'; font-size:12pt"><span>Buzatu R, Luc= a MM, Bumbu BA. Does vitamin C supplementation provide a protective effect = on periodontal health? A systematic review and meta-analysis. International= Journal of Molecular Sciences [Internet]. 2024 [cited 8 May 2026];25(16):8= 598. Available from: </span><a href=3D"https://doi.org/10.3390/ijms25168598= " style=3D"text-decoration:none"><span class=3D"Hyperlink" style=3D"color:#= 000000">https://doi.org/10.3390/ijms25168598</span></a><span> </span></li><= li style=3D"margin-left:21.3pt; margin-bottom:0pt; line-height:115%; font-f= amily:'Times New Roman'; font-size:12pt"><span>Dethlefs-Canto J, Osses-Barr= =C3=ADa F, Vergara-Zenteno R, Bustos-Ponce A, Villavicencio-Duarte J. The e= ffectiveness of vitamin C in dental alveolus healing after dental extractio= n: a scoping review. Medicina Oral, Patolog=C3=ADa Oral y Cirug=C3=ADa Buca= l [Internet]. 2025 [cited 8 May 2026];30(1), e124=E2=80=93e128. Available f= rom: </span><a href=3D"https://doi.org/10.4317/medoral.26893" style=3D"text= -decoration:none"><span class=3D"Hyperlink" style=3D"color:#000000">https:/= /doi.org/10.4317/medoral.26893</span></a><span> </span></li><li style=3D"ma= rgin-left:21.3pt; margin-bottom:0pt; line-height:115%; font-family:'Times N= ew Roman'; font-size:12pt"><span>Mi N, Zhang M, Ying Z, Lin X, Jin Y. Vitam= in intake and periodontal disease: a meta-analysis of observational studies= . BMC Oral Health [Internet]. 2024 [cited 8 May 2026];24(1):117. Available = from: </span><a href=3D"https://doi.org/10.1186/s12903-024-03850-5" style= =3D"text-decoration:none"><span class=3D"Hyperlink" style=3D"color:#000000"= >https://doi.org/10.1186/s12903-024-03850-5</span></a><span> </span></li><l= i style=3D"margin-left:21.3pt; margin-bottom:0pt; line-height:115%; font-fa= mily:'Times New Roman'; font-size:12pt"><span>Assaf M, Rabi H. Assessment o= f vitamin C levels in periodontal patients: a cross-sectional study in Pale= stine. Journal of Pharmacy and Bioallied Sciences [Internet]. 2022 [cited 8= May 2026];14(Suppl 1). Available from: </span><a href=3D"https://doi.org/1= 0.4103/jpbs.jpbs_94_22" style=3D"text-decoration:none"><span class=3D"Hyper= link" style=3D"color:#000000">https://doi.org/10.4103/jpbs.jpbs_94_22</span= ></a><span> </span></li><li style=3D"margin-left:21.3pt; margin-bottom:0pt;= line-height:115%; font-family:'Times New Roman'; font-size:12pt"><span>She= rif MA, Anter E, Graetz C, El-Sayed KF. Injectable platelet-rich fibrin wit= h vitamin C as an adjunct to non-surgical periodontal therapy in the treatm= ent of stage-II periodontitis: a randomized controlled clinical trial. BMC = Oral Health [Internet]. 2025 [cited 8 May 2026];25(1):772. Available from: = </span><a href=3D"https://doi.org/10.1186/s12903-025-06115-x" style=3D"text= -decoration:none"><span class=3D"Hyperlink" style=3D"color:#000000">https:/= /doi.org/10.1186/s12903-025-06115-x</span></a><span> </span></li><li style= =3D"margin-left:21.3pt; margin-bottom:0pt; line-height:115%; font-family:'T= imes New Roman'; font-size:12pt"><span>Elbehwashy MT, Hosny MM, Elfana A, N= awar A, Fawzy El-Sayed K. Clinical and radiographic effects of ascorbic aci= d-augmented platelet-rich fibrin versus platelet-rich fibrin alone in intra= -osseous defects of stage-III periodontitis patients: a randomized controll= ed clinical trial. Clinical Oral Investigations [Internet]. 2021 [cited 8 M= ay 2026];25(11):6309-6319. Available from: </span><a href=3D"https://doi.or= g/10.1007/s00784-021-03929-1" style=3D"text-decoration:none"><span class=3D= "Hyperlink" style=3D"color:#000000">https://doi.org/10.1007/s00784-021-0392= 9-1</span></a><span> </span></li><li style=3D"margin-left:21.3pt; margin-bo= ttom:0pt; line-height:115%; font-family:'Times New Roman'; font-size:12pt">= <span>Ozmeric N, Enver A, Isler SC, G=C3=B6kmeno=C4=9Flu C, Topalo=C4=9Flu = M, Selamet H, et al. </span><span> </span><span>Evaluating the effects= of chlorhexidine and vitamin C mouthwash on oral health in non-surgical pe= riodontal therapy: a randomized controlled clinical trial. Scientific Repor= ts [Internet]. 2025 [cited 8 May 2026];15(1):3703. Available from: </span><= a href=3D"https://doi.org/10.1038/s41598-025-88100-6" style=3D"text-decorat= ion:none"><span class=3D"Hyperlink" style=3D"color:#000000">https://doi.org= /10.1038/s41598-025-88100-6</span></a><span> </span></li><li style=3D"margi= n-left:21.3pt; margin-bottom:0pt; line-height:115%; font-family:'Times New = Roman'; font-size:12pt"><span>Nisha S, Bettahalli Shivamallu A, Prashant A,= Shashikumar P, Ganganna A, Das D. Effect of non-surgical periodontal thera= py and vitamin C supplementation on total antioxidant capacity in patients = with chronic generalised periodontitis: a randomised controlled trial. Jour= nal of Oral Biology and Craniofacial Research [Internet]. 2023 [cited 8 May= 2026];13(4):511-516. Available from: </span><a href=3D"https://doi.org/10.= 1016/j.jobcr.2023.05.003" style=3D"text-decoration:none"><span class=3D"Hyp= erlink" style=3D"color:#000000">https://doi.org/10.1016/j.jobcr.2023.05.003= </span></a><span> </span></li><li style=3D"margin-left:21.3pt; margin-botto= m:0pt; line-height:115%; font-family:'Times New Roman'; font-size:12pt"><sp= an> </span><span>Jaafer SS, Alasady MS, Hanfoosh HS. Evaluation of Vit= amins C, D, and E in Periodontal Health Before and After Therapeutic Interv= ention. Odontia: Journal of Dental Innovations and Oral Health. 2025;2(1):1= -8</span></li><li style=3D"margin-left:21.3pt; margin-bottom:0pt; line-heig= ht:115%; font-family:'Times New Roman'; font-size:12pt"><span>Dixit D, Kaus= hal S, Lal N, Singh R, Verma UP, Pathak AK. Sulfiredoxin levels in gingival= crevicular fluid: a new antioxidant defence system-case control study. Jou= rnal of Oral Biology and Craniofacial Research [Internet]. 2025 [cited 8 Ma= y 2026]; 15:1373-1377. Available from: </span><a href=3D"https://doi.org/10= .1016/j.jobcr.2025.08.020" style=3D"text-decoration:none"><span class=3D"Hy= perlink" style=3D"color:#000000">https://doi.org/10.1016/j.jobcr.2025.08.02= 0</span></a><span> </span></li><li style=3D"margin-left:21.3pt; margin-bott= om:0pt; line-height:115%; font-family:'Times New Roman'; font-size:12pt"><s= pan>Mohideen K, Chandrasekaran K, Veeraraghavan H, Faizee SH, Dhungel S, Gh= osh S. Meta-analysis of assessment of total oxidative stress and total anti= oxidant capacity in patients with periodontitis. Disease Markers [Internet]= . 2023 [cited 8 May 2026];2023(1):9949047. Available from: </span><a href= =3D"https://doi.org/10.1155/2023/9949047" style=3D"text-decoration:none"><s= pan class=3D"Hyperlink" style=3D"color:#000000">https://doi.org/10.1155/202= 3/9949047</span></a><span> </span></li><li style=3D"margin-left:21.3pt; mar= gin-bottom:0pt; line-height:115%; font-family:'Times New Roman'; font-size:= 12pt"><span>D=C3=B6nmez MF, Balci N, Ergene Sunkar A, Toygar H, Kantarc=C4= =B1 A. Taurine levels in periodontitis: a pilot study. Journal of Periodont= ology [Internet]. 2025 [cited 8 May 2026];96():984-993. Available from: </s= pan><a href=3D"https://doi.org/10.1002/JPER.24-0574" style=3D"text-decorati= on:none"><span class=3D"Hyperlink" style=3D"color:#000000">https://doi.org/= 10.1002/JPER.24-0574</span></a><span> </span></li><li style=3D"margin-left:= 21.3pt; margin-bottom:0pt; line-height:115%; font-family:'Times New Roman';= font-size:12pt"><span>Rosa A, Pujia AM, Arcuri C. The protective role anti= oxidant of vitamin C in the prevention of oral disease: a scoping review of= current literature. European Journal of Dentistry [Internet]. 2024 [cited = 8 May 2026];18(4):965-970. Available from: </span><a href=3D"https://doi.or= g/10.1055/s-0044-1786845" style=3D"text-decoration:none"><span class=3D"Hyp= erlink" style=3D"color:#000000">https://doi.org/10.1055/s-0044-1786845</spa= n></a><span> </span></li><li style=3D"margin-left:21.3pt; margin-bottom:0pt= ; line-height:115%; font-family:'Times New Roman'; font-size:12pt"><span>Us= tianowski =C5=81, Ustianowska K, Gurazda K, Rusi=C5=84ski M, Ostrowski P, P= awlik A. The role of vitamin C and vitamin D in the pathogenesis and therap= y of periodontitis: narrative review. International Journal of Molecular Sc= iences [Internet]. 2023 [cited 8 May 2026];24(7):6774. Available from: </sp= an><a href=3D"https://doi.org/10.3390/ijms24076774" style=3D"text-decoratio= n:none"><span class=3D"Hyperlink" style=3D"color:#000000">https://doi.org/1= 0.3390/ijms24076774</span></a><span> </span></li><li style=3D"margin-left:2= 1.3pt; margin-bottom:0pt; line-height:115%; font-family:'Times New Roman'; = font-size:12pt"><span>Van der Velden U. Vitamin C and its role in periodont= al diseases: the past and the present: a narrative review. Oral health &= ; preventive dentistry [Internet]. 2020 [cited 8 May 2026];18(2):115-124. A= vailable from: </span><a href=3D"https://doi.org/10.3290/j.ohpd.a43334" sty= le=3D"text-decoration:none"><span class=3D"Hyperlink" style=3D"color:#00000= 0">https://doi.org/10.3290/j.ohpd.a43334</span></a><span> </span></li><li s= tyle=3D"margin-left:21.3pt; margin-bottom:0pt; line-height:115%; font-famil= y:'Times New Roman'; font-size:12pt"><span>Aytekin Z, Toraman A, Kara=C3=A7= am K. Investigation of effects of local vitamin C application on inflammato= ry response and periodontal tissue destruction in rat periodontitis model. = Selcuk Dental Journal [Internet]. 2023 [cited 2026May.082026];10(2):371-376= . Available from: </span><a href=3D"https://doi.org/10.15311/selcukdentj.11= 15391" style=3D"text-decoration:none"><span class=3D"Hyperlink" style=3D"co= lor:#000000">https://doi.org/10.15311/selcukdentj.1115391</span></a></li><l= i style=3D"margin-left:21.3pt; margin-bottom:0pt; line-height:115%; font-fa= mily:'Times New Roman'; font-size:12pt"><span>Espinoza Arias CJ, Pulgarin F= ern=C3=A1ndez CM. Frequent oral pathologies in adults with fixed orthodonti= c appliances. Literature review. Anatom=C3=ADa Digital [Internet]. 2023Nov.= 3 [cited 2026May.08];6(4.1):35-8. Available from: </span><a href=3D"https:/= /doi.org/10.33262/anatomiadigital.v6i4.1.2767" style=3D"text-decoration:non= e"><span class=3D"Hyperlink" style=3D"color:#000000">https://doi.org/10.332= 62/anatomiadigital.v6i4.1.2767</span></a></li><li style=3D"margin-left:21.3= pt; margin-bottom:0pt; line-height:115%; font-family:'Times New Roman'; fon= t-size:12pt"><span>Mu=C3=B1oz Delgado MS, Cabrera Padr=C3=B3n MI. Periodont= al health in patients with fixed orthopedic devices. Literature Review. Ana= tom=C3=ADa Digital [Internet]. 2024Mar.5 [cited 2026May.08];7(1.2):76-5. Av= ailable from: </span><a href=3D"https://doi.org/10.33262/anatomiadigital.v7= i1.2.2996" style=3D"text-decoration:none"><span class=3D"Hyperlink" style= =3D"color:#000000">https://doi.org/10.33262/anatomiadigital.v7i1.2.2996</sp= an></a></li><li style=3D"margin-left:21.3pt; margin-bottom:0pt; line-height= :115%; font-family:'Times New Roman'; font-size:12pt"><span>Abad Cordero DS= , Reinoso Ortiz SA, Cede=C3=B1o Zambrano DA, Le=C3=B3n Velastegui M. Deep m= argin elevation, systematic review. Anatom=C3=ADa Digital [Internet]. 2023D= ec.28 [cited 2026May.08];6(4.3):401-24. Available from: </span><a href=3D"h= ttps://doi.org/10.33262/anatomiadigital.v6i4.3.2813" style=3D"text-decorati= on:none"><span class=3D"Hyperlink" style=3D"color:#000000">https://doi.org/= 10.33262/anatomiadigital.v6i4.3.2813</span></a></li></ol><p style=3D"line-h= eight:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'; f= ont-weight:bold"> </span></p><p style=3D"line-height:115%; font-size:1= 2pt"><span style=3D"font-family:'Times New Roman'; font-weight:bold"> = </span></p><p style=3D"line-height:115%; font-size:12pt"><span style=3D"fon= t-family:'Times New Roman'; font-weight:bold"> </span></p><p style=3D"= margin-top:8pt; margin-bottom:6pt; text-align:justify; line-height:115%; fo= nt-size:12pt"><a id=3D"_heading_h.m2eci05r1w34"></a><span style=3D"font-fam= ily:'Times New Roman'"> </span></p><p style=3D"margin-top:8pt; margin-= bottom:6pt; text-align:justify; line-height:115%; font-size:12pt"><span sty= le=3D"font-family:'Times New Roman'"> </span></p><p style=3D"margin-to= p:8pt; margin-bottom:6pt; text-align:justify; line-height:115%; font-size:1= 2pt"><span style=3D"font-family:'Times New Roman'"> </span></p><p styl= e=3D"margin-top:8pt; margin-bottom:6pt; text-align:justify; line-height:115= %; font-size:12pt"><span style=3D"font-family:'Times New Roman'"> </sp= an></p><p style=3D"margin-top:8pt; margin-bottom:6pt; text-align:justify; l= ine-height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roma= n'"> </span></p><p style=3D"margin-top:8pt; margin-bottom:6pt; text-al= ign:justify; line-height:115%; font-size:12pt"><span style=3D"font-family:'= Times New Roman'"> </span></p><p style=3D"margin-top:8pt; margin-botto= m:6pt; text-align:justify; line-height:115%; font-size:12pt"><span style=3D= "font-family:'Times New Roman'"> </span></p><p style=3D"margin-top:8pt= ; margin-bottom:6pt; text-align:justify; line-height:115%; font-size:12pt">= <span style=3D"font-family:'Times New Roman'"> </span></p><p style=3D"= margin-top:8pt; margin-bottom:6pt; text-align:justify; line-height:115%; fo= nt-size:12pt"><span style=3D"font-family:'Times New Roman'"> </span></= p><p style=3D"margin-top:8pt; margin-bottom:6pt; text-align:justify; line-h= eight:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'">&= #xa0;</span></p><p style=3D"margin-top:6pt; margin-bottom:12pt; text-align:= justify; line-height:115%; font-size:12pt"><span style=3D"font-family:'Time= s New Roman'">El art=C3=ADculo que se publica es de exclusiva responsabilid= ad de los autores y no necesariamente reflejan el pensamiento de la </span>= <span style=3D"font-family:'Times New Roman'; font-weight:bold">Revista Ana= tom=C3=ADa Digital.</span></p><p style=3D"margin-bottom:0pt; text-align:jus= tify; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times N= ew Roman'; font-weight:bold; letter-spacing:0.25pt; color:#2c2c2c"> </= span></p><p style=3D"margin-top:6pt; margin-bottom:12pt; text-align:justify= ; line-height:115%; font-size:12pt"><span style=3D"height:0pt; margin-top:-= 6pt; text-align:left; display:block; position:absolute; z-index:-2"><img sr= c=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAN8AAAA5CAYAAAC25P6zAAAA= BHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAIABJREFUeJztXXl8VcW9/82c7S7= Jvdk3kpBI2AWUolAVFbUW7dPWorEubRGXPLFQQ1WktXq0PsSVimvEKtW+vmeor1Vb26oQCyKKkX= 1PCNm3m3tz9+Us83t/3NysN8lNSEja8v18zgdyzrkzv5kzv5nf/LYhMI6AiGS0yiYAAITgaJU/E= GRZprqmv+1xe24mBIDn+N1mS9w1siw3jnbda9asmaKElDJAzEpJSf15SA09K8uyMtr1dsf69eun= N9Y3fqZpekJCYuLejMy0wqKiohOnk4bxCH4sKkVE8tprX/NNTd/QZZkwAIDlr39esGzjV2mjVec= PkepVv9rqNPCCyjMMpFsVZdHMSb7bFuUHR6vOCFLiUnK+3vvVd4KhAAAACIJQkCPknVdaWvrnws= JCfTTrbmlpIUogSAARgCGJT7SOZnV98PTTT5sPHzz8a6/HbbVaEg8qWuimR+Rf/tszHsAYMd/P3= 9qVRCW2WCj48gMAcAMAVLUF/uuYTSkEIABkNBZABJGnIFHNxxirD4Jo/8uh5k+v/q9PPkWeO1Jg= DNheWHl1aBQqhuqG6msCQb8FAIAQApqmWWz21uI9e/Z8DgC20ahzvIDn+fk+v09ISEr8S2ZW1s8= ffvjh42NN03jBqIl5/eGuknLBFwp9t8mjrJwYzy15c+XFNgCAy9ZufaeL+UavfkQEQAQgBHhgII= mc10DYsWSD/rdZk7I2nz2dHS6aN08dqfpuuOEGq0D595muXUw5ThUF4XAwFJpjMBgcU6dMv2nS1= ElbCgsL9eeee87Y3t5+5/GjRxN6l0EIYdkTJhzQAT5av3594PHHH885sv/QTRpqhs6XWPifxITE= YEpm2ubHH3/85NIbb1mg6OpNhJLbECFeMkif+IOhzylC49Szp2985JFHcN26dQlKIHB+ZcWJeYq= mcMAACMex3Oys/Zwk7Vy7dm0bIQTfeut3N//lg/cKgAEAHbjNhHBaVkbWp9l52Xvq6uqgqalpJt= FxiWCUHNOnT9+8c+dOu1EUlwKSxN5lmc3xSm5e7ocAcFiWZe0Uu39c47SvfApqeScdvucURm0Qf= 3pFIIDwyoMQ3vppQEEPYZyPkG/4dGFO+9HWW9xB63/LZYfWyYtmekeivvT09EvsrbZzAAE4TtiX= mJr2ZmtD09OKoiQ4XPYf8jX8DgDwAYCRAhRTIHkI0DlBQHiywNZWW8vEifmrN2zY8I7f7c8hBNY= QBl2M2jFhebxuRWvQbly/fv1/NDU03VhXU70SGQACQCAQvIICuYJw3P7MzMw3ioqKUjSFPa0qgW= /rupZEECghAMh0bGxqdhok47ZVq1bdJ8tyFersRxTItxlBGGznTIDpDqe9OVPPXHHttdd+8ObGj= RMUTXuQIDgYY+Umk0kBTb8XCJwFvcoK+LxaY139nWdNLPg+AOwbiW8wXjHIHDay+OOe9gSfxjY1= ull2uM9HZHwPAxQioxUpAQIAQQ35Nj/kfXrcVXxgT0vZXSUfn/LMsG7dOqtAuR8BohmBwLzzzt8= tgfCR0WxsZrpOXY72byUkJEzq/AEjgIhgNJlqz1/wzU8uuPCiv2bl5GwBQgJqSElvbWtZ7nA4Ei= VNOiwZTN+VJPGKyJWVkVWYnpm5BxCI3+c7JzkpdX1qeuqG7KzsH/M85+AogaysrDcmT5m6eErBl= DsPHjxoFHnx2YDfs0TXtBRzXPzxWWfPuj07P+/6OItlr67riT6f9yrQ2asmMKWxLi5x8QJ/sySJ= V4iSuJQAtAIATJk2vW7BhQv/mp6ZtZPyvBIKBCa4Hc5f7Nq1yxhZviICjcFgcIgCf6vEd9FvjI9= bPCE39+8CL+putzufUP3ZU+3/8Y7TuvL94fOjN+yqal/AgDvt4m53dG0pSeeNyC1VZaYv6oJzz0= rk//Hz33/x7bU3L2gZbj1ut3tim812PiJwvMh7Wtua17pDbjsvCn+jlBb5vN60qoqqywDgAAAA0= PDKHPAH9jQ0Ndxx+eWXexxOBwn4Et9zOtqvVEOqheM4c/Evi5sRcHv3VWPz5s30ow8+KGfIPkbE= STs/3zHllZJXqu9aepcEBEKEECAcOZGSkfLpihUrlEcffXRm5fGKy5Axg8Fo3CcYxOtVYNXV1dW= Yn5+/k2n6//n8vvlOu2NeXt7EczhCIhO1oiHufPt3v6spuu22qWpICSAiJCUkfTKFK7jbl+FJUo= LBd1wu50K315ukMI1262kAANi0aVMQAL5A7GrAo48+SkwmU5W7vf1PqleZUVNXNwERKSGEDbf/x= ztOC/MhIrnvnb3zyg7bntOQ0rFlvQGAEB4lhNJqpzbLXBfcLH9w7PvyNVPtHU9jRmlpqfHEsYqb= dcbSgAAIPK8pQaU4zmBCTdfzPMSp67rO2e22e2RZfrEHGcj0ioqK0LPPPhsCALjx+sJKCnAlAQB= JkuD1515PerjtoTea7mj5LiLrpB0p1yFWA6iKSgAANap10c0AHA4HEkLw4V88fC4lJJ1Sygjl/u= HxeJpefvllDQCguLi4PSEpoTwUCs4HSqwa4jQgwEWqYbrOCCG47NZlGJ4xGDDC2NUrrw6tWLHCx= wmClxACAAihUKjP137vvffiDx44uOHuortvUVVVAIIACMAYAyUYDH8GSi3V1dUWAHAOpd//mXBa= mO+pv1ZOaHWGNjV7mJkAABuGNhMRO2fPsDVwkDI6hhyBLp4K3+62l+p4o5McEi6cIQAg0GM2Zf5= Eu+eVdR+fuOPBb01yDYXenVu3Jtm93iuRMQkQIRAIJNbV1vwUsCcP+32+sxgjlwPAV93I7tOUiA= WUalSocdWsrjpx4irGGHA8387zggIAgEznCCFWQBSidEUPaIg6YFhNYzBKRgM1dnao1WpFp8OhA= QAgok4Y03CA9SeWrxnZZ1NKyY4dO25pqm/4vqaqAuU4lyDwQQIUGNM5AhBPAKQYivynx6gz3wPv= HY3//GjztfsbvXmEUAJAhrnRDLMRz1E9QSLtiOCP9ZcICDoi0RmNV3XNoupIEQAYEADSU31HIiI= o4SCko/jp4bYL7e7Q/BtKccvmQhKTTU6WZd7rcs1lLtckRASO51sIRytpdy6g1KopymRNVyWnw7= 4+JSXxyv6WVtLtf/GWeGu7x3ElQxQopThn9rm3z79w4TFRBDhw4EDy9rJP/1tnLKc3yyEgIKIp0= lhR5A5SjjpRxSQ1qMyZkJebgYgnCCGoKIpVUbTzma4DCmK7ouv7gZJrYml7T3r73hdF0cABvUjX= dQMAgWnTpxVfsmjRl6IoQm1VrXVL2SdvuJ3OaadfD3/6MarMJ5eV8YeOOOZWtfp/qTBiOrXSEBA= IxEvUf8mM9MdFopSJANDbVSPaPVBVcHl1qnJcllfRvlXvDC5pdGrZgIwwHMi0wSCoQnp9e+ixGe= Y9BwEgJo8UURQT1aByF9NZPMfxzJqQ+MLZs89+2Wg0dnJEc3PzpIpjFe8GfN6JDnvbJMQpF4SX3= IERYiFFVdRaAjALEEh9Y+0Nte+8fRCAAup6vKZpxu7vJycnM4etTfX7fOB2OW8GSrUnnniqHlH7= Y5zFsjcUCl0SCPjPsTU3P/Paq6/+/d57793vdbmWuV3OcziOZ1artTwYDB4FhkMSu/sD0XWma5o= tsuo6Xa5b3nnnnUwKAIQQUzAQiB+Jev4ZMKrMd/yEdYLd6XrEoZBUYHhKutUO3SQA4TSTwVi7bs= ms/cMoZm/p53VlWw83v5WbGHp8V43/akVn0FMw7VmrCkDb/drseKNwy10l5b9+rWhgG6Asy1TxK= RM9Pt98pjMiGSR7WlLae8uXL2/v/t5LL710LCU17Yt6v2+CpmlifV3tvWaTyRBesKJ0VFgUBp/D= 56EE14uS4byg35fZ2txyE8fxHYIBQm+xNj8/vy3ObN5Tebwiw+vz5QcV5RGn07F/4SWX/C4QCDy= gBoMbvT7vrHZH+3e/3PnFt4KK4qIAmYAYSstI33fW5MmPtbW1OSLlUUJoVlq2oSdxPftuIC4NqG= ooqCm/MZiMi4M+/5TG2vrLOYG7PFIG03VARGAaU91u94jZW8cjRo351n18wnqkxn5HtUO5ABA5p= KduOycAQE+xkMILcgIAsGdN6e6lVqPh3b8dblvIIhuqXmWTjs2gX2XGfVWtt6RmGH8DAA4YADNm= zCAcJ6VPzM//imkah5R85fY6+7hTLV++3Pf7t35fMm3KFBOiLhqNpgAyKMvJzvmGIAqHq6qr1Pf= ffx8AAC6/8oqjHHB/53m+jg/y9goI1Sb6/RefvXDhOsZYHKXdBdPw4Oclsfb1N38Dra2tLjEk3j= n3vPMXm4zSDZRSkQBUL126NPToo4/uy0zO/o/Uc5K/V1NTe01DfYNAgUDepPyvKce9KGnafkEQ2= mRZ1jb/z+anL7v8CiCUemmQtgMAXDj/Qg8xkB2IeBR1fBMAYOHChUGn0/lnChR4gT+GgEFKaasW= Uv7O8YJD1dWKvXv3NuXm5i6effHFazVFTYYo9BuMhpbZs2ePuuvfWGJUmE+WZbq1vLKgzq4uD+m= 8FBEZx5MY/0ThXNtD7x/98TS797NDzcEsAAIkYtjuBR0Bmrz61NmS6QoA3AwDmJkLCwv1srKyvy= clWbYAABw/flxftWpVnxmcEIKlpaXbFKbszM8rAAAAm83GsnKz6PHjx/Xu3h2I+OpZU87aaLPZ2= A233aCSsIN45YcffniL0WiM2q02m40BAMiyzADAVlpa+nufz7c5Ly8PbDYb6yhDA4DGsrKy12x2= +xuKrhIAAF4QEACUX6xd26lmQQ4/LZg6eUcgEMCrrrpKWbZyGdTZ65rPP//8ZUajkdhsNrWj/Up= ZWdlr1dXVb5jMJlZYWKiWlpbuSs3N/V7gQAB3OXapmzdvZgBQU1paeltqampUeSgQCCAhse2x/1= kxKvyw5v+OJJcfb/rkcEvwnLCOkgMCOkCHqYgjAKlmbvfsFHFxzO5lHdrOpDip/epzcm5ft6Tgj= 6dKZ0lJuXBAYrduOWp/3RUitCPyIfrLTIepqcZNF6uX3h5xBj+DMzgVjPjKJ5eV8Vu3VV9f5YI5= QCgAEiD97qnGFkVF89S7Ssq3FKTEV+xp8E4F6H+/goRCiztwZfq1J1JADnt1RIMsy7S+vj7V5/M= lnip9Rs6IIIJKKfUlJycHFy9e7Fu0aFHM/o7FxcVJzc3NfSJFJEmCvLy8almWx1SsW7p0qSEUCu= X1vi9JEphMpvqXX365jwvUddf9MI3ng4k8z/cYUAnGBIU38w0vvPDCqDjHDxfXXnttvNlsnhDt2= YgyHyJyS35dNr/ZQ55hCIQQ0tebZPyhLd4slkocPBhgIAykJvdqJHnLl5VTAfpnPpfLJRko/5BP= 1X+CA6oeBgEh4Ne8IDARCMBxv+ite3fz5o3Fdxd/ZW2z1subB4/JI4QsZar2bG9bJxFENJlMUwG= gYvgEnjo0TZsImn4EeymJGKGQmJ54IQB83vs3Ahd6lCC5HVWtmy2TgG7UGiROuggAqkeX6qHBbL= bciGpoY+/7lONG1rfzztd35do87DWPTuMosFMZeqcNWU3fCHIcbJE40k6QDKiq0xhKoinhxkELp= RQI6bAZDveCMLNoqgKqqkxps9kut9vsv21ztb7fltp699q1a5MHJaOjjLCiqqvs8TUR9m37YCFl= 4Xb16qvT6qU8NBBKe33bsK17xEiW/3gywRlUH6hxalMJQUDCjatP3B9kmTCjSOuNEjaHTRnRuQ8= 73LaqGtsXxRJxPxoTDyKTNFWd6XI41zbUNbxZ+tvS3Fjo6D2nkHE0LY5e7oJxjI7vMSLMV3YSDd= W2tsX76z236jDGXtPDgGSi7kyL2cZ3uJdFR1hj6w1h4qa91aclFqq3OBYxfaiaamp32K/a+nnZn= 1asWGHpv4TI543SpnGyM4puXR0Y42fqODWMCPNt+suOSYdq2mSfQsz/jFPZtNTsQHJC/BFKQevv= y0cWRBVo+hfbKlKHW1eEoRCx36v7e1FpCcfc8S6HfY41Lv63ZWVlhmjvMcb6qWO41I8C+uuDMcm= xcHpxyk1cU1qReqjR9oAtyCYDcP0a8xAiQZikjxg01rjy0lT1YH1zPRCiQT99giRMdEDR6c4G9z= AmrXCLRUkKFEye/BnH8QOmjwj4faAoofPr6hvyUNc5QvpuhBCR1lRXX/HVF19cBwD/C7261ZJg2= ZovTVrdm1hRNEBSZpJ96G0YWRQUFNjUQGg1Y6zHMkApzyyCpXooZY2n8RQrTon55LKThpYax3Un= Wrw3qIxQBOjXUN29dyggGgROMVmlcWEvm0xI6LyH/rKP6VQBoFFXEeiYPBgQ8ISG63RPgFDqTE5= Neeyee+75bLC3EZGWlpZe9o8tZRva2x1TAMJhPRHBjBAAXddNlSeqfrJmzZpPnnjiiR4MLcvyXg= DYO0xiRx2yLDsA4KmxpmOsMGzmk2Wk9ZW7p1S0uNY4g7qxU6/Wn9jW6TjEwMhz7Ytmpr173XUz3= C/9eLgUjCxSLSZwBEOg6TDgpgMJhQvnZKedBDg29Fr6+l4OhI5A0k8eeOCBK3XG3vO4XXN7i6OI= SP1e71SjZJovy/KHHR4tAABQ8kxJiou5+ihlBEGACRMmHCksLAzEQkdpaWncvn37rAITzKZEU1z= MDegGxpja1tZW9cwzz/gi92RZNplMpmm93+U4AwoCnFi5cqX7ladfSfOgJzvy7MDefWmqopDeEz= wiE+Pi4mY89dRTSd3v84xXVYdavfqp1Z6OOmlWSlaB0+8ccjtCbrfP4fN58/PzlYyMDFdhYeEpp= WAcNvM1Zn4dH2TaulqnkocdjDeQMT0yZARC9FlZpl2CBq/OI2TcOM5azRJwnAIwgENTWPIkcMX0= 7Lt+B7B9OPUMRzyaN29eU1N9/eO7d+8pUUKhPvtNXdetGmp3SZK0AwA6HbgbnHVLmpqaf9VbYjU= aDMjz/AIAONkvnYj0xRdfzAh4vYt3bN++IBAIztUUxcrbxOEpmxAdwNHvAcDRyC2Xy5XRUt/4N7= 1br1AE4ASRZeVkXS3L8t7D1YdvC4WCP6MAAEiAEmImhHA9yiYAAZ8/qaWx+e3W5pauL4gAhBC7Y= BALIZItAICvrKr4rdPtnARDACEEmab5gVDHiYrK1qpjVdsee2zt1nPPnXXgmmuuiTm8rTuGxXyy= jLTNfPBHn+xpvjSIQje/2IGULQgUEVLj+YZLZ09Yc8+i/LFK4BIdHB/mrn5MDQQJRFKEESD9iKa= jg8LCQl2W5e3xFmt5u73tKsb6SOu82+U6u1USs6Ab8/n9frPH5UrtzXyaomLAGej325eUlAi/ev= jheTZH+9Mup3OOpqpxnStuIKbFsg8QgOjQM8jXZrMJTFFTe6/moiiC351gEIwC+Hw+c8DnHVTBp= es65/W4k3rfR0CgLhAjf9vtdgI6S/G4XMNVmuV5PW7gKP9tj8/doodCpatXr374ySefHFKwNcAw= tZ2JC2sWfF3Z/HgQeSPF2HxfCQDEG3iYM8Hy01Rb3oFBf3CaEQyFBg1Zw47Vvdrm/sNpIqsTM2b= McGdmZP6Jcpwv2nOm6okmyTSttLS026owrM9LWlrallRWnSy122wL1JASN5Dm9d8Vuq4Rv8+bce= JExd22Ztt/LVu2bMhxiEP+OutKT1j//FXNw3UuzUIYAgOu/5cROlXJHEGYmS69zwH3l8IYI8JPJ= 9rb3aDrgzFfGH/49MhpT2lXWFioqEwt53ne1YcZwjouK8dx362pqTmlVfnFF1+9quLokVfVUGgC= Y4yLGIQjUY8I3f4zVjyJGHvd/eXlGHKV3UwhEDYHMwDQdE3w+X13ckRYvmHDhiFp4obEfOWIQq3= PUVzR6r0CCQWgdMD4OuzI3EEAIcMqNF08O2/VYMGoY4GyMuQzU5LSAfqfSZAgUCBACQPCBcZk2M= Xz8TZCOVuf4FUCoOkaOVl90tLQ0CD08/NBIctyxte7dr6lKiErENJp3ejhkIZhriPd7pPe74wgK= DAGCBoiaIioIWJUAQXD0BFA67wQNSCg6bQrgUdycjJiWJE1nAsAwjsTAt3c95CJQb/nfkdLy7lD= aVvMez4ZkT6+4bPZxxu8RQpyXCw5kCIKGKMA/oVT0l/MsH9RPRTiThdsaWBIbrTMI9Vusb93wns= +BIkSnJ7A43DC6E8VHs3ji4+L9wb9vihGeALI0KTr+rCYr6SkRNi/d+/GgN+fHMWkGA7pIkQnHN= eempoamD5zJkpSz+7SdJ3u270n3t7WNiIeQLIss+Li4icls/mFyD17m/0ZZOwWgJ5O8Bartdkki= VerhNR1L4MxxnRd79QvHDp0SC/IK/hZMODrkxl8IIiiaEGGxW63O1fXdbG3QVvTtLjGxpbzZVne= HetBNDEzX+NbX2friva8W4O0WEOEEAhIHGhTk2i5nzlfKbxpgENBEKErl3T00iLvcQOpJIeBw4c= Oi812d4GOyPXXrrC6BUHieefF35zqfmdEKYgNmZmZuhIINrcRyhD1XlILQkJS4szMzLxEGMb5Dy= dOnDjX5XRd3N9zynFoTUj8hyku4Z5nn33iaLR3Vlx1lWQzxz9NAFdEZeBhYP369QEA6NTyFF5fG= KTRLFqEMBBF50u//vWAzgObN2/WAeDPw6Fl48aN7x4/eux3jQ0Nl7BukxwBApQQSZDEGwVFeAcA= Ysr1GhPzLX+pLO5Ei/O6Cps+lyGlBGKzjVNCID1ecF96bu4rC6flZP7wZCid8qina1Jdfj7pEUt= WkGY8lhAff7S/HKlhDxkCJolvixOgPiYCYkSL6k+od7gzdexfDA/L+QREDDYtv3RGyz0jSUCMyM= nJwbbWNr23Z3TEghoM+MHT1jDkcjds2CBVHj1+F9N1Yw+mwa5/0tLSj589++wf33nnnf32fSUAx= MNpiJnoyvrY8+9Rxh133NG6du3aYntr27sBPTClKz8lAkMAu72N+uz+mJs/KPOVlJcLO8u1bzY6= Xfcrmm5Ewg2aq78TiKDoIP3jcPO6HUeaFB144EHT5uanvgkAT3d/9XuXznrBSIS3BiuS6Sxg14w= jdrIPIpIfvPBlmlshGQyx32gWBASKDM6ZlFFFxuicPwAAjutfwcUYg9AwHKZra2utHq97HiL2HA= 8kvMXjBcGXlJL004EYb6xxOjyKCSH44IMPNnCCUE9CwSl9TSRC/JSZUxJgMzTHUt6gzPfeVpaso= 7bGFdCyEGjYfSxGMCDQ5FHNLW7FDAQBkYDAoTYjO3F+73evnhxvgzE4LuvRP39ttMRJ14ZUSKIY= jlyI/iURDJQCMPW3p5vGCBwOAFWLrq8ihIDI8yBZhu76FifF5TYpDckQyUvc0f7I5iI5JbkGEb8= eJtnjFqWlh8RQaHd+TU1NemtrKzcgM2jhhDcBT8BMCWREW27N5riMhISEdOjmSDAQBqzvBvmQqB= uct5RXuxdqwHWGYYb1foODAAIF7IiFo+HlmXQdUjIe4HHTVJvTc6OiaYJOaL9aO0IoGDitLXdSx= q7TTWMENtsx6nW7jdAnnjAcqcAA7JTSIVvBPT5PKgAY+8pzAEAI8Dz3qcViiWpf7As27pJl9UZZ= WRlfXV190VdfvvlUU2PTZKbrPMYSjoPhsAAEiK6YQ+QopTHrUQZ8cea5ZMHb21yP6Az4MOf1mBg= HByGdk+l4dDuX5TL+63rHuQdsaqYGFEjvqb87ECE32byH7DhrzESvyspKTguGUhAx6t7U6/XU6M= hiZJIuGI1iBiFE6pM6EQA4ngNErHC73TFquei4CtbtDUQkjzzyyLdrT9b8dyDgtwJ2nIsWo4JoJ= FvWr4Lhvrf2pX2yv+H5AMN4JDQcUvMvhtazLJMdIXxV15iRw4FPfTTwJChQfEOWx25k5ebmpqia= lhLFvQwAACVR8ptMpiEfKMkI0fuL8qKEgFE0RnsUFeN9lKxdu3ZWQ03ta6FAwEoJAUppzIw30og= 62pbKZYY6t/ehGod6TsTuTPs7KaPDi6Xr3+hXp3kCI7q5sUNpKXK3vvzZ1BP1jtJap56uEx5YJO= 1Fjw/BwrQjglWkx32q/vFAOTtHE4hI29ra0lRFSeitxkcAoJQLCqK0bfLkyUNWubjsriadsQ7tc= /eyERgyUHSlX/vneEEsH6W8vFzweQOv+ny+rL6/7gjiJQR4ng9fgtB18eGL43kYKTNKH7GzpKRc= +JPLd3FVdfttDITOsYj9zmlh25xAGXCUIu1XIRO+z1FESvsO4G0VmKpxoaTBRo4EAGKHF53i6bo= fHx9+KAIAhAB0Xgq+//yjdbIsIwDA53Vo2F3blLal/GT8G1XbLrR7fT9r8pPJDKHfzkSkQEAHke= cDs3Mt78SHkrxbBqFvtPDMM88YRUH8AQJEMQ4T4Cj1GkTDnhUrVigrV64cUtlGg7GlHTEQbd3Sd= R04Xjgf+jkGY1wgRl7YunVrXn1dzcyo35sQMBpNxyRR3B5viQ9FLRcpMGCS026/MhAI5J6qz2sP= 5kNE8qOXtxW4fIHnvTpvjqUABAIiJZhq1L+2SvAG0/V+3cc4ACCUMAto1b2f/WbrFz9t85EbCEd= hoHmMEgDakXqe6V1v8nwk5CcMTWehA665uyau+gABAJa++KFhQlL8rJZ2nzWg0UxVB0knFOgABn= sCDHigmCyyI0Qjb7+wcuirygiBVFVVpXtd3oW6pkX1YCE81yQYhYbhmEFEs9hiNBo9fr+/h/dE2= I8Tod1uXzhpYm46jN1RwiOCA7sPWDWm9Ml5wxAgLi6uyhRn/v7ChQsrB4rTW716tVUQDX8IBoMj= y3zLX/kswReCe+u9eBYD2qEu6TtLIITFUEZoeIBypCHbIt035/5F2+UYThL9KMq9ujb/5EpbYIp= GBlEWdUqt0b1set4RZkW4UVMAjjX7AYEABRbOroYIfSRv7CqXIAHKQ0uGVVgzccZ5TYO1a7Rw33= 33mXRNl51q+9RozaaEBBMTk96dOHHgIUUvAAAIZ0lEQVRiTPal3hBFsV1HthUApgBAH+Z2u1zJC= uIDdXV19+bk5PSrTS2AARKajjI0VeUppSJ0GyG9cd3137+/9H//p2N70fPZzJlnf7TqvlWHX3jh= hWg/7YGR2iF2jrwNH1ZIdg0WH27x/0BjRKQDCJqRwU+QgUBQzbaKX05MTdwXC+P1C0JAJ1zPfIx= R81lG/k+jPoceF+1xEUI6NFsdJoU+Wq6I07AOADoIAlEuLkgru2jqhJ3yIjJkRUbPLiOAOHQV/L= a/bcs0Sqa3mxoaCwHCGXR7QxRF59TJU8tWrlw5rJVZlmUFCSmhhPi6R9p39DYgInfk0OGlfyj9w= /rS0tIBtS+jnT7TaLZ0fLKe/KWEQskG0XBRSUlJv7O3IIkp4cNR+z5TFXVWrDSM1KafBwgHx+5v= 2D31hC14v0cBy2C+mxQY6BBeOYxGvm3uROum5249dwSO7x1rXVnHYAMEQgjLs9LtGYTdvfq70zy= D/zam4kHXtIQD+/fL/3nnnTYAAEK4PiOWknBaVUVR4l9/q+Q7iqJE3ZciIlBKtby8/I+vue6a8u= Urlw+btFWrVlX/ZuPGo63NLQs6nKh7PNd1Xfxi5+dFiceSLrt/1f2vTZ82eW9BQYHK8+GxHjZAe= 8Q//fG9Ce3O9ig1jAwuvHA+/GPLFmB6z+2Cpml8Q0PDhgk5E6wAsD7abzdtens1T8hXve8TADh0= cP8Fv1zzi4dmnTvn2cHTa4xM6iEeAKBxytdJttbgcptfPwcgHKPHod6lAexTdVh043lOnZ4m7Fk= wLX9YKRWiYiz5ryNWi3JUOzsRy2ek8D94smjekCOUoyHSLE3TjE674/Iez7oN9O77COxggv4VQg= iSJB0yxJkeGkgcjAVz5szxPfnkk8s8bk95wO83dRfrI+e8EwBwOhyTnQ7H03W11fDxx590pTrse= I5RGHcksX37tqcQ8WboJR4TIBD0B8zbP9323J233/7L5KRkj8DzYI6zVGekZCxbWrT0xE1Lrlc+= +uSvIY/H08MNiBAEVVVIZWXFr+rq635157Lbu04ohp61OGxtEAoGoR9zz5BAZbmMdzv0hUeavEs= 1BgQIBUoQsCPleXQQIEDQSLUmi1H8WeG8pFMeoKd0rsEQQLqZPxARGBIAxgAZA44AxonUcdnkuD= /On2j99rNFi9pGvP5oonI/z2lHmnGAXrGrHU0wmsyOjOwJRQ8++GDtSNC2evXqI7POmfMwx3Guc= DXdRVDoFNW7091JaxSaRwMXXPAtnznO0txnlu5UxCF43Z7Emurq3MrKytzm5qbprqArAQDg4PGD= B1PT0v9GoHcwd5fXVSgYBK/HAx63G9x9Lhd4PR5Q1ZEJSaX1EwyTK1ucz/hCIBHAsB2u84KoFwE= EylN94fS0A5dcmVk9IpRAlCjpEb2wc2XrPoo50EHkkVmMnG1qumnH9+ZlFX9nVs6P5VsXuEeqXS= OBTtc+RCAchbj4uJp58xbcs2TJkt0jWU92dvYLqelpj/G8YCNIBkzeOxa4++4fteZNzFslSGJb+= LPGTp8sy2zm7LMfTEhJPkopxbFuG2/iYAND7qxkc+QAy54E9VYdRf42UL2uINty/235+SNyzFSS= mYMUXyRBUd9NbbTokf7ei9alEbGIUmCMgU/iqKaqocYJKYntBh4/SzAbPslJshyA6ya1FZ6K4mg= UQQgBUZK8aWlpXyYnJT58z8r//IKMMK2FhYXKc8XFr/Bp6c3tTsdjwWAojzE2QK6Q04+UjJSPVC= z4RUNd/eM+jyeVMRbzanv8+PHjc78xd/nuXeWPebzu+ZqqjUgyrAHZuJ+HPAHtoZxE0yMAQ1tK4= wTiDOz4/TByV0ZHpiXuEU3zPT9S5fVEx/aABxA5DimwUIJR0l1Oj2NafmpoxnmTPIU55JT2TBHk= 5OSAvdXWmetjWHvYyIxMCHCUal6v70ScOa49MTlpOxL8wGKxHPP5fG2DMR5HOV9icnIfzx1JksC= S2n/yrlXr1wc2bNjwbpzDutsgirfVVtcuJoDTQooi9jfQIzZBRVVBU9Uo7/SdFgtyC4RWR2vX/Y= 5/eJ5nCSkJ/Rpgi4qK1NLS0k1Gnt/tCykP2pqb53Icl4MAfPcakCGY48x+I2fsXCBkWWaIuL2+v= r6wIK7gppNVVUs0TZ9OCEkmpxArhgBgMhpDANAjjWBaWrKohEIdmRA6ugEQKOGAf37Zwi+HWd+I= 4sXb5sUUhjHeUVxcHHzyyScfAo6uG4nyBEFAXhKDoijqCUkJitvtDt1///0xrXbGOOPbvMT3ido= 2Go2QlGQeMHxr5cqVIUQ8tmnTpkecbve6eEoNbQ7HgCETRCGSoroeA4Bboj0XxZ5eakkZSRUqUb= N7vycIAqakpDgGoq+wsFBBxK/Xr1//Q8pRMwCIqqr2mRXMZrOSkJbQQyfRwWOtJSUlLyenpb0JA= AZVVYed+yYCk8mkSZLUo66JEye+abfb34v2/ljr9s/gXwhvbHgj9Vjd0S+qq6rOorS3xY+0Jaen= Xvbiiy+Ou7SRY4V/g7NgzmAokGV5WHby1tZWU42t9t662roJfRy/EcFoMOoJCQnDyuz8r4ozzHc= GPRAIBC4CXR9S9jGfL0hAYz+pPH5sIeq6FCUPDBpM0q6cnJwRN938M+MM851BD9RUnXyJAJw9rB= 9j3z8JAIiCqFktSW8WFRWNiMPCvwrOMN8ZjBz6hOAgEMrBlBnTPrZYrWMVjTVucYb5zmBk0c0tm= Od5OGvSpPLUtLQ7ioqKxpXTwnjAaDuhn8G/AXoeaY3AGANBkryTp017Pj7B+p2ioqIxC8cazziz= 8p1BD+Tk5g7NNxPDPqAcpRAMhaokUao3Gk1bsidm/7a+vr4uVpvkvyP+H3Gg7h/nrUjkAAAAAEl= FTkSuQmCC" width=3D"223" height=3D"57" alt=3D"" style=3D"margin-top:27.85pt= ; margin-left:252.5pt; position:absolute" /></span><img src=3D"data:image/j= peg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAEBAQEBAQEBAQEBAQEBAQEBAQEBAQEB= AQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQH/2wBDAQEBAQEBAQEBAQE= BAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQEBAQH/wA= ARCABVAKIDASIAAhEBAxEB/8QAHwAAAgICAgMBAAAAAAAAAAAAAAoICQYHAgQBBQsD/8QAUhAAA= AYBAwICBAcLCAQPAAAAAQIDBAUGBwAIEQkSEyEKFDFRFRYiQXF3thcZNzg5QnKBobHBGCMoYXaR= tfAmVnPRJTI1SFdYdHiGl6bV1tfx/8QAHQEAAQMFAQAAAAAAAAAAAAAAAAIDBgEEBQcICf/EAD4= RAAIBAgUBBAQLBgcAAAAAAAECAwQRAAUSITETBgdBUSJhcZEIFDI2N3aBobG00RVSdbLE8BYjJk= JTZvH/2gAMAwEAAhEDEQA/AH6WcpHSKBHMe9aPmypQOmuzcoOUVCD7DkVRUOQxR+YxTCA/MOv2c= mAWywlHgwJnEOBADAYCiIfPyAgPu8w182rG2c8zYbfklMV5RvVCdkOmc/xas0rFtXAImE6ZXrBu= 4Bi9SKbkQRdtl0hAxgMTgxg0+lsKyfdczbOsKZMyHKhOXK001y6npf1ZszNIOmspKxxHSjdoki3= IuqgzSFcUUUyKK96nhlE4hrc/ej3N5h3aUtDmUuc0ebZfX1hooilPLSVUcwiecdSFnniKFI2syz= EhgAUs1xqHu572aPvBqa3L1yipyytoqMVkmqojqaaSMyJCRHIEhkDhnBs0Nrf7r4Vbk+rJvdwZn= HKENGZQLeKhA5OvTBlUshRDCwsU41pZpNs0YIypEmdjbINW6aSTVJKY8FuRMhQSEhQKN9HTi6qc= Xvfs0riyxY2d0bJtfqa9udu4qQTlahLxbCQiop6dodz4ErFvAeTDMyLFZKQRMh45/hEpyFTUT13= Bfh6zX9bGQvtXK6tu9H+D+mXeR92B7N+rm5UL9/8Au10R3n923Ylu7Ou7SQ9n6KhzrLshoa2Cty= 6P4k0k7JSq/wAZig0QVAkEjajJEz39IMDe+hu7vt92uTvBosikzusq8qr86qKWajrn+NokLPNYQ= PLqmgKWBURyBABYqVAAciLzwHPl/n/P/wC66UpJsYaNfy8m6RZRsYzcyEg9cqFSbtGTNE7h05XU= MIFIiggmdVU5hACEKYwjwA674CA88fMPH69QW6mNyfUPYdufn41Q6T42LZyEbrJmEiiI2bwa6oq= QwCAlOmjJqGKJRAQEPLXCKi5VeLkDy5NsdrDgX8sK074+tfuSzJkmzV3bnd5jDmGYmUeQ9bc1QE= mN1uLNo5FBCxSthMgaVihlOz1tlEwq0f6m2cJtnqz5yQyoRhjsx9XWXYtpOJum/uTjXyJHLOQj1= M6PGTtuqHek4aumyCjdwioUQMmqiodMxeBKIhrPOilhqsZj340FK3xrOZh8ewFiyOSLkESOWjqZ= gEmreCVXQVKdNUI+WkWsmmU5TFFdml3BwHAvvkIUgAUocAHAAAeQAABwAAHzAHzBq6kdYiEVFNg= Lkgbk+dwSff8AoK4WO6buUd/MTtU353TKy24mfyvTqOzmsJtMywd+n5RawMq1bHRW9Tgbg0VcTB= lpJGMK8YRjZf1lUGqSyZjCkXUtekTua3z7gbBm9rvDrFprzCsw9JcUU9ixK/xoR07knthTnCtV3= sRFhLnSRaRoqpJisLQDkOIEBcBNYpvjs9hpGzzczcqjMP69aaxhXIM5X52LXM2kYiXjq4+csZBk= uX5SLpqumRVFQPMhygYPMOdUXdDLd5mbJSm7aybiMyXK+1rGdHpFmbrXGZVk0K+zTPdXc68aeMA= AgKzOMRFcQHg4NkgH/ihps+mkj9NeVGoDcElVsAANiAL/AGnxwYZ65D3h/frzpIrJ3U/6iG+fPr= zHm0p9dKrCyMjIFouPMZoRbCfUgo05wJNWu0u+0yCh23Y6k3LiWjoJgdYES9pSlVVkxgTCnXcjc= 2YlkMpOs2jjVnkSoOr4WTzRi2SjzVNCcZKT5X0cxvrt69ajGlcAu1atXDhdPuTSRUOYpRoYGA9J= 41Nr6Wax8Psv9vvwYbd5AfYIDoEQD2iAfTpInfvu83ux3UJzdhTC2dMsxzdbKcbUKBRK1ZVGbQH= ktHQaEdDxTdQyTdEXci8AqYHUTTBVcRMcpREdayyrmrrNbTUq5fcyXfcPQ4d3MEYxMncJGOn6w/= lE0juSxT5IFJiJOq4bprKkZSJU1HKKK50CnBBUyahTkhbuilgCoNwTcA2sbefhff7jD4XICHICA= h7+fLRyHvD+/VI2OerM3+9iOd5t/gWDnJNfeOcaq1RioLKMtmV0l02MQZoIiZRpEyLVZGyy7dET= qsI5tKosxWOih4i/9W3h9Xze7crJJYTteYp4Io/rL+FxCzaVuo1Vq8UVMxYrPE02TJJQ6ZDkaJy= sq4knZEFTgdwKaqgIWFzqvZQraSWIte9tvV43wYeYtzp8xq1jfRRTnlWcFLuoxNNIXCh37ePcLN= CEblAxlzGXImBUQKYVBECAA93Gl/8Apgbu+oznDc5MUndTUbjB4ta49tUuxfTuEpLHrE1jYTEA3= iEST7uDjkVl1GTuRMmxBwYzkhDqlTEG4mLrzpyV/qq1jMmQpneAtnNvi9rgTJJ4le/WOMk4VC9p= rV5eAWbt2co9WJKpM0Zg7RfwQImmVyBlC94AbQnRO3bbls3b0rHScuZtyDkKptcSXqXbwFmnV5K= NRk2Nhqjdm+I3UAClcNkHblJJQB5KmsoUB4MOq6NKzfIeyghhe4+Tsp9d97ew+ODDcHID7B5145= D3h7vaHt937B0pNn7CXXblM45dkcVus2Fxq+yPcnVBJGZpxdGx5agvPPla+DKPfX5o8ZNAizNgb= tXbZu4QS7UlUUjlEgQtyTuV6xWw240+ZzzdsqV1ScOq7hIrIM5V8hUy1N4xZH4RjFXMNJWCL8VM= qyQPWreSZTDZByi4IKJVUFhBCWtpeMki9g2/h4eq5v7PXgw9Zo1RPSeu3tplKZUZO2RUxEWmRrE= A/ssSyXbLs4uwPIpo4mY5osqUiqzZlIqOWyCqhSqKJJEOcpTCIAaR0pv+J/u/X2/2djCcpg5KP0= c/3een6el1+T+26+XH+g0iPH02Of0gub2D9A/u0/R0ufyfu3X+w0j9op/XcXwqfmn2c+sJ/IVOO= Mfg3n/VGeDzyI/dW0+EdtwX4es1/WxkL7VyurcPR/Pxyb39Q9l+2dC1UfuC/D1mv62MhfauV1bh= 6P5+OTe/qHsv2zoWth95f0L559V6D+hxB+7/AOljJfrFP/PUYcgL+d+kP8NQ16huPH+U9k25WlR= TdV3LSGKrK/imiBROs7kYBqM+zapFKAiZRwvGERTKAcmOcofPqZRfzv0h/hrgsim4SURVIVRJUh= k1CHKBiHIcBKchij8kxTFESmKYBAQEQEBAdea6HToYcjSR9ljj0Gx8+bpL7kqltf3qY+uuQZJGD= otjYTdAtM66N2tIFtZW6ZI+VfnDyRYM5prHDIOBDtaszLuT/IRNw+gwzXh2TZt37DKmOnbN2kRd= s5b3SuKoLoqlA6aqShJIxDpnKICUxREBDSwm+voG5ElsmWbJWz17WX1Tt0k+nXmJ7JKErz+qSki= 4M6eNKrLOkxiH1dO4VWUYR8g5jnUOj2MUVH7chFEq+CdEDqQkKBS4nhilD2AXJ1GAA/RAJ4OA/q= 4DV44imIfqBCRbSbDjzuRb28cWvgw3Pvvt1VtOxbd8NZssDYis8BZKK7NBy8fLFamVqkmZIrgWL= lcERUKQ4pgp2icCmEvIAPCsfSgaSr7a71VmsKRZSTW20xpWxG/PjH4jMjGWIkBflCczcFQAA8x5= 9g6sg2KdOjdphTZ9v9xLkijMYy8Z1xyFexrHJXCuSqMvKfFa1xgoLvmUm4ZxZBeSjJMyr9dBPtU= MoAiVM4l2Z0Yun1uG2pSO5JruSocTBQWUavSoKKboWOv2RGYRjl7WScaOkoZ+9FBL1SYbEN6yUp= FyrHKTv7DgCFKJHIuoP6aEEbaxdDcffex91sGFltkdR3cXjK0pXdmM9LQmVHNUerPSwN+rWP5eR= rDV8wO/aNZCyTUGlIkTdixdOI1k4Wcimh62ZuKDVVRO9za3ty63dc3E4bnc3WTJ7nEcVfIJ7kFC= UzxQp6OWq6LooyZHkMwujx7JICjz4jRs0cLKhyUiRxEAHTm4noT7q8WZhkcgbL7OxmqmtMO5epI= oXM1DyLRQeKqqjEjJPF2LSQbsk1haNJZjMEdOmwdrxi3OBjq5PgTZH1oK1m7ElhyNdcmusfwmRa= hK3Vq83FN5dmvV2M4xczaLqJC2uBkm6kem4KqxBBb1kgmR8I/f2C48iuupWi3U3Dj0r8WBPjfYf= pgxD/cF59c90PHP9MDFgh83tk6YIce7n36vF9ITKX+Q7Xx4DkM107gePZ/wHav2/wBft1DfLnTI= 3hWzqnr7nIPHkU5w8fcVQsglsB7lV27savBPa2tIvQhVpMkp4iSca6MVr6t6wp2ACaZhOUBtK6w= W2DMm7Pa5DYzwhXWllt7TJtcsq8e9mYqCSLEx8VPNXa4PZd00aidNZ82KCJVRVP3iJSiBTCDbMp= emNx6KDVxZSNPPAHHmOPDBhYmbbSKvRRpy7UFBj2292XNJ9nd2FFagPU2ZlgDy7fF7ykE3l3mDj= z4Abx/R2pymr7Sr5ARzqOC5x2Xpp7Z2RFUQlPUn8LCEgnrlHnxxZqoN3DZquYoJCq2cJFMKiagB= mGyfpp2g3TjyRs+3X10lUlrverHPsVoaWhp97XnB0IJxV7TGvI1w7Yi9jJaNFczJRYnrTUi7F0B= Wz0/dTZN9EnqS4VuUqTCUtGT8WqZZqyulCycnQnUrFgoYzckpGysjCSLRcyZUzrsvFftUF+SIPX= ZCFWOoujrJEXVW1lgx3BHo8WsLXB4N/YLYMOdZG4+59eOQAQ+J9lAPLn2wr3SWHQcmWta3uZHsL= 8TeowO3zK0y77AExwaRk3U3q/aHHmbwkD9oefn9OrIem1sm6jeHs2Xuw7mHVofUKZwTkSpRLaZy= +0urI9zm3VcNBh8Ep2GTFBUWzOTIWRO3Im2IdRMyyfjgBsX6UHTI3Vbat0Vwvue8dxUJjyy4ivt= IWdNLfW5xRy7skpXlEWR2UPIu3ZE3LBm+71jJFSTEgFMcDnIBkLpjSZTIrXVbWsL3I1WBJOw5P4= bnBiuf+Wv1POoBuQtFX25ZCvEY8XPPTNZxtRLZC0KDrtOiHZG6YryMo/hWjxdui4ZldvZGQVePH= S4iQBKJCE0Vvvw/1Jsb1ejSG+SWucpV5CekGlI+NOT6rfkUZwjFNV+LVrA2ObXYKGY+GB1l0kEl= CABCnMYoF1NrJXRS3+4SzbZLHtTlySdZXk5Ven3aq5Ha4+trCBlFzLEhplF5IwzxF43SMRq89Qc= O4554JXBFC+IZBLXmQulZ1gctNGEflFCyZDYRTlR3Fs7nnWv2NtHOlk/CVcs0Za1uk2y6iQAmoq= iUhzkDtMIhp9WjBXS8SqANrWbgbX8PcOPPgxRto1bp9446jH/RDA/+ZFD/APftGnerF++vvwYri= N7B+gf3afo6XP5P3br/AGGkftFP6QXN7B+gf3afo6XP5P3br/YaR+0U/rtH4VPzT7OfWE/kKnHG= Hwb/AJ055/Am/OU+EdtwX4es1/WxkL7VyurcPR/Pxyb39Q9l+2dC1UfuC/D1mv62MhfauV1bh6P= 5+OTe/qHsv2zoWth95f0L559V6D+hxCO7/wCljJfrFP8Az1GHIC/nfpD/AA1y1xL+d+kP8Nctea= y8D2D8Meg2ITZ56iO0PbLe/ua5uy0zpVzGGYWAsMtX7TJqDESarpFi8FzEQr5mALqMnRQT8fxS+= EJjkKUxBHSw9ZbpyceW4mN/XT75x9mdLdekDfj7p+z8CuPw8gAPIJK1+7W5cNej7XfMOG8ZZaY7= javDEyVj6qXtpCO6NKuTxhLVAspxCOcPUZohVzNAelbKuU25SqCmZQqRQEC6uVji0K7uw1AG3rN= jtYHw232vzzgwzZgbfVtN3MSR4PC2b6ZcLCmmor8WQcuoWzLIop+KuuzgJ9tGSj9ugT5bhwwauU= UC+axychqRdwvdIx7FEnr7cKxSYNR2iwTmLbPRddizvnBFVUGRX8u6ZtTO100F1Em4K+MoRFUxC= CCZxD5zG4jb/nDp+7ikqXYpU0DkClOoe5Uq8VB48btpJl4wuIWyV96JGrxEoOGyrddFUiard42d= NFQOUgmOztumvGN9/XSiwHkXNGcK5t7aWW705/YrrPVuaskWtfqxGXWtzEI3ia2RV83NLP0JWUa= Km4Qbtm/hKCBlCANHhVTHpY6HsCRY6SPKw3vxb1HBi/Kn3qk5CijTtCt9ZusIR0sxNMVOdjLFFl= etypmXaDIRLp20BygVVIyqHjeKmVVMTkADlEcq1VF0dcb4xxVtMfVnFGboHP8AVhypb5M18rldn= aywTknUdXU3cGMbYE035nDBNugqo4AvgKFeEKmIiQ46kNlPqN7H8L2V5TcjbkscwtpjVjNpSCYv= 3tnkYh0QeFGcuhVWM2MU9SEQ8VlIC2dp8h3ol5DlrSblV1NYkX0kHm24ttvtgxNfWubnmHEuOHj= SPyFk/H1Ffv0DumLK4XKvVp28bJqCkdw1bzMiyVcIEVAUzKokOmU4CQTAby1CL77z05P+tDUefZ= x8X75z+2qBqsjrLYZ2257yRg645L3iUrb+CmLll6vGWOiXO0LWqAlJYZJvPNF4BuJGbcSrpperP= CJuREe4SAA8BVUuwV9SA330k8W4Hu549l8GGFbflfH9HxlO5jnrPHJ40rlWcXWUt0ec0zFFqrVk= MirNs1Ygr00kyMx4dIKRxHIOURKZDxAMXnTG3Devtr3avLSxwDkdrfXFLbxjqyJt4awRQxqEwd2= lGnOabi44q/rKjB2UAbiqJPBHxAL3EE1a+6fcFtswL0u2m3eXzZAS1ovWyhvXcQOUoayNQygxLQ= m0BCzkQgMWuWMbzixElm7aYdNVm3rBSOBL2mNqoHoVbtNvG1mybhnefcmROOG1xhcft62tKsJx6= EqtEPbQrIkRCFipM5BaketTHFcqQCC5RIJuDcLEWqNnGq6kabD5QuPPc3B8MGHUtGoj5D33bTMU= ULGuTshZlgqzRMwMF5TG9ieRdmXa2lg2bMna7lmgxhHb1uRNvIslRCQbNDiC5QAomA5S6VL1d+n= IYxShuip4CYwFATQN7KUBEeAExjVUClL7zGEAAPMRAAEdNBWPCsfDgnBix9Q4JpnOPsIUTD9ABy= P7NQfxF1HtnOdsmtMO4ry+ytORXxpYravJV21sFFBhEll5Ph3JwjNiX1ZJBU497kvf2CCXeYQKM= lcb5exfm2lJ3nEd8q+RKi/TdIt5+py7SXjwcoJ8uGThRqoc7J+2ExQdR7wjd62MYCuG6YjxpJzo= 6AH30apf7fLf+FS/+4NOJHrEt7gxqWHrsdwdr3v4e/Bh7EPYH0aNGjTNvb7z/fh+PmcGPmHG9g/= QP7tP0dLn8n7t1/sNI/aKf0gub2D9A6fn6XQgHT9268/6jSIf+o58P2D5D7tdzfCp+afZz6wn8h= U44w+Df86c8/gR/OU+Ed9wX4es1/WxkL7VyurcPR/fxyb39Q9l+2dC1UfuC/D1mv8AryxkL9lrl= QH9urbfR/jAG8m9c+z7hFm8/m8rlQ+Q+nyHy1sPvL27l888/wDC9Bt47fEcQfu/IHevkp/7FN97= z/8AuHIy/nfpD/DXLXEDlHnz9nv4/u/V8+uWvNcbADyx6DA8eFxe2EePSBvx9yfUtQP8Stem4tj= wB/I02q+X/N6w/wDYGA0o76QN+PuT6lqB/iVr1PTAHX+294fwJh7FErhLM0vOY1xdSKM/fx61JS= ipGSqtajoVy6ZqubER2Ri6csjqonXaFXKgconQBQBT1cFGeGLSpb0Re3h6Kj8b38rYrjTnpJDGJ= SzNtzfoJoFmXWObQ3fnIBAXUYNLEieOBYS/LFMizqR8Hv8AkgJle0Oe4dRwtK71boKY/TdCoKDb= eSogwA4iJStPgq6LGKmA+QE9bVcjwHl3Cb5+R1BvfZvHue/fcGfJj2tnr7IGEdTMe0Zk6UmXUVC= oul1GjNV0m2bjIy8nIvl3TpRBoiU67hNsgmKSKZhum364Dl9tfRF244usjUGdraZco1itbQUwTV= Z2C2w+RrE/jnIAI9zmL+EU4xYwiPJ2YgA9oFAHT/lrArGzGRdvIbE7+rx8Lnk2wY1rts3CWnbh0= Lcq2qjSjmDuNu3BWTG8BNM1VG76JVtcfViSb5iukdNZu+bwLOWFk6ROVVo68F0iYqiRB1FrpfdK= tTqARGQ8l3rI0vRKBUrGnVUHULHNJWxWe1rRzealP5+TVFu0aRTORi1nK6qDpZ8vJFIQUhQVUPu= rGWJrBlXoJ5JNWmDqTksc7mZbJSzFkkdZyrEQTCtx86uVJMBMZOPh5l5JuB/MbslT8cFHXe6M/V= Awhs5ouSML7gFJ+ArFiuf3QqrcYSAe2VBvJvYWLgpuEmY6IKvLolVSgop1FOmce9R8Qz9N6ZoX1= Y6tAzBJDHcPquSPlWGnYbDz999htgxA7qf7J6jsRztW8TUu5WK6xU7jaJuy8nZm0c0fIvJCesUQ= oySTjEkm5myaUKisUxiiqJ1lAMIlAgBNTrrgATOybgOP6Llc/ez1HbrIbrsJ7v8AcnUMj4Isb+z= VOHxLCVN++ka7OVpZKbZWa1SThsVjPMWDtVMrSVZqA5TSMgYyhkynE6ZwLInrsf8ALWyb/uuVz9= 7PSlLE0976rPe/N/Rvfje1/swYnnuk2JY4z50yMGbmLLZ7bE27b7sLq0jWIaGUiyQUutF4/YWBE= k0V0wcPTEO6IVJT1Ry3EUBECiU/ytVOdJXp4Yt39TeaI3JdtutVRxtG017EqVBSITUeKWJzYEHR= XvwrHvymIiWJbi38AEhAVFfE7/kdrJtjZun/AEP1mrJA7lwfp8MFCIplEyhit8NtXKvYUAEREqK= Sh+AARECjpfvojb3Nvmz29ZyT3AWt7SYnIdbqBYCwJ12fscd6/WX84d3HPUKzHS8o2XcoTKazNY= Y8zMwNnKa7lBUUCLoRpOlJpuSHstuRcjgePjt58DwwYvQ3ubD9mQ7ZNvVA3I7gJvEGMNtca7qtO= tT6ZrcbJ2VWSjItn6m6QexTxSZlxaQBXKMfX48zsxQdrA1MiQfDo1yDtV6MKNLs6+Pd/t1Vu7aF= knFXbzdNtDmHeTbdqqrHMn5EMYsVBavXREmx1U3iPhFV8YDiBRAcl6+eYEsw5b20WanWB9O4Ws2= A2l5x87FtKR8XJuLJap5KVl28ZKtmLlu/XjY2BSckeNUHqaCTRNZNMOAHEavhnoeucTRMnYd0ua= 2+T1aQk8k4ZWu25u3SuhogVlowSMsSvY0jUkwPqpTIS7pv4HaYJBUOVxrGpCKxeUFiTaMXAOoXv= cbX8duTxgxnfo9OT7VAbpMj4mZyzhakXjF87PycT4igsDz9SfRpImaQQOYCouvUJKRaLKkIU7hu= ukC3d6ukBNK9HTy6o9T/AO0Zb/wqX1k/QIKiXfjKFbGMduGHMjAgcwCBjog6hQSMIGABARIBRHk= AHnnyL7Axfo5/lRql/t8tf4VL6UdjUeuFQdgLkjk2Gx24wYex0aNGrHBj5hhx8vp/b/nyH/PGnb= +mPug26xezDA2PpfN+MIa6Q1Vex0vWZe5wMZNRrtafmFyoOo989brkUMg4SWAhg5FM5TB5DqYqW= wDZKimCZNqWAuAAAAT4wqShvL2dxjxRjmH5+RNz5j566T7p47HpAhk19qmC0wMAgJmePK9Hq+fu= WYMWyoD5jwIHAwfMPmOule8vvk7Kd5WV0OVVeUdocqSgrzXw1FNJltUXfoSQaJIZZIRpIl1ArKp= BXk74537v+6ftX2AzKqzKkzLs/mTVlH8TlgqP2jTqqGWOYuksUTsGBjCi6EWLbC+KLsldC9zle4= 3e/wCMd3mNp1a42ixWpCIc1U3qzU0/LO5QrI8vA3GfOsm39a8EXZYooqgQFAbp8imEfIvpJdTba= 1akclYHsFSlbNFlVRRk8V5B+DZRzHmUTWVZvI65xlWQkmLk7dAXMUoL9BwciZToq+GBgYk+9hbI= UVwdReEWVcclMJyOKpcsh1VVI/PICiav2yO8HtH2An2lD5i+Y6y2P2T1GsKEVx3mbczjoyJBIg3= h85221xCQcBxzXMpGyBXVezgPDBeLV7A5KTtKYwDYU3fnn8FIMvbPxm+XdFaV8v7S9kctNLLTBF= ToTyZVmRllQqoUlo2J5Oo3GLubuZyiWpFcMjbK6/rGpFbkHauv+MRzs5kMsK5ll6pE2tmZRHKgU= GwIxWJhLqr7gMKO2FD6i+3e94/Ap0WKWbK9TpRKFU7RRQ9btUKgm4jVSc+M4dzVRkFETAYhG9ZK= UDKDeNjXKuPsv1aOuuM7jAXarSiRVmczXpFtItDd5QOKKwoHMo1dJ9wFcNHJEXLc4CmskmcBKGl= VMRZ6jWS0WnnCuZWhVSim7ic54krso6etjFEpmoTeM3mN45qKhOSqOXtPnAEBERbnHyHT8Bs4j6= 9Z396xVDIbWMmqqFdPZPDk+Wfw/eBSIUCsrzi2Xiq3FSZHInUUdqx8HBzyIGOpH3JB2JVR1vntV= 2RzsvV0lDT9m8wYkuuUz1VVkU8htxl+YRQ5jloPnRvXwLYKlKgBbE+yOn7V5MEpqqqqe0FCoCr+= 1IqenzmFRYEiuopJ6HMCABYVgo5XIJaqJIU4Pu26S+2jehlcMx5ancpR9qCtRNVKhTrLBxUQMZD= LP12igtZGry7j1ox5FfxlAdgmcoJAVMolMY8Yx9Hh2Of61Z+H/wAbVX/4Hq5KlWS4mTJCZGgWUV= ZUQ8MZauquX1QsAJ9oeuxKrwicjEqr8gqpBTBTuGRzKNmknOINhk1doB7A492oMTLCxj6lwttJR= leNhsQUYCxU8jg2NioOJ3FIsqBwGW/KupV12BsyncEXsRxtsSMVfbaOkJsp2wWxjfapRJa53iJc= ldwlmyZN/GlzAuiB/NOoiMTaRsA0fIn/AJxvIhEGkG6nB27lIwFEJK7wdoGMd62K2WIMsPrXHVZ= jbYm5Ir02TYRMsMrDMZZg0TO6kYqYQMzMjMOhWSBoVQ6hUjFXIBTFPKzRpssxIYkkjgk8cceXGH= MQs2+bZMF7A9u9vocBK2FfEkO4tuRLXIX50zsDtuzcxLUbEdyEVCME3MYjGxAH9TJGrrGDxigK/= iFTLQblfF3o+eUbW/tjXOUvjJzKOFnT+Kxs6t8ZAKul1DHVVbQ85Q7C1jCGOYRBrEgxZJ+xNsTz= 00Xk2gxWVMeXfGs66fsoS+1SfqEs7ilG6Mo1jrDGOYt44j1XbV61TeJIOTnbHcs3KBVikFVBUnJ= BozD0cjZn8+V9y30BacZ//VIfu05GwBJZ5FJtutiSPG5P2YMLFbxaFtXic7RFD2OWu7ZRoL2Er0= eM1Z/EcyEtfpaSeJOI2ED4u1xw4YpNloZsn3RYGPImeESXXTAgg5juH6VuBt4cXhiQzbNZHYT+L= MXQNBYlo89DQzJdBmzamdKO0ZKuzaii4u0zgQ5F0iFS4KKYiAnHFdsfRV2a7YMhRmUoZDIGTbnX= 3Sb+rvcqT0JLx1akUgEEZSNhq5WKvHLySAj4jV3LIyZ2K5SOmINnSSSxLcwDtKAeXkAfR5aVLNq= 0BC3oAgsdi17He23gMGNW0DE1Qx7h2pYOZILTNGp9BiMbNWliFCRcSlXiIJGvJt5sybZs1eqvYx= EU5AStEEHBlFeG6aZgTCoyz+j/AGw+xT0nMsVsw1FtIvFnZICt3eN+BY3xzioZtHJzdXmpBJqmJ= uEEVpFwKafaQD9oAGpOdSLcHdsT41qdHw9OyrLLOTbvARJ2tJhlLVkuHxe2cLOsi3On1huyk13D= 2FiW4IJvlGKqbRR54rcSPSt1EvVttzcthJFlEDH2i+1i1Ud7lGhNsh2Obir9T8W4+qDJxka1Zel= 7vFDMxjhxZFGsdXIp8WUkJCYmCtlHkXHFEsbnqbszm0+W0eZU+gjMJatKWnLMk0sdF0etKTIFjV= W6kjREvZ0palrjphXjNR2qyylzKsy6YyL8QjpXqqgAPFG9Z1OlEFTVI7qUQS2T0GqKcWbqErmmU= OmntYzHt/xht4yFXpqcreGoJrX8d20swVhkCvNGrVFmoqjYGLJBsuZ+i2R+EWjmMWinayCCx4/x= UETEhKHo8uxkef8ASvPnv8rtVh8ufm5of6vnH+vUbEc+ZssMNlFmtnXI+OrFmC5xRzwDNKnuatS= Y++x8hkHIrhaYsEJK2qKNg/BUbBml0KzI1VCPs87FlFY0i7ci6sDZ7zbDQcSsr5ANbTf42tuquF= hgcnqR7W9zNLtFWKGOlq6vT6vB1+ItVxsEzUjepTLayKuWko8QO9Tfxz8kbl8x7C5xQGBYquCsk= qKgQLFEJY1DyR07oTLUJHCVmmlenjZXdGliY6lB2xWX9vssrhM8kFRSwQQmZpZDHISFklVwIone= YNFFGs8qNGrqkigBipOMs2mdJbbRszyorl7E85lOQs6tZlqodC42SDlIkI2aO1O7OVtH1eIXB2U= WiQIqC6EhAFTuSOIlEvQ259IjbDtgznHbgseT+Vnl5jTWAyDSzWaCkIExrIg5bPxUZMqpGuTgVN= yoLYCvieGcCifxClEB9FBdQ2OLZso2Bmzs9siDO7TKwlZlJGqwdWpuMcKwUdF5ByLH2JtEqSkmx= s2QHkjV4NnIKSQzNihnLeKcsGCS5086wBmOe3R7lGGQvAnaLScXYdjYQaG6kzLC+yxkZhXLhc2M= sDQEG75TG9edVSEcC7bpmZzkzINyJNnSbpEmKn7K51Sw1dVXRimpqal68kzspJk0osVL0Q4l6jV= DinZivTRg76jGupsnB2uymsmpaaikNVVVVSII4UDACIMxkqjKU6XSSBTNpDdRto9IfUFs5DzAPo= DRoDyAPn8g89GoxiTXP7p94/X2/wBnbzo0aNGFYNGjRowYBDnyHXHsD3eX6/38/wANGjRbBjiKR= RAOfPjzAR55AeeeQ8w41+geQAHu0aNAFuMGDRo0aMGDRo0aMGDQIcgIe8ONGjRgxSluWhYKB6iN= Xd2trJ3GEzLgYlVXhUJ6Tqi9bQoVwQtaiLOYiFFHD6AtaqBI+01pZu3ZzDEy7WQcO2LlwxUmXB7= YsKZrpEBYr1TgcjMU6z1dvHRM7ZoBgwx9c5pCxjRVEISaYISEPDPmEW5igcIlSj5Fgk/iWsUHY1= SNGp/n9ZV0uS9lKumqZ6eoOUQx9SCWSIqsM1VTx6FRlVCIYYkZkVWk0BpGZ/Sxr7JKOkqc57T01= RTQTwDNZZenNDHKC8sdBO5YurM46s8rqrlkj1lY1VbKPem2J7XzOju1saouVV/jeV2V3YbU8SfE= vrRiytSb9JzOKleJygR7V2Yq/ieBJEUkmwpPVlVj7AU2z4eVx1D4tc1x09p8FMQNgZNntgsTqUV= l6wq1VhHkhYF5U87JHYkZNGiRH0gukDBugw8P1NFNEpo1EJM5zaZozLmdfIYWDxdSrnfpum6NHq= c6GUyOQVsQWJviXx5NlMQcR5bRRiRWSQJTRKHRtIZXso1KQigg3FlA4GNbr7Cdra8c1ivucGbsW= 1dkakZFlabixF7XJKbb2MYiUUaWBE8qyj5xqhJQyUiZyWHckE8aDYTn7t24rwbjLDKU+jjquFgi= 2ecf2GZMeRlpVZxKSjlZ8/UTXmH8gs1QcPl3L4zNsok0B47cuQRBZdU5zRqlRmuZ1cbQ1WY1tRC= 79RopqqeWNnLBixR3KliQDe19h5CyoMpyullWamy6igmQaUlipoY5FXTp0q6oGAC7AA2AJtycbg= 0aNGrDGQx//9k=3D" width=3D"162" height=3D"85" alt=3D"editorial1.png" style= =3D"margin-right:9pt; margin-left:9pt; float:left; position:relative" /><br= /><span style=3D"font-family:'Times New Roman'"> </span></p><p style= =3D"margin-top:6pt; margin-bottom:12pt; text-align:justify; line-height:115= %; font-size:12pt"><span style=3D"font-family:'Times New Roman'"> </sp= an></p><p style=3D"margin-top:6pt; margin-bottom:12pt; text-align:justify; = line-height:115%; font-size:12pt"><span style=3D"font-family:'Times New Rom= an'"> </span></p><p style=3D"margin-bottom:0pt; text-align:justify; li= ne-height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman= '; letter-spacing:0.25pt; color:#2c2c2c"> </span></p><p style=3D"line-= height:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'">= El art=C3=ADculo queda en propiedad de la revista y, por tanto, su publicac= i=C3=B3n parcial y/o total en otro medio tiene que ser autorizado por el di= rector de la </span><span style=3D"font-family:'Times New Roman'; font-weig= ht:bold">Revista Anatom=C3=ADa Digital</span><span style=3D"font-family:'Ti= mes New Roman'">.</span></p><p style=3D"margin-bottom:0pt; text-align:justi= fy; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times New= Roman'; letter-spacing:0.25pt; color:#2c2c2c"> </span></p><p style=3D= "margin-bottom:0pt; text-align:justify; line-height:115%; font-size:12pt"><= span style=3D"height:0pt; text-align:left; display:block; position:absolute= ; z-index:-1"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAjc= AAABrCAYAAACL+6MLAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAIABJRE= FUeJzsvXeAnVWd//8657l1ajIzSSa99x4IxQQpsQQ1IFEXQWm7VFfdXfiuKH6XH5bdRUVAhagro= OJPRdRQRHpNaCE9IZNMejKZZJJMb3fuvc9zPt8/nnLvlIQWILDPG2Zy597nnuec8zzPOe/z/pSj= REQIESJEiBAhQoT4kEC/3xUIESJEiBAhQoQ4lgjJTYgQIUKECBHiQ4WQ3IQIESJEiBAhPlQIyU2= IECFChAgR4kOFkNyECBEiRIgQIT5UCMlNiBAhQoQIEeJDhZDchAgRIkSIECE+VAjJTYjjDmHqpR= AhQoQI8U4QkpsQIUKECBEixIcKIbkJESJEiBAhQnyoEJKbECFChAgRIsSHCiG5CREiRIgQIUJ8q= BCSmxAhQoQIESLEhwofMnIj3k+IECFChAgR4n8rIu93BY4t1PtdgRAhQoQIESLE+4wPmXITIkSI= ECFChPjfjpDcvAsIk9CFCBEiRIgQ7x/e0CzlT9RKqW7viQhKqW7vv79w/W3c6r4/9fL7qmef9dW= HIUKECBEiRIh3B0clN8aY4Ad6T86WZR03E7YACoX3//sCYwyO4wC9+0ophdYarUOxLESIECFChH= g3cVRy09zczLp16zh8+HA3IuP/O336dEaNGkU0Gn33a9oHxP9tpzFdLRg7hYoksBIlYMUBDUq9J= 2Qnk8mwY8cOqqqqMMagtQ76yRjDwIEDmTFjBqWlpceIEIrX/t7tc4lez2Nzx/lGs+ODloYIESJE= iBDHFkclN4cOHeKRRx5hw4YNRCIR6urq2L59Ox0dHQDceuutXHHFFe8BuRFvxla+8ckzi4Gkm0n= tWEnThmV0NO4jWjqQftPOoGjsKUQL+iFYaAUqCBM/9sqJiOA4DvX19axcuZINGzbw2muv0djYGJ= ikFixYwK233sqMGTOOyfkCcuMxFCVev3h9pEWhMIjyyIxIHus5nsyJIUKECBEixLHFEcmNiDBmz= Bi+/e1vk81msSyLxx57jP/6r/+iuroaeC99SFT3V77Drt1F547XOPDUr2naug4700ksnqRh335k= ehtjTjyDsvKBYHmERt49m1UikeC0005j3rx51NTU8LOf/Yxf/epXtLa2HtsTeU0XpdAeXxMlOd4= iggKMAiUGJQAWChDteMdYfck7IUKECBEixIcCR5QxlFLEYjHKy8uprKxkwIABlJWVEY/H38v65V= XIf+HO7hqQzlZat6+lfU81cZOhIhmnJCLYzYd5+C9/4uEHHyCd7sp9VfGupfhTSiEiaK0ZOXIkZ= 599NhMmTOj2+TtFfopCJeBkMohtgygEhUtdlPufuATI5XOuzxRGIRmDOK6iEyJEiBAhQnwY8ZZs= NH6UlI93O1rKP5/7E5zV/Qxwsl10tTaSSXcQi0VIFsRQsSgUJOno6mLp0qU0Nze/a/ULatTDFwm= goqKCysrKd+FsXkcYw+HXN7P3+eW0796LZLMuwVEu0VEiIBrEcvuqs5PGDa+z9/lldByoexfqFS= JEiBAhQhwfOG4zFIsItm2TSqUoKiqmO4dSgGDFC0j0G0QsXkAm3UZzSmPHCuiyimnrPEht7X7aO= zoC/5z3EolEgoKCgmNapvJdqJWCrM2+519k9+NPM2TaZIafOZ/yOTNJDB0aHKOUgmyGtl17ObRi= NXufeILO1lamX3k5xUOHgA7lmxAhQoQI8eHDcUtulFJs3ryZNWvWcPHFF+dyxuQdo5Ml9Jt4Mpn= aKpq2rKIzC2lrAJvqMqzZvIPBo8dTXFTsffe9Tax37MO+Je83ZNrbSe2pQbZvp277VprWrKb85J= MY/PGzGDR7BvGyctKHDnFgxQr2PfEcTSvXk6nbD4UFNFVVM+yj84iUFAemLsURXHDC0KoQIUKEC= PEBw3FLbgD++te/sn79ei655JLuH3hcRXScxIhZDDzrUjoTA9n82krWVzfzys4aJFHCl770ZcrK= +gcJB/2vfhCRF+gECKn6JlJ1B0lgsAQyu2o4sLeOw6vWMuDMUxk8dRoN66uofe550rUHiGcdkpa= mqytL8+ubaa+ppXTKJAQwCEoJWlTgc62EHsTng9pzIUKECBHifxuOO3LjE5GmpiaWLl3KqFGjuv= my+BRFvGlZxZIkx8xlcLKSfclJFK9/nXnjFSeedCoLFpxJLBb7kIQ9+2120XmwjmzTYbQR0BZaG= ySdIrVpMztq9lDbvz/ZxhZo7yAStcCy0FhEHYf2Xbto3L6N0knjUDqSc7zyY8uVmxcHxHXCdmPJ= Q4ITIkSIECE+EDiuyE2+wvLYY4+xdetWJk+e3OexrqVJ3NwuOkrp0HGcurCSqfM+RsSyKCsrJxK= NfmginnOGNYUyQseBfWRbmiDrkLEE3a+YxIAB9K+oIFJSgopGkUyGTHsbmfpGsgcbyLa0YjlZso= cP0rB2LYPnziZZOQTlm8+UQinc2Cpl0MY/M2HoeIgQIUKE+MDguCA3+XsyKaWora1lyZIl2LaNZ= Vl9fSO3h5TvLaIUxSUlFJeUeETgvXcWySdnx7xsQHk2I0lnaNu5j1R7iuTIUQybewIDT55NydjR= RPqVEonHUZaFcWycdAa7qYXWXbs5tGoN9atWk67dx/4nnyXb1ErR2HHEKwdROHgQxQPKSZaVEik= uRsWiGDRKRTxH5pDZhAgRIkSIDwbeNXJztM0ij/SZUor29nZ+9KMfsXr16m7Hdv9+8A1AoRFEjG= dR0W40kbx7SQaPVv98gpNfd9u2gz26esIY02dYfU9fIT83TUdzMy0Zm+HnfJoxn1hA6YRJxPuXo= pMJFBqjAQyWKGyl0I6hbOZUBp8xj5ZtO9jz+NMceOY5av72OJF4Al2QRBcVkehXQrK8HF1RQdGc= aUw999NEkhEMChWapUKECBEixAcEx5Tc9MyB47+XzWZJp9NYlkU8Hg/UmJ4koba2lttuu43f/e5= 3dHV1obUmEuldRff4/IlWBWHSwV5SRyE2b0Zh6XnMkdrW1taGbdvE43EKCwu7+wflve6L3Pg5fI= 4UVdWLJHltixcWMPuCzxMrKSJRUYaOxrp9T+N6yBgEC4WyNLqggEhBAckBAyibPJmhJ5/I5l///= 7St20ikowMaGknv0aSBVsemIp1i2jmf9pIBQmiXChEiRIgQHxQcc+XGn6xTqRTPPPMMjz76KAcO= HAhISiKRYPr06XzsYx9j8uTJJJNJGhsb+fvf/84vf/lLNmzYQHt7e6CCHDp0iBUrVnQjF/5rrYT= ShEWJJTgmiyMGS1uYWCFplUDpCJZlkc1msW2bZDLJiBEjiEQipNNpqqqqeOmll9i1axfZbJb+/f= szd+5cTj31VMrLy7uRL5/sKKWoq6vjgQceYPny5ezcuZP29nbKyso45ZRTOO+88zj55JO71bPna= /9vv7z6+nqWLVvGmjVrqKtzE+yNGDGCM888kxNOOIGCggJEhKbGRg7U7iOTzhCNxdCNGVRzE0op= 7KxNxs4iYhg7agz9yvpjxHD48CFqavZiWRaxWAzHONhZm8jwIQz78oXURP5KavUaYiKIViAOlhK= Gjh2FjsaCfalykVohQoQIESLE8Y1jrtwopdi/fz833XQTS5cuZc6cOXzhC19gwoQJtLe38/jjj3= PnnXdyxx13cP755/PVr36VZ555hltvvZX6+npKSkrIZDJkMhlEhBUrVnDxxRcjImQyGWzbJhKJE= InGyKY6mFRm8empg6iIGWxjoxKFrGtQrDnk0JjK0NzYSKqjk0wmw5QpU3j66aepqanh5ptv5q9/= /SudnZ04jgO4JCaZTHLWWWdx/fXXc8IJJ6C17kZEnnzySa6//nqqq6txHIchQ4YwfPhwmpqa+Ol= Pf8qDDz7Iv/zLv7BgwQJisdgR+0opheM43HvvvfzoRz+ipqaGQYMGcfLJJ5NMJnn88cdZsmQJp5= 9+Otdeey0nn3wya9as4c4772Tv3r00NTbS1t4ekKbKykpKSkowxvDDH/6Qj370o2SzNq+88gq33= XYb6XSa3bt3E4lEGTRwAGXlZVz9T1dw8jWXseEnKbo2bCGOa/KzykopnzwBpbXru6QM78aGoyFC= hAgRIsS7gWNKbrTWNDQ0cNVVV/HCCy9w+eWXc9NNN1FcXBwcc9ZZZzF+/HhuvvlmfvzjH3Pw4EG= uu+46/v73v6O1prm5mQsvvJBNmzahteaMM87gJz/5CUopurq6AnITi8Voaain+tk/k1n/d5JdHT= gmS1GRw1WXXU1s0gK27t7HZZdeyuHDhwFobm7m+eef5zvf+Q7r1q1j/PjxLFiwgEQiwdq1a1mxY= gXNzc088MADNDQ08IMf/IC5c+cGxOahhx7iyiuv5PDhw0SjUb7//e9z6aWXUl5eTltbG88++yx3= 3HEHP/jBD6iurqa9vR2tdZ++NqlUim9961v8/Oc/J5PJ8N3vfperr76a8vJylFK0tLTwhz/8gf/= +7/+mqqqKG2+8kU9/+tPMmTOHVCrF0qVLueWWW9i7dy8AJ598MkuWLCGRSNCvXz+MMcRiMRYuXM= gpp5zCXXfdxZ133smVV17BZZdeSjwWI1lcREEiTqqxkY23LcHU1mE7GeKDBlE6epwXReXXPZRtQ= oQIESLEBwTyFvDwww/L9OnT/dxucvvtt0t7e3vwuTFGvve97wkgw4YNk+XLl4vjOOI4Trdj1q9f= LwsXLhRAotGo3HnnndLW1iYiIq2trTJnzhxRSonWWi688MKj1MiW7S/cL0uvnit/OH+U3HfBcHn= hujnSuu5+kWyHtLS0yAknnCBau/tnl5aWytChQ6WiokJuvPFGqaurC0pqamqSJUuWyNixY4P2ff= 3rX5fa2loREXn55Zdl3LhxopQSpZTccMMNfdZo06ZNct5550lxcbH0799fLMsSQObNmyerV68WE= ZFsNivf/va3paCgQJRS8t3vfrfPsjo6OuSee+6RyspKmTx5svzpT3+SbDYrIiL19fVywQUXSCKR= EEAKCwvlscceC/raGCPGGMlms/L000/L5MmT5aqrrpKmpqagfEccMWIk29gkL3/7JvnLxJnyxyG= jZdk1/yrpxlYxImJL1i1LRMxRrsSxhDHv1ZlChAgRIsSHEcfU1tDc3Mxdd90FwOHDh7n11lupra= 3t5TBbXl5ORUUFWmuy2SzLli2joaEBgEwm003p8E1GvUgZkGpr4+C+fXR0pNEoEkoojkXBcR11H= cegPedlXw1Jp9PceOON3HTTTQwaNChw6u3Xrx/nn38+ixcvDvaEevHFFzlw4AAtLS38+Mc/Zu/e= vYgIFRUVXHrppW49evjVTJo0iSuuuIJhw4bR1NTUq/4iwuOPP84999xDZ2cnQ4cO5fLLL++zrGQ= yyUc+8hFOP/10Nm/ezO23386yZcswxlBeXs5FF10UJDns6Ojg+9//Ps3Nzd1C67ds2cJ3v/tdhg= 8fzje+8Q1X1RHBiAERjAGrXz/GfHIB8WHDECtKxeQJWIkIDqDRQZRUqN2ECBHi2OG93RLn/UfP9= v5va/97i2Nqlqqvr6e2thaAdDrN6tWrWb16NcOHDw+OUUoFZiXLsjDGcPDgQdLp9Js+jz951x8+= xNYt1XS1d1ERs0haQoEVQXvaixgJ4sZFhHg8zj/+4z9y9dVXd3MS9svr378/kyZNoqysjM7OTmp= qamhoaKChoYGVK1eSyWQAGDJkCAMGDAjak982gFmzZvHxj3+crVu39iI37e3t3HvvvTQ2NgIwce= LEPncP9+tVWVnJtGnTePDBB1m1ahUPP/wwkydPZvDgwSxYsIDFixfz85//nKamJl566SXuvPNOv= vnNb2JZFnV1ddx6660B8RkzZozbZshlINauP03F9OmUz5pJx+59dB3YT6a5hVgiDqIQ5dCTBx9v= WZ9tx6GuvgXHMRyZhr31OksudWLe3yr49M2XmPvOmzuuey16f1/1+LznJ0c6X8/ypcdnR66flzf= TfXXUjcj8v9RR/uq7Vrn8VDo4qntW8txfR2pL/plUr/YdqQbvDEopSgoT9Ct5e5vlCuCPFJrcFi= hgQAwohSiN8VqkwR3n3ieIn8Dc+EI3gMptxqsMgsGg0fn+euJdSeUABiUWYLn5uxC3deJGw4qb0= QP9gdvgLncfKjeRPmgbUTZKIiARRNsIBoWF28IgY9vbPJ+fVV51f/LFuHVQ4l0zd7Hq922f53yT= Q9Sbuf3ezSvmz99HwjElNwMHDmTGjBls3LgRrTVDhw5l5MiRfVYq/99UKnVEheZo2L9/P1u3b6P= SyaC0piBuEY36Dw4o1X1A7d+/P5dffjnRaLR7Dpm8f5PJJPF4HIDOzk6am5vZvXs3nZ2dQTmO4x= wxZw1ARUUFM2bMoLy8nEOHDnU7x+rVq1mzZk1A5gYNGkQqleoznw9AJBJh6NChFBUV0dDQwLJly= 1i0aBGDBg0iFotx+eWXs3LlSp5//nmy2Sx33nknCxcuZPLkydx333089dRT3HjjjZx22mm5Qv3x= R0AbwdGC6lfKgBNmsf+ZF9i69FFIFDLxiktJDK5EBXl4dK9rd7yQnEMNrXz1+7+lvqkDwULwFDv= JTQKCRpQ/ab7xoylKEGVQGJSJAQqjbEAjotHaRhlBCyhlQDRG5aZTUfmDsoUShRLjDfy5vEV+PZ= X4Q41C/AlBOXkDvtsK92XEmygMqCxGCaLcbERaNNp47fTaoL0TClYwMWl/MsG4fYNGtEGwg3r4k= 6wl4u03phEibju9drhkx+AnIHCrqTEq4rZDOShx0Jig/oIC0d5eZoI2uOXprPsdSQAOGsedAEV7= 5/OvqwFvYgDjnd8rHwuRiNeL2bxr0JPciM8gul+Mt4FkPMoXFp7AlV847W09E6qPn9yHRyKT7xN= U3r9eTjH3756V7F3pHPHOZUXvTbCPp8YeA3ihpvl5wnJqeI6yv/1WH/mbKkjjAT3zlB3xnEdf4x= yDWr03OKbkpqSkhBtvvJHf/va3RKNRPve5zzF9+vRexxljupmfjDFHnNyPBMdx2LO3lpp9B6gsA= 21BQUIT1QZxskjwXw7xeJyioqKjlpufTE8pRTqd5sCBA4FqA67p7EhkTClFNBqlrKyM4uLigNz4= 8J2WfdTU1PC73/2uzz7w67FmzRps2wZgx44d7Nixg/nz5xOPxxk9ejRXXnkl1dXV1NTUcPDgQW6= //XYWL17Mz372Mz7zmc9wwQUX9CjTn9x9Cu5unNlv/DhiA8qJbNnK9nv/SDbdxdRrrqBg2BB3Ad= nzjs8f147aq+8FlLsiIkowMbtLlyBPj+BPgO7fb1SeP+8p/7Uy7gTtlYvYbn+KDshBbmTw6Yk/e= foRZ8qboHvXQ5QEgx3KCVTHvifmLOg8JcXX4wLeJnnHglF+1JtHlFRPiuedVxQof1jwiJoyOOQG= ShNoDCa33hTtEjTlkg13HWm7n4sKVuMon0/410hc0oegjYWIWypoj/Hl+lv5uoVor7U5QoMYl2A= Gz73DBy3C7wjZrsinBN3Iz/v40AX3jTraAic3nSq6v1DdnhXHO1bnSKby7753PvW/7/BJoE/GA7= KTv9B6p+3rS8X0+83QvQ/fxPneRHWO9yvyjsiN76+S//qcc87hzDPPREQoLCykoaGBpqYmOjo6g= vDugwcPsn///oDcaK3f8mqnta2N6q3baGxoxCovIGpBQTyChWBsx5uwu5dpjDmq4uK3w4cfru3X= +81CRHol7fOjprZv304qlQrqtmPHDpYsWYIxBq11t+0mlFLBe5MmTQIgGo1SWFiI4ziB+nT22Wf= z3HPPcffdd5NOp/nb3/7GihUrGDZsGNdeey1FRUVHlPD8XcABCisHESnvRyaiSWQy7Pjjn8l2dT= HjK1dSOHoUwUreN+Udi2fymEEhxEAygcRLIOKLp6IYt71vapXuNk5J3poruAXyTF+Cp5i4mbEVG= iUO/rbqgY7j74MWXAN3YpdgssdVWbw3RDmeChLxauL3t682ON484CpCORrkJ7F0jw8ITNDk3H3c= bcgTn96ovP5RQZ0lrwNECUoEjeNNRpb7vIl/dreOypu0kIhXrjuYe2fp1g8aBWLhT3viKzLBkb6= +T44wBR0nfve5Q3nQR94N6ktVAdQRXr+/6Lsm3d/1p8P3s9bdej2vIt3pd06Z6HXr+Zejm2rTYw= IWwVUtAfragucDhHxmFzS552LlWF5Vt7zgGfOZcPDM5LsmfHjxtsmN7zvT14RZWFjIjh07WL9+P= a+++iq7d++msbGRTCZDNBrFcRy2bdv2tiutlKL+8GG2bN1KR1cXWiVJRBSJqEuSeikMRyjjzZ6r= r/eO9n3Xmdnppu4opejs7KS+vp5sNhuQpfPPP5+FCxd2C3HPRyQSIRqNBufzzX2+6cwnkVdffTU= rVqxgzZo1tLW1kU6nWbBgAcOGDTtCJb2bWxGsqiNFBcRKCukCIpZFkWOo+esjmLTNlKv/kf5TJn= lbW+QRwDfRh+8VckqENwn6c1swPfp1f3MrevFUn5yg7K++vM/FVRhcU1dwcreP/K4V5Q3iXh188= 42vCuUvgX11Q3wiZoFHGNx8Q/6J/VWvCYhI98EqkJzyyvbt+hJc9xxh98s2AdHJ33DDN14FbUBA= KYxY3SwRvTNZW0HRgi/gdF89qjwC5poB/To53uu8jT88xQbvWKP8IdwjTmLlle0RrG7ql+S1I68= tHCf3cbe64t27uelfe8cE5LVbO95L+OZHFehpitxT5feoyju+Zw8HAo3o4N4LjpL8Y/xrqI6Ti/= TGCIid5N5x4V2vgNxpT318Z03rcde8aZr0AenOt413RG7i8XgvvxXbtnn22Wf59a9/zcqVK0mn0= 0yfPp3Ro0fTv39/+vXrR1tbG42NjRw8ePBtV/xAXR3btu8gAVhKKIhpElF/hXl04vFWcCTl5mjl= 9EV+tNak02nS6XS3786ePZtPfOITb6lOPc8vIkyfPp3LLruM9evXY9s2tm3z0ksv8cILL7Bw4cI= 3LE+Bu01DJAqi0QaUZVGYtdn51PMUz5lB+ZRJmB7k5niBIBjlOu1p/LE/byVovGnan0yPQk6DaU= +B6DxHvXxlQnz3R+0uMnHwhxXxV04iuTooP2ovQ84ZVvkzvqdGeJOtCEpZoLT7g/GUHAEscCJeH= R0g66kkmpwrKvSa7kSjjOvzo/xFnNIuocCfpjx1xNtzw1XoXDVKgpnWoMUzJ/tET3sqk1Ie+fXI= huOb2exgsZp313rER6OUxkF7ZjmDiIOYLEqrgED6yo/2y9MGozRGWS658X2fjH/t3D+UiJevSQe= KUW9qfjzczzllKme+dN/x9C9A0MqAuIsm411zlUe/35uqusohCgyRPBLs3/05wu2TcPd7OYKSOw= rvW1Zwj+S+517tfL+RD9yUrI5Uc5WnXr1LbQpO3PMcH7A+fJt4R2apnuYkx3H4y1/+wm233ca6d= euYPn06F198MWeeeSaDBw+moKCAWCzG1q1bqaqqoqqq6m2dN5PJsGvXLvbs3sXkYrC0oigeIa4V= 6R7rhXcC3yyVSqXe0JyVj3xzXf570Wi0l9rl+9IcrSy/Lvl/90Q2myWVSmFZFpZlkU6n2bZtG3f= ccQdjx45l/PjxPVuXtyJ0JzPjOJis6xiLMmQdm2w8zsgFpzPkxDnus2jEjYg4TgmOUuLVLe+BFl= BiiCghYokbdaLUEe8PX61wjI0jBlGx3GJaDEqyWFqwtOURGc/pWMCfRMXrIkeErONOBqrXHmJuo= VoB4qBwiFigPVKRtb26akVgZhH3ymljiEYNSjkYDLaxcHwlyd+eROfuF20yxLXyfFMVGcfxCIU/= OSl30vQFJI8IKk/h0Qpi0SgxLSgnAyI4WuOIQVkaxxgyjoPBVXMiliauNFrcqVnAJcZ+2UH7I2R= syJqcWpGIWGhMjlx5fk2+bw5KkxVD2uBF8SmiWhO3QIt7LRwNSkdQysK2DRk73wfHUx1ypzw+EO= whl5sOfa8iHVCdLKis96nvOJ9HlN8TuJRLCWilPZLVU0PKXeFAScirnq/5uOQ9R60DRQ9wiZtHp= IAPnHnqDS+Hv3Dwxqw3WJgfDblez/VkzjTtLQ6CSnkrvHyNR/Uuq+8aH+HEb/CF94OaHhOHYt+f= 4+mnn+Y73/kOW7duZfjw4Vx33XWce+65Qd6YfJXnnUTZNDc3s7mqipamRqziIqKWIhmLENGQhkD= LtY6wIeVbgTGml9ryRvB9bvLNUsYYkskkpaWlwX5X/rFHQ09Skx+6npvENE899RT33HMPF154IW= 1tbfzlL38hk8nw4osvctddd/Gtb32Lfv36+aV6CwfJhc0rsDtT2C1tWNh0OTaZwkJGfvYcpvzjl= ymeMA4cPyJGuav044rgKJAoSATEBE+TKEHEYUB5MbOmjGRQ/wJXsejrMVPg+2oZEQ7Wt7J64w6a= 2rIuacJBORkGVSSZOXUUFWWlBARFfDOL5+WjFbYI6YzN3n31VG/bRUfKRnQMIZIb1MVBsEnEYOr= EEYwZMZBYNIIR2LR5H1VbD2DEVTeMGJQRYtowcVwlUycPIRoxZG1h+94GXq+uIZV2PLkbN5eRUm= AMY0aUccK0kSSiMVDC4aYUL62soi2VAR3zIrnciSpnkfcJmzv4VpQVMXvaaAaVxtEIDm7ElCOal= 1ZUsbOmDsuyUBgGlRVz6pyJlBfFEONSQCcYR90zaKVpak/z0opNHGhoRVkRxM4yclgl8+ZOQovx= FLaccqaBrozDpq0HqNpeQ5ftTv8V5UlOnTORitIEIBglmEiMPfs7WbVqIxk75d4PAYHgOBMDlHd= P0IME4FIYk8Vua8LuaESRItgSRfx76c0vvt4pBI2KxokVlaHjJZ65DJQSb4GRr9z43/GJsrtAUl= 6ouPLb7ZF2lOCun3KSRzcB4oOAvEVBThyUXg0Qb+AVMcH1VG+bwOUUWL8OrqnPXRgEwTXekOA64= B9dNQpSpfiLqrwxP5iXvPO9p8rhm8QxITdKKVpbW7nllluorq7MO4b3AAAgAElEQVQmGo0ya9Ys= Fi1aRGFhYS9n1r6UjbeCQ4cOUVVVhbFdqT4ZVRTElBeOa7AiEdLZDNu27nJz3bxNiAiRSIRkMtk= tEeHRorv893v63BhjiEajDBs2jHg8HhCmrq6uN12fdDrNqlWriMfjTJs2jUQiAcDGjRv54Q9/yP= jx47nhhhtoaWlh48aNVFdX09bWxtKlS5k6dSpf+tKXsCwruNFzzqfuT7ruIKaxEdvO4PTvz/gvf= pGJF/0DiRFDEc+ckf8wHC9h4D4Ubg4JN0zYNU0YcbAsw5RJw1i88CSGDyzxxYO+CsgtZgRqD7WQ= Sdm8tLIasRSCQzxiOHHaGM771KkMLCvp9tVuZSowAo4xHKpvYeW6gTy7fB0796dQkTiCxog7yNt= 2hkEDyln0sROYOXGE51QurB13gP3/8yCHWzIY0RhRaHEo61fAuWefzEnThqEtMAZWvb6H+oY2dt= bUoywvb4gAjkMiHmPB6XP45KmTiEejKCU0tqWpO3yI1a/vQeko+CaObv484E+agqG9vQXH7uKku= TMZVl7s3jYK2jOGNSurICtYSiOSpSSumTd7LFPGVAbkuSeXUArWV9ewcuUatMoiopCs+93PfvIk= YuQmBIFASao73Mbhw01UZbNYWIjJEpUU8+eOZcqYIa7TrYJdh9t5fctLpNMZfHOUUvlOzQQDdy+= jwftA3nNpCnK6o+UrF3YnB9a+TPP6V0jYzThkUNpC2RGX42j7PRNu0iaCHjSGkfM/TenwEu95y6= UeCKqRt8BwybKXY8V7PvEJgBeB6Js0877qX7Xjbqx5I4jgjpnkR0mqHPHx7zuVI0IK6XkbvikEV= FL8KEW6KUGuguyeM6I0xvHGcpUX7Xjkgr2iJBANAkKjVO/npA8S937hLZGbnqQk/3VVVRUvv/yy= W2gkwujRo4M9pXp2QGtrK+3t7X2We6Rw6PxjD9YdZNvWbcEDkIxFiUcsdyWg3VXA/ffdz6p1Ve+= IT/pqy6RJk0gkEnR0dABuIr729nYGDhzYjbjlE5uurq5AncnHrFmzKC4upqWlBaBXqPiRoJRi58= 6d/Pa3v+Wkk05iypQpKKU4dOgQP/jBD3Ach//7f/8vY8aMwRjDtddey3XXXUd7ezt79uzhN7/5D= RMmTOCUU07JKT7447rr2Nm0bTup+kakchCTLrmAcZ//PPHBg/CdGJU+OtN/P+EaZHLRUcG7ShGx= NAPLCqksL6J/YQyUCqT0nvCTHLomScOA8mKUMhhlcIzBikaorCxncEV/SpIRAslcRXqYBdw6GIH= y4gIGV5RSUljM7x54hYNNKYjEQFsYFI5xKC1OMmxAP8pLkihxUMpi/KhKSgsTHGzqAs/cgxj6lx= QwYfQQyktiIA6iIgwdUEr/4iS+z4N/pRzjUFQQZ+yISipKCnB5kyYWizKgvAR3KQdGxDeoedU3w= UDl589pbU/x8qtrKCuKcuE5H6VfUQzQZOwsXZ0duPFTFkIWx0kTUQ4lBbHu5MHvIuOW7aSzpFIO= jiRQOoEIZFI2yUiMorjKsRpy7Khet5Dq6sAxBmUlMDhk0l1YQFEyRkQrujI2Lzz3Gus3bCLr4JJ= 6d8bpFRHpX63Au+r9IDbkYsGAwG/MDW/PIk6KzP7tyJbXUB11aJ3C0hYq6xJhE3XcKLF3HQpH4n= S1dZCdNT+Xb0g8AqNzS6dcy/I8bPwJX4Gfs8iflAXLJUD+JOoO5eggjcDxOfb0hPuYiifEuc+R0= lHcfId5kUqKwAcw9823f04jAuLkzZlW8NpSiiyumdxSyq1bvrJ0RHgpLUQhxjVBK49sBvX2z3c8= Cfm8xUQQRwvZ3r17N6lUTvrtqUj4LM8YQ1VVFTt37uyznJ7l+yHPPtLpNHv27mH/gf0ARCwoiFn= EFChxc8w88cijLLnzTmKJGFbk7YtTIoLWmrPOOovKysqgbk1NTdTV1fVZX3DNZjt27KC1tbVbWQ= Cnnnoqo0ePDkK+36zfUTqd5rnnnqOuro5Ro0aRTCbp6urijjvuYNOmTfz7v/87s2bNCqLYzjvvP= C688ELA9cdZtWoVd999N/v27QsUG+UlP1MIpqWFQ2s3kGprYfiCMxj3+cXEKweCCFoU5kimnOMI= ChvXJ8Fxf3w5FUVEKe8hNd4A67sJd//R3n3qr+qzZHG0g60FW2uMimJ01F1le87AuYc8vzKu+uG= SH0O/4iQnz5nICXPGonQayCDY3mCnsBRY3mCnPIfdmBIsAYv8yVaIaLc97miScRPkKSESBG35Ls= 2AErRWWL5px+QmCY3lqiW4TTHKYKQLY7cjdgeO00nW7nKTVmIhOkFrh81zy1axZWeda6UEssZ1G= bY1ZLXCURZZASdQTb3JS4m7ahcbEff62EawRWPrGBmlsLXC8ciW/13EQTDkl+aoLLY2ZJV7PgeN= LSZwWznc0MmqVZvIZGx3d3vxHLxFsLTG0njOuTaOncGxM4hxgnH6+FAKxJMAHCBNlBRxu5mkNFF= stZCQBop0M8WqlWLTRqnT/h78tFHsdJCULjS2qxr5T48Sj6iYoPq9Jjxx3OspnlKoFEpZaG1hKY= VWBIqgUd7T04eydlzDe6aVZ3ruSnewd+8eDjc2uU+Cp4IH9xr+/Ph2TyfBIlv5446ClrY2qrfto= HrzFuoOHsbxTur2scI3jR8J3biyV35zQxN7du2is7MTP3NY/mU+nvjNW5r5o9FoMCn3fPhLSnIS= fTabZe3atdTU1HTbegFgw4YNPProo2QyGQoKCoLMv3550WiUZDIJuBetsbGRdDpNIpFAREilUuz= fv5+Ojg40EItEKExoItpGlKKlLc2rr6xm4SfP5fMXXRKoST3R1+qtJ5RSZLNZJk+ezKJFi9izZw= /t7e2k02lef/11PvKRj3Qry7/BtmzZwvLly/tUboYOHcrnPvc5Nm3aRGNjI6+88go7d+7MbY3Qw= 67pv7dmzRoef/xxZs+ezezZs9Fac//997N06VK+8pWvcOaZZwbXRkQoLy/na1/7GuvXr2fFihW0= t7fzxBNPMHXqVK6++mri8bg7XXjkvWHTFhrXbUR1dYGOECku9nxPHIzOC8GV42Xg7wl/7ZtvBfZ= X6oogjDjPztyRsmnrtEFpIlFNxHK/ZRAcMWzYcZAtOw7gYLkDlfKcYv3zKddwgIL61i4aWtPY4q= ZVT0QTDCkvpCCq8B2cy/sXcsL0kby2djOHmm1XwvfIpRY/Gku7KpAvJ3sDiKuyKVAWBuPm0kGDc= tUTt6nimTK0N8l4xys/K75HcIJXGhELjJtwLxHVTBg9ggkjBxL1zAft6S427zjAnroON2onEqG+= JUVVdQ1zJg3DinkDpM5lG/ajuiTHFAJFKRBw8mYxR2kUDkoEowVbmdyYqyBweM677UTAaIPRNuI= Igus8rDyVp765k9aU4wapKQdlDGXFBZx2ykyGVZZi2wbbcUjbNqmuDI4tdKUNG7fWsO9gc2AmcI= UjtwaOVnmh5ccWiu4rTf9yBWfTIBHBWDZEbbIqhUQ8Q09Ge9f8XalaHty+tcSgJYsi65JOJblJF= T9z9BG+710f/1I2NzewqaqKAwcPEYkmGTliDOPHjqaoKBnc8/464ngcdXrBvwb+5RDhQO0eHnz4= SUZNmMWnPnEGza0NbNu1n+KSMsaOHEoiHvHGYsF6G43MRZN5hMVkqd2zk78+8gxr1m2EdCflQ0f= xD5dczImTxuXNM56G1Nd47rUjly7KJUarX1vB8y+8wMVXXs74MWO9dAxenqp8Yf84YDlHJDd9pd= fPJzcAsVgs+Py0005j0qRJbNmyBWMM1dXV3HLLLXz9619n1KhRZLNZXn31VX7yk58QiUT40pe+x= EMPPcSOHTu6naOoqIiBAwcGE/uePXs4dOgQI0aMCMhGa2urm/QOl9Vn0HTpKC0tKXY2NPLJRYuY= ft41JErLu0U5+aqG/7ov6bmvCx2Px7nmmmtYtWoVzz//PLZtc/fdd3PGGWcwYcKEbmapqqoqfv7= zn7Nx40bi8TjZbBZjTHCMZVl8+ctfZuXKlfzlL3/hwIED3H777fz0pz/t5nCdX58tW7awZMkSot= Eo55xzDmVlZbzwwgv8/Oc/51Of+hTnnXder8zLSinGjx/Ptddey1e+8hUaGhrYv38/f/rTn5gyZ= YoXfu5O+HZTE7uffJr0nloSDjTv3I3pTCFFRRglWBhXGlb6OB9h3ClCPLu/8mzFuczBXhu80OvX= q3dz/8PLSGVAWYqI8hzvtIMt0NCS4eChNrSKI0bQxkF7odBBN3jXavW6apY+sYpOJ41RBnHgjNl= TuOTzZxCPugpJNKKoLC+lvLSEQ43NaEsDdqAigW/ZcnUWo8BYglGGiLgmLBtwVM4BUcTNyOyvBF= 0Z3w2fdUR56ooE+XX8vD2u2cPdzsAS0OJQEI1yyqxxnHvWTCKeMJQ2hr89u5Y//30NTR1diKWxT= YSaA004JmdIcRVuQwTbyzrsj29593Lw2wrq4VZcY4kbwp8WVwgPcqaIaxYLEgsqPCIY8dxRvWhD= sVxVynumOzI2GdE4ShMVg2WyjBtWwefPnsvAfsng2TcinsOzUNfQSVtHB7V1zRijUNqdMLR37+Q= npns30G2lHJBRjTtMRxDRKLHQRiNWBKUtJGOhxY+4eTMP5zupe272crPbOIi4iTGN8SIVVS4vfK= 42eYZSFQFxMKaTfXtruP+hJ1j+0svEvIzcBUXlzF9wNmcvPIshFcVowPHSKBzTdPrvFhSeCcdBt= LvIaG85zObNVUSKKjE47N2zkz/e9zgTJ82icvEA4nErCBrIN+i9ebgLOyMahSbT3srfH/wrL71a= xczZcygtsMhaSdKO41JPrTx/v75TCKjuv7p9cGDfftatXcvn2tvzFJv8ZzxPjnqfcdT7JZPJsGf= PHmpra7Esi9WrVwdbBziOw7p16xgyZAhaa+LxOP/8z//MN7/5TTo6OmhtbeXuu+/mqaeeYty4ca= TTaaqrqxkxYgQ33HADWmuWL1/Ojh072L9/P9u2bWPw4MGsXbs2MOeICPv37+eXv/wl1113Hdlsl= gceeIBHH300qGNX1mbvwXZUO5DNUFJaxojpEyirKKO5y+72KKfTaQ4ePEhxcXGQHE9EyGQy2LaN= iNDc3Bzs+2TbNl1dXdi2zdChQ/nP//xPrrnmGtauXcvatWu5+OKLueGGG5g9ezbpdJrly5fz61/= /mr1797J48WIOHz7Mk08+GfRlR0cHbW1tJJNJbrrpJlpbW3n00Ue5++67KSsr42tf+xrl5eVBfT= s6Oli2bBlLliyhsbGRb/z7N5gwcSIbNmzg5ptvprCwkPPP/yLRSIS2tjaKi4sDVu5HeU2cMJH58= +fz0EMP4TgOq1ev5he/+AX9+/dj3IQJFMWT1Dz9AgeeeRYr1QGRCJ37aunaf4BYRbnrtBiEbH5Q= ofp83dKWYsv2fbSmxVVnRGEphagMRrlhtlpHPQXLJzS9tXYBmto62FlTT3vW3frDyWQpEMVnP3k= SA8qK3eBjpShMxChMJhDjABFPX/JMfsq3x+eX3dsunkt0l6uLm+fHuOl8lFeiFpTjoMXupTgEwo= hSbui5F0WRiEcoLkoQzfNFqawoc5W+jgxaxcg6ivrmdozJDW0BIe/LFIE/vflDdx+LiiMaPXv3S= M/P3Y0Y86QewDG2N+THPF8EIZlIUFSUIJmI4GB7+2V523VoRWtnF0plXXOhlwPIlU9UYN58t4hN= jybltdanohG0RNGOhZW10DqOYyuiThyNxhEb8NRAT/Xz/SJUniIcELQe0lBPdzHd8z3vA1+NEM9= U6BehVFAoAf3zLl3+1CeiUNrQdHAfS//wG156vY6zPnkuJ00bRbarlWUvr+Kxx58mEi3gvE/Np1= 9JnMhRIojcK2SC8ns+LP7TcbRoHv+K9vXNvmZpt0/99vkNzDvO6zzBD+G3EXHJhwAjRg7jC1/4D= CX9KiksiqNwTc0969izBrm/cxQoEFa8BQVK0dbUyLYt1Zx40klc9KULKSkuRERhxWI4SmFJFq2j= b9AXvhKu864riNIIFqI9C46X7Ur18HCRoAz3qJ69+PZI3FvDEcmNUor29naef/55HnvsMfysu6N= Hj2bEiBEAVFdXs3v37iAq6KabbuKee+7hpptuYsuWLXR0dLBlyxa2bt1KPB5n/vz5XH/99Zx++u= k0NzezcOFCampqqK2t5ZprrmH06NEMHjyYG2+8kSeeeILbbruNzs5Obr/9dh577DEqKiqoqKhg8= eLFxGIx1q1dS8pRtHZBpihCZWUxyZISHvrTn3nmJw/SYit27dqJv41BU1MTF110EeXl5UFkkWVZ= 3H333bz44otoramrq6O1tZVEIoFlWfzqV7/ikUceIZPJsGjRIn7/+99zyy23cN9997Fy5UouuOC= CQDVpbW2lvLycr371q3z2s5/lpz/9KfF4PFCgrr/+euLxOIlEgu9973v8z//8DzfffDP33nsvN9= 98M3/84x+ZO3culZWVtLe3s3HjRmpqajj11FP59g3fpq2tjX/713/l9U1V7N61i6FDh3DTTf8f7= e3tnHXWAv7P/7mOZCKJ4Iai/+a3v+Hee++lra2N0tJSb7UqLH9xGTuv2sGkseM4e9xUBq7bgq7d= j9be2ruhibaduymZPtUND1bKi9o4Duj4sYA/D2uFoxRGW6CjGMd9kJVyFUHLiiDGeAOyn9Cudx8= YACviRkFlLVQkikWGlvYO2rsyDPCOiQjEIxEKEnEvYgTPiJP7eaOBuGdD/GPFGLKZLJlMGq28DS= dROHYaJx31yFSPbytym196PlWO+D4OBBNUPB4hGhWUtwmlaBvbyR4H0rM/mbmmvfzqxKMWFmA5G= olESGth1+EmNuyo5SMzRpFQEfBNZV4vun5ANkobz0/8zeQ6P8bNyUNgwBFvlzJlMJbBWKCNwhKF= Vu4uWraKYmET1RkcR6G1e80trdEojHHQlsYRAeVtRCq4CqDy1Bfv/FEDbhdoz+DgZ/zWKG9bENd= dw1UKtEeQ3diuvHtS+XdobuJTGjJdaarWrKdq0zYWfGwxF1x4Pv0TLvkaM24y6TvvYc0Lz3HqnA= kkCoZSvfFVstkMw0aOYfOGLeyvrWfoxGnMPXk6SS3gZTfLpjW7t+9m0+ZN6ESCSbNnMWzIEOIKa= nfvZvfW7YybMJrG9ia2bN6KihYx97TTqSwvJSog3ibCWimwM9TVbKOudj8Vg0ZyqKGBXTW76Ddo= FDNnzGBAv2KUMeBt0rxv105Wr3udpo40E6bOYs6sySQUiBe6oCJRskrjGAftZIhaEXQ0gVEWKIM= ynVS/vpHXq3airWJmzj2FEaMG0ZXuYu2LL6FjUWbMm09cayJZm4N79rJj915KR49k+KiRFFoRop= LlwK6tLH/mCfYdrKej4ABPvfQqZ330VFIdGV6v2sEpc6dQXlLA5k0baGlqY+yEsWzfvZPa2sMMH= jGGqTOmUlIYx02rmaa9oZENa7dSd7CRsRMnksooJFpMBjeTfoQsmXSGTes3sX3Pbor7lzFt2gyG= DhqIZLvYu3M3tYdaSfQrpq7+AIXJQqZPm0ZpURGifAWZXMRYr6EvnyK9NRxVuenfvz+XXXYZl1x= yiVu4Ut3MUvl7NYkIsViMWbNmcfrpp/Paa69RXV1NS0sLxcXFzJo1ixNPPJGysrLAJ+Tb3/42ix= cvZuvWrbS0tDBw4EDmz59PWVkZZ5xxBp/5zGdYt24dxhgKCgqYOHEiM2fOJJFI8A/nf5HXXn2V8= kiGmSMKqSiKoZVgK+GURsXgNousilD49X8hYkVAufXt6nIdJAsKCujXrx/RaJRzzz2XefPmobUm= Go1229ogk8nQ2dlJe3s7I0eOZNy4cdx1111cddVVPPLII6xevZr6+nr69+/PrFmz+PSnP83JJ5+= M4zj827/9W9B3xhhSqRStra1YlsWQIUMYOHAgt99+O9dccw3PPvts4H+zadMmCgsLmTlzJv/xH/= /B/PnzKSoq4vDhegosC0lnKRs6lLRy6EqnQRwqyga4ShSCoxQ6EuGz55zLqaeeSjTmJg/0o0WU1= qiszaGXXmXffQ/SuWcfCe0qF1GEjo4O6rfuYIhjsCzLS1Hn2VU/DPDN08ZGOSnEdoegmI5jbIOo= DJayEBKecmPh4LhEp1sW4BwcxzUvRbx8NEYMtg2O4z6a/vDuPkMay9sk0wiI9HDWfkMemb+Wc8s= vKkwybeIIIokEltJYGG9BYlNRkqSsKOH53fTsC++eULiTlfhTk69UKaJKiOKgxEaL5a0SHXjbw8= 47R267KL8PTDe7TlFBgpjloHEVWR2NsWNfI7ctWcqauVOZf+JEJo8fSmlh/nYnvvHE22xVucYXo= 7w8Rn4I83vRvqBGub+NFmzLwdY2MfH3Q88iWqGwcCSLliyomOvwrhWCF+WnXfLmiKC0QiuNFjwH= b29fJ6X8oCf33CIe8fG9vvCUmnzTUz4VdzeGzGVVUTnzY9COLKnOTja9vgOsfsw7aS6lcY0xWSK= WMKSyjFOnjOLRx5axdd9ByoYOZMOrz/PYE0+QLRiIlbVobWgnFS1i4Tlnc+Vl/0D/AouWploeee= BJ/vbwC9hi0yUZKkaO4Ytf+iKnzZnF1qoqlv7uj0gUWjJtpDNd7DvUypSX1vGNa/+NiYOKXdOnc= dVPcTLs2bqO39/7Rxq7kjhK0drRSBdJTpl/FldecgGjhlaisimee/oJfnH3vXTZCrHitP3pYc48= 86NcdcmXGNgvhqAwRjDaQimHmu1b+dOflzNm1mlUfvYsMq3N/H3pH3n0sccRK0FnqxD5/QMsvuI= SPv7RE1nz8otU7d3LNSNGMXHkcLraWnnuyWdYuWETn7nsywwfM9odP0yWHRvX8sLTT1Gz/yDrD6= TYXtfAyHHDaapr4Z5f/YEh5VdRNHk8Lzz1JC889yqFA/rR2tFMa2sHVsEgFn3+Qs475ywGlUao3= VXNH397Ly+9vBlUjOKiYupbM7QbhWjXdN56eD93/89dvLJiIxkM2Ygwetx0Lr3wImaOHULV2jX8= /oFnOdTVSnu6gY/OP4NBQ0ZQVFjkms4NRL1ko8YYrG5OR+9sXDkqufGjo47kQJpPdHyICIMGDWL= RokUsWrSoz+/5Emk8HmfWrFnMmjWr2+e+j8q8efOYN29er/IBpk2dwrSpU/ooXZiBYsbRGtajrN= mzZx/1GH9TS78fHMdhzpw5nHDCCX32j58fp3dW4O7wieHEiROZOHEi11xzzZGPFaGiopzEuPFse= uhRioGJ805BFxcHmW8d34kUN0HaiJEjGTFyZPe6GYPpSnNo+Svsf3o5hTV7iYhD2riDXdRWZDMO= e7btYFomjY5F3QnvQ8JrXLj9dMLMCfznf3wFRwRtgXIUlgYbobE1xQOPrWTt63vQluvUqKzuu+f= 4sABtHCTdgunKoiIRTKaL/kOGUFQQ98w2noeIY0hnMvg7Wrv3zjuIRPMm9CGVZXzp82eR9bYh8L= wwENyHvCBmeRmLexchuO+bIEeFO6n5onomncXJZl3zgFhExBC1XKfn9wOS99vnOOK7nHg3auWAE= oZW9qeueR86ksTYrinncIvh/kdX8cyL65kybiDzT5nOiTMnMKisCMECFcUYn+L4ypprenhPTFJv= B04aS2uUZeFIDCMxxLaIWgpjbDeTtnKTRWpLYZNFSYaI8tpmLDAay7ibv4oojHI9vET52yxEUR5= 5EY5mog6uCL3Nwa6fTsa2OdwuRIsG0a+kBK01NlFsBZYWhleWUhx3aGxowMlmsFOt1B5s5hMXf5= nPnHEaSQV//cM9vPDQb5k8bhQfP202615+haefe46PnL2QTy74KIf313DffX/k2UeWMrayAtuxq= a+vZ8DwEfzTpZcyYng/1mys4j9vf5gnHl/OpEvPBqWwxFucOGm6Uq00tbQzYPxMFn9hMQNLYzzz= zN94dvkzPDNqOJ9b9CkOVK3mF0t+wdDpH+Hyiy4kFo/xynOP88CDD/H3geVc8IVFbjJZ46cgMDh= i0+VkMca9Di+/+hp/eXYD8z/+D5x95jyi0sXvf/07fveb3zJ90lhmzJzA8ytf5fX1W5g+YigN7U= 1U7ztMNlnBkIpBFIAbYakjzJg3n4JklLt/v5SKEz7JmWfNZ8aYoTy9exmdGTffDeKQ7krT0JRi+= kfPYuHZ81HZVh56ZDkvL3uZmZNGUzi+gif/9gwbq+o49+J/Yu7sGZj2Bn796/tZ8fpOlEpj22ke= euBvrFuzmYsuu4pJ08ayfddm7n/wGR59/CmGXfAJHJXhYHMrIydN4gvnfYyJ48dRNmAABkUEV8l= zjLim0D5XX28fRyU3bzXXQ8+ooSOV9UZbCfg+I30mCepZnnIHIO2Fw/m2d+1vuteHY/SRcvX0rI= OIsHv3bvbs2cP48eMZPHgwjuOwadMmmpub0Vozc+ZMSktL37DsI0VB5Tsb97lrt/8dz55aWF6Ga= W3mxe/9gNGnz2fc4nMpGT8WqyCJFXWldo3C1m6kjZtqQTBZG9PZQdu2HWz/2xPsevQppLWF5JBK= oiWlJIqKiZYUES8tpX9BEQVTx3tuNr719HjMQfl24a7CK0qSVJQMy70H+INzR5dNXX0H6zft8WZ= O/5Dedn2ASWOHc+7Z80hnssHqdvr4kZSXFuGGM2cwxGjP2LSn0l7OoGBG7l7kGyo3+XW1ECNEgN= JYJHi3dyG9JxwRX8JSXhM1XbahtTPtis4CHWmb3fsbaU8JRkXclPsI/UoK0dbRn+OjwidS4ht/c= mUpX0Hwy+7D9wPwHCI1/j5HfmoeEYfy4jif/+zHOXD3nznY2I7SScCCiMKKxGhOZ3ll/V7Wbz7I= hFFVfPL0GQwZPhhH4igV83yUTPdzKglMRMcTosp1CM/aCqPjKBX1ZH6FIUbWuLmeIkowHsHRRrC= zGZSK5LnKeCq88vdlt7GwsZVP9lSQifvtwb3njZsQ9jMAACAASURBVHFIZRwi8SQ66kfVWQGZjE= QVkEYyaaLioEyWUWMn8dGPfYrp44agMVxxySK2V69jxap1TBk/jI1r1lJSnOSkU+YwcEA5ZUUJT= p45lRUb11Nz6ADGilJYVMpZn/gUp57yEQoKFMmiIvrdvYxDB9w9DpUy4CisiGuyjlgW/QdVMvf0= 05lz0gkURxT9Cuz/x96bxuh13Oeev6qzvFu/ve97c98pkqJEaqEoWZK12YmjODY8CeybXBhJBhe= ZwAnGGCAfnHwZZIAAGeB6EPjasX0jT+LYdxJLiiVHuyyJpCRu4s4m2c1e2Pvy9rufc6rmQ9V5u0= lbtuXr5EqDKUAQ+13Oe06dU1X/ev7P/3mYHL3IuQvnuOvAfo7++B0y2VY++7u/y6YNg7gCejqeY= PjMUV565VUOP3AIR0t8YQQytX2EIiGQDhQXJ3n3nWO09G/loU98ki19bThU+cJ/+Awz/9f3mL8x= zvqtg7S2tXDx7BVKDx5gcmyYyVyObfsO0dHRiS/spkVI6lu7GFo3REN9io7OTravG6Qh7SJViJA= +wjFzhOd69A2u49HHP8HenX2ElTmuXLrO6MhpKvkc83Oasxcm6Fu/h4/dd4jevg4EAXtOnOPi5X= E8XWa5MsvLr75Jd+9G7jhwgGTaxfF8tmwcZ3R4lOnp60QioLO/n0cee5x779pPOuESrEl9x3QlU= x6/KmL5q2g/M7j5oCW/P+vzt7738459a8XQ+7V4f6rt51ZLBt8/YFgbXP2sAGpmZoa//Mu/JAgC= /uRP/oTOzs5aeunFF1/kqaee4qmnnuLgwYO36Az84tf0QfpBAWTSdG7eyPQ/P8Pw3/0Dk28dofP= O/XTuv42mDRvwW1qQiaQxFlIaVa1SXVxk6dIwc2+/w8zRY+RHRsH1GfrE42z4zd8g1dmBm07ipF= PIVALhGaE7XfN0WRWG+/9KqwUA2q6Kwq6McbWVgIRr0MlIx6q2azD7m5pm97Yhtm8bqu1bBeABR= PHi7xCEmpn5PHNLBbCwrjmZNdKDH3Bsa+LKqZibYXbIhjRiyH9i7Umtvf74t7RASodSucK/vnqS= M2cu4xGZ4KZcYXwmz1IZlOOBquK5it6+9pq9SdyXHyTIEZagHqdIzGv2BNfk3mvy7z9x3YLYwEs= QV+qsXp0G7tqzDv/3f5MfPP8G50cWmFusILWHUBIpEygvQT6C45fGGJmYYPOGQeZXAgQuQoWrJu= 3EnfXhRG6kAkc7BNI1goUSPGnQQLehFe3XEazMo8pzRsANiVYGpYpk3LsRyMiMdO3gKG3QAK3Nx= hETLAn793/H2SKFS8JRFFSFUEXm0dRYYqqiFIVUESRd36TOVIjvJxHCoQKkRIl0ZzvNXT0sr1SY= ncsxNT7OzPgYT3376zh+Gl9FLE6OU5WCajUiVBLppUlnskbBmzKGeB+QiFdBW1FoLBGEqQZ0Jdp= 3CG2+rqm5mZamFoaXCswt5Lg6coP2zj66utooC0FGV3G8BEObNnH6jTHmc1XqhESrCE8YLSuERE= iJ5zkUcvMszc7QOThIS8pwXSBiaMtO/ve/2EoiKQkrk+zasYOT568zcukaI9euUopKbN7aR0PGM= 3G33aSgQ0pVUwSjgjKBRYgdB1yUJVaZ6izHkfhJlwhlUD0JSVfhihJLi1VWApfe7kFS6TSKCpIQ= KTRpIhIiZGFhmqVCgZWVMf7q//g/UV6VclhkamKZ5kyKqJonpIqXTpJMpa0PWbwlw6xPWuM60qx= Xv+Lx9ZGorvtZbRU8lrW/jb7Jzy9bNiq0EcViESllzQMLjFbPj3/8Y1pbW/nMZz7Dxo0bEcKIBB= 48eJDJyUm++tWv/lzjy19VU8KqSBRKJFJpUm2tiLl5uDbKxNURJp79F5KtHaTaWnEbskjfh2pIN= ZenODtHdXYOVvIklCIpNM76Lroevo/mO/eC68bguxkksTp6TeTpwy7f90GbeUrKlZB8oWRAhDXV= ChpNrlBh7MYiYRQhpFGB/WnNTPrGWNIhdoZRpgtjIiimpmB6PsexE5eZns8hHZdav+qIWO+mFh3= 9wldirqUaRKwUClSq4U/gNY4jaazPkPQs92xNL6zNN4aRYnR8lqsjkwgdrN55L4N20ggiRBTQ2p= hm5+Z+XNeJD/SBp6U4XPY8F8dz0bq8Bvn9OWiQiFEbUyKuAIRAOKsl8WhTgXJw13o2ruvj+HvDH= D1+keErM0zPFilVI5AgXYV2HZbKAe+euQgyhcLw91Q8l2BELD+swY0xgXUounXo9h6cbIrizAzC= T9Nz78Poulbmj75ENHwUL6wiwgAHYwGCUrWqKKU1WoQIEYAQKC0QeFbnR4K26MrPEX97/ybQuPi= eR2eDz/TEKAuLC/T3duEoY58TRiETCyuUdYLWllYSlvMXV+fEs7wIAxwdESqT4pVaIxwPJ5lGuj= 4iDOjo7qWtq5uu9g6uLVwj1JJI6ZpfmkbjCVDxHK6VdSGxdgnCpOEcu+8xVXchvqdBCqqRuSKlF= EGMsFtktxqE1vLAlHhLYTmq9nmNtDZzi9A4JoIzc7AGo53lkEi7OI7EdZvZe9tOjh/7HsffepP5= 3CwdnW0M9nfEILSJa6QA4eA6Ho4VRbR31lS3VatW/sGeqa0CNZwgSRAYWQQBSNegnJrIaj4JE/S= 7jhG7jEIEkihUuI7AT3goV+L4LuvXN7O+v4Pm9jauTs4Taocwsr5jGkO0EcLwa3S8GbPo+C1Vj/= 897SMf3Og1u+rablTcDPP/NEuH+LWFhQXeffdduru72bVrV+315eVlGhsb+eIXv0hPT89PoDtRF= OG67k2eU+9nHfF+6amf91rtuPb/EijOzpKfm8Ora6DqJXF0FU9AtFIhmh9heXiUIOPjJROExSKi= VCGJJOU6CMeU8EVOkpade2jesgXlOnZ3FhMyZQ2Wrkls6zgt9v734aPVzD27ODLBD186RjlU+L6= PtBORImJ5pcTFq9MIEdOofzpyZQKAOHVo8WFpFZAtIbUShEzNLvPSG2d549g5IlwksmYXIdE3l2= rf8kM/a0k1QlwOU7MLPPPy21wcmcIRruHcCAiiiOaGDJ/95CE29XfeNDRqiA5xlkiYoEua3bVAo= OKqGRUidYWmlMOj9+1j21AHzi058g+C9Maf9Fwfb42KuJBmw1GthpD86SXAZhNtJ0Np7ot0xBoy= og1KlIMC2up8HjqwlTt2DXFldJrjp8c4cW6UiekFlgp5QgTK9QkJQCmr+GzIyArru6VXRQo/bEF= OJDRVoSlnmug49DjZjRu4/uIL5HIFOrffRbKuheTkOEtX3iahI1MVGZoFyxVYPzGHwMg2IwnQGi= okQDs4WmHUfkwfxPrev1wvSJJJn80bujh96ihnTp9kaGiI5kwKTcT0/DynLk2g0610drbhuybIq= FSrVKtVu3F1yU3PszI3S9vufTQ2pGhubmGwrp3f/L3/mcG+DpIodCWkGmnS6STXz19D6ZsrBrUK= icIAz3q5rZbtCLDBHIFClEMcZThoudwyswtzpDMbaGupo6unkZPnrzA7NUdXpg6kpJAvMzYxTWN= zI41ZH1UITI/JWMfGqDNHGtKZelqbmxhfWGBhKUdncz1CaGZu3ODIqcts27GNDT31DA50s6EjwW= svv4Df1sme+w7T0daMEkZx2GwwDLE8jBRKRVacE4yWVoTrODV+Zmy24ljZiEhIkD5K+CiRJFufJ= ZsOWVkao1TKg85YvmBEIAwu3JhtpClbz7rBLfynP/1fSNclUVpTDqsIXSYZLaKCy2g8G4Cbce+6= N6+Z2pp4ri4xgv8/uAGw2g1xFGraKgG2JtalFEEQ4Pur1RFBEPDee+/x/PPP86lPfeqmw6bTae6= 88048b1UP4BdNK8UE5J/GQbo1iNFaUywWb0KN1vKN1n5fIKjkllmeHCeRTlJKJKBUMdCy7+O31J= NobyHT2YqfraeyuMTyyCjBzDyqWkGiCAHZ2krztm0kmprXFJjEA5w105ZeA3f+rJvwYWs3pzJuW= YKJtUBuzC7x0punyQVGFVgqxxg/itBouAjHIizY78RBiL7lwIKF5QKOdKjPpCwBO05iKa6MTvH/= /PAIR0+MsFgKwE0Aq7A/NhAxTdeOqe2Ee0vYWzsfwKRjgEKpwtnLExw5PYKQPo79XhgGdLfV8fE= H7jAIUw2diic4gRbSLlfGiNYRwgoBaqQrcDxIpVzamjIc2LWRx+/fR30mUTsjtWZyjR+XNTmvta= dLLHkao4SplE/CdzE6PWY8VYOQlWKZlnrbT3FAIcz1Kw1hZK9BgBYa33fwXDvu7W5QoJBa2tSVo= injs29bP9s29nLfXVt5/dh5nn35BDcWSijHLN5CrPru3JwmjCVn//0qpn7RpjBVosrzEM2d0LWJ= KHua6sRpqhdOIutbKE+P4WiIcAi0A17WCAJGJVyUIaFrw4UItINyM1TcFiLh4Kk8XlAkEVVxkAj= lm7LwX+ZktSCRTLBtzx42nD7NsddeJ+Gm2bNrM0FU4c1jR7lw9QYHDtxLZ1cbghDPcZm5McGJt4= /RnxK4qsiLT79Grurz4J6ddHW0s3HnbZx57lVee+ElvPvvwpeCCxevEirNXXfsRQqFDqtEak2qP= VIQRQRBQE0SQK1G/y5Qyi1y7uwp1m/op7nO5e03jzE5E3HXQzvp6Whn74F9HDv9Hs//tx+Q/sTH= qc+mOPLma1yayHHPwx+jsznD+JSmElRROjABYmTMK6NIk27sZNfuXVx++iXeeOkF3OgeXBHxw2e= f50dvneXL/9v/yobedlra2ti6pY8X33qH1kwnG4Y2UO9aOQO7yTDj2AXhmGIVrWrzldQKpQKrTW= VQuSAM0BaB0RhUqxpqlHZobWtj2+Zu3jpyktff+DF33n4HK4tznD93iXwQEMo09Zl29t62lXePn= +PFV15l394dlEolzgyPkE55HNjaDlFAFFZXxXTXzA2GT2dDGvGrV//+6Ac3AoJqhbGxMRYWFhBC= 0NTURH9/fy0wmZqa4vr167XAoquri66uLs6cOcNTTz3FuXPn2LNnD11dXXR2duK6LhMTEywtLRE= EAYlEgs2bN5NOp993dxqGITMzMzUjTCkl3d3dtLS01IjD165dY3h4mEqlQk9PDxs3buTYsWOcOX= OGJ598kpaWFi5fvgyYAKexsZGBgQHDSbDPQLBSYGV0nKzrotMpY2PR2kK6s41USzOuIyjMz7N0Y= 4bGzg7a9+6iMLXA8shVKvNz4LjU93QSRhVys7M0N2ZtmjlGvmqr00/084e9aauQanbZVptYC2Rt= zKyFKUAIB+n6SOWiMSicVgYyFW68e7DwhlZIHZnJ/ZbOUELyzpmrFFbKfOye3dTX+Wv8cDTVUoV= r124wt1KBpG8WcetLZcqOb2HzxJVKQptqlfhMauTj2NWl9liAkHhegkQyDTKBRKOIEK6Hl6jDlI= OBWfSlZeWYHaQSDkJHJF3Jut5m+rsbcYR51/NcGhqydHe00tvVwlBvB9mUjyAyaQqhiYS2po0x0= md4GXG/184xrt8Wq5uQTMonnQAtIyJ8hHAoFMvcmF1isLPBBm9x2bmZhAvlgHwprJmfahHRkE2S= 8j1zb2KoWyhqGivClEULFGlPsrm/FRVu4OS5EW7MreA4CbMwYHaSEUYF2XxbGZXktc/Qh6kJjPB= 2zVvLBe3gFZeRI2cJMw1U58aJFKh0K15rN6nGXiQOlfwclYUbeCsLKBRlJ0GYbqG+fwepjs2m55= fHqU5dIpwZxatUzX2Nn8UP2GIF7qauAR78xG9QfvolXnvheS6eeZtAR0zPLbF7z+08+MjHaGpqR= JSmcbTCFYpzZ89TXZhD5md478Iwe+97jIP799JQn2LP3Ye4Plfg5KnjzE+N4XouU7NLbNu5g0gr= UgmfpqZ6EkmX2KfMcxK0NtVTn01ZuTppEQRzr12tcXSVketX+cFzP8JXRSZGxhjccAd333EnTXV= ptt52O48+McOLr73DP/zf89Q313Hm4nU23XY3jz10P3W+h3Q8GpqbSad9hHDxvDRNdXXUJRNIP8= vtB+9hYnyc904dYWZ2CqECxsZu8Ou/9gTbtwyBELiJFH2b1tHa20/3+q0M9A/hCGFd21bvhEYjv= QR19c3UpZK4FoX3fZfm5jp8z0UIQSabpbGpEd8zY0YIh1Q6SWNjHa7vkamr5/Dhu7lxY5IXXn6R= katj6EKBfL5ER08XUqbx3Cy/9hufpFyt8MPnnuXS5XOElTLTuYD9t+8F+shm6mhpSJDy4/Nb3Tw= Lu1lZfY5/tYvMRz64CYKAt99+m2PHjtHe3k4ikeC1117jzjvvZP/+/eRyOf7mb/6G7u5utm/fzl= tvvcX09DR/8Ad/wMLCAsvLyxQKhZoPVjab5cKFCxw5coQtW7bgeR7PPfcchw8f5vHHH69p4MQtF= jccHh7mhz/8IR0dHXR1dXHu3Dk8z+Oxxx6jp6eHd999l29+85sUi0USiQS5XI4dO3Zw5swZnn32= WbTWtLW1MT8/z549e5iYmODatWs8/PDDtuTccIiC3ArFsRvU9XTTtHUzYRiQbqyDSkj++iSFqUm= quRwyUEyNjJDu76N5aAOpfXtZGh8lrASkW5qYvXiRzOZNtGxYZx41EWFUNWOHX9M+nD5SP6Npgw= is4gNYzsBavyIzMceihioKDccAY0BpdGrAEfFkF8OopuIhhllqhTwCpueXePnlk9TVZbj/4DaEj= BDCRUrB5g19fPLRe1j8wetmIXXTZudrkQChhbEUqC3M5hzNbloitcCxCmtSSaRyrFOyDXhu0u1X= N00etQXZpnGENmrTBngXONqozQqlyHgu99y+hUcf2GXsFzDlmZ7rkvL9NWkoZWETA+NLqO38pTb= 97SBwLDejhgTW1sPV17JJnzpX4iiNdszzVswXuD4+w4GdA3aZkbUdXhjBzNwyi0s5KwAmEJGkJd= tA2vPj+M1qv6z+3trpP/63FOC5GoeImtZLra1Nu3z4UlFrm2Uf2RBQAAHoKqTq8dZvx2lsxl2co= 1RYomH7Xup3HsRLZpE4JIUguHqS8lvPsrQ4C70baNn/CM2bDuBmm1HVAFXOUZq5TOGtf6F04SQR= ITXy7QdoGiyhVOD6Gbbs3EN9Uw8XL15icXkBpENrWydbtu+gpa3VGDxqjQ6qdHZ0cs+hu8iERaJ= iPTv2H2Dnnr20NdYjdERn33qe/Oxn2HTmPLMzsyAldx/sZPPWLXS0NcHWzfzW73yWgQ3rEI4C7d= DY0Mp//I+fo7O7exXJlPYcNUilaKpvZMu+vXT2D0Bphb279rB16w56+zuQUlHf0MoTn/wUPQMbm= ZiYIIgUW7fuYeeu2+jragJVpaNnHb/xm5+hvq0bz/HoHdjIb/xamsbWdtJJn0S2n0/+5ucYOneB= mcUcAsU99x5m3x0HySQMoi6Eh5fK0tzRxeYtG2lrabDzz2puWVjUPdvWw2Of+gyNnQOkfBdFxLb= tu/gPX2ijt7cT1/e554FDbLttN+1tLSghcd0Me/bcRkdnP0NDPSAdBoa28NnPfYGzF0fJ5ys0Z+= tpamyiVK3Q09GBltC3bgu//fnf5cR7F8nll5GOy33dA2zdvJmWOp/tuzXZ7i10D/QgXXFTIHbrU= /zT//1+r/z89pEPbkZGRvjud79Lf38/Dz74IKlUiqeeeopvfOMbdHZ2Mj4+zte//nX+83/+zxw4= cIBiscgf/dEfcfDgQQ4fPsx9993H3Nwc+/btY9++fVSrVZ5++mlGRkZ47LHH2LhxI9///vf57ne= /yz333EN7e/tNvy+EYHl5mX/8x3/k6tWr/MVf/AUdHR1Uq1W+9a1vkUqlOHToEN/4xje4cuUKf/= iHf8jg4CBf+9rX+Ou//ms+//nP89BDD/Hiiy9SLpf5yle+wp133sno6CjHjh3jW9/6Fr29vXR1d= UEYUpmfpzo/Tynh0dDXS2l+iaXzlyhNzaHzJaTU+FIiPYcoiMgPX6EyPUv90CCN3f0k67PkF+ZZ= PHuBnjsPoKohwveQ1sMH4gHz0WtrcJZaysLEMWsghBriIfBcSSbpWCKewBNxOkkSak0QKIJqhJY= +EQ4IacXG499T9kim8uHGTI7vPfNj2trr2bmpyxLxFOmUx70HtjC3kuOff/gWCysVcKw6aQ3hWX= MVtuRPKoHQjgmoYrRDKJsSEKsXehMJb5UEHv8nahhHfP0xCB/a/yIEhouRTri01GesBsqaptcWR= q+K3QmEDb6Mx1HM2aqGkqn5ElcmFoiiYI3HmyDh+7Q115FJutTXJWlpyOAojbI1AEGoeffUJbZu= 6KW7s5mEZ1R7giBi4sYS75y+wtJy3vDdtEQql9aGZjIJG9xIqIYwdmOWajXE9X0838f33FqApjS= Mz6yQy1cMUseq8NxHrUmtcaIIIkPYNU1T9dKojkFESxvV+tP4vetpueNBwuZBJs6dxCkXaBwYws= vWUxEeUVM/bff+Oq0HHqWSr1K4cpEov0K6o4N0ezeVplaqFhFcA4d+oGYCHAnCw/UkfUOD9A0N3= dTrKpYCWJPWRzhs376NPYOdplpLWnsDrUEJhHRo6ejk/o4OM1SURjjCKHBrTU9vDz29fUCEIgAc= UukUDz10uHZe5lCqhtwoZcQ9e/v7eeiRh8k6seeZRhNXlkE6k+Xuuw6CAKVkTa9FWQHJxpZO7rq= rDyUEQkFLWxd3dXSZ+VZbDbOufu7vHrBjLLL3VSJ0RCW/yPWxMd5+9wL4GbZtWYcvBSoy3Gdp6v= 5r81Gmvpn9B++xekUADr39Q/T1bkBjyMzbdmwz54tJazpuknXr1rFu3QBamCom6dSxbv0O1m3Ya= SQ9hZmGYpPMSEcI6dLVP0B3/6BJgyONVx0ClKZ/3Sb611tPPPtbPz2h+f7j7pcdkR/p4EZrzalT= p7hw4QKHDx+ms7MTgEOHDvHMM89w8eJFenp6ePTRR2lsbGRqaoowDAmCgKmpKRKJBJ5n1Hvr6+u= pr69nZWWFbdu20draitaaxcVFHMdhamqKSqXyE0iGlJLZ2VleeOEFDh48SG9vL0II1q9fj+u6HD= 16lDAMOXbsGJ/4xCc4dOgQLS0tfO5zn+P73/8+hUKBr3zlK/zxH/8xhUKBXbt24XkenZ2dbNiwg= b//+7/n/PnzRmOnVKYyNYMsFFi+fIXi2CQqV0CXKka7wlaLRChkKm0yNMUiIpdn4ewFCtOzZDvb= Kc0vEC4sUBwbI8yv4De1YMwMP+oF3/qmRWp1qbLpKoFFMBRCwPreDv6nT32MQDk4UuA7Fs2Rggj= NyPgirx05y/RSGeV4KBSRlRtYTa8YcT6hHbSb4szVGf7un37Mf/r8E/R3ZE0lA4rGTIKH791NPl= fgmZdPsRJUEY5vpslIoeKd8BqQIZImdRQJCKUmEooITSSoTTarly5MOs6mmkTsC3Pr7tp+RwFaQ= kiEK1d5G6FWaKUtBWtVc8buDa2ehgmeYr6P1hKFixbGqFK4PjP5Kj946Tivv+0RRlWTMgGUFqQS= Hvcf3Mndt20knfLZumWQ108MU6gaITLhpjl5YYzi379If087dRkPtKZYqDAxtcil0WkKoQTpQRS= RybgMDrSSSvm1bMmZSxN8/5lXyVcC3ESSRCJJwndxYwKlFkwv5BmfXUG/j8/OR6NpXG3Sba4WaO= 2DSKBlgkgb1FFph0gmSDa04je0UqwGlMdHCa+epvROSDIsUphfJnvno7TseABRLTP9o+9QPX0EN= yhTbWulrilNMHYJXxco6/dRg/zFTtc+4sbqRFnemTHLUCZw0iCFY/A9IXESGdLpMkIpIsCNjR8N= cIgWEqWxqVGFg7WD0JFFM0z6RgltyuaFi7bVYDX5f5vojVhN84pECiedQTjSlMBDTSzSEKxt2tg= iKMoWE2istQUCIV07frTlxFgDW72a/oq3IkKZqsvAWqI4QuJEVYZPvsnf/cM/MVVwueNjH2fTUF= +NCHwTjaA2TmN0OUZIHXN1tZSbnediEm+sSq4jNIFNLTugXXOewkCyGrWKXEsjFKtFSIyRC2vCW= zuPVfdbc51i7RX/27ePdHATBAGTk5NUKpWbCLlDQ0M1N/LBwUEef/xxXnnlFU6cOMH4+DilUgnA= MrVv1ufIZDLcf//9vPLKKzz//POk02kuXbp0k7v42hZ7Vs3MzNDQ0FALftLpNJlMhsnJSRzHIZf= L0dXVRSqVAmBwcJD6+npOnTrF4OAg5XKZTCZTS3u5rktDQwOlUonJyUkAqssrlCZnkOUAGQaolR= IuAhyHSBrOidRmx+E21JHyk8xcvY7juLgagplZ5uZmjc5opMgND1Oam8NrabFVNzeHBB+1tkr2j= a9hVSj+piuyAm19nU10td9u9hJC40hRy05oobl+Y5HZ+WVmjp5DWI8egVxNIRGnXcy/I0dSkQmO= nhihs/Etfvezh2nK+qCNPkR3S5ZHDt/O7HKFV49fpqpCM2mIaBWZYfX0tU2JaSFsIGJ2YlqsVrT= F/BwzQ1uvGxGtueK1WW7Q1qzTqGk4COGgtADtmsogEaeAYg6WJcOvXcssYTqe1GJ7Do0CaZyH84= HizPCY0e2wJfFKWNZLtUzS99i1sYe6lM/+vVt48ch7nDh7A9fPooRDvhpx4vx13rs8YaorNEShI= gwVkXDQ0pQo66jA5o397NjcjW8heInDqXNX+fE7VwldaTWFHFuuH9V6I0QSCte8ryPLt5I1DZ4P= c4uRM8B4ThF3s1nMlPAMh8TutP0oIpqZpDp5lbotdzBw4B5KjSkKV88QXZ8hLIckujYiG/rJv/t= PFE++SGp6lISqoJYcVnyHKIxIaIcAWZsvPug5OyJmgktTam7T7XGKRWrMIiow98JNsGXvXWSHqn= Q0Zm0wonE0aKVRjp33agu6rM0Dq75hAmW5YQbtYxXxVNqWUpv0rtaYKkZX0rVxK4dUgt71QySEs= JlRXRNHNV5z5nhaOJbJY1LbWsf6yC3IfwAAIABJREFUTWsduE0niFiXygYn5qeNrEFttNqgzCCm= Ls3NHWw/uI9DDx2mKeODDpBSo/FAiRpnUghJTe9KUytEUUKhUIZEju0qDEdLWGNYcyk2MNOrc5s= JDpUd3/GX7eu2ihCN4TcqA+9ooWtIlVAg5Zq56pb15dYw+Ve1+nykg5vYGgG4qbIonU7z4IMPIo= Tgtdde49vf/jYPPfQQ+/fv59SpUz9xnLVozMLCAv/8z//M1atXuf/++xkcHOTll1+uEYV/1nncW= vIdl3jf+t7aFr8XhuGq/9PqQVBoIyYFlGbnKExOosPQ8EGs8FFkdyWOfcCEAieVItPThxoZA2F2= My6glHmApVKsDF8lPzpC/fp1aNezXjKwdjGs9cxHIuZZTenUtoh21K5qc5i8OhocR+C4sja64pS= G2XQJmusStDUk8agSKQF4uEqanSGC+EDCklsiqdGepBoqXnjlHTpas/zWrx8kIRw0EY6Adb0tPH= JoN2PTi1y6NoNwXLRycOPqk1hQEMeUZgOetVRwhNndOVrX7v2qc6/RKNGErBoYmqsSSDOpx/Npr= SdAKivKpsBREle6NVG9tfc7HiKrY8VeO+A6IAkRKkAqk1aQOhYPdNDaraE9AFFUoVSqEkXmue5t= beCTDx9kbv4lJmdXrFaNBOFQjTTVMAQdW8GYIAUVQhTQ19XExw/vZaCnDc+qPgugWCwTRQ7C92s= 7e22RDGk9orRNR6EVEkVDYwNhpCgUS2YXjhUFrQ0GHa8K/zbtFxpj5hoioW0gLgiFoiIg8B0MZc= 5UxsSohKM0flghP3mF6Td/iFeq0NC7hea7HqN+z92U332Z8I2XEX4SHJ9gfh6KK8ZrTzooFVCta= iIS5lmyMgG/zAVK60mm8GooApihJJQhcQtpF1IUwvPZdvs9bFKCRCZjuGCR6QcERBitGKEFcdLI= pJY1CgetLDpjqx21iHWR4hheEPuSCYHZLBIhHEnX0BaauzfiJdJ4taIOE8CYhVtaM1GBlqvl8YJ= YId/qAsVyBdpiy0JQq2QSErMMi9qU5QiXSEc4KIT0Wb/7IL8ztJNMfSN12Ywd41UiBNLOE3F/xC= RdZVEtYQe8sNct4iANW4K9pn7SdIeD1sYMVdhjmu6JA1FNzM80hRtGdlAIgbTpQGSElgqTInVqg= biw6Ta15r6vPtU3PSa/krXmIx3ceJ5He3s7ruvW0BgwHb20tMTy8jJf+9rXmJ6e5tOf/jSNjY2G= 9BUEN+vIrAkoTp8+zQ9+8AMefvhhHnjggZo7+K2WEmuDqcbGRhoaGlhaWqp9rlwuk8/naW9vZ/f= u3bzxxhtMT09TLpdJp9NMT0+zsrLCoUOHSKfT9Pb2cuXKFSrVCslkkiiKyOVXcF2PjvZ2UJrC9B= Tl2WkjxCRN+WxN1EprpC1fBgg8D9nXjfYciGLPKbsj0AIPh/LENLMn36N17178ljabcnifzv7QB= zaAhbprwKedPEIFhWJAEEb2fYeYoFrLstjJhbhqDEGkNOWqGchGYCsi1IJcuUI5DMkIF7QZsivl= kt2haaQjKVYCnvnXt2hpy/LgXTvxrQaL70FXWz3tTfVcvTILuGidoFKSVMN4wTVarflilXK1git= ARxFSmqm3XCqzsJyjvy1tvo+gVAnIlwLQdsKzuSSJR6mkyK1UTNxkmcJVDSuFPEIopDYiZknPIZ= FKU4w1tbRdz7Uh3xokW69m+ADtaHA0rU0tXL+xbCHoeAcNAmX5GWaxkkh8zydTl0VLh1LVGBXuv= W0TK1WPp587wvj4JKHVZxcIq2VjBOdMjKTxpGCgr5uHH9jH7u2b0MKjVLU33lHUNzaTSvkUbHWY= Iw3aYCkaxJRziakk2bi+n21bt3Du4hXOXbhUg+3/fVscea6q6dieNEhHBJGWBMJHez7pbDO5ckC= ltEwYVdB1HXjZdrRSVFYWiIKiCRSEQglJoGDlykWCmXma2wfIrt9Fw+47qTtwP97UDSrFHIQ5sv= 1DXEs2Qz6P4wBOgki5hMrBkZpIRyZV8YGbABy7AFpUVQsTtJvLRksjeGnWVYOkJdN1COHWuggha= mlcIQznK35Q42BC2QdY2GBU1r4cGU0XHevDmHOJl/kY9RFS4CXSuInYKHb1fhhxPBvUWBQmtiVR= 0lhb1Gh+wsYv8RAQJvgXwji6Y1GTNWCJ+UJc/yAFqWwjqfomg4LoyKSNxdoNm6UV2+Og11oX2d/= GpPks4Gqus+aXaOc+vXrcGi6r1/SxMgi3PRF7S83aKG3qCanRUlr+pkWl4qVHS4sgmefAgkVW8V= rdfC7xBltgiyBW7+Iv2j7SwY2Ukttuu42BgQFGR0dZWVkhm80yMzPDW2+9xZYtW8jn84yNjTE6O= srs7CyvvfYarusSRRFRFFGpVCgUCiwvL1MsFllYWCCXy9W+MzY2xtTUlBUWq7K4uEhTUxNCCIIg= AKCtrY377ruP8+fPMzIywtDQENevXyefz3Pvvffy2GOPcfLkSV5//XU+9rGPsXXrVr7+9a+TTqf= 5whe+gOM4fPrTn+bLX/4yR48e5eGHHmZxaZHLFy6yc/MWdu3YiSqVWRkdp7qwRCzcH+8TDBptFm= CzhIDyE2QH+sBPoPMFQ64D4lHmCJCFMlNvHqX7gUO0NbeYyaVWritqn+aWwO7D2UScSCHGnaUdP= mGkeO/8NV5ur2f9YI8xfBWgogjHqg8biNUuwMK4+J4dnuDEhXEC4SOli0aSD+DNU5fJNKbZ0N+F= 7zhM3JjmyLsXqVSquNrFxQNHMrWY59vffZ652QLbNg2BY6pyLl+fZXJqwZ62gd5HpxZ5/vUzLOT= KpJIeYah44eg5ZpfKJuARHgIT0M4srvCDfz1KbuU26lIJyuUKR45fYPLGCoIUQrn22kEIj2Ix5E= cvvYNDSLbeCI2dH77O+SvjCDdhHX41xSDghR+f4PjZc6vdaidDaWfP+MmTdjcYERIJh7mlMtJJG= d6DFYXT2qaqHKO5IQXGodpzuTw6zX/5znMkpDle5CQoKheFNJNjHFzEi4RWZs7X2uwqpaQaRbx3= 9hpXL40idYgQkeFeOC4zC0UiVyEiUxRvuCfKIl6WH2F3k1IIKuUyV64MMzM9w0/3s/r3aGuQX8Q= aArd9nqWpZoyUT0PvJhrufgBnqcDMe8dJ65Cmgw+T6V2Pzo0il6cQUQFEFSUiqm4Cv28Tbd1tFO= bmWb52nsLCMn57P8kt65ENjSxdP0fr7CXSGzbTe/evMXfkOeaWp2jo7aF5aCOVseuUrpwhsmaav= 0x4YxY1c0cisaq87mBvt7C+Q9qIXNZMStZsvJSEwNJTffwaEmF5tQTK3D/Dr1rliThao0QEwkFo= 13iRWZTIEV482dl+d2o0fClMqgqtrcSDOZ4SipAAVzu4eHY8YCxFbKQRCQM0OfY4oFd1zHBrri/= awmyR1WZyidN1IZEV3nOE6TChJDhWoyre3sYBQRy46MjMLdJ8JlRmXnekqAUK5hVd28SIePNix0= uELUaQZpWRSqJ0hJaSmLcoAU/Y65UQwhpvMlXjRKFXEaNQB0i7YVFa2+DW7qKwD4FRmrD7TXsn4= uDnF2wf6eAGYOPGjfz2b/82b731Fs8++ywtLS1cunSJ9evX09PTw+///u/z53/+53zpS19i06ZN= PPTQQwRBwJkzZzh+/Dhbt25laGiIf/mXf0EpxdDQEJ/61Kd47rnn+LM/+zPuvfdePv/5z/PMM8/= wzDPPcP/99zMxMcHZs2dpbW3l+PHj1NXV8Xu/93v87d/+LV/96lfZtm0bo6Oj3HfffTz22GN0dX= Wxe/dufvSjH/HlL3+Z9vZ2VlZW+Ku/+iv279+P1ppHHnmE8fFxnvq7pxgbvU6+VMT3ff7gD/6Qz= q5OypM3yF0eRq0U8GScD4XVUW8Wd2UnB+16ZHr6kNks5PI4ck2RsDAPjofDyvnLTL38Gg2D6/Bb= WmrIR3xk4CMQ2JhmZfZqvQH23KXH9ck5vv0Pz+K5LpFMId0EkYqQSKQw1VFoheMIVGgIsBUlKYY= SLVyiMAB8tPYYvr7AxD++TAKBowwXpKgio+KrqmiVQrhJAhkyNrfMd77/EplkhkiGRJGmHEkqYW= R3jGW067JUCXn6xXd58ZUTthpBsKwEhVDiqQipNcoxO9PlQsCPXn+Po+8M4wtFFJQpVzUlncSIh= IVoHZmgyJEEYZVjJy5z9uIVPE+itUOuWCLQPlqmCaMIVwpy+RInzlwmrosS0oiNaS0QUthA0KRa= dYSZKGVANQxxZBqECcriXbLSFbQIUELgShcijVaKUCiujk1z/fokhFUc16UaAa5v9HgUBnELDXd= ISJOS0yqqVbAopRmfnmVscgpCDSqwKsUpIu2hnAqhrhJVJa7rokSEkJIwEjZQBZTCsSjr1SvXLH= LgImIy67/z81trdqdqRzSIKpDHExVSKDwFWvs4Lb007RwgtesOHCRe+zrwFHNvv4oYv0xdtglp0= 3fCc0mu30zLgbtoUglalipEMk2muwexeJ307HUWR65ROdZD+vCTtB3+NJmtt1MtzZGsc0i4IeLV= 5yiPGOhrtQz5gzWlDEpYEZIVrakqKywKpASkhMQXJoXuKMcipobqqyzxVTjSpqBEDZnBplYFa7z= KFAhlVm2TDnIM7yQMTPpeGARXK5ChQjuSSEqWihUujI7i1zexvrubeov42NpA82zYaMDV4EgFhO= S0YDEy1UtJBGkJ+TBgeG4Kt1plT08fSSlMZaAN3aSgFuzF1ZVSC0RkEFEhlQ1C4rQstlzdOP9FO= sARDl6cAhMghDRihDbVFEmzcXPRBMowhhzhoHUIKkRKB+zmTaMtSmvGnhQSVIAWEVp6BPY3HBzc= mC+kNFooSkBJCzwgZV3lhXYsd9DcQwez7sjQXouFgSNt7kVNRUyYuVsJTFVpLYz7xdtHPrjxPI9= 77rmHzZs3Mz09TbVa5ZFHHqGrq4tkMsmDDz7Irl27GB8fp6Ojg+7ubh544AGmpqZoa2ujvr6e7d= u3s7i4SHt7O83NzWzevJknn3ySSqVCb28vdXV13H///URRRH9/Pzdu3OCJJ57giSeeQEpJNpulp= 6eHP/3TP+XatWvk83n279/PwMAAmUyGV155hdOnT/OlL32JdevW4XkeGzdupL29Hc/z0FqTzWb5= 4he/yOjICFNTU6Trs6z7zGdoaW5BSElhaor81WvIaoBw3RqJy0C0Bn7V9oE2yreSRGsLiZYWovF= J+8DcHBAJR+IWq4w/9zLt+++g/e6D4K3m02uWFv9jtrEfqGmw/j8xF8SoCRv0QID0qW+uJ5ttIF= 8KmZ1bIJlKUCqVqFRDGpuaqFRDisUSvT0duI5gZnaJUrlIQ8qjt6uddDrL1NwKk7PT6EjR2NpGx= vWZnlkmKlfp6aynpd6nUpSMTBWoKofm5jrS0md2Jg+eT3NjmoTSRPkC2WySUhiSK1dNHtqVNDQ3= kfbTzM7OU62WaW/P0t2QBqUYm5pBCIeurn6TYpjPEwVVWrqaEdJherFAJQxob24k4WhmF+ZYzuf= paG+gub6FsKqZmBzF8z16+3oZn5hDS0EqnaKQW6Iu7dLXM4DnJZmemWEll6epvYVUuo6VfIH5hS= UTcAhBU0sTxWIRLcqsH+xkemqesFqlo6WBleUCqWSCltYmQhkwvZAnv1SiKZWmtaUZ7TlMzc2hl= CblJ1hcmKOxpR4tPJYXc5iaL0FfVweZujry+WXmZqbJNtTR3d1FqGDixhzLuXnqG5K0tDQRRZqZ= mUXKRQHaxfcF6/u6SUozxc3MzrGSL+LXZcgVSyT8JK70CCoVWpvbyNalyReKzM4vUgnV/4CUFLV= nN4biZZxDsPRvFZRxoiq+iMiNjZB75p/oOHgvdZt3QFMbavYGM+8eYfHI8yRX5kn4LkxcRRRXkE= vTLC3Ok0plad51F9mN20BJqhMXmH3rWaJr79GQW2bu1WcpLZVp3/8QmaH1pFUHleunGXvzZcJzx= /FVuEZW6YOGf2axXimWePadd3j19BlCTBWgijTb+4Z44uBdbOjqNPwNIQ1/SAscqW0aySFQEFnu= VYQ1o9QGdY4EGAsJm8SwFVSRwRFwcJGuNOgHJo5UkSEaa2GQh7l8kddPn6K1Z5Cujk4ytopSCI0= jHIgriHSE1AohElyZmeB7L7/BuRtzJDxJS0Mdjz78KJlMhteHh6kLKmzp6ibpJAyaooTNosehjV= HIdqw5KdKkc6tKg+NSm+5lPCu7KGwaXGsQhoGjY/TIEcjIOLBHjmvQJ60M/8waWCKMtUacnosJ2= IbSJGymT5uKLwFVg3MalE0b/qZjMnSUKgFvnj3LxRuzfOzAHWxsaUDaACy0KTJXC3RoKuOERZAE= Rhk5lAKtBZ5N48UonLIcPvPZDxZOf+SDGwDf9+nu7jZaMKwiDUIIfN+nt7eX7u7uWh4ykUjQ1NR= U+0xPTw89PT21vz3PY8uWLTcda2hoqPb3wMAA/f39NcJwfNzW1lZaWlpqr0kpiaKIo0ePUldXxy= OPPEJ/fz/ATZ5Ucaurq2Pb9u1s2brVIg52+qiGrFwZpTg2bh5QbbgZkli1RBuNEZsDFhb6T7Q0k= +xoY0FFONoh3gPYwgAEkoTjURge5fJ/e5q69evJ9HWjlF6DAK76Xn2YERxzurFqg/Uas9VjoVJk= 6lLs3387WkuujIyxks+xb/dORkevc+nKMI89fAcnTl1ganqBhw/fzo0b02zdspGjR0+ydX0/He3= NLK0UGVo/yInTiiAIObBvB5mUx+R8mSPvnGHPzs34HlwfX0RPF3BxePTBe+lsTPGt//oMgfC477= 79NDUmee21o/R193NjZpH3Lo8QqYjOzg7279qGJz2iasQPXnyVj917B9lEyKWLk8zM5diyoY9dt= 23l5LlryEDS1VbPlq1DXLoywXLxOn197WzbvI6kJ5hfWuTYu2fZv283CS/F+Pgc1yfH2DI0yG99= 9nH+yzf+nnIpZMOGAY4fP8Y9d+2hLt3A+Pgs6XSZVCLFnp07CFTE5atjLC3mKKNIux4H993G+Us= XKJSX+eIXPs2Rt45x7OgZHjl8Jy+89Ca9/QMMDHRRrJbY6Xq8c+wkzfWNrF+/joVcnsVcAeE4HL= 7rTs689w5bt2/i7PlRZqdmSSQcMul6Dt19B/MLC4yNRcigwp592wkihev5dHe1cfz4cXZsW09zW= xuZdJbr1yc58vYFypUAx/FoqKvnoXvv4NzF6ywv5kk1eWzYuIkjx07Q39VBXX0dkxOjHNy/G4Xk= wuUrLCyvoIPg3z24McE5dudq+Qq12EGASBFJnyohWadCKpijcvkYC9PDzCYzRI6HK6G8OItTWKJ= easT8OMvPf4/ASxCUiiSCkIWZURaPvIjjpNFhSFhaIlmeI1NdxnMF+dw4hTe/x+iZl1GpFEpERJ= U8bn6RRCWP50iEsH5bv9R1aspKMbpcJPLqePj23fQ0N6AiaEjX0d3UjAcEWlMIAxzXJe26KB0iC= QiQhFJQCEIc1yGhBZ6EUGsKhOC4pAEdRQRK47mOpdcrhHCoakkURrhA0jWVSBpNgAlsimFEJQqo= BEXCICDQgiqSBODYuVdZqowJ1jxGl3P8zfOvECnNF5/8dVK6yjM//hFfe/qfuP+RJygJn0RQQWu= HYmgCKQ/LkZSmimslrCKFS9YxC79SIYGA0ElQCRUugqQU+FJQiSKqGjzXxTeJSoRQVLUiH2i04+= JJQdIx3zN4q4PW4EqHSGsWKgG+71Iv/VrqWUgoRxEVrfEcl4RNPUZCUgYqkaGBe1IaLW8n7gfjK= N7X3Uci20ZrXT0ODqH2KYQhgQxJOS4OPo4EpKCCphxG+I7RnlJoXJuGXglDEFDnurgCIh0n0T5Y= +8gHN7cGGGvb+1Uv3eoLtZYcfOuxbj3G2mOt/f21AcCtxGOtNU8//TSTk5N0d3dTrVYJgoBNmzb= x5JNP0t3dvfo7QiAcBxkfU0B5fom59y4QLCyScmStgiO25ZDKlOCpVbYYuAKZzVDf281SysfxPF= sSaxENgCBEK42nYPJHL9K2aRPrf+czONk6apOr4KZU1Ye3aQRVQ/DTsWeSNoRZIlzpoYIqU1Nzj= I6OUK0GeK5niaYBCVeTdE0JvioVmLp+iZ6NO2hsTNPU1MipMxe5eHWEhx+8i3UDPYyPLZKbW2BW= F0i39pH0BVSLjN1Y5vy1GarVKp3NTTT7KUpzC3S1ZhmdKZCbX6Ih1cq6/i481zVVb5aQ5wlNtZx= jYSlHd0c7vo5IOZK52TlOnxkmn1MktiYpF5a5MjxMYTmkvz1DIbfE5csjzE4v0NNWT1BYohpWSC= WyJISPGwmmpke5dGWcfLFIwnO4dP4q27ZuYvj8JZJC0d7aTDqd5cdvvM3I+AzS81k/0EW1WmL8x= gQjEzeoKIFyXJRQpFyNJyMSnmRydIKetjZ6ezpxdYTjGD7M2XOXGL42wj0H9tLX1UaxWmVmYZpr= IzdYXFomrEaMj1zjiY/fy5lz5xm+eAU3mSIiJNCgVJkrI+e5MVNg69AQwhG8+MIrNNQ3smfvbjp= amkngsDI3h2gISXkOUmocCflCiaPHjrFz4xAnTl7gytgNtqxro70lw/qBXjrbWiiFAVJCWC0yPj= XHtdExiuUIbUn5Rtl6je/Xv2WlFDEbblVgYBUYMWC+dly0LwmrRVII0lEZFopUrMJ2JQpoTKUQr= kRHEa5W6KUcDpCRHsJJEhWKREvXSUSBST84HqCJVICfTJJRVQhLqNkbpmheOCAdPAEyiogiiZSe= Tdt98P6QQoDwCLw0DR297Nu0lXX1mdr7Cs30So4j585z6spVunp6ObB7J+sbGqiuzHFs+Do5L8P= o9VHu3rcPqorluRkW8rOMrSwysHErvQ2tXLs8zMT0BFs2beC2jVtpTqaJqlVOXR7m3QvnaMo2cv= e+2xhoaWVyZZn3hsephppCcZnWjhSeZ+bKKzMLXCgX2dnVQmfK5+qNRcZmc2ztb6erMYFAMLUww= +jSPA/cfYi9vb34aJIPfpy/eeFNcrkCnpYs5gs8d/JdZmeWGOju547N62nNJKmEAWfHrvL2uXNo= mWb/jp3s6O4kUiEvnjtNRaaZn1hh09AgSVmlUFhgem6GxeUy+3bcxq7BPlKuZCm3wHvDFzk9Mkq= mvZO9W3ewrqmeRunhKNOzSJhcnueNM2e5NH6Dgf51HNi2ha76OiSasZkZ3jx7lqV8wM5Nm7htsJ= dcucCl6WmmFwuUcgEDbS2kdYUtG9bRkE1RKC1z+eoFUg3NlJ16KkIiHYd8pcLJ0RGOXTiH6/rs3= bGTjd3dNLsu+UKBNy6c4+zoGN3tPdy7eztt2RSlUHF29DrHTp8g4fvs33k7m7o6yDg25P+Aj9tH= PriB90cUftrrP8vw8hd97YN8RkrJ4cOHee655/jOd76DEKJWfRWGId/85jf53ve+V0OGdI01YpM= rmv+3vTeLkey60/x+59wl9sjINXLfK7P2KrKKa5NaSFF79/SgIbd6BjMwbMBtG/DTYCD7xbANGL= DnwQ9eYKMBDwY9PQ2opzVtW62WRG0kRRYXkayNVVmVWZWVlfueGZGx33vP8cO5EZlFUt1NtkSR1= P0KmVmx3DVu3POd//J9FJYW2blxHdHwTMt2GIEJs1BhDtiUwglt9GZFPIaMx8kO9GE7MZwwS62F= BClQ2jczRa2JSYE4qPDOn/4Z8eF+hp57Bh1zQl4T1rFo+THPTgnQRlOGZhA3HJyQmgCfdNZhqn2= MUq3K0qKJgkk0IvBxJOigDr7HyFA/E+O9fO8nb1DaL+AKgfJ9ZJgacBwHSwTku3PUgiQ35peplc= q0pbLke7upK5urV64xPjLJYF87taLPsdER1nduUSsXWFoo0tubJx5PsbCwgo2H0D4EdaYmBunL9= /KX/+F5yo0KWtaZmhpjZbXM9cuzCAKGR/o4f/E0V9+6h5CS/t4epiYKVIq7CFXn1PQYiZjLd7/3= E4p728RdwekTkyBj7G1t4siAu3NzJFMZTp2c5GB3G1tLvGoNr17GdkFLH6UbtLWnSbZNslers7S= 4ZbRgLI3GRwGOtNnaPmB1fZVHLj6EbtRNXl4KbFsTqDqVgzJCBbiWYGSwj0QsRu36TbbWi1QO9m= lPO1SKFXxPIi2XIGwZzWSSPPrYWa69s4y0bIJAIISL1oJGpQqeKTj97NMXqdR8vv3v/xq/doAUK= QQCy5UISyMd24irWQ3au+KcOjtGwkkwt7CIr3zS2QTHMuPsFGssLq3TCMK07buusPc4Xfzqr2Cz= neaDd29PGHFJLSW+72MyAppY3KWuFa62ESIwekhh7kBYqlU66vsNEzVwQDoapY3OjxQWUls0Gj5= OswvHTRDgogPj62QpY2AZaJNeaLaZf2CE+XTfUpRUg81ymZRlDjTtCLYL2/zbF17m3t4BfZ1tvH= zrOpdWV/mvnnuWjFfk3774PPcCh6dGxik1PF558y3m7txifChPgRo//t5f4sbbmOjpRZQK3P75i= 2w2Ap46cZo3X/8Fl+/MIjMJbq/P88p3LvMv//l/zEJxn//9B98l42R46sw0ebczFMtssFzc4q2b= M3jBCR4fG+Gnc3dY2KnS19dOn04AmsGOdoZzMS7fvko+186x9g5GO0f4H/9ojOVSie8s3OL6nds= U6lW0Vvxi6Ta7osyTp8/z9sxNXnvzTTLxBHuqyqvf+y7/+VeeozuX4F//4EfU7CSPjB6n3Svzxr= VfsLi8wNTYKNWDA27+6Lt86Xc+z9TICD9/7RcsrdyjLd/N9fl7XF7Z4r/80hfJtsWxA8CGYnmDf= /P9v2F2r8JgXw8vXPsFby+t8s0vP4s42OKvL73MZh0Slsvcz37I3hOPQzLBv3v+eVQDHh6bIt/f= wY9+/FP2bYsnT01zb3eN/++lH/HUs1/i1vY2ixsl2nJJ1mev8/zVGWK5dqhtcHP5Hp95+lnOj4z= w0s9+wu2NdZz2Dt4xn18zAAAgAElEQVS5cZUb92f5F9/4A34wc4P/55XXGWtP45R93v7B83z9M8= /wxalBXBFeOx9gDPpUkJuPO86dO8dXv/pV6vU64+PjjIyMUKvVeOWVV7h69Sp/8Rd/wbe+9S3TU= he2B7bq5EoV9t+5SfXefRxpPUCkjvZW6GbLrRJGZ8SJIVwHt6uDqlbIagNhExIVaKoNqPBqcVwX= b3WbK//L/4WbSNH79BMo10Wqw1bSj7+0GRiSI1rFdS2DBMuiUKqytnafza1NgiDA9wOGh4eoexV= sJ81BsY6QNrfvLLG+vkom045mjUD7jI0P4wGpTI611XUavsfufpk3r1zh/laRzkw75bLH7bv32N= 7ZJxa36RvsZObWHVStzMTkBNfmNtDaZmt7H2m7nD87gm0nUIFEYyGky8zMMnfn90jmerDcBRAuN= 2dmWFlcJBmPo3XAleszfP/7l3CsHMFIPyurGyws3gPpI6TF9XeWiLkW8VSGWDJOrV5n5eYq9xbX= cRwbpMYPBFeu3uSbf/i7LAcNDm4tkM5kOHHqGMyvmiJhW7Kzt8vK+hqFwj5CQrNJVDUjiEoh7AQ= 35uaZnBqmr6+TBj5CKtq7MkzLcbr7+5i9NY8dEywuLbC6skHg18j3djB5bIJLr95gZGyKvsUDVj= a3kRZYlmRzc4+fvPQChQOP6bFJBkd6GB0fJe46JJMZavVV6o0GL/78Gp2dXWSzOazNA/x62H0ih= dGntyRCxvD9BPPzO1y69CajI8Mks1mkZVM8qLG+scL+3i5SGr2Oj7qYOCxdeOBxs/4GAhA+aN/o= EgUCKRy0E6MedtsIwJYSLRRWU+MGhQwLTQNAOCbPbZyhTaG8FhY+whSIWqADDyEtfF+hLB9hW6h= A4UthSKeWRtCt2WLzgQ/UtBErFbCwtsrfvP46+aRLwrU4O9rP1uYKhUqdrzz7JZ4YH2V2fYP/+4= c/4fVbN/jMVB/Ekvzjz32ZPzx5kkatxkuJGCPHT/KffOXL7FX2+falH1P2JP/R575Mql7jP7zwE= 9Z39nhraYlX5uc4dvIk50+dYrNe5C//6k958/4s8dgA8Z4RvvmFz/O5sT4Wt1ZoCB9tW3R25HBi= kuXNFe5nkywV9mgfHCHZljaTT6Xpbevmm898kb968WW+852/oqe9g4dPneDs8Wks28JxJA+dOM4= 3v/R1atUif33pJdYLRd5e3+CFO3do7+3n8+cfopqO8+ff/Q43l+9wvu0UpNv4x1/5Xb42MsZGYZ= 83byd44sJj/NPPPcvOzhrffflFZpaWyHV1MzExyfSp48QyGRIrG7z6+tusH1QZa8sZPS8BB6UCa= 5vrjB47z5c++3kK1Spzd5fYrZa4O/8O+7rKk888S8pJcvntN7m6vEB33zCp/CCfO3uOL02MErc0= c1czXLl7m75j47y6somf7WBgYISZ7XuUtM1iucz81irHT03x7ONPYdcqvH7tOq7SvHX7FpfXlnj= 4qc8yOjjIwuoqP3/++1xZW2Jte49kOsOzz36JdjfOlYVlpGWkPJAfjNhARG5+7fB9n29/+9u88c= YbfOtb3+LLX/5yS015fn6e3//93+fWrVvmzc2qsfCB0JrKxgY7b11B7B+Ym9f7bkU35RIwouBgx= 12kbZHu6cbNZdGVrVDiXNCUwdbauJU3nanjlqA6O8Mv/tW/4hH1L+l56jFIuEYN9GMdtQEzEJiu= habeTVh5g0ZQrfkUCiWGhyeIJzu5evUaN+fmeeihc5w4e54bd+5zf32PWDLLrYV1FubnGJs6hY/= LlZl7HJscZ/TYFCvbRWbnl7Bth4XVHUoNC+EkqfqK3VKDkYlpcgN1rly7yuLqBvM35/FrdR5+VK= CEzepGkYNyhfW9MvUgxm6hgRIJND77Bz537m9TKi0xPDaM66a5e2eJ0eFeHn10gOvXbrO8vkuqG= kfKJFoLtvaKdOU7OX7mHHfnbrNdqFCureE36rR1tBHIOGvb+wz2jxDP9fLWlSssbexjO2lWtwu8= /c4s9UqJnf0K78zMMTwyyMmTnWysb7C3s0G54jM2OkUyu8+Nd+7gVUooBQuLaxSLNaygzr3FTfa= LHj9/+W0mJ8eo1gKKB1VGBsZIZrtZXtlifmWD7nwnvQMDnOjs5+79BWpVn/mlVeZm3uHswxdIpx= Kmw0JYePUGi8sbBIEDCNbWN8kuuAyPDNFoeNxf2WBjt0gsHadS2ya1sUcylTaaLNIIuEmSzM2uU= yxWQEsqZcnKcpXAT7C3V+GgriiVNYWCx8DAMNJJMjN7l3qxDOJBA9mPAq3m72YdMTpkPE2ROYGl= LePjJSQNbdOwLCwdEAsUImzPtUOhPNOubBtdFxnaspheGYS2aNGp0EbEtMCZ92FJLOGD9sJlRUj= ATTu/Pqqo/YEQAD5SgOs4pNJxEokYMSeGFhYHxQpdyQxDySTtwGRHJ6PZHJWDfWpBJ2knzYCdoB= PYA4Rlk3ZjZKWR/u/XFhUZp9tycaiR1uBpwXqpyA4erK1R8gOqtV3S8RRBYBMIl1Sym+50B1k0M= TwCAjwEXW05xjrb2d9d59qCQ82rc7ozSdw1tSsKgecHHO8Z4b/+J5PcnLvLazeu8qPLr/La+hqf= fep38OMJOnwYEIKKgA6t2an77JYr7NQqHFSrvHj9HYQd4PhVpIS6r7Edl8H2TrrQlAJNXFjknTi= 9aJJxh+FMmtn9OlIKUjGb2cV5SpZktehTLVWpeoq6hpjUSHw6O/M8+dCjXFpY4Yc/f4X+9g7Ojo= zhOgGb+3tsF3e4fusaQjvs7e3S3d5OICTZeIZ8OkNOStLC49GTE/y7165wc2eXyxtVLhx/lA6RI= BmYpv6dmk8pUIxmU3S7Dlk3x8iTT1EGvn3pBTb9Gm/fu8O9rU38wja5ZArt2zw+fYrdnSI/ffkF= evLdjPYMc2K4G9eSfBjZqYjc/Jqxvb3N888/Ty6X4+GHH37AJmJkZIRTp07R2dnZeu6owK72PAp= 35ti5ccNU5Ycf17tvuSZK0ax1N084iRjCksTaO3Dbc3irGzjCDpsDm6rGFsTiaFuipVHMjBGnur= jKa//r/8nDUjDyzFMg5KFy9scaHggP3VT8bNE9i1rN4403rmNZtwmEwAt8SutbrP/4RYSlaXgNt= LbxKg3euj6H0A12r1wnIMbGzh5LK+to16bi+4jAwxYl9gsVAu1iO3F81eCNy1dwHItASurKZ+/a= HJYvkNrh9cvXzexZmfMeqAYbW79AiwTaMp0fe8UD9goH+IFgfXsb27Z4+80Zrl4RSBmn0TAt3kK= YVkxBwNyd+9xdWEK5Gh3U0A0Jet8Ifa1sooTm4Potbt6+SyMAL1DsH1RReh/hxHjh0luhA7jmxq= 05Zu/eB+niNWpIHfBW8TpCgq/A80M3cg0zN+fRWqJ0nc23LqOFw/z8HvMLRRSK+dJ9lhdXUUrQ8= D0CIVlc3WJ9cxtLWjSUEbK47y2jA583Lr+DJR1sy0ZpRcOrMjMzEzoW29TqDa5fv4F059AIAl+B= dpm9v46mgQ42kFbMKHBL23SEBC5vvH4N35HE4jb7+wWKe1Wk9NjcWcfblWjf5fXXrhKLKTytqAX= vl5D6iNEsvhFh6FFaGLFGGx1OUKRWuKoRKseahRQ2aI2lPQQBgZShp5JpPZEobKXDTqTQdUgbRR= OpPRA+gRQE2CjsUPFcGRkCQWj9oUwUKfQ/+jDHJrTAFoKxfDdff+QxRtqyRrWmUWBl6Q4N0aChz= P3M9z3qqoHjJHCUg/JCyQbCmiilcKSFrTWO1lh+gIWRTrB1gIWgKi1sy8KybfrSKaZTaayki9Xb= x/TgJDd3qujAx9am0NjVIJRFoCRttsuxzg5+unyPme0FhnqGGM9lSQqN0EZ+4N7aJrfWdrkwfYy= LxyY4NznGi/fv8L/98BLt2yW0nSAjG8jm+VR1hIhhS4FjSXKOy2Q2TdwSnDnzCMeH+vAsgQ7MBN= R8+gFae6EIHqbK1jf1bYuFIrMzN8lon4dOnSAe97g3v4Rvgd9MbWpAWTx29lFyQ/ss3p7lzs2b3= F7e5vHHTmM5Dm1OnIl0J222i2zvorOrm5VSnTteA0upMGqrmJo8gfvGFa7fmqVcaHD66eMk0VhB= w/RHSVM3qkLF4kAH7BULlC2HwDafxWAiw1i6jVgiRWpkmoGubhKOw+8990WWZ28wt7TAD++uUvE= UXVOTJCzrl1xQvxwRufk1o+kRtbOzw8bGBr29vS1F5evXr7O9vc0f//EfmzeHrd3NVu367i6br7= 9JfWWNREt1k/ensOFMr6lYbCfiptWvrY1kb57C3Bw4oQy+VvhK4Y4O0/OZJ4nl88YLrfkl0FBt1= DkoH+DXG1jJJEai/uPObgQt58TWb3NAjmPTlcuwt1fEsS168r1srG+TSiawYxarG5v09PRgacnW= 5jonpiYIAp/b86uk0ilGe9rZLBQ52CvSk2ujtyvD2maJ3f0GuXSckeFBlhYWIbDI53uYX1okl+0= mE3fZ29tjfHKUdCaG8hUbOwV29jdIxVyKBQ/pWIyMDpFwLJaXN9jc3qOvO8dg3wCb2yXu3F9ESd= PBI4SN1IKY1PT1ZrCFy/zyBkp7DPXnca0kKys7JJMpal6dQAdMj0+QiLnsFIosLa1S84z7sRACr= UybZ28+S39vnkKhxv3FFWypGewfoKOri3KlxPLyCo26RyJhMTjYT1u2g4ODGnP3btHVkca1Eyyt= 7GMJm4nhTjxVZ+H+Jgk3QW9vloNqg8JBmUZDgZIoaYFQOAL6+nrpHRymetDg1tw8QsDwQJ58Tw9= Vz2Ph/irK07Rn29nY2SPXnmVkqA/Ps1hYWkVTZnCwn5XFbQJPkcvnuL+0hiVheLiXdHc3QaPO/O= x9bOkwPTVGQI3FtU32dir0dHXT3d3G7v4+S2vbBLrJLkI0w5YfFecRgqbrdet2oB00hrSZspUAR= 3vY2rTK+sIKVUQkQgRIBL4I086hIJ7UoXWH0HjS1PdZWmApH0mDQPooaeHjgJLYCiwtsHWAQhAI= U8vT0pD6UAdnAx6W5+PUa6RUQBIjVYTt0t/VxWv3Z3hn8T45fGbXV9kq7vHk8QkSxCAwdjQBpl7= QrjewMTVAWhun6kAYgT+0xg8UQaDozeXojSXoslzO9vYQt23urS7SaUkSQR0aRWxhNJosLXA8Sc= wXpDRMdnbyopNgbmeLh090MZzJkERhS6PjclAu8eNLr7FdKPKFE5MINMXNLdqsJAnLpuT7BMoYT= AZa4akGUjfojsUYzqSJKc10vpuuVJb7a2u0Kaj6PqJu2rsFIKUgCOos72wyt7XJ7tYqizu75PKj= 4CvKNcXxkQFG2tqZ37yLVy+hVD00/JQIHHZ21njh6nXyE8f4/JmTZHMZ/mZmgboQDHf10tg9YCj= RxvGuHgoH+4BkN1DYnoelVFhE7pBLd3JsaJgfv/EqJ48/wmgmgVUvIZSPFXh0JeJUYwkWV9eY7V= zEbtS4du8ePYMj5Du76IunGEymudjXT6A125tbpIXgrZk5disVPjM5Qn97B4tvX2V1t0BDKYQdk= ZuPHTo6Ovj617/On/zJn/Bnf/Zn3L17l3Q6zebmJi+//DLPPfccTz31FITEpSkQpQOfg3uLbL1+= GbtWR9hOKGn9fjeVZm5etMhPPJUEAVYiRiafpyBFqCgpCDSIjg4Gf+8rTH3zG8S6ug7XA+ZmrhU= 6CIwUt1Ktmd7HOjulHcAxxc/QmrJofJKJOMePj3PnzjyJeIzjJ47z0t4lRvp7yLSlWFleZHyoj5= hlsbe5wpOPnse1YWvjewyP5Hnudy7w4muXWd/eY2K4l6ceO8tLr16juHuXrkyOZ566yI1ckrXFT= R555DyL9+8x3DfAQG8Hly69Qi4V56GzU+zsHrBfOKAjm2JybJg7t5dxYi4nJ4bw6jV2NrbJpGI8= /uhZCKBW99FSgXBMykAHiECSijlcPDeNZbls7+xQ8TzOTE3S09XHCy++RmdnFzuFAnWvwqPnT7K= 7vW0IQy7HK2/ewLIChNYo7ZCKJ3j04TOk4jFu3l7EdWGgr4epyXGqDZ/+gW7SqRjX37nDyakRBk= eG2N4tIWWcQNSZmjpGys1yf3mb9nSCzzx9jopXZWX9J6TiDiePDbO4ukapuI+lXcA4nQdBQDrl8= PmnL1DzBOuruwjt093dxSMXz7OzvY/0ApLJJK7lMjU5ROXqNcaH+zl9fJzl1V1Wlpfp6M7xxWce= 58ovbrOyvMaps+OsLd1jZGiQi49MMb+2h2WniCdc2nNtnDs3zeLqMht7RdpyijPnjhF3Y9RmG1h= Shuq3v4lrPaTjIUdvRkZkU01ZN0XZwNdGc4SmDYEOkMJoivhhz5XWNkK72Mo2M2qh0QQoAZ40qe= im4q3WLoGQYSWeNB2YYaTBwDI+Sso4bn+4wmoB2NjCJh9Pk/A1CVMEZDywpMWxwVEu7Fa5eu8Of= 7Fwm2rgc25klAtDI3BQYCCdpt2xQ2VcyMfipBMJpDB1dblkGwkcHEDaNrlkgqRj8VB7B53T07x9= 4zbfKe4jhCCuG5w8PkmnazGaiROX5vzGpcNAMktPLEVWC5xcO8P5XgZKmsHuNtIORksMB7Tk5MA= IX714hl/cusWfb68iHJu9QpEnps5wvifDtV1FMuGgBdiWQ2eqnVjgcCyVJnfsGK9evcL33nwTO5= ZE1Kr0d10knYgznEqRU6F6swLb16zurPG9Ny6xd1AkHk/z8OQEXdkc3toSs3M3ub92n51qnc6YQ= 1ZBIiS0CE0ynqZeL/PCpRe4nMpS8TTnRoY4096B7U5T2dzj5StXuBZPEUNz/tQJcm6MgWSGdss2= ZEEH2EJw4cRJbs7O8/hkPx3SWFnkYjGGYoqJZIq+8WO8eP0q3730cxCCjkwbpzIZBro60eNbXJm= 9zeLKEspXDCZTnJ2YICcC3rpzi+WNe3ha0eUkeGKon5wVWnaIqKD4YwUhBM899xyJRIKf/exnXL= p0Cdu2SafTfO1rX+OrX/0qtmUbFc6wTgTALx6w9dqbVO7cIyaO5Mdb76All60x4WvjRqtQEtxMB= gDLdkh2dBL4Ab7XQGiouRadFx5m8AvP4HR1Hq6v+T8hMNWj0oSz9T9kpvZRoVmSGdYVHZldmpbe= gFwuyfHpcVLxGO3ZBLb2caUiYQPKwxaalAMWPpbyaE+lOD4xQL6ng3TMBs8jG7PpbkvhCE2+PU0= yBlL57G2uM9DbiRsEJGyFpQNcWxNzBdVqkRvXL9Odc1le3eb2zVkGR/LEwy42B0lQq7G7uUlhdx= 9huWitqZT22N1dQYrAJBJDWXkhAtrbsrRlEjQadXo6M6ysV/AqVWTgMdzfgROLUSiaGopGuchrr= 7xAT76fp59+hqs373BQMarVoMzAGCga5QMKu1vYlmZkuJdatcDLr15mfHyEsZFBujozjA71Mnd3= lqszS8Rsm1rDI+bYpg1bK/q6siRiZuDtbM8QVHxiNrgiQCofgY0WpiBVopBCYgtolA/YWFtAqxo= nT04R+B4vvPAylhMDaTMwMIDjSqQMsKWHXz1gZ32V4v4u3V09lAoF+nq6EfUqKUdia4/jE6Nsrq= 3x8kuXSdoppIB8vg0VlNna3KKwV8G1LdCK8sEB+3t7BIHptmtFTD7ia9hssins1oxCaoxgXBh5U= Yb8BFISSKP35mhC4T9CgTkzEEilsVSAkppAPGjuGFqImXSWcAh0YAYvLbB0YPRqhcJr5jXU0cjo= h7sbaARJN8ZnTp9C+Q1yqYSp9RHGZLE91cEXzj3MQGeepYN9sskM00Mj9KbT+JbNH3z2KVI93UB= A0pU8e/4M0rJM3Ukiw1NnLxIgyMVjSNfi2Ucexbcc+pMpxk6epq+tg/lCEYRgtLuLXDLLeJfNHz= 55gb50DKWhI9vOc48+QSKeIW1J9n3Q2mKqL89Irs0IzYUWIwjIxCVfvHiewe5OZncLVB2Lh5Npz= gyOknEFXZPHsDXYlkUinuaJM48QKEFPJs1k2zg98SSzuwXqGvpzOfryvbgo/vmznyOfiiHRKK2x= LYeRnj7ODY9TAfq78xzr7iZlSXIXznG7t4t9zyeTaSNuWYx0dRMLtWO0FrTlOvj6557hncUl9ho= +uUSasb5++uNxYrE8ycc/w63VdUoNj650hmMD/UigL9NGV1vW2CQIY0xxYmCYP/69f0RfTx5XBF= hujIvT00zXA4bScZz0OIlkktntHYRlc6y3n7GODtJS8oWHLtLfnWepUsKRDsf7emlLJ3ni9Ana2= rPM7W2DtJjsyDPV10s8lFNBfLCUcURuPgI0lZIff/xxdnd3UUrR0dFBJpMJUwMaLUUrJaRVQPHe= AksvvoQol7Bs16SkzIuowPjCAtiWCOXizcsBmkAKnLQhN9K1SQz0IuIJdLmOJyWJyUnGvv5V2sZ= GDVUKAz8tl+QQJhh0xB32Y41mT0ioLit0y/CuGe+yhEUyniSRcJHWoTmc47oEGmzbQaAIdEC5Uk= b5ZSbGhxFKsbS8ggqgPZMhk05TLFfpaE+TTSUQ0mZ1dZOAgHMnJgn8pjKyj0IRoPECjfIlni/wl= TQpBiQqNHOUUiAtB4RDsVTntTdvcO74ABcunGbvxbcp7ntIW6AlSBkwMNhHKpUFWWBwuJftvQLV= So2l5UXiKYv2zhxLa+to3xh+NhoNKpWKMfGTJrysEWipqdZrXLl6g5NTo5w6fZxbs3exMVo1vqe= oVhvoQOFIB1sKquUqQSDwNAhlY+k4QtnEpMVgvh3lB3h1n4F8D0sLa8bDR4XGlZZJlShpzAnL1T= ov/fxNpqeO8+jFC2zs/IRUMobvVWl4DRxhNb1gDcKB1hI2UrgoYSGlxcrKFo2y5tj4OIFrispjj= kux6OM3TCpDOsZWwQqtJCQOxf0SMzdmOT49wfHj05Sv3mCvUP6oL17gCJcK64i1aFKR0CFbG00r= S0kTpZHgh9IOWh9qY+mwQQAUUjZMy7c0P5aSWFpjBWHXEsLUqGkHJXyU9nDC7HcgQEmNH+Z8pNC= HSrVC0tK5ORLS/dtuE2adAulYjOU7wmlIc1IujDEjFu1Jh8emszxM6MmEmaDEkklOjY3iCwioIy= 3BRG++6byAa7uM9/SFQXANlk2mfyC0NgCJzUPjE5wOd8Zs36MrmaA7mTbmmQriToLRoSHQAeuFb= X4yO8ed1U1OTR6jP5XCDpWE0eb7qHSAY9mcn5hiegJ8FHE0dhhBznT1mumWMtGloZ5+LA0oozx9= ZnCEiSGjGuxgtIeFDnhodASfAKF9fOkR2IKBnjzPnjlnImw6nNAKTb6ji3xHt8nGhROgILQ8CHB= MkxqawWwXfac78MJkFcKkKx0ko+1d9Hd04nFIXy2gJ2Va3oU23XICSZsteWhswkiK6ADLijHUlQ= gvhQCp4fTgCCcGR1vnuvk5ZhIJHp+a5mGBsZoAfKFIuC4XxsY4PTZhPs/wG6HCbIT8gBXFEbn5N= eNo63Y6nSadTr/HYfzoHUELgV8ssvrCixRvzJCQAl8H+EoZXxTLQbdljbVCKkF5aRlZLIUeJcJ4= JDkubjZtVm3bxPJdyFSaxkEFke9i6Gtfovfxi+A2L3paGa13c2Pxrv37WEMEIDw4kpbS4UxTCId= i0efO3B0SSYeTp06C5VKs1DjV28vpM2fJDwywOHsTpE3d12xsbtA7MEijWmNnv4BwE3T1uNSV5N= bdJfrz3XT25KnVAnwd49adGaanx0mls/iALzS+kChpE0gHXzgoaaGlJBBGjygQEAhNud6gESji6= SQJYRGLZ9kv1pkeGCEeczlQPlJZCOHjxlwy2Q7uLqzRCEpk2nMkMhl8JOtbO7gpm9GpaeyYS7le= wU2mmDpxmvauXu4urVCqVkG6ocy6jx1zcRNZSvWAfGcWy46zvVNgaHCYU6fO0tXdTqVaZb9wQLF= YYWr6FIGzhmO5zN6ZJQhsfClJZRJ0dXVyd36RwDK1RzvbBexYgoHhUQ4aFls7BSp1zwQBFKTjCd= xEhr1CmYljk7hOgrtzd3nikdOcPXeKQMFeoWjSKQq0tgmURakWEAibdCqNtOL4gWRu/i6jw4PEk= 3E8ZbOyvs309ASnd+vEZJytrR2UL6lVNY26TzLuIHUCaUk8zyedyRJznRbhh4+2uLgVQQ3vDbJl= g2t8jeq4FEUWLT0s4eOHURUtBBZO2HRgSJEWygwyoRFsICwCaWEJ0RJ1U2EaRmsbsENTSd9I8of= q6IFUoTiohVRmQnCARSCz+CIZfteOdBscSpsfwXvP4aHvuUVTJFSIw1ycBGLwwOSkGcQy7QKyVR= UldOg9Jg4fmwlZWHz8rntbTHPEtbv5osJ6N2HTikqlxMHePsfzeR4bGSbn2KY2sfWZaZq23xqIo= YmjjqTzBCo8P/LougnHAG0oVozD4xbaRNiscDIrhCYbi3F+dIz+VBsSga0P16NCkmrSiM3nAoyf= k91sHjXb1woLHZ4T888YL5u9c4S57kw/bZNAmahgc33GJuLwc7Q5zCwclXa0tMbmSApTmOCf+Xw= 08fCdKtwLHdaFxWlWvOnQX+rDV3dF+IjxbqXkIy+A71G4cYOF7/0AVSrRSCYhnSLW3kGyv4/06D= Dp8VEyI0PEU0nmvv3/svb9H+B6jVC+WiPiMeK5nFmlbZPo6sbNZinu7DL45KOMfPlZnPa2MDVg8= MvreT45EPrwDtd0StchO6s1AuaXjNJmrGRhxZapej4rG5vcX1lnfGyE3d1d7iwsI6TL3fub7O7u= sLRVMekgJHVPYds2M3cWWV1ZYWe4QqXhU6nWWNnaY7dQ5+XXZ8jne1HCZmtnH98HjY2v4O7SGoV= iCWkJKqUqi0sbHFQq2J5Fsdwgnm4jna1SrlXp7monlYpz/Z27FAplpHvkliMc7q1ssrq2jCV9o3= rtBazt7FOtVAh2fWKpefYLB5TLVRZWd8h29lGuNbgxcx0dBAjZbDvWSCHJdLTjJBPcXVhkbWOTT= SkRThy258kAAArNSURBVIbufA+NRoN7CysUSiUu37zD9PETDA32UirXsKTg/somruOgJNxd22bm= 9m1i8Tj9fQPU/YD1rR26urrp7uqgeFCiVq+Z1IpSSFw6u3pIpxO8dW2GYqXOwf0lOjra6R8cola= rUzwocXBQZGFpjUrVZ3unRDZdJ9OWJZtJsbdXwve32NzZ59Lb1+nqbkdLl3dm50m1ZRgdHqJR89= na3mRvf5/17QPa2jopV3wCv0FHZxfCdphfWKR4UELQtP4UR0h/czT5NX5DwtUfDouHukJCuGQnz= oGycbwSQvs4MiAuA1BmKGwuo82XgWadTvNYWgPWkeM5TH2FSxpDoVZaTolwXfrQRdrGRXSNk2gf= CPe0KQwk/hZyY/bgMAjXHOpDQUAOF31gDe9ziwSMR9QhA20tF676yJvlkeXeG14SYWqpefKFPLp= Bm76OPL97MYMbi5NNJY0D9pF9k02R0weO1QoJT/NeZAwghDQRjHBLhwdjlnjgIFumCcJCIMknsn= zh+ClcaR0uFp60pmXH4eEKJHZIII8ev9kbEZ7o1p2yuZxo2n/Iww00z2u4Hy2q2TqV1uFzrd8Sh= OQ9E4MmwXrXxN6imSqVLdYp3/P7g3/zhD7qLxDhNwONMb9EUN/b5+q/+VOWn/8pnX29ZEdHSY0O= kRkcJN7TQ7yzHTebxYrHQQp23rrCG//9/0Tj+g1cKfB9n3q+h+f+9f9B7sxpFJry3QVe/W/+O0p= 72zz2rX9B32efBvvQILPZdfp+t6XfBN6X+P0dWN3c57/4H/6c7b3Sg+vi8MZpWUaQTAiwpCQIPL= QOiMfjxOIxGg2PSqmCtCwsy0YphQqLqS1pHUnYaXw/wLaNqKJSChmqxlqWbewHGg0sy+iReL5/u= H2lw/cLpDzUGUrEXWzbpuE1aDTqJONxHNulVKlRq3tIyzYpLMCyRLg9D4HCsS1UoBFSosP1246D= Uj5aBSTiCRxb4nkepXIVYbthRMuoIgmhSSZsHFtQr3vU6z5o48EWj8fxvAbVahUV6qjE43Hi8QQ= 1r0G1UjPHKS183zPH0GgghMC2bXTg4zoC140RBFBrePh+81MxbcipZAzXtTioeNTDdveE65BIxt= FKUy5XTMpUWPiBwrUECddGSotavY4fKIS0aPgBUlrYtkXd89GBic4k4jECpaiUqyA08XgCy5LUG= w18zycRj2FZkkqtTqNh7Bf0kVm8CAt6adayvA8SMYdvfPkC/9k3nv7wHmxNvimaBcWhJxIKfA+/= Xkc1qqB9hDARncN9elcnY4vlfEBCJqClChimA2iuJvyPEjbCSuDEk0hph++TIKzWJOnoAHaUTH1= 87jIRPun4u8aJKHLzMYI2xRfkH77A0KMXSeXzuNkMTjqFFYuDJVEhF1UhNek4c5LJb/wjri0toY= tFUAGJbIZYW1u4UgWJOInTJ8nl0vQ89ohpqwtnZyqc0ZjJiw7rbj49aB6LIRU+TesK3wuQUoCwK= FfqlCsNtFZYlmNaTVXQmkVopQmUfxhxw0TfPD+gOSEMlEIIY5Tq+Z4hH0GA1gFSms9Nec1iVYlS= Gj8IWjPpg1INMDUTlpQUDiqgq8YPTFoobZZDKwI/IBDN/ZE0PNMyaoQljDZGo+6HM2HJQbkaFlW= DkC46tNLQZpKOBErlmlEblhZhQJxKtUG5YkTCzH5bKK0pV+qUynWENDM07SuUCsJz4iGlMemr1/= 3WeSpVSiCkIWnCjN5SCHylKJSq4bVnm+0LSb0RUK0VzMxUWGFEwxxf3VPU6lVAm20BOlAgjMNwo= +YhLLOtct3joFJHSmmOQwvqpSpamZofIQSNUhW0QsojM279EX8PNK2CccRh2sSYJ0iElNjJOCSy= 4WenwqhSc579EX9rlanZ0S2+Ih+ckeujU4EmxHueiRDh14WI3HwcIJphSnCTCQYfu4B0HHPjFkd= nXs0Cw3AxLdBujJGvfZHta1dZ/s73EDog1ZUjFnZLCcDNZpn4va+S7GjDTmcOZ2atdYbr+rAzzk= 8AmsTEcBuJlNAsPG46tOtmrQ5mgAWjxBpm+5orOoxuN1N5zXVjJtFSmiCzVhppSRP9QYSDfnNAM= Jo1ZlDXIXExY4R5WYYkSJl8dGsWHm733aF1RKjiKcyx6aaha4CQtonRhIXLgTKJdFM+rsMwuIOw= NFqFxFmAkIaAaB16zx+ZlDdD2s2aAyGbVQ2Hv5vyAVLIVvhMEaZAhSbQGiGs1uy/tT8YOQRpxwD= jwtyKDmC8j4RlocMqgNZOEZJPS5quQSFA2FhOU606/Bytw7G4GQ5vtlkLIcOo1kcMAcJ6b9qkla= 5oNg0czb007xsPLvLrRzgJe2DDD+5chAi/cUTk5mOC1j3CthGO0yIg7y3vbeZQwxu20LgdnZz8Z= 3/E9pUZ9q9fp6e3C5lK0MxeOok4+VPHzUwb/UBeuVXkJj7dt6aj7u1CHNpYiHCQUGHkpVmv0KxG= aJKEcCXhc00CEgbcVUhAw84yk/oSrU64Vg1Haz1HCKsIIzI0SxKbNRJhjUMYHRE6fL3Jz8LIgxn= UrZAwNWUCQgocpnJMN4khKko3vX10OLibouumOaqQAnSzDbm5T+/Kkz+ghW6iUM0+O0MEw6oCIV= sEAt0sYFStfTwclg1502hkqMektQzJqLlmD2s5zIXaVN19v8+5WWeCMkRHvfszFxw50+EhCdONp= I6IQLbW2XrTrznmIP7Whw++9puciHyKJ0ERPj34uEvO/vbhaOfA3+e92lSjt506xcn/9J9QjqVo= 6xsCxz2890uJtG2ElL/Zm+JvCIekRoTHr1o/WpsfEYb6RZO9hDX8GsJ2gSZhCH+kIZdKKzNcC7O= EQrfUZZvL6PA13eIIGtOm9u59aA65Okw5mA1qpR4o/QRComrWpbVpKW2uTzUfN21Dw7ZgFR7T4f= Z1a39Es6Yk/KtFc30PRvmaPketvzI8DmnWqdFhPWEoGGdCQTTLFE1Hh27J+gutDVELI05aBygVN= I/MxGaOnhd80AFCGbcjYfI5xldJq1aHkUAbXqRCwwKlwsJbffjX9Kib8484EiF71/XT+vnt++5E= iPBJRVRQ/AnE0RRIc8QNhEZWyjz/3/7PDF84z6k/+gPjZaSNUNonCR+moFgpTaFU5f0u57+v6dr= 7ve/BpOB7Z9OHEaAHHzefe/fjD4J3H8nfd/n3289ftu5fxXDd3N4vOxfi79qhd7/+9zmAXyF+Ve= ciHnNIxt1/6O5EiBDhV4CI3HwCcTRNosK0glQaLEF1Yx3tK9J9vQTSaB980qI1H4bcRIgQIUKEC= E1E5OYTiAciN82KDqVN9EaEtRo6oJlD+aQRhYjcRIgQIUKEfwiiguJPKFqdOoBRGzVutkFYIiHC= ItSo+C9ChAgRIvy2ISI3n0C8N6px2FMVClQatd4IESJEiBDhtxARufkEQxz5X1NmQrz3xQgRIkS= IEOG3Cp+sNpoIESJEiBAhQoS/AxG5iRAhQoQIESJ8qhCRmwgRIkSIECHCpwoRuYkQIUKECBEifK= oQkZsIESJEiBAhwqcKEbmJECFChAgRInyqEJGbCBEiRIgQIcKnChG5iRAhQoQIESJ8qhCRmwgRI= kSIECHCpwoRuYnwsUNkmhkhQoQIEf4hiMhNhAgRIkSIEOFThYjcRIgQIUKECBE+VYjITYQIESJE= iBDhU4WI3ESIECFChAgRPlX4/wEx7UlurPMmEQAAAABJRU5ErkJggg=3D=3D" width=3D"567"= height=3D"107" alt=3D"" style=3D"margin-top:10.6pt; margin-left:-0.3pt; po= sition:absolute" /></span><span style=3D"font-family:'Times New Roman'; let= ter-spacing:0.25pt; color:#2c2c2c"> </span></p><p style=3D"margin-top:= 6pt; margin-bottom:12pt; text-align:justify; line-height:115%; font-size:12= pt"><span style=3D"font-family:'Times New Roman'"> </span></p><p style= =3D"margin-left:28.35pt; margin-bottom:0pt; text-indent:-28.35pt; line-heig= ht:115%; font-size:12pt"><span style=3D"font-family:'Times New Roman'"> = 0;</span></p><p style=3D"margin-top:8pt; margin-bottom:6pt; text-align:just= ify; line-height:115%; font-size:12pt"><span style=3D"font-family:'Times Ne= w Roman'"> </span></p><p style=3D"margin-top:8pt; margin-bottom:6pt; t= ext-align:justify; line-height:115%; font-size:12pt"><span style=3D"height:= 0pt; margin-top:-8pt; text-align:left; display:block; position:absolute; z-= index:26"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAEoAAAA= mCAYAAABj5g1QAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAABXpJREFUaI= HtmktoXFUYx3/fuXNn2mljbG1UEIuJSTW1WmE2lqq0Cj4WWlyIFhFRoYpLEfEBWkHRjeJCN0UFN= z6xWAQRRe1CqVa7MLaxvmq0sdpWrGk7k2Tm3vN3EdN53bQzziSmmB+cxf2+e875zv/c85wxgf02= b/WlMm3EtBbMaJw/MXsxLZ7tKny6r9LRvWz5ZUibgSUV5nFnuuvH73a/PGno61t+cYS2AEubqHc= SAZ8bwRN7vt/5LuBr/K5n2fK1kh4BLgMabZuAPxxsikv23NDQ4O/ut3mrV8vpI4wrmhQJYDHSfU= W0ZV/HmiUnfr3tGHCJV7Sle1n/LVQLYT19/ddKeg+4nMZFmiy3y8NDFurVc89dcbbD8TCQajHYX= heVrmyhjJYwM4dsA1Vi3OiE3UWrbTNWYv5+J/xVLcYJUuidzmq5nFYwdVU9rzlooNNbLlec6k13= p8BcXZ1QwmwkOZ8CpM6qfOYw1OywPRFHgXGbmC9qYqADyNSYE+q3uuwGJcFIUrDCUqBTAFedhVT= SZ+kFnxfD8LpTE5xRXDqjGPMZkORuH6Z7Az//7ShSqdLsXCCC/POG3aTmh5UXbFNpdJ0Swk+lit= 0xfIixqM6XWJxM5/y1dSSpN/fOX7XANT3nN4/JRen0+MgPPwwWa33dy/p9fWSNMzQ09FeSvaen/= yh142uCKcxz1DInVIPMCdUgc0I1SNObsYyL4pLCw1RN9Br1Rt2ke7IRhz5ysTuctNFoWqiufGrk= wAJ3faxyXm8+jnywv7Uw/3s6M5kDR8bidc65Ol2aFsrYNkqer9oT2uxiYGAgD8ltm5ujGqSVA+N= MESTYpn/HW8OsFqpQSGe7z7vgcvOEkzYz74WdpfafLY/LrBZKmdFF5t0mwbFbAAlIEknTu+rOaq= EqOOHXIzQwnQHMaqFc0fkpIoyAMSAGiqAhF/AUCYf4djGrhSoWdTSdcodAXVSs0Ab7JZ4EDmP87= uanv/pxYOAg/1ehOjvdkbGI1yXuB+ZP2gULLaUP9uze/T3TKE4ls34f5QleAwo15k4i1udyuRnr= 6H8llMAlpGlZrqPCwp8NhpiYj8oxmLvhl9HR2uvgduCSUtM9spvVHfuyutVcediaJxK2ncKnX7Y= t3H8YHt422tO3/AXQ00C27FH/KbFbeRC2Uf973r9i6dILF6XS0c1mFtb6mhYqm6UDeEyejkmboC= DT40DbhQKIKL0fkMpTJRRpoVtzudz2HTt2tEWodFqLY7ONQp21vqaHnskbEwJnysnSwTQeKxaG4= TDGgE1sC44h6eqDxeLCdtUjyZBCqto2kWb9ZA4wODhYxGyTYLzKIZamxkpradOipImPIJGTQiiA= iPgTjCNUbwec4LZcLpd0cG4rJ41Qe7+9aL+Jj6kZfmCXjoyUzpju+k8aoeDN2AXuZag7/C6KXby= OaW5L4qpnThpiTeanBF+sQtosMJv5KyHGAr5Ix3ZIKEt58TDQenK5TTS2+qm3tzcTRVFdAyLnwm= CKnUaSUCaxIsyOb07qIlkqg8rHiZlkeNeuQz19/W8B90D5jgop15PPn78Hvj5BEQas8BZudqmwT= igznwUWJGVMMTE5Vv2vCFhs2DWJhygde6cCTzwzX5ic9HpsdieVQsE8vFsP7OT4Zz8DThNce5xw= az0CcGBT9YIdJ9W+Gpss8ff8dpNOu6+BX6kRROKG3t7e9DHD1i6BDk9RTBNtowB84GQ8Q2tHACE= OOB9/2EIZDTM4OJiX9ApQqvaoLyK1qvz8poS9Q6ttM/YEsgec8v4NjAeBX2juykJgeTM+CWW3nz= lW+rWFgJpBgWwz9atfYM7uqHj22ZCXgEfBhmm6bRw1s62BZ0MUFb5pMeb/D38D9Mv36MSLkf8AA= AAASUVORK5CYII=3D" width=3D"74" height=3D"38" alt=3D"" style=3D"margin-top:= 14.8pt; margin-left:271.2pt; position:absolute" /></span><span style=3D"hei= ght:0pt; margin-top:-8pt; text-align:left; display:block; position:absolute= ; z-index:25"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAALo= AAAArCAYAAADPNJIXAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAHrxJRE= FUeJztfXt8XFW1/3ftfc6ZzEwyz7yavvKYJu1A08JQQEANqB+VC171SlUeReT+RPEBiIjCBaso4= ANR8XHRe3kpFFr5oVcvKBeu9QkIAzRtJ5lmkk7bNGmaZJJMnjPn7L1+fySpaTtpgv4+gjTff/LJ= OXvttdY+a++91t5r7yEs4ChsbGoyogcPigP5PE0/q7QsviCRcAjQr6ZsC/jrQHMXef2DAfpxY6N= HwB0UpP2k9Xks6EzByGvAJmLBmm0CPc7Ai0VkZxzHGVyfSORfbdkXMD8c94a+ORbzOzbHiMQFYD= 6NCS4BatdajRDJXQTuZKYSEK9igh+AH8wjAP3KMHjrANGeK+Jx+9XWYwHHxnFr6JsBqdac0sjAJ= wE+i4AdxPSMYt0FUK0Q8DKonMBeYuFo8EECxib/6k5iqiQhljHrX2ZNil8Rj4+92jotYHYcl4b+= QGOjV5L5OQG6BMwHhOZvaikWA/gXgKsBKgNgFSBlAFkCMmDepYl/wg7tJ8kUGMv+8dxUKvd3VWQ= B84bxagvw98aDq1cHBcyNAH1IK94iwY9rKW4DsBiAB6CjOz8zAwCICICfAT+IlhPodAid0kpfVe= 73LwSpr2GIV1uAvyd+fuaZJZKsL4NwCYBrQLqNpdhEwAoAXgA0ZdTPA/xlKLEu28te6YwXSWe8a= Gxi2Eca5zLzt8E8BMBPQpwspPHzXTa/YzMukK+qgguYFceN6/JAY6NXauMGIcVHoPnbIPhB9BkA= YLAGKEuaH1fA7ant8Z0bAb0RENE3vMGFoaFJA/b7VZnLZZ+9davzvWi0OCCLLhSCbgaoAsCYhl7= ftu3F/9m4sAT5msNxYei/aWoyegaGz2HgHs3YAcbzQtB1AFwA8gwkNOuPZcayLwWGPYZT5gq5ta= 6SUhcpEp9gQimxbhaMR8dZ7LdgjDjILy3a8dJLuRNOrpGS7iHCqWCM2ZrP3LDjxZZXW+cFHI7jY= qp9RzBYCRbfAxMT4ccEuh6EEgA2wE86bH/okuaXd1yWyYBrly02pb4UAhtZiBIQ9QGcZSYvhMiT= QJ2Avdjvkr93gkGMq9wEYD0hJC0h0Gop6Iz3hwObtvT2Lqyxv4YwVzA6c8TnGc+4QNmZ5fmI/4+= sYy5es9EUkqcQ30PYCAhW8s0griHw3cx0JYiDNKnGk46Bj2yIN3cDAKKxxYL4BoCzBPHeIYOTH4= nHnXtPOqm0SNN5zHStAE+QkH8aUepP4y7XqDePqg/sjG+7N7ruGpfUCqB/UUbRSQB+P5uiS5Ysc= ZeYZjkz08D4eG9PT89YAdlFTU1NmUeIEjky0t3c0zM6R5sVatu/pU0L1TMXj0Lf/SiaWCxmjvX1= leYNw+ux7f7te/cOzpO20DsjEolUAoBlWQcTs2ziFTT0JUuWuItdriuJ6C0gMpl5m9b6Z4LoJBC= 9FQCxlBclk8lhAIhGo5bK59cL4F0gCjDz83Ji4g7tcl0OojNA5GWgBcyjIKpkZh8L8bWRkZEdXV= 1dY9FotJht+yZmXieIMpp5FwOCiJZB6/yEUh/1Oo5HFxV9FUT1YO5WzPeXBAJPjQ4OfoiEWM/MQ= 0z0lDTNe2YquygWKyKbPwdGPwAQoQYgAeAlm+0Pb4g3HwSAnzQ2LnE0f5NZv8xj1ncuTj2Xnfoq= Zsk4Gsig9QT9rwJGj9bO21jIe13Mt7PEGABclnj+wEOx2NVwtBdMlzLwBzriQ62qqVmupbxaACY= DeQCBUElJpb+kpG9XKrUBAJqamowDe/euAtHHAUARCe3zldSXlKSlbX+nZc+e7lgsZo4OD3+ImN= 8JoJSBl5lZgrmMmb9uFBVt43z+EhC9lZkrQLR9qu2LGajTwI1tbW0vr1qx4iYApwFgaN3OQvigd= REBt7a0t+8AgFXLly+Cad4Eonpmvqk1lXp22sgaGhqqSKlrAZwIoi4F3GISLWatNzAQAdEB1vq7= yfb2ZwGo2tpavwv48OjQ0Go2jKxF5LUtK7AyEilzgItN4GwG3g5gMQEdsO1/a9mzp7upqcno2b/= /02A+mYk8YI5POM5XPYZRp4DPE9AGogZt2/sb6+q+3tzefvBImy646tLZ2ZmzvN5/Z2AbmFc4wA= +MoqI/e8fH/5OZv0VEZ5NS92JqrTmRSNijExOPOkR3gNnHUt5e1tmZndD6AWbuATM00ddYytsg5= XWa6OuS+Q6fx/PDSCRSlkgkxmzmrxDg1szFU+W+ooBbGCj3eDxGWWdnVjJ/CUAfiOql1ol4PO4Q= 81YAVWzb142Oj9+fSCQO26UscZwaJqpm4BmGOBsgL8BDzPx9KHnOptVrL/zJ6tiFEuYNJJA0Ve5= b00a++YILpCdHZ5KBrzOrL1WEfC+sb/7zbqEm7mM41xPTNQxRPs3rwni8b3xidIPS2LYlGvXOlG= Nlbe15bBi/Yq0fyml9o7Csmx3gama+SQBLMTlaye59+94EIb7NWn/fIfosS3ktS/kJAmrYNH/RU= FPTEI/HnZGxsZ9oZslAmSb6EhnGzRDiD0LKH2N8/DRzePhhAPcQsFYy381S3jZh2zeDebvhOD4A= cNn2XWDeA+YyaH2ntKzPMNEEC/Hrurq6pQBQUVPTawO3QmuLgE2rli+vPDSILFp00AHuBJDTjvM= tn8+3z11S8qxD9D0QLQLzfYroBQC6rq6u3BLiaS3EkBbis9Ll+jct5acd4MopO/KRZT3CwBYQVS= oh7vaUlvYBwNatW5VndPS7YP4Za71NOM7dhmGUMNFmAXxTWNYdttbXA1g8IWWokE3Ptryom5ubR= 8HcxUS24zijiUQiH+/qGtNC7GGtdwP4p5WRyLVT5bmzs3McQC+IWpPJ5PBWwLEsawxEYwBGiSib= TCaHW1tb+9va2p5nra9n4E0GcHk0GjVSqVQWRHkA+WQyOZxMJofb2tp2gflmt9ud2wo4O9rb90H= rLzDghpTvjUajJgtxmZ3LXZDcs2f3lAyHjaJCyw0AT0jip0C8asqgnjS81oMbdr70MNj5vUG8Fq= ALAbpOG+7fbmo8+Qv3RE4q08ndq6TUP2TwI8OWeOHsrVsdAFifSOTbtm17QQt1CwifeHD1utppf= pcnk8MX74jftT6RGJlh5PUk5X8w85d3dXQ839HRMZRIJEZSqVS2tb09zsDLZWVl3volSypJiDsZ= +HZy9+7mVCp1qM0U8EkAXjKM6xsaGoqndJ0gZscwjGxra2u/tO3NALLaNM8aKylxCMiCSCvDGEs= mk8PpdHow5zjfUqbZDgB5j2eMicZAZLPLNbJz586MrfVtYK4wiE6eMjInlUp1MtHTTKS1af5h5e= LF4el3AHqJqNnDvCcej9vxeNx2MQ+DOa+FGE2lUrmmpiZpEj1BRHtHJyY27dq1qy+RSIwkk8nhV= CrVS0SfMxynPJFI5KUQI2C2Ta1H4n9JreB4V9eYBnqY6IDh8w1bQDkzV7DjZBKJxEh7e/s+0vpW= x3G6X4mhHxtEvyXmKwj41Kra2iubmpoOuUCs9dA8atBjtt1CRP8L4HxnaoQ5kktdXV04p/WOGQp= jXKkUMX8XwAZt2+8D0JfauzcxGyMmaiKmg5rFGgKFwTzCTI/gmSV5AJBaD2imcaX1FZrzFQy6TR= O9rcgj25n414CIG458+CPxuJpZbygSMUmJk8D654KdpscjEdcsIkgS4sNgHhkcHv5ZoQLJVOqa3= t7eUbKstxOzmxxnW4FiWQCPAWgi264uVI8gYgI0MRdcZGhsbPQahmHs2rWroDEAgBDCJCLFWnfN= fE7AkCY6l4gseDw/XL1sWRAAUqmUzcwjWSFmjb8O7Nu3BsAaB/jWVAc9DC1tbb9rTae3zkY/QzY= lmfuz2azSWtsgcpFhvCcSifgAiJb29h0dHR0F7e+v3jAazuW2aOBhSPmJnv37z8ArXMEpLi62mf= kAEVVJ256e5glAuKG29pT6mpqzDKJbDcMonUmXTqcnoNQveXI0u004zkOz8bi3uqmIibyaeD8Ti= 0kZqcdw+Pn12KIAQGmrFERnQDh/vGj79oEPNr/w0xEDZxPr+wGSBJzsGPqhh09cd/oDjY2H3JHK= sjJBgooBsc8W6pF9s+yMRiKREBO9k5knegoHlIdAQnyAiBS53UelEixJpRQxtxKzASGKZ77L5/M= UjUYtW4gTmNnLSiWWpFLTHdOEUifW19auy42MXGIynxOJRMyZ9MwsRT7vbWhoqDKYP8XAL8g0W4= +UQWvdpZS6jJhjeZfr/9TW1vqPpc8MXEtEJJU6MM/yBUFEjKkZu7WjowPAo0z0OQP4xcpI5LQpg= y8YgP/Vht7Z2TmhgDsYSAD46ooVK+otreddn2EYTIACszOlwKQyQEAI8UYS4k0EFGzIceYhrfUT= IDLZMN42Gw9X8bgfjFLScMCIAAAT9o5rOQpMpudqkyIA79fAwDSdx7ZrIei9gLqOHLWemNpY6H+= XMDc+0NhYDgD2yEgRgJNIO90bmptHZ8tglFKaxOwulFlQAOHZXmwFtAY6AUwc9oKo2BTiXDUxcR= ERXcnMP3KEeGor4AAAmA3S+lRB9CZBtIaIjlqAIKIAS3mp0PoBIgrklbp8eqHhSLR1dDylib5Iw= McMIS6ORCLFhcodBiFKp7Mo/kawJtKGYTAAZ8K2P0rMNxJREQEPG8CVJyxZEiwowt/CNJVKdQnm= LzCzkszfVURlEPOrcmRkxGCgnIFOcrun/VlmoL0llboz2d5+mwNc4x8by8yka2pqMiwhVhARs9Y= Pgujz9fX1iwvxIGgLYAtAHFNGRMCAW4zkAOCLAEmIIBH2bWhuHgWAu2Mx0yDzas3YnTXEox/Y+d= I2afFnBdP1AjjLJPM/719zar2pjUXEqFJC7z2WnkqpEQbaicgVmd29mVQeeI4Bl56YOMqVa2pqE= mBeDkCAeeYSmq2ADiFECxznM6O53I9SqVT2L41A42ya97S2t99hE12vHed/U6mUcxhf5gki+rXW= ug1Ep5lKFQzopjE8OvoIMz8ugasN4HQiMo9VHszPExEYKOSiHgUCSDMfaUikldJSqQPT8qfT6Ym= WVOoeLcR7GNhCRFcoyzojFosdJc9fa+jTAmu3379LEd0Aomoiup20LpT1d5QuQojFANYx8JOysr= JsgTI6lUp1dgOoqalZPv2ws7OzUki5XhHdm2e+C8yGcJx7owWyDR2XdohgE5EmwqTbwNAThsGbo= +sq6xtPuZ3BN2pgycNrTq2/OxYzfblcJTPeIpX++HTq7fp4fEisrHkyT877wOg0Wf9CC/E+Aprt= bLbvWIqmUqkRJvoViMIWEC1Upra2dkVdXV0ZKfUEAy4yjBNxxNJvOp02SMooiPrIsv7iPzPnDMN= oaUmlnm1Np9OFfOAZsmRb0+n0qpqaJbGqKs/0cyIa1UK0I5+/BcA4TPM/GhoaSmaQChBZWmsCgK= 6urnEW4gsMtAC4i4FVXseZ3ZYc50dgHiIp348CLm5jRYV3ZV3dGZNFnRwTmSxE9czYLxKJWAycP= dXJVUNt7VVTQbFOJpNdZJp3AOgB0aL+/v6jeBzT0FmIo+ZbPemeHFpiisfjts/ne4aZr8Hkeurh= /h9ADHjcudwh5isXLw4ZwJUEvKiALVPRe0H4PJ5TLSnfAgANDQ0lJtFlRBRPpVJdHR0dnUz0eZL= yjXrFivOPpB0Dhhjo09CnELB76rFXCWEmEs8fHM+5bmGQIzTXs1Z3+W08o6XrDgD7xM7Ijpl1rd= +yRV26bdv+iWzJNULzJ5nocs38wmXp9MSRfI9sMmN8/MesdTsTbZ4O4qZRW1vrt4S4VSmVzxP9j= pn/DODmFStWLJtZzjCMWgLeCuCzLS0tPQAgpvzR/Iwjf3OhsaLCq6W8pd+yjoopkvv2dTPz1QI4= Qyh1Oabqr6qqKgLzchdzYKoo79q1q5+0vpaAEQCnjVvWrJuPren0Xg3cT8yXr1qx4swj39s+38e= hdRgAtBBJBg4CuKg3lTo0A2itK4hoUU7KLgAQQuS1233u9HtmzjPzIBMdDIfD6kgeBQPIWCxm+j= yeJgJuAFBqEGWL/f7dpaWlAYPoRiJ6QzgQGAyGwy2ZTEZ1d3drt8ez1yVlGYSgvkzmv2OxmGmPj= 79RAJcQ0WolRHlpILCuNBx+B1vWdRLYQpb1jWQyOVZbW+svC4cvEcA/g6gsFAoFSsPhteXB4PkQ= 4lNE9GRZKORm5n8jondrpX5bXVvb0t3drf3BYKUgeieA80tDIcNbUtI+NDQ0AgC/7O6231e5eAO= Dc4BoIcI5ANhQ8pFPHuwaumZ1nR4dz78fhKeTYd9HQ6Pj7UKIDwNwi4pM+5WrGtL3p9OHGcTPB9= PqgsrKtUz0NmgcfH9p8Jm5tvt7s9lxXyCwWRKtYCk3hkKhYVdRUWpRaWnUkPJHBAylOjo2DQwM5= MrKy58Cc71g/lQoGMyW+P3tFaWl5wrmbwK4sTWV+g0Ao6GurglCXERE1cScKy0uTvdns9N+tWio= qzuDgY8R0WpoXREOhapLg8E3ssv1MQANqY6OHwRLSt5ORBcRUSUcZ5/ldrfv3rOntSwcFiD6fFk= o1Lc8EGgny1pPwBVaiGVlgUBH38DAQQDoGxjIhIPBnQSs08DmTCYztmr58kVKiH8VRG8kwBUIhV= oymcxgfybzq9JgcAxEt5eGQuESv7+ltLTUUx4K3QKii4VSt/QODo5kMpmxitLSNgAf14bx7tJQK= FIaDr/DEOIqrfXXUh0dLQBQEQqNgWhTyO8f8IdC7ZL5KgBDDvPDO3fuPCq+KDgSVFdXF5mmuUYy= F011F1so1eFYljQcp0YLIYUQyhgaemnm1nQkEvEVES3e0dbWUl1dXeQhatRSugFACKFZqQHKZtO= J3t6RmfxOOOGEENt2VGt9VMcjIDc0NtZcXFy8QmgdAAAB9Ln9/l3xeFw31NScQFIGZ8qZSKcPRf= ebVp98LwsRJeBuAN8BME6sz39/84vPbcEFwlnTcSMBxge3xW/eHI0tUwbdA+Z7IOgLYP2ctvmmq= gr//uk19E1r11aD5R80688Ex4YfSwH41Cs4cFFXV7fUJFoLIou01oq5d2Ri4sWurq6ZJ5RkJBJp= kECEiAzWemw0l/vttFtSXV1d5DaMKAMl022r8/l9rel0eoperKytPQFCFPa1DWNPa2tremVdXQx= ExQAgiCZgmjsTU+v/J9TVRWzm5RbRLgcony7HSg0kd+9unlGbiEQiNZZl7UskEvkTa2oqHClXHn= qp9e5ER8d+AGpK9oBLypNJiABpzRAiP+E4L+zevbtnpoirly0L2pa1jpi9ijln5vPP7uzsPCxeq= 6+uXimlXKUAEPM+JcT21Czf4nWfvbhpzSknMeO/SPNHIXEnQBFm/kFgbOjT70yl8g+tPuWdgnBm= svmFmxpOXHs6iN4yMTzw9UAgUDTB8tMMnAXmrzlwfl/kuEqUwXcDsGzk3zcdwC7gtY/X/cGLUWd= 8jwAGWCIG0HMEKCJ616DbX0MANPEBAEuXNpzpZSF8ivVL3nTafs/LLw/2jg59RSvcDqIrDDY+7h= h8J6CrINXlC0b+j4XXfZruz3t7c9srqxSBzmfGAyCczcyVIKo+z209ZhZ7xknxW4vAv9MSxXmV2= 3Fxb+8wADyRyagPlAb3aVi9JOjLRFwNzZd8sPml5Kut1wJeGV73IzoBmoT6BYM1MSrB+kUiUkR4= u6skdGmuv3+EBB615YRHgANaqUMj9W+amgwlrFMg+A4AzzDTdSwptvE4aLfXG46LDyYjkR6h6Rs= gvIeBHwB8EIBFQtxZ5C+9IM/ObxwhDMUcKgmFHAC4AJDdA8M3QMrvM+MW6TUvMxpqNtu5sZ/WR9= esYmw8Ltru9YLXfTA6jc3RqJU3i94jlV4KiHZIcS8mUwxGNeMbTn7kLrIt2dHe3Le8eq3PXSJvY= iAuB6zH1nc+M+smzAL+MXDcGDoAfCcScQU8gRV5ZXa5DfufBPjbAAUBzjPwZyH0J4QQ6QHAns+F= RN+JRFw1fr88Lx4fP/KQxQJeWziuDH0mNgPSaVz3NgJ/D4TlACSBexn4A2lsUlK9nM+bw6vduv+= UGQlbd8diHl9OhLXkRRI4FYy+1lDxTzceY3d3Aa8+jltDBybTEx5au3aNYHkVQOcBmEoJ5hyD0m= D0CEKzxuRxOTFJEybwWgb8zPgNtHHThTue65mdywJeCziuDR2YNPb71q71u1ieSKArAD4LoKWYb= emVOc/AdtZ8q+MYv7209c/9f1+JF/DX4Lg39GlsBERtY6Pb0O5iMnJuUuaZDPUmBjwgVkw4IBj/= o22kTFE0nChzZRfclX8cLBj6LGCAvnhE+2ycDDgXgs4FLGABr00U9EObmpoMwzDCoVDI25jJ5NN= z3yUoa2trfeFwGJlMRkUiEVcoFAotMU3qGR2d85L8hoaGkkAgEFgcCBSXhMPe8vJy0d/fPyfdtJ= xVfn9JoLzcXVFR4fT29h6Vi3wkYlVVHk95eTAUCnm9Xq/OZrPzckGampoMy7JCU3x0Y0WF1794s= T8YDKpMJjMn3ylQLBYzu7u7j3UR1GGorq4uCgaD4SXBYHF5MFgcrKgQ/f39zlz0sVjM9Hg8pVVe= r6s3m83Pl18kEvEFg0H/0qVL0dPTM68fOYhGo1YwGAz29/dPAKCGhobicDjsq66utru7u+d7F6W= IRqPmfL7hNGKxmOn1esM+n88aHBy0MYuOBQ09n88XuaW8RjA3stv9Qvfw8DGVjUajplBqPTGfWl= 1bu00MD3tBdKNtWYP9AwPHPGoGAOWh0JulUqdqIS43iPxa68h0rvux6PL5fJFHyjuUEEsEcx07z= vh0rvSxUFxZudRgvp6IAqaUa8JlZXv7+/vnXDd3HMdlEl2ulYoEw+EW2+VaI7TeYDjOjr6pHPi5= UFVV5RFKbajwejt6s9l5bURVhMOnCeZzIOW7WIhlxLyi2OfbOTg4eMwOWmqafgjxSZhmbSAUenk= +nTFaW7tMM59lCrE2n8vVVgUCvQcHB+dMYPN6vSUGcHNZMNh54po1/cNDQxcIrc/MO862/v7+eV= 3PV19fH1ZKne7z+brm0m0afpdrmRDiWoMoWL5o0c7ZOknBbeyurq4xSPmCAJ6PH54nXRCJRCKvh= PgdiFaOZDL/vHLv3iwL8aeSYPC5+QhLSiVbdu++D0IYPD7+iLSsJy3LmnP06erqGmMpDUH0tB4f= f5RNc17G1tbW1gGi7MjY2EMAetlxTpsPXWdn5zhL+SspxMWk1GlSyp2SqDUn5bx/7aLENCsYOFk= XFdXPl4aU2p9nflAT9UGp/6ulfLy6unpOQ9i+d++AEOIlJcTTs+Vpz8Ta6uqAFuI2FuKpiiVL7j= Ok7HWk/HDjjNsPZkM6nR4kosdZiKt69u6tkUr9Ls/8X8lkcr5ZnpK0foeh9XvdRBXzpIE3HN4PI= MvMO2e7jg44Rq6L0Hre0wcASCmHiOi/hRBnbY9EzhJEg/Ej7kKZDYmOjr2YSszPu1xOS0tL97GE= ngkCoJnfDY/n047jzDt1log8JW73aQDOIcOYV4cEJg85APiqFOJynctFAeTFMe40KSBujWB+VAM= nVVdXF82HqDWdTvt8vslZtagon0wmu451/HAmFMCmUvMqO6p1iAAzlUoNb9261XGADgKiExMT7v= nQwzDSrPV9SoirIGXYyOcL3SlZENXV1SYz92tgPwtRile2UMJSymPq+P81MUk4zkFofScBXyLme= ffKvxVE9ETecb7mcrkGXwHNhCLaK4VY7DjOK/qxLS3EQRu4RZrmTRqoewWkkkzzLBiGJYDVLpfr= mKft/94wDcPB5GhKAOBiJiZSpmnOy8dmZioBthNRXDO/27GsOWeCaRQJsQyAC0TdmujN0SOu9Js= nCLO447MauhYiyFLOuyNorZdoIaItu3d35pkvZuBdr1hIZpcQYj63CBwCA2CtbQCwbfs8zG8kIJ= 48Jphl4F6XlJ+JRqPz4mvbtgUA7e3tu0mpHxAm74uZD1ZWV5/FSj0yNDKyVTPvh+M0YJ6DTS6XE= 8Qctm37FZ0hIKJiZZrlc5ecnFk182P1tbVXRSIRlwLOJq2/sXPnzszc1AAp9cExpTzSNB8EUbdF= VDo31SSYaIPU+iXD5XpMADUin5/3QElElmYOrIxETl9ZV7e20HUXBRuturq6SDBraD1SEggMzRU= YxGIxU42NeZVSBzNDQ/0DAwNDnuLip4aGhuY6IX8INTU1yy2lXoDWun9oaF4j87Jly4ISaDG0Bg= nhNxwn2Tc0VPDinSN4VUCpdgMwKpcufX4kk2kX4+M8j+DQLPX5AoJZ9A0M9J+4Zk1qMJv9o9/vH= 5lrZSESibiI2UvMYyzlsGTuZq1HfcHg8HwCL7fbXVzEvEdJqTKZzDDm8asaVVVVHjeRVo4zXFFV= lZ3PakZ/JvNsaSAwILQ+3SZ6eld7++65aIBJm7GU6ocQ+Za2tkyJz7djwrYPZLPZOWfLaFlZsTC= MAwQM5ZlzQut2dpyhvqGhOV0ft9tdQlp3SaXyEGLcOz7eFt+1a+FH0xZwfOL/ATqc5/s9I2FpAA= AAAElFTkSuQmCC" width=3D"186" height=3D"43" alt=3D"" style=3D"margin-top:14= .75pt; margin-left:97.8pt; position:absolute" /></span><span style=3D"font-= family:'Times New Roman'"> </span></p><p style=3D"margin-top:8pt; marg= in-bottom:6pt; text-align:justify; line-height:115%; font-size:12pt"><span = style=3D"font-family:'Times New Roman'"> </span></p><p style=3D"margin= -bottom:6pt; text-align:justify; line-height:150%; font-size:12pt"><span st= yle=3D"font-family:'Times New Roman'"> </span></p><p style=3D"margin-t= op:8pt; margin-bottom:6pt; text-align:justify; line-height:115%; font-size:= 12pt"><span style=3D"font-family:'Times New Roman'"> </span></p><p sty= le=3D"margin-top:8pt; margin-bottom:6pt; text-align:justify; line-height:11= 5%; font-size:12pt"><span style=3D"font-family:'Times New Roman'"> </s= pan></p><p style=3D"margin-top:8pt; margin-bottom:6pt; text-align:justify; = line-height:115%; font-size:12pt"><span style=3D"font-family:'Times New Rom= an'"> </span></p><div style=3D"clear:both"><p style=3D"margin-bottom:0= pt; line-height:normal; widows:0; orphans:0"><span style=3D"height:0pt; dis= play:block; position:absolute; z-index:-65533"><img src=3D"data:image/png;b= ase64,iVBORw0KGgoAAAANSUhEUgAAAuYAAAACCAYAAAAU0xnuAAAABHNCSVQICAgIfAhkiAAAA= AlwSFlzAAAOxAAADsQBlSsOGwAAACRJREFUWIXtzjEBAAAIA6Ctf2h9beADCWiSCQAA8KHfAQAA= 4FhSMQECHc0ENAAAAABJRU5ErkJggg=3D=3D" width=3D"742" height=3D"2" alt=3D"" s= tyle=3D"margin-top:-40.38pt; margin-left:-65.3pt; position:absolute" /></sp= an><span style=3D"height:0pt; display:block; position:absolute; z-index:-65= 532"><img src=3D"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAE0AAAAcCAYA= AAAk2zLiAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAAE1VJREFUaIHtmVl= 4VFW2x3/7nFNThspMCIEQQgIIBBRkaIYWkEFQQbG9Aa+EQRlUtBlaBZtPbMBuVGznDuA1eMMgiH= yIAsokqJhIEpFJgiaoCVAhQAKVpFJVp6rOvg+VFAkCfr7f9XJS+5y19lr/vaa9InRdl2fPnSVgG= AgBCBAIgiQbH42/hQDZuEbz7wAhkciggGYkpQzKRSDl1feimTwZZG8Simwp4dptAVAQIVktXrXY= /homrm4i5NUPZUszmtlD0CYpMQIGHVLTUFQFUVl5Vs54bBaj77kbiXH9PRotESL4bDJdIhv/aHy= 2xOu3JJsZKiUGEmkYgEBTlOsbLq41vEkvgTQkhiExBCiKQAjRUg3RwoiW/FIBKQlII2iPAEUoIV= 4hQAqJlBJFKOzdtZd/Lv0X6ekd0epdDbRvn0pCQsJvQWsyLiDRdR8ejwevruP3+1EUBU1TCQ8Lw= 2Q2Y9JUhPI7qEmQUqDrOpcvX+ZKrZP6ujqEULDb7URHR2G3R2Exm2h0ebhGJ8Mw8Pv9XL7sxFlb= S63TiTQk9ig7UfYo7NFRWK3WRl3kb0ATQhAIGNTUXKHW6aS2rg5d1wmz2bBHRRETE43NZkPTtND= eAkFax478/PMvQdCQEiHUkMDmYEkJXreO48w5Thw/TllZGZcuVuNqcGExW7BH2WnXLpnumZl0SO= 9AdEw0iqqFTqr5wSJBGgaXLl6ioKCAY98fxe/3Y7XaMAwDt7uBSHsE/fr/iR639iAqOhpFDXqPb= IxNw5A4rzg5duQYBQcLqK+vJ8wWhqIqeL1eFEWh5209GTBoEHHxsaA0BkAoQiQet4cffzjFvr1f= cOnSJWw2GyaTCY/bQ0AGyEjvyB1D7qBtSjuESQt6umwC30AIgQZNYSFC+afxNc4rTvbt3sPX+7/= C4/EQGxtL69atiYiIQNd1ampqKCr8jvxvCkhNS+X+v4ynU5fOKKoIRmzQxxEyKPtSVTW5772H1+= Nl3LhxDB8+HLPZjKqqOJ1OtmzZwhd79lFaVsp94+8jJj4WTVwN25qaGj7Zuo1fT5czcMAAsrKyi= IuLw2QycfHiRQ4cOMC2bds4efwkUx6ZQuvk1qFYNQBXvZuv93/Jns9307dvX555+hnatm1LWFgY= NTU1HD9+nLVr17LynVU8PHkSnbp2QTGrhHJSE1KlpaXyzXfe5s9D/9wYnsE4djrreG/V//DD8RO= ktk9l4sSJjBs3jpiYGCwWC4Zh0NDQwKlTp8j5z384ePAgiqYw5dFp9O7TO5hjaAIM6l31vPbKv5= GG5P333ycjI4P6+noWL15Mp06dmDNnDnV1dRz8+iB/X/R3OqSnMv7B8YSFhwPgdrvZ+tFWyk6Vs= WTJEoYOHUpERATV1dXk5+dzzz334PF4KC0tZcb0GXh0L/MXzCM8IhwhBD6fj2++/IatH21l/vy/= kZ09ifDwcOrq6vD7/URERGAymbhw4QILFy7km/xvmP3UbDqkp4GAwoJDDPvzMEaNGsXVY5QilAK= 8bg/vv7uGI4eP0L9vPz7avJk5c+bQpUsXkpKSiIuLIyEhgZSUFIYOHcp7ubm88MI/EIZg1TsrKT= lxEimbPDZYVQ8cOEB5eTm5ublkZmYSFhaGy+Xi4MGDfPHFF0gpiYqKYsTIEcyfN48jh4/gqDgXS= hOOsw6++uIrxowZw6BBg4iMjOTixYts2LCBV155hcLCQqSUdO/endw1uVyoqmLXZ7tCKafKUcWn= H3/K1KmPMGvWLGw2G+vXr2f8+PGMGjWKRx55hIMHD9KmTRtWrFhB+5T27Ph0B676ekLGNLpbi5I= lEcgA7PlsD8WFRfTs0YN169eTnpGBzWZDUZRQjmnKMyaTiZiYGGbOmsmKf7+K1+Nldc5qrtQ4g+= egQIO7ge0ff8rMGTPp2bMnqqricrm4ePEi06dPJysri+LiYgDMZjNjx42jR2YPPt32KboeIBCQf= PLxJ9TX17Nq1SomTZrE3r17GTFiBEuWLMHhcDBr1ixOnTqFpmnccsstPProo+z+bDcetxfDkBQV= FRNlt/P4YzOxWMxs376dOXPmcP78edq0acOhQ4eYMGEChw8fJjExkeeff56ff/4ZxzlHs8i8FrT= GYlV1vort23dgt9vZvHkz8fHxSCnx+/34/X4Mw2hWKCSBQADDMFAUhQkTJvDEE09QU13D3l27wB= /ACARwOBzofp2p06aiqsGic+bMGbKzs5k/fz5Tp05l/PjxjTlVYLfbGTJkKJWVVcF9AwEqfiln4= cKFLFu2jIqKCrKysigtLWXatGns2bOHrVu30rNnz6BRisLEiRPxeLw4Kh24GlycPv0zw4ePIMoe= hdfrJScnh9jYWDZs2MDOnTvZuHEjAAsWLACgY8eOxMXFcfbcWQSisQflWk+TSAH5Bfk0uN089de= /0rZtWwKBABcuXKC4uJjCwkLOnDlDIBDA6/VSVlZGfn4+x48fx+l0IoTg6aefJioqikMFh6i94k= QIcDe40RSN1PapwV6q0VsNwwiB33QYTUanp6ej6zqGESAQ8KP7fPTt25eZM2eyf/9+Xn31VQYNG= sQHH3xAVlYWu3fvpqysjLq6OqSUdO7cGSkldbV1eHWdWqeTrt26opk0fD4fFouFzMxMkpOTAejU= qRNWq5WjR4+i6zoWixnNpOF2e5BG86Zdol3FTOLTdX48WYKmKGRPmoRhGDgcDubOnUtJSQkmk4n= ExERWr15NcXExS5cuDXnH6NGjWbRoEfHx8QwcOJADX+6n8kIV9viYxv4s6JUQrKpmsxm73Y6qqk= gpadOmTTNVgiAKRaAIJdh0ChHqDxMSEpgyZQqjR4+mqKiIvLw8Fi1aRKtWrRg7diwPPvgg7dq1I= 3ibUEIHFQgEEEIQHh7OsmXL8Pv9xMXFoSgKgUAglHIg2N40XUNa3nNky/B01dfjdDppm9yW+Ph4= fD4fb7/9Nvn5+Tz22GO88cYbJCUl0dDQwMKFC/F4PLzxxhvMnj2buLi4kKjBgwej6zoXL14ECVH= RURiGwQ8//BDyrNatWzN79mzCw8NRVZV33303lLQNw6CkpASr1YqiKKiaSkREOCdOnGiKCWpra1= m/fj3R0dFkZ2djsVgwmUzs2rWLyZMnM2vWLBRFCVX7mNhYioqK8Hp1hBCsXLmSxYsXU1JSQk1ND= cXFxbjdbgYMGIDZbMbj8eDxeIiMjEQRollwimaehsTtbsDt9tAmLRlFUfD7/RQXF2O32xk2bBhd= unShV69e6LpORUUFY8aMYfDgwfTv3z/kPYqi0K1bNwIBg7raOpCSVq1aEREZwepVq8nMzMRisRA= REUFycjImkwm3202PHj1CYXuh6gL79++nXbt2mE0mpIDUDml8/vnnZGdn07p1a2pqatixYwd5eX= l4vV7S09NZtmwZ8fHxbN68mddff51IeyQJreIxmU107tyJgwe+5sKFKlI7pNKvXz+2b9/OlClTy= MjIoKioiLi4OJ577jl8Ph9HjhzB5WogJaV9s6ZfAUSTpwVxVFUFVVHweDyhMLJYLOi6jtfrJRAI= cPr0aXw+H6qqUl9fj8/no7a2lsrKSnRdR0qJy+VCCIHJpKEgsNos/OW/HuDDjz7ks88+a1FMmvZ= p+u1yudi48QNKy0q5Z9xYVE1FUQT3jr2HijMVrM3Lw+Vykdy2LWvXruWFF14gLS2NdevW0a9fP9= LT0+nVuzd+I8C9943FYjGjKoLb+/YmgGTJkqW43W6ysrJYsmQJcXFxlJWVMXToUHJzc+nduzdnz= 57lH0v+QcdOHUlsnRi6mzaRFopNICwsnPCIcBwOB36/H5PJRHZ2Nk888QRz584lPT2dffv28eab= bzJkyBAKCwuZMWMGVVVVNDQ08PHHH2M2mzl06BCaphEdFR2aEvTt15cTR08wZ84chBCMGjWK5OR= kHnroIbxeLwB1dXWsW7eO1994nTvuHEpim0QQEkVAq6RERtw1kpyVOVhtVqZNe4SkpCSGDRtGam= oqbdq0wev1snvvHubNncutvXoxZOiQoD8ogpj4WCb890RWvZPDU0/9leXLl5Odnc2ECRMIBAKoq= orVauXHH39k+vTp6F6d+8ePx2y1tJiCAKhPPjX7hcKiQlI7pKJpKke++56ff/mFMWPGkJKSQlpa= GsnJyRQUFIT6oaysLEaPHk1paSnHjh0jMjKS1157jZSUFACWLl3K5SuXGX33aKKjo4Nep6jcdls= vTpedJicnh6LiIrp3z2T48OH06dOH4uJipj/6KB9u+ZAhw4dw1913YbaaG71QoKoKySltkTLAqp= Wr2bFjB4mJrbFYrZhMZo4dO86zCxbw1ltv0alzJ2bNmolm1lBU0TTCID4hgXZt2/H+mvfZsGEDY= RHhREZGovt8nHM4ePnll5g3bz6BQIAFC54hPiEWoQQnJ+fOnqND+/akp2cgSkt/lG++8zaDhw1B= SoPi/EOsfHslQ+8cxsaNGzGbzQD4fL7GkDM1qzBGKFQ1TcMwDAoLCxl25zDS0juy4O8LsIVZr6Z= QqeDz6hQVFbF71x4c5xyoioJEYhgB0jMyuPveu0nvnIFmNjWb7V1Nw37dR+mPP7Hzk52UlpaimT= SQAsMwSEpK4s6Rw+nTpy8WixlDbWpjBFIYSAmqVDh/ppKtWz/m5A8n8fl9KELB5/MRlxBH//79G= DliJBH2CALCQApQpeBQ/iGG3TGEUaNGB8NTSok0JBJBl65dSUpOYteuXXz00Uc88MADWCwWzGZz= s4TY6KaqGmpWDcPg/PnzzJ8/H03TuPveuzFbbc2GkMEsYLKY+dPAAfS87VauOJ24PR6EENhsVqJ= jYjGbtcZ7K82mg1eBM5lMdOvendQOHalz1eNucGMYBrYwG/aISGw2K6oSvGQr8mrVE6HppqR12y= SmPzaD2ro66uvq8fl9aKpKTEwM0VH2IB5IBKA0zWGbtSOalJJ6Vz0Xqqowm0zYbGFMmpLNv1e8x= tPPPE1iYiL9+/cnIiIiOJBTlFBv1iTI7/fz66+/MnfuXL777jsGDh5It27dqL1yhYDfj9I0Gmu8= qjV1PlaTBavJEsLFXVePR8rrDx6vIYmCWWiYwiIbv5d43W68bncI5OaNQospb7NhaERYGE1TDL+= uc+nipav8zfo0V50r5DSipKREDhw0kMjISFRVZex94+jVpw/FRUWsz8vDZg3jiccf54EHHiA5OR= mLxdKin3I6nRw6dIjly//F90e+55auXZn6yDQCRoB3V79L7WXnzSy/Pv3uBPgm736P94/u2/htf= X09eXl5jBo1KuhpNdU11FTXAPDhps0kp6TQ9099sdmsrFvzv7z88sts2bKFQYMGkZmZSUJCAi6X= i4qKCvLz8zl8+DDOOieDh/yZcfffj81q4/01ayg58QM+3d9CB5PJFGqEGxoaQusul4uwsDAMw8D= lct3QXovFgtVqxeVyYbPZCAQC6LpObGwsQghqamrw+Xw35A+mAhuJiYk4nU6uXLmCqqpERkZSW1= uL3++/IW8TadcuVJ2vJOed/zB3/lx69uxB4tN/Y9+efRQUFFByqgSTZkLTNKSU+Hw+JMEr0EOTH= 6ZTl05YLVY2rF3Pt998+xvAAKKjo9m0aRPnzp3D5/ORl5fHpEmTePLJJ8nJyWHx4sWcPn36hgp3= 7NiRF198kXnz5nHnnXdy6dIlLBYLDz/8MIFAgNzcXHbu3HlT41esWIHf7yc2NpZFixZht9t56aW= XeOqppygrK2uRv64leT3QAv4A5b/8wovLlvL444+TkZHBxOyHGDN2DOccDsrLy6msrETTNDp37k= JKSgrxcXFYrWF4vR7ezVlN/jf56I2917WkaRpms5ktW7Ywfvx4ysvLsVgs5ObmcvbsWc6cOXNDh= QFsNhtpaWksW7aMU6dOoSgK9913HwsWLKChoYHExESU5v+kuQ4NGjSIDRs2sH37djweD5MmTeL4= 8eNMmDCBF1988aagieuBFgTOz/lz5/nnsn8xYtRIRt41gvhWccQlJtDjtlsbiwBIaWAYwQRc9O2= 3bNq4icrKyptu2gRceHg4drsdTdNYsmQJhYWFdOnSJXSpv6HSQvDTTz+hqioDBgxg27ZtREZGUl= 1djdvtDo2ybkSKovDkk08ycOBAnnvuOdasWUNmZibl5eWMGTOG5cuXt5i4XFf/665KQEo8DQ3s2= PYJB7/8ioyMDDqmdyQxMZGIyAh8uk519WXOnDnDqZISKs850HX9ppsBodlcq1atQgBVVFRQXV3N= +fPnfxc0v9+Py+XirbfeYtOmTbhcLrZv387zzz+PEIJvv/2WI0eO3DCvqarKs88+y65duygtLaV= z587U1NRw9OhRMjIyuP322ykoKLipDuLkyZOya9euv2usEAJFVdBUDZPJhGEY6Lr+m5HK71F4eD= j9+/dHURQcDgenT5/G7/czePBgvvzyy9895bi4OGJjYzl79iyZmZk4HA5cLhc9evRASsmJEye4f= PnyDXVSFIX27dtzyy23UF1dzZUrV/D5fJSXl5Oeno7X6+XXX3+9Lu/OnTsZOXIkory8XE6ePPmm= ija/UF9v/Xrvbiarqc/7I7zXNtbN6Y/Ia95fNpfbXMaN+FesWBGaDv8//UH6Pw/h65aldWKXAAA= AAElFTkSuQmCC" width=3D"77" height=3D"28" alt=3D"" style=3D"margin-top:-31.= 25pt; margin-left:365.7pt; position:absolute" /></span><span style=3D"heigh= t:0pt; display:block; position:absolute; z-index:-65534"><img src=3D"data:i= mage/png;base64,iVBORw0KGgoAAAANSUhEUgAAAVcAAAA1CAYAAAD1eqj9AAAABHNCSVQICAg= IfAhkiAAAAAlwSFlzAAAOxAAADsQBlSsOGwAADtNJREFUeJztnXvwVVUVxz+H90NAoeQhwS+Vl4= GpSPJQRE1FEQLF8JHDKJbNiCZaTaWoZeno+AhNUJMmtXyWQj5HKEMxTFGRITKtER1FEPH9QidXf= 6x9uJtz9z73XH7397u/YH1mmHt/55y99tprr7P32fve+wUMwzAMwzAMwzAMwzAMwzAMwzAMwzAM= wzAMwzCMZmY/QDL/7qirR/XjWOCb9XYihweBmwtcdyGwEejYpN40jm+jufbFejvi0RaYBtwNPAG= MA/app0MeLdm3WrE1OZEApwODAucOQWN1JdC60d5tJecAY1FHuwDj6+UI0AqYU6e6j0JjUG9iMR= gKzChQfgAwv4r6rqb5290VHSiaur+L2m8HXAdcBPQF2gNTgKnN7EeIpvatpZDmRFFaA0cAf0Xj6= zMAfUjcGTgNGFED/7aK89EOGw10z7muD3Bcs3jUPPU3R3tqWccUYM8C1x1HsUG4nowBZtbbCY/T= gEvZcpJpCwxvhM1a9X1T+NYSqSYn2gFnAl8DfhY4f7GzB/ANdBBudjoD69HH8Xsy5y4A3gNuARq= AF9x1o4C5wF3Ab9GB2We8KzcCXaKOAHoClzkbM9BZfCmaMJ2AS4CRwFrg0Ar1D0aXDjEfsnU1pj= 2HuTJT0ZnwFmBCoH0NwK+A1ejyhkwdYyI+nQA8SmlL5rpMDHoC1wJ3AuehN1Ve23F+fBeN7xxKs= 3q23FB0+yB9Agq1IaUncIW7BvRmn+TKjwBmAdd411fycaaLg9/WPq6O59EbIq03G7fxkXqz5bP5= FPOpvWtzP8opkssh2wMp9f00z49Q3sfaWck3KO+ziS42I11cZqCD8CPoU2+l8yGbaRxCMffvqSz= ZNsVspMx0fkF+/nREl/qD0K28IzN2OgHLgDbu77PQlXmzcwB6g7dy731mozdzyo/RBt2CBmgwcF= XE7n3onkd7dAC/AB1g0n3N9s7Ozu76A93rTZT2XEL1NwAdcnwI1dXY9ixGB5LOwG3oTey3r4f7e= zjQDb15Onh1DIn4NAS4FU3CCeiA5cegC/BHdF98V/RGzGs77vxqdOBMy/fIKTcPjWleG3Btv8Gd= 64wmd4Im8Thn41rPh0oxvdXZSdvaDZ3c9wd6Ad8i3pehekPl/Vjm+bQbujcXo1Iux2yn+er7Ecr= 7vJzN8y3WZ/OBo5292cBkdGLu48rlnY/ZjPV19p5KCbUpZiMlzYlK+TMNvV9AB+8+mfNDgZ+79w= mwKHDNVpHde6jEGOA54HPgscy5eehTHej+xu7ogHA78BTwJeDxgM2+6Iy9AtiEPpKfCEwH3kE/m= NmEBro32onPoIHtBGzIqX8NOgPGfAjV1Zj29HV1/gmNUTtX1m/fBOB64Gl3zafueFrHVyI+rQXe= B1YCxwA3ZmIwFfg18Hd0O2BZhbaDJtbvgFXAR8AHrs5QufbooP1yThtSEjS33nW2ngT6u7//gd6= Uf3PXVvKxG/q0g9fWieiTylJgnWtDrC9D9YbK+7HM80nQ7bDQhx5Fcjlk289X349Q3uflbJ5voT= 7r7HxegvbtJ8BC59daF6+887E8iPW1f0/5hNoUswGlnPgwEk+fXugEIMAP0M+MfHYAXnTvh6Er8= 7UBH6ummsF1J3RGfgF9hO6HLicT4HjgY3SW6eOcfBSdTdagN/GxwLMBu8PQp4iN7u9+wI+A76Ez= Ubr8WIduYm9CB5khaKe3zak/3WuK+RCra2vbsxeafN3RWfo6d63fvp7Odg90/+cGtOPTOhoiPn2= MDqwjgFPQhPBjsA868I1Fk35lhbYD7As84HyZhW4n/DdSbgjwZ+drrA0pw9DJtyf6YcFzlPp5A7= pfv9xdW8nHoegNs7/X1n7utTP6pN6ReF+G6g2V92OZ59Ma9Gn/LPSe2AHdy9uXYrkcsu3nq+8Hl= Od9rJ2VfAv12T7oxLIROAj4PfBldKukbYHzebmcjXn2nvIJtSmWL1DKiV6RePrMQceowcDZlA+u= b6KDcnfgh+gWR00oOrgOBN4Cvo7OTp+hN/JnaJCvB15HG/s2ujzZBLyEzlbpTNolYHs4upROeRD= dfP4DGqh/uuPvAm+gsydoQD4Cdsypvys688V8CNXVrhHt2Q9djt+LzuaLAu1biM6g96BLuPSrbG= kdSyPt74smwDxnYw8vBp3RJ9br0afPTeiAkdd2gL+gH1DeBfwLuN8dD5Xb29WR14aUdDugNdoHO= 7g4pPaHUcq9Sj72B15Bn+bStj4AnItOXq+gN20sb0L1hsr7sczz6XP06zz90Bv+LnTZvpxiuRyy= 7eer7weU532snZV8C/XZKHTC7I4+Ma5F7/VPXbwrnY/lQTbm7Sm/p3xCbYrlC5RyYl0kniH2RFd= QKcegDyr/Rgffh4EF5G/5GHWiFboP1BTsgiZfR3SP6XB0CdUcnEVp37RDhWsNwzBqyq7ociz9pL= /WdEI/2V6BLh/PJz5D15pL0CegPZqpPsMwDMMwDMMwDMMwDMMwDMMwjEYxmtJPL6fV2ZdaUVRdp= 15KQ0XVrapRCWqJKlOGsd0zCxWHqPbXXbWmVgpJRdR1aqE0tLX+FlW3qkYlyL+2pShNGcZ2z7Xo= 9y5jNKV6VFPYLqKuU0+loaLqVtWoBLU0lSnD2O7pTOmJJ6Ra08CWalQhpRtfNejMgI2UospBDRR= X5Qmp5/jqOiHylIZCdYeUscZQTHEpJaRulR4PqSFBcZUg/1pfCSqkMhWqs6jKFBn7MZ92An6KYW= znHEDpiSemWpOq+8TUe3zVoGqVkrLKQQMprsoTs5mq68SIKQ3lKUOFlLGKKC5BWN0K8tWQ/HZUo= zKF82tXwipRRdWKYipTqf2+BXwyjG2KavdNR6M3FoRVa3x1n5DSTVY1qBqlpJBy0EiKq/KEbPrq= OjFiSkMxRaCQMtZ7FFNcgrC6FZF4plSjEuRfm8ZxNOUqUbE6i6pM4dnft4JPhrHNUc3g2h1Vxln= t/g6p1vjqPnlKNxtzbEBx5aDeFFflCdn01XVirCGsNDQ8UndIGWswxRSXIKxuRSSeKdWoBPnXpn= FsoFwlKlZnUZUpPPtF1NEMY5ui6OA6Ah0QD0eX5hBWrfHVfWJKN75qUDVKSSHloMUUU+VpFbHpq= +ukKjlZYkpD10bqDiljFVVcgrC6FeSrIVWjEuRfm/q1hHKVqFidRVWm8Oz/J+LTruiHhYZhGLk0= pTKWYRjGdklTK2MZhmEYhmEYhmEYhmEYhmEYhmEY+chCkBtqbPNIkKT02pTIFSDZn4EaWyDXgQi= I+7ltS4iZHAmyCuSi+vqRh5+/krg4Br47LWNBloFcDtI5XN7YVqjmRwSnhA/LmPD7QiSQiPdaY3= x/knMg2VT7OrYp7kV/AOFoETFLgKPq7EMl/Pw9GP2xSQbpgX4XeCL6XWb/J8JNlP9GPWmkbKB8A= Zhc/r5Q2X7Ay6XXWlOtP9s7TdUPjaEl+pTF91F6oz8rXh+4cBTwMCRvoj/OOLm8vLEtsRWDq5wA= 8ijISFSx6fu61PHfy/Mgl4JcCPIMyCFuuTTfW2YORb8X6l6lFchMd/08XTbJQyA3gcwB+Q5Ia5C= z3TWz9W8AGQCyGGS1HoeMP7PccneJex0PshvIWpBDw3aD/iTu2CqQ20EGufrvBLkZZDLIcrf8O9= lre6XzAbtyn27DyIkgT+pTuPQEuQfkHJCMDGHQRjZ+HUEuA1nj4iAgwzL9kdpLY9YhEotQzAI+Q= 7nfwbKhtvk+tQX5hbN7sCsrIONA+oFsApmUiUnMn0B7yvI863MoxzwfJQFGQRL7f+/7snnQTT4A= dtT+yMbd2A6RHi7Z+rqEnu2OzfXOp+8bQH4D0s0l5go2D4Sb7U3MvB7mEr4DyMUgw53NhS4JcQP= R0SCdQH4JMipjs5u7YZIt/QGQu5ztyyntj+0Stxv05xDX7vbooLzY1dUF5F7X7qEgd7j3e4FcVe= B8yG4PkAUg/XVQkAtAjgAZH+mfmA0/fn1AbgTZEWQGyPRAfyygtOeaxiwWi2zMAj5Dud/BsoG2b= fapAR0ku7j4Ldd8kvkgvdHBPrB1EPUn0J6yspFY+zm2hY8Hg7jtALmasj1XOQ3EUzKTtc7vieV1= GNsC1T65boDkVXQZ06HCtesgeReSlcCrqDqSQ/qqjfQVUPnAJyD5BJKfQPK0O74ekvS36ruhcnw= fomIiA529BOQgVHd07wrtekjLSXvgjRy7IX/2AJ7VfchkESri0tXZeBuSNa6tH7r3r1HSLc07H7= LbRf1LXvauewo4Hv3AZFCmXTEbXvyStcBjwAJKe39k+iFEKBaRvijzmYDfobKZa8p8Wg/J+5CsQ= vULOgLzgZOAA7VdciqlJ/I8fwLtKSub9SeQY1v4eCrwlpbnDOB1EP+/0XkNlZ5EB2heQvdmbUtg= G2Vr91zdh1AIurzJvgcY4J6QBgEf6Y2xma+iAiPpK6hq0jR9OonyCnozdYIkgeQmd3wqKmt3KfA= IKhCS9SdlCapF2hqSz3Lshvx5ETjOPRH1d9e8l+NvUUJ23y+/LHkTkumoCMq51duQbkBXSMZBMh= mS590Jvx9CrKE8FrG+CFDmd6Bs2TW+T58DvUB2QLcx3nFL62XosrqPm8hvdPYSSF6orj3ZsmX+h= HLM8zE5oVSea4DekGzw6nwcmOAG3CNQnd9KcTe2D2SBm9VPB9no3k9G97XOA2njvW8AmQtyN7qV= kM78bs813Rvz98ikrS7bZCXI9eg+2v0gS0HcNxWkDci56J7u7SAD3PGxrtx0dNk/KeNPun/ovko= m09i8VI7ZDfrTGuQsdJvjdpDdXfnbnP1ZIIvc+zPR/V7xXmPnp5fbDcb7DHftMyAT3eTl/n+qkG= 9l8esC8gSlJ7Tb3LG0P073jnsxC8YiFLOQz1NAhmT8DpXNXpPdPz0J3U+eC9LHOz4BZGgVOTsl3= J6ysll/Qjk2qbwcsHlbwO8fQLcjVoBciW4JRMobRhRpALm43l4YWWRvdO+xDTrJTWHLpev/GdIG= xP4vMKNFUsUXl8W+h2cYNSWxHw4YhmEYhmEYhmEYhmEYhmEYhmEYhmEYhmEYhmEYhmEYhtGs/A+= q+6ZCopTiLAAAAABJRU5ErkJggg=3D=3D" width=3D"343" height=3D"53" alt=3D"" use= map=3D"#awmap1" style=3D"margin-top:-41pt; margin-left:86.7pt; border-style= :none; position:absolute" /><map name=3D"awmap1"><area shape=3D"rect" href= =3D"http://creativecommons.org/licenses/by-nc-sa/4.0/" alt=3D"" coords=3D"1= 0,34,224,47" /></map></span><span style=3D"letter-spacing:3pt; color:#fffff= f">            =      </span><span style=3D"letter-spacing:3pt; color:#f= fffff">Inteligencia Artificial & Medicina</span><span style=3D"letter-s= pacing:3pt; color:#ffffff">  </span><span style=3D"letter-spacing:3pt;= color:#ffffff">P=C3=A1gina</span><span style=3D"color:#ffffff"> 1 | 62</sp= an></p><p style=3D"margin-bottom:0pt; line-height:normal"><span> </spa= n></p></div></div></body></html>